Heart rate and blood pressure variability : association with white matter lesions and cognitive function following stroke by McLaren, Andrew
Heart rate and blood pressure variability: association 
with white matter lesions and cognitive function 
following stroke 
MD Thesis 
Dr Andrew McLaren 
Submission date: 31 December 2004 
Supervisor: Professor Rose Anne Kenny 
Co-supervisor: Professor Clive Ballard 
NEWCA'13TLE UNIVERSITY LIBRARY 
205 36535 2 
---------------------------- 
Contents 
Contents 7 
Declaration 
Acknowledgments 
.......................................................................................................................... i Glossary 
.......................................................................................................................................... 7 
ABSTRACT ................................................................................................................................. II 
1.1 BACKGROUND 
...................................................................................................................... 11 1.2 METHOD 
.............................................................................................................................. 11 1.3 RESULTS 
.............................................................................................................................. 11 1.4 CONCLUSION 
........................................................................................................................ 12 
2 EPIDEMIOLOGY AND PATHOLOGY OF VASCULAR DEMENTIA ............................. 13 
2.1 CLASSIFICATION 
.................................................................................................................. 
13 
2.2 EPIDEMIOLOGY 
.................................................................................................................... 
16 
2.3 PATHOLOGY 
......................................................................................................................... 
20 
2.4 RISK FACTORS ...................................................................................................................... 
26 
2.5 WHITE MATTER LESIONS AND NEUROIMAGING ..................................................................... 
31 
2.6 NEUROCARDIOVASCULAR INSTABILITY ............................................................................... 
33 
2.7 AimS AND OBJECTIVES ......................................................................................................... 
38 
3 THE ASSESSMENT OF CARDIOVASCULAR AUTONOMIC FUNCTION AND BLOOD 
PRESSURE VARIABILITY ............................................................................................................... 
39 
3.1 CARDIOVASCULAR AUTONOMIC REFLEX TESTING ................................................................ 
41 
3.2 HEART RATE VARIABILITY ................................................................................................... 
91 
3.3 AMBULATORY BLOOD PRESSURE VARIABILITY .................................................................. 
107 
4 METHODOLOGY ................................................................................................................... 
130 
4.1 CASE SELECTION ................................................................................................................ 
130 
4.2 CLINICAL RESEARCH TESTS ................................................................................................ 
138 
4.3 MAGNETIC RESONANCE IMAGING ....................................................................................... 
153 
4.4 NEUROPSYCHOMETRIC INVESTIGATIONS ............................................................................ 
157 
5 CHARACTERISTICS OF THE COHORT ........................................................................... 
167 
6 CARDIOVASCULAR AUTONOMIC REFLEX TESTS ..................................................... 178 
6.1 INTRODUCTION ................................................................................................................... 
178 
6.2 METHOD 
............................................................................................................................ 
178 
6.3 RESULTS 
............................................................................................................................ 
179 
6.4 DISCUSSION ....................................................................................................................... 
181 
6.5 CONCLUSIONS .................................................................................................................... 
184 
7A COMPARISON OF CARDIOVASCULAR AUTONOMIC FUNCTION BETWEEN 
STROKE PATIENTS AND CONTROL CASES ............................................................................ 
185 
7.1 INTRODUCTION ................................................................................................................... 
185 
7.2 METHOD ............................................................................................................................ 
186 
7.3 RESULTS ............................................................................................................................ 
187 
7.4 DISCUSSION ....................................................................................................................... 
194 
7.5 CONCLUSIONS .................................................................................................................... 
200 
7.6 APPENDIX .......................................................................................................................... 
201 
8 THE ASSOCIATION BETWEEN AUTONOMIC FUNCTION AND WHITE MATTER 
LESIONS ............................................................................................................................................. 
203 
8.5 CONCLUSION ...................................................................................................................... 
214 
8.1 INTRODUCTION ................................................................................................................... 
203 
8.2 METHOD ............................................................................................................................ 
203 
8.3 RESULTS ............................................................................................................................ 
206 
8.4 DISCUSSION ....................................................................................................................... 
210 
1) 
9 BLOOD PRESSURE VARIABILITY AND WHITE MATTER LESION VOLUME ....... 215 
9.1 INTRODUCTION 
................................................................................................................... 
215 
9.2 METHODS 
........................................................................................................................... 
216 
9.3 RESULTS 
............................................................................................................................ 
217 
9.4 DISCUSSION 
....................................................................................................................... 
. "13 
9.5 CONCLUSION 
...................................................................................................................... 
226 
10 CORR-ELATION OF WHITE MATTER LESION VOLUME AND PULMONARY 
FUNCTION ......................................................................................................................................... 227 
10.1 INTRODUCTION 
................................................................................................................... 
227 
10.2 METHOD 
............................................................................................................................ 
227 
10.3 RESULTS 
............................................................................................................................ 
229 
10.4 DISCUSSION 
....................................................................................................................... 
231 
10.5 CONCLUSIONS 
.................................................................................................................... 
236 
11 CORRELATION OF AUTONOMIC FUNCTION AND AMBULATORY BLOOD 
PRESSURE WITH BASELINE NEUROPSYCHOLOGICAL, FUNCTION ............................... 237 
11.1 INTRODUCTION ................................................................................................................... 237 11.2 METHOD 
............................................................................................................................ 
237 
11.3 RESULTS 
............................................................................................................................ 
237 
11.4 DISCUSSION 
....................................................................................................................... 
241 
11.5 CONCLUSIONS 
.................................................................................................................... 
243 
12 CORRELATION BETWEEN CARDIOVASCULAR FUNCTION AND WHITE MATTER 
DISEASE PROGRESSION ON SERIAL MR IMAGING ............................................................. 
244 
12.1 INTRODUCTION 
................................................................................................................... 
244 
12.2 METHOD 
............................................................................................................................ 
244 
12.3 RESULTS 
............................................................................................................................ 
246 
12.4 DISCUSSION 
....................................................................................................................... 
253 
12.5 CONCLUSIONS 
.................................................................................................................... 
260 
13 CORR-ELATION BETWEEN CARDIOVASCULAR AUTONOMIC TESTS AND BLOOD 
PRESSURE VARIABILITY WITH LONGITUDINAL CAMCOG AND CDR .......................... 261 
13.1 INTRODUCTION ................................................................................................................... 
261 
13.2 NUTHOD ............................................................................................................................ 
261 
13.3 RESULTS ............................................................................................................................ 
262 
13.4 DISCUSSION ....................................................................................................................... 
275 
14 DISCUSSION ............................................................................................................................ 
280 
14.1 RECRUITMENT 
.................................................................... ................................................ 
280 
14.2 CLINICAL DATA ACQUISITION ............................................. ................................................ 
281 
14.3 CLINICAL STUDY DESIGN .................................................... ................................................ 
282 
14.4 FfNAPRES OPERATION ......................................................... ................................................ 
282 
14.5 CARDIOVASCULAR AUTONOMIC REFLEX TESTS .................. ................................................ 
283 
14.6 HEART RATE VARIABILITY ................................................. ................................................ 
285 
14.7 REVIEW OF AUTONOMIC FUNCTION AFTER STROKE ............ ................................................ 
288 
14.8 SUMMARY OF RESULTS ...................................................... ................................................ 
289 
14.9 FURTHER STUDIES .............................................................. ................................................ 
293 
15 BIBLIOGRAPHY ..................................................................... ................................................ 
295 
3 
Declaration 
I wish to certify that no part of the material contained herein has been submitted by me for a 
degree in the University of Newcastle upon Tyne or any other institution. 
I wish to state my independent role in submission of this Thesis. The hypotheses and content 
of the Thesis have followed my own design. Screening candidates enrolled within the 
Cognitive Function After Stroke study, subsequent interview and recruitment for 
cardiovascular investigations and Magnetic Resonance Imaging was performed by myself 
Cardiovascular investigations were performed by myself I obtained all clinical data from 
patient interview and clinical notes and entered clinical and cardiovascular data to the 
database. I performed all analyses on cardiovascular data. 
The study arose from hypotheses generated by Professors Rose Anne Kenny and Clive 
Ballard who provided guidance and direction to the issues addressed within the Thesis and 
acted as supervisors. Dr Louise Allan contributed to study design. Sandra Davies contributed 
to clinical assessment of participants. Jean Scott provided administrative support and arranged 
clinical assessment. Elise Rowan designed and administered the central COGFAST database 
for collating clinical data and organised data input to the database. Emma Burton and 
colleagues designed MRI analysis systems and provided all MFj data. Sally Stephens, Sandra 
Campbell and Michael Bradbury performed all neuropsychometric investigations and 
provided all the CAMCOG and CDR data. Simon Kerr provided all cardiovascular data on 
control cases in Chapter 7. Nick Steen provided advice on statistical analysis. 
4 
Acknowledgments 
I wish to acknowledge the contribution of colleagues who have inspired, guided and generally 
given a helping hand to the completion of this Thesis. First and foremost, Professor Rose 
Anne Kenny for providing the opportunity, motivation and support. Rose Anne has always 
been a source of inspiration and expert clinical assessment and I have learnt a great deal not 
just on the technical issues but also the teamwork and management skills that make a study 
work. Professor Clive Ballard has been an equal source of support and knowledge. I am very 
grateful for their patience as well. 
It is difficult to know where to start to acknowledge everyone else but one person does 
deserve to head the list. I am very grateful to Jean Scott for her immense contribution to this 
Thesis. Jean's dedication and knowledge is outstanding and I think we are extremely 
privileged to benefit from her services on the COGFAST study. Everyone else is in order of 
distance form Jean's office, the very epicentre of operations. Sally Stephens, Sandra 
Campbell and Michael Bradbury perfon-ned all the neuropsychometric tests and generously 
agreed to share these results for the benefit of this thesis. Emma Burton was the lynchpin 
behind MRI data, and in conjunction with Professor John O'Brien, Michael Firbank and Bob 
Barber devised MRI analysis techniques and supplied all data on white matter and whole 
brain volume and white matter hyperintensity rating scales. I also acknowledge and thank 
Emma for her help in the description MRI methodology in Section 4.3. Louise Allan and 
Simon Kerr deserve special thanks for their company and good humour in recent years. 
Louise's contribution deserves special mention for devising the autonomic protocol and 
setting the machinery in motion. Stephen Lloyd has performed sterling work and has provided 
thesis-saving deeds at critical moments. At the RVI, Pam, Mary, Katherine and Anne 
provided superb support during clinical assessment and could always be relied upon to help in 
times of crisis. Sandra Davies deserves special thanks for her reliability and contribution to 
clinical investigations, being great with the patients and even more patient with medical staff. 
Adrian Davidson devised the software program for autonomic reflex tests under great 
pressure and came up with a first class product that revolutionised data analysis. At the 
Freeman, Professor Alan Murray kindly agreed to collaborate with the autonomic analysis, 
providing the software and hardware for power spectral analysis. Alan also gave highly 
valued advise on methodology and autonomic assessment. John Allen provided first class 
technical support and advise, and contributed crucially to the success of the heart rate 
variability analysis, and acted as the scientific role model for amateurs like myself. Nick 
Steen steered me in the right direction for statistical analysis, and demonstrated great patience 
when presented with raw data. I could not have completed the project without his 
enlightenment regarding numerical and philosophical dilemmas. 
5 
The study could only have taken place with the successful collaboration of consultant staff 
and teams at the QEH, Gateshead, Freeman Hospital, North Tyneside General HospItal and 
South Tyneside Hospital. I wish to single out Professor David Barer for special thanks for 
support in my time at the Stroke Unit in Gateshead, and particularly for stimulating an interest 
and providing excellent training in Stroke Medicine. Other collaborators are represented by 
Professor Gary Ford, Dr Richard Curless and Dr Alan Rodgers. 
Finally my mother, father and family who clearly deserve a dedication but they will be the 
first to acknowledge that the most deserving recipients of this work's dedication are the 
patients who agreed to take part in this study and never failed to impress me with their 
generosity of spirit. 
6 
Glossary 
30: 15 ratio The ratio of the longest to shortest RR intervals that occur around 
the 30'h and 15th heart beats after rising from the supine to standing 
position 
ACEi Angiotensin converting enzyme inhibitor 
AD Alzheimer's disease 
AF Atrial fibrillation 
BMI Body mass index 
BP Blood pressure 
BPM Beats per minute 
BRS Baroreflex sensitivity: the quotient of induced change in pulse 
interval over the causing change in blood pressure 
CAMCOG The cognitive subsection of the Cambridge Mental Disorders of the 
Elderly Examination: an objective cognitive test, forming a mini- 
neuropsychological battery 
Carotid sinus massage Digital pressure over the carotid artery at the location of the carotid 
sinus 
CDR Cognitive Drug Research Assessment System: computensed tests of 
cognitive function measuring concentration and reaction time 
Cl Confidence interval 
COGFAST Cognitive Function After Stroke study 
Cold pressor Immersion of the hand in cool water bath to provoke cardiovascular 
autonomic reflex, normally leading to a rise in blood pressure 
COPD Chronic obstructive puhnonary disease 
CRT Choice reaction time: CDR measure of reaction time to visual 
stimulus 
CT Computerised tomography 
cv Co-efficient of variation 
DBP Diastolic blood pressure 
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ADBP Change in diastolic blood pressure during an autonomic test 
ECG Electrocardiogram 
E/I ratio Ratio of longest to shortest RR interval during respiration: longest 
interval occurs during expiration and shortest during inspiration 
Ewing protocol A series of cardiovascular autonomic reflex tests involving three 
measures of RR interval change and two measures of blood pressure 
change 
FEV, Forced expiratory volume in one second 
Finapres Non-invasive blood pressure measurement device, able to record 
beat-to-beat blood pressure from the finger pulse (FINger Arterial 
PRESsure) 
FVC Forced vital capacity 
High frequency (HF) Frequencies between 0.15 and 0.40 Hertz from a power spectral 
analysis of heart rate or blood pressure variability: the HF power 
spectral density is the area under the curve for that band of 
frequencies 
HR Heart rate 
AHR Change in heart rate during an autonomic reflex test 
HRV Heart rate variability: measure of variation in heart rate or RR 
interval during a defined period 
E-1 difference Difference between peak inspiratory heart rate and nadir expiratory 
heart rate during cycle of respiration 
IMT Intima media wall thickness 
Isometric exercise Skeletal isometric muscle exercise that provokes cardiovascular 
autonomic reflexes, normally a rise in blood pressure 
LVH Left ventricular hypertrophy 
Low frequency (LF) Frequencies between 0.04 and 0.15 Hertz from a power spectral 
analysis of heart rate (or blood pressure) variability: the LF power 
spectral density is the area under the curve for that band of 
frequencies 
LVMI Left ventricular mass index 
8 
Metronomic Timed and deep respiration at a set frequency for a defined period to 
respiration provoke cardiovascular autonomic reflexes 
MVC Maximal voluntary contraction: measure of effort during isometric 
muscle exercise, usually expressed as a percentage 
mmHg Millimetres mercury: blood pressure measurement unit 
MBP Mean blood pressure 
mi Myocardial infarction 
MMSE Mini-mental state examination: a point item test of cognitive 
function 
MRI Magnetic resonance imaging 
ms millisecond 
MSNA Muscle sympathetic nerve activity: direct measure of sympathetic 
nerve traffic to skeletal muscle using transcutaneous 
microneurographic recording of superficial peripheral nerves 
OCSP Oxfordshire Community Stroke Project 
Power band Frequency bands of interest from power spectral analysis 
Power spectral Computerised measurement of RR interval or BP variation in the 
analysis (PSA) frequency domain: illustrates how variance distributes as a function 
of frequency 
PP Pulse pressure: difference between systolic and diastolic blood 
pressure 
DD 
A-B.. The time interval between succesive 
R waves on the 
electrocardiogram 
RSA Respiratory sinus arrhythmia: the nonnal variation in heart rate with 
respiration 
SBP Systolic blood pressure 
SD Standard deviation 
SEM Standard error of the mean 
ectral Spectral density Area under the curve measurement following power sp 
analysis (the 'power'): frequency plotted along x axis and amplitude 
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along y axis 
SRT Simple reaction time: CDR measure of reaction time to visual 
stimulus 
SSRI Selective serotonin re-uptake inhibitor 
SSS Scandinavian Neurological Stroke Scale 
Tilting Elevating a subject from the supine to the upright position whilst 
secured to a powered tilting table, therefore the upright position is 
attained without normal skeletal muscle contraction 
TIA Transient ischaemic attack 
VaD Vascular dementia 
Valsalva manoeuvre Prolonged forced expiration with an open glottis, at a set pressure 
and expiration period, to increase intrathoracic pressure 
Valsalva ratio (VR) Ratio of longest to shortest RR intervals during Valsalva manoeuvre 
WML White matter lesion 
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1 Abstract 
1.1 Background 
Dementia presents a significant health care burden. Older post-stroke patients suffer high 
rates of dementia. Subcortical ischaemia may be an important mechanism of cognitive 
decline, particularly in older patients with cerebrovascular disease. It is hypothesised that 
abnormal heart rate and blood pressure variability will increase white matter lesion volume 
through hypoperfusion. This may lead to a subcortical pattern of cognitive decline 
characterised for example by deficits in attention and concentration. 
1.2 Method 
Stroke patients aged > 75 years and free of dementia had a series of cardiovascular 
autonomic, brain imaging and neuropsychometric investigations performed more than three 
months following incident stroke. Autonomic reflex tests comprised blood pressure drop and 
RR interval change during standing and carotid sinus massage, blood pressure change during 
isometric exercise and cold cutaneous stress, blood pressure overshoot and heart rate change 
during Valsalva manoeuvre and heart rate variation during metronomic respiration. Heart rate 
variability and baroreflex. sensitivity were measured over five minutes using power spectral 
analysis. Mean blood pressure, long term blood pressure variability and diumal variation in 
blood pressure were measured by 24 hour ambulatory monitoring. Cortical white matter 
lesion volume was estimated from magnetic resonance imaging sequences of the brain at 
baseline and after an interval of two years. Annual neuropsychometric assessment included 
CAMCOG score and measures of reaction time and concentration using a series of visual and 
numerical tasks presented on computer (Cognitive Drug Research Assessment System). 
1.3 Results 
Stroke patients suffered deficits in both parasympathetic, sympathetic reflex tests and 
baroreflex sensitivity compared to an age matched group of stroke free control cases. There 
were no associations between individual cardiovascular autonomic tests and white matter 
lesion volume from the cross-sectional or longitudinal analyses. However a composite 
autonomic reflex score indicated a trend towards an association with white matter lesion 
volume at baseline. Systolic blood pressure variability, mean diastolic blood pressure and 
diabetes were significant independent predictor variables for baseline white matter lesion 
volume in stroke patients in sinus rhythm. Inclusion of all stroke cases (sinus rhythm and 
atrial fibrillation) in regression analysis found an additional positive relationship for cardiac 
failure, and inverse relationship for forced vital capacity, with baseline white matter lesion 
volume as the dependent variable. Multiple regression of all risk factors with rate of white 
matter lesion volume increase over two years as the dependent variable yielded cardiac failure 
and ischaernic heart disease as positive and thiazide use as negative independent predictors. 
Daytime mean diastolic pressure was inversely associated with CAMCOG executive subscore 
at baseline. Increasing nocturnal dip in blood pressure was inversely associated with total 
CAMCOG score. There was a positive association between blood pressure rise during 
isometric exercise and vigilance tests, and an inverse association between Valsalva ratio and 
working memory. Decreasing high frequency baroreflex sensitivity was associated with 
impaired reaction time. None of the cardiovascular indices predicted deterioration in 
neuropsychometric function over one or two years. 
1.4 Conclusion 
Autonomic function is impaired in older stroke patients in the long term after stroke. These 
deficits are weakly associated with cross-sectional measures of sub-cortical performance but 
do not predict subsequent decline in cognitive function. Twenty-four hour blood pressure 
variability is associated with white matter disease and excessive nocturnal dipping is 
associated with impaired cognitive function. Again blood pressure variability does not help 
predict subsequent change in white matter lesion burden or cognitive function. 
This study provides limited support for the hypoperfusion theory of post-stroke cognitive 
impairment. However it does not indicate a role for heart rate and blood pressure variability in 
the mechanism of increasing white matter disease or decline in cognition in the two years 
following stroke. 
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2 Epidemiology and pathology of vascular 
dementia 
2.1 Classification 
Vascular dementia is one of the three most common forms of dementia. The term describes a 
state of intellectual impairment due to organic brain failure resulting Erom vascular disease. 
There are several diagnostic criteria in current use. The format for most of these definitions is 
evidence of dementia, cerebrovascular disease and a temporal link between these two key 
features. However there are subtle differences in how these features are specified within each 
definition. Five of the most widely used diagnostic criteria are now discussed. 
The American Psychiatric Association published the 'Diagnostic and Statistical Manual of 
Mental Disorders, Third Edition (DSM-111)' in 1980 (American Psychiatric Association, 
1980). This has been updated on two occasions, DSM-111-R in 1987 (American Psychiatric 
Association, 1987) and the DSM-IV in 1994 (American Psychiatric Association, 1994). 
DSM-IV is widely used in routine clinical practice in the UK. It requires the presence of 
impairment in memory plus one other cognitive domain for dementia. Cerebrovascular 
disease can be either focal neurological symptoms or signs or laboratory evidence of 
ischaemic or haemorrhagic brain injury. Causal relationship is by clinical judgment. Inter- 
rater reliability is moderate (K--0.59) (Chui, 2000). The DSM-111 diagnosis for vascular 
dementia (VaD) was proven accurate by neuropathological criteria in 85% of 25 necropsy 
cases (Erkinjuntti, 1988). 
The World Health Organization published The ICD-10 Classification of Mental and 
Behavioural Disorders: Clinical Descriptions and Clinical Guidelines in 1993 (World Health 
Organization, 1993). This requires patchy distribution of cognitive deficits, focal neurological 
signs and clinical or laboratory evidence of significant cerebrovascular disease (CVD). There 
should be reasonable evidence of an aetiological link between CVD and dementia. Specificity 
was comparatively high when judged with other diagnostic criteria but this study used a 
'standard clinical diagnosis', not neuropathological validation (Pohjasvaara, 1997). 
The Hachinski Ischaernic Score (HIS) is a checklist of vascular risk factors and clinical 
features theoretically associated with VaD with a weighted score for each item (with various 
subsequent modifications) (Hachinski, 1975). Although widely known, it 
has a number of 
limitations. It does not specify the requirement for dementia (Homer, 1988; Rosen, 1980). 
Accuracy is less than 70% (Swanwick, 1996), specificity is 0.88, sensitivity is 0.43 (Gold, 
1997) and inter-rater reliability is moderate (1c =0.59) (Chui, 2000; O'Neill, 
1995). It has been 
superseded by more advanced criteria for research purposes. 
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The State of California Alzheimer Disease Diagnostic and Treatment Centers criteria for 
ischaemic vascular dementia (IVD) was formulated in 1992 (Chui, 1992). Note that only 
ischaernic damage is classified, dementia due to haemorrhagic brain injury is excluded. The 
cognitive deficit has to occur in more than one domain and be of any type. For probable IVD, 
there must be at least one infarct outside the cerebellum on neuroimaging plus evidence of at 
least 2 strokes from history, clinical signs or neuroimaging or a single stroke with a definite 
temporal link to dementia onset. Possible IVD amounts to evidence of a single stroke without 
a clear link to dementia onset or clinical and radiographic signs of extensive sub-cortical 
white matter disease. In the neuropathological validation study, sensitivity was 0.63 and 
specificity 0.64 (Gold, 1997). Inter-rater reliability is fair (K--0.44) for probable and poor 
(K: --O. 15) for possible IVD (Chui, 2000). 
The National Institute of Neurological Disorders and Stroke - Association Internationale pour 
la Recherche et FEnseignement en Neurosciences (NINDS-AIREN) criteria for vascular 
dementia was published in 1993 (Roman, 1993). They are perhaps the most stringent 
diagnostic criteria. Memory plus at least 2 other cognitive domains must be impaired. 
Probable vascular dementia requires the following criteria: (a) cerebrovascular disease must 
be evident by virtue of clinical signs and a relevant neuroiniaging abnormality and (b) the 
temporal relationship required is dementia onset within 3 months of stroke or an acute 
deterioration in cognitive function. Possible vascular dementia is diagnosed if neuroirnaging 
evidence or the clear temporal association is absent. In neuropathological validation studies, 
sensitivity and specificity were 0.58 and 0.80 respectively in a group of geriatric inpatients 
with retrospective clinical diagnoses (Gold, 1997) but 0.43 and 0.95 in a community based 
post-mortern series (Holmes, 1999). Inter-rater reliability is moderate to substantial (K= 0.42 - 
0.72) (Chui, 1992; Lopez, 1994). 
Thus the current diagnostic criteria for vascular dementia have a number of weaknesses. The 
underlying problem is that all these criteria were designed by consensus and not 
based on the 
gold standard of neuropathological data. However the issue is further complicated by the 
absence of recognised pathological criteria for vascular dementia. Thus one of the 
difficulties 
in this field is the the process of validation any of the clinical criteria. The pitfall of 
inconsistency between diagnostic criteria is underlined by studies documenting their poor 
concordance. The rate of diagnosis of vascular dementia has varied as much as 
fourfold 
between criteria (Chui, 2000; Pohjasvaara, 1997; Verhey, 1996; Wetterling, 1996) and even a 
tenfold difference between DSM III and ICD-10 in a community study (Erkinjuntti, 1997). 
DSM-IV tends to give the highest rate of diagnosis, NINDS-AIREN the lowest and ICD-10 
plus ADDTC an intermediate rate. DSM-IV is valuable for community epidemiology 
by 
virtue of good sensitivity and absence of requirement 
for neuroimaging. ICD- 10 also benefits 
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from not requiring scanning but sensitivity is poorer. NINDS-AIREN strength lies in 
excellent specificity and is widely used in research fields. 
These consensus-led criteria have conceptual weaknesses (Bowler, 1999). The diagnosis of 
dementia is historically based on Alzheimer's disease but vascular dementia usually results in 
a different pattern of cognitive decline. Similarly the criteria rely on established dementia, but 
vascular dementia is a preventable illness, therefore early case identification at the stage of 
mild cognitive impairment will prove more useful for research and treatment. Some criteria 
rely on a history of stroke which may be lacking in cognitively impaired subjects with 
numerous vascular risk factors or neuropathologically proven vascular dementia (Emery, 
1996). Another key difficulty is the emerging evidence of neuropathological overlap between 
vascular dementia and Alzheimer Dementia (Kalaria and Ballard, 1999; Rockwood, 2000). 
This situation has led to the pathological term 'mixed dementia' but this condition needs 
better recognition in diagnostic criteria. 
Criteria should also take account of the subtypes of vascular dementia which may have 
fundamentally different pathophysiology and clinical presentation. One review identified 8 
subtypes of vascular brain injury resulting in dementia (Loeb and Meyer, 1996). The most 
common presentations are listed first. 
Cortical infarcts due to large vessel disease 
Widespread subcortical disease due to small vessel disease (lacunar infarcts) 
Binswanger's disease (probably synonymous with small vessel disease) 
Mixed large and small vessel disease 
Mixed vascular disease and Alzheimer's disease. 
Single small strategic infarcts 
Haemorrhagic stroke disease 
Subcortical disease due to rare inheritable arteriopathies e. g. CADASIL 
For a discussion of small vessel disease, see section 2.3.3. One of the most difficult areas of 
diagnosis is separating AD from subcortical vascular dementia since they share similar risk 
factors and an insidious onset of dementia (Ransmayr, 1998). In some instances subcortical 
disease lacks chronic focal neurological signs, increasing the difficulty of identifying vascular 
dementia. Further developments in diagnostic criteria need to defme: 
Vascular aetiology, in subtypes 
Cognitive changes 
Neuropathological findings 
The temporal connection between evolution of vascular disease and cognitive decline 
Exclusion criteria for similar presentations of different forms of dementia. 
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2.1.1 Conclusion 
There are a number of diagnostic criteria for vascular dementia developed by consensus. 
DSM-IV has good sensitivity whereas NINDS-AIREN has excellent specificity. Concordance 
is poor. Clinical diagnosis of mixed dementia is a problematic area. Neuropathological 
validation is required to improve diagnostic criteria. 
2.2 Epidemiology 
2.2.1 Incidence studies 
The literature contains work on the incidence and prevalence of vascular dementia in both 
community and post-stroke cohorts. The characteristics of diagnostic criteria employed in 
each study should be bome in mind when comparing diagnostic rates. Vascular dementia has 
a poor prognosis, three year mortality being as high as 67% in over 85 year olds (Skoog, 
1993). 
Table 2-1 Incidence of Vascular dementia in community studies 
Study author 
and location 
Age range Sample 
number 
(number 
screened) 
Incidence all 
cause 
dementia/1000 
(criteria) 
Incidence 
VaD/1000 
(criteria) 
Incidence 
AD/1000 
(criteria) 
Cambridge 75 1173 133 12 (95% CI 27 (95% Cl 
(Brayne, (CAMDEX) 7-19) 16-44) 
1995) (CAMDEX) (CAMDEX) 
Japan 65 828 M 19.3 M 12.2 M 5.1 
(Yoshitake, F 20.9 F 9.0 F 10.9 
1995) (DSM-IIIR) (NINDS - (NINCDS - 
AIREN) ADRDA) 
Scotland 40-64 6092 M 0.25 Probable: 
(McGonigal, (hospital F 0.13 broad = 
1993) casenotes) (HIS) 0.23 : 0.41 
Liverpool 65 5222 19 2.6 4.9 
(Copeland, (6035) (AGECAT) (ICD- 10) (ICD- 10) 
1999) 
London > 65 502 20 4 8 
(Boothby, (656) (DSM-111) (HIS) (NfNCDS- 
1994) ADRDA) 
Canada > 65 5747 3.79* 
(Hebert, 2000) (8623) (ICD-10) 
Sweden 2612 (lifetime risk 
(Hagnell, M 34.5% 
1992) F 19.4%) 
Sweden >74 987 148 75-79 yrs 
(Fratiglioni, (1473) (DSM-111-R) M 12, F 20 
1997) ý: 90 years 
M 15, F 87 
M, male: F, female: CAMDEX, Cambridge Examination 
for Mental Disorders of the Elderly: DSM, Diagnostic 
and Statistical Manual of Mental Disorders: 
NINDS-AIREN, National Institute of Neurological Disorders and 
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Stroke - Association Internationale pour la Recherche et FEnseignement en Neurosciences: Nl-.,, CDS-ADPDA. 
National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimers Disease and 
Related Disorders Association: HIS, Hachinski Ischaernic Score: AGECAT, see Copeland JR. M 1999: ICD. 
International Classification of Diseases: * Incidence adjusted for mortality rate 
Therefore a short screening interval is necessary to optimise case recognition. VaD is under- 
reported on death certificates (Thomas, 1997) and is under-represented in referrals to 
secondary care facilities (Nolan, 1998), presenting further pitfalls in epidemiological studies. 
The incidence rates for VaD can vary markedly between studies, as shown in Table 2.1. In a 
meta-analysis of incidence rate studies in 1998 dementia rates rose exponentially with age 
(significant for all-cause and Alzheimer's disease, non-significant trend for VaD) (Jorm and 
Jolley, 1998). Some studies are hampered by small sample size (Boothby, 1994) or use of 
insensitive diagnostic tools resulting in high rates of undifferentiated dementia (Hebert, 
2000). Note that in the McGonigal study (McGonigal, 1993) incidence rates were taken from 
referrals to secondary psychiatry services and extrapolated to the general population, 
therefore this was not a true community based survey. A review estimated an incidence rate 
of between 6 to 12 per 1000 for vascular dementia beyond the age of 70 (Hebert and Brayne, 
1995). A review of epidemiological surveys in 1998 stated incidence rates of 20 to 40 per 
100,000 in the 60 to 69 year old age range, and 200 to 700 per 100,000 in the over 80 years 
old age range (Leys, 1998). 
2.2.2 Community prevalence studies 
A comparative study of prevalence studies in Europe in 1991 (Rocca, 1991) identified 5 out 
of a possible 23 reports meeting their inclusion criteria. Prevalence rates markedly vaned 
between studies. Prevalence increased with age and was generally higher in males. 
Subsequent prevalence studies are summarised in Table 2.2. 
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Table 2-2 Prevalence of Vascular Dementia in community studies 
Study Age range, Prevalence all Prevalence Prevalence Comments 
reference and sample size cause vascular Alzheirner 
location (screened) dementia dementia Disease /1000 
/1000 /1000 (criteria) 
(criteria) (criteria) 
Japan >- 65 67 31 15 50 59 
(Ueda, 1992) 887 (DSM-111) (pathology) (pathology) dementia 
cases had 
autopsy 
Sweden >85 298 140 130 3 yr mortality 
(Skoog, 1993) 494 (DSM-111-R) (clinical) (NINCDS- 66.70 VaD 
ADRDA) 42.2% AD 
Italy 64 80 22 52 AD 64% and 
(Prencipe, 968 (DSM-111) (NINDS- (NINCDS- VaD 27ý 0 of 
1996) (1147) AIREN) ADRDA) all dementias 
Rotterdam 55-106 63 10 45 AD 72% and 
(Ott, 1995) 7528 (DSM-111-R) (DSM-111-R) (NINCDS- VaD 16% of 
4 (55-59 yr) ADRDA) all dementias 
432 (>95 yr) 
India > 60 33.9 19 13 AD 41 % and 
(Shaji, 1996) 2067 (DSM-111-R) (ICD- 10) (ICD- 10) VaD 58% of 
all dementias 
Honolulu 71-93 93 18 21 14/1000 
(White, 1996) 3734 (DSM-111-R) (ADDTQ (NINCDS- mixed (with 
(4678) 21 (71-74yr) 42* ADRDA) AD or VaD) 
330 (85-93yr) 54* dementia 
Hong Kong >70 61 18 39 
(Chiu, 1998) 1034 (DSM-IV) (CAMDEX) (DSM-IV) 
(1503) 
Egypt >60 45 10 22 6/1000 mixed 
(Farrag, 1998) dementia 
Korea >65 95 25 45 
(Woo, 1998) 1674 (NINCDS- (HIS) (NINCDS- 
(2171) ADRDA) M 31, F 21 ADRDA) 
M 32, F 53 
Utah >65 65 12 42 
(Lyketsos, 5092 (DSM-IV) (NINDS- (NINCDS- 
2000) (5677) AIREN) ADRDA) 
Beijing >65 35 14 19 
(Wang, 2000) 3728 (DSM-111-R) (ICD- 10) (ICD-10) 
M, male: F, female: DSM, Diagnostic and Statistical Manual of Mental Disorders: NTNCDS-ADRDA, National 
Institute of Neurological and Communicative Disorders and Stroke and the Alzheimers Disease and Related 
Disorders Association: NINDS-AIREN, National Institute of Neurological Disorders and Stroke - Association 
Internationale pour la Recherche et I'Enseignement en Neurosciences: ICD, International Classification of 
Diseases: ADDTC, Alzheimers's disease Diagnostic and Treatment Centers criteria: CAMDEX, Cambridge 
Examination for Mental Disorders of the Elderly: HIS, Hachinski Ischaemic Score: *primary or contributing 
cause; M=male, F=female 
Some general comments can be made from the studies shown in Table 2.2. Vascular 
dementia 
rates clearly increase with age and vary between continents. In Western populations, 
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Alzheimer's disease is usually more prevalent than vascular dementia by a factor of 2 to 3, 
whereas in Asian populations prevalence rates are more even for these two causes of 
dementia. Prevalence rate for vascular dementia increase with age, for example rising from 
10/1000 in over 60 years old in Egypt (Farrag, 1998) to 298/1000 for those aged over 85 
years in Sweden (Skoog, 1993). 
Prevalence rates in two reviews of vascular dementia were estimated to be 12-42/1000 for 
ages over 65 (Hebert and Brayne, 1995), or were quoted to vary from a minimum of 221000 
(female) for the age range 70-79 to a maximum of 163/1000 (male) aged over 80 years 
(Leys, 1998). There's a consistent pattern for Alzheimer's disease to be more prevalent in 
Caucasian cohorts. VaD is often the more prevalent subtype in Asian and black cohorts. 
2.2.3 Epidemiology of post-stroke dementia 
Before describing the studies on post-stroke dementia, there are two points relevant to 
prevalence and incidence studies. Firstly the prevalence of pre-stroke dementia has been 
recorded at 10- 16 % (Barba, 2000; Henon, 1997) which can account for approximately 1/3 of 
the post-stroke prevalence. Secondly the high attrition rate following stroke will influence the 
recorded dementia rates in survivors since dementia rates are likely to be much higher in the 
group who die early (Desmond, 1998a). Therefore timing of sampling is important. 
A study of 463 consecutive stroke admissions in 1985 recorded 237 survivors at 6 months, 
189 of whom were assessed using the Mini Mental State Examination (Ebrahim, 1985; 
Folstein, 1975). Twenty-two had an abnormal MMSE (of less than 21/30) thus 11.1% of 
testable survivors were considered demented. This is probably an underestimate in view of 
the low cut-off value on the MMSE; secondly it's likely the prevalence would be higher in 
those who were not assessable. A selective study of 108 lacunar infarct survivors from a 
series of 750 stroke inpatients excluded subjects with pre-existing dementia and diagnosed 
incident dementia using DSM-111-R criteria; 25 (23.1%) new cases of dementia were 
diagnosed over an average follow-up of 4 years, but the study does not quote annual 
incidence figures (Loeb, 1992). Cognitive function was recorded in 122 survivors at 6 months 
post-stroke from an initial inpatient cohort of 149 subjects (House, 1990). Twenty-six 
subjects (21%) had an MMSE less than 24/30. The same study also noted that 8/95 subjects 
deteriorated from a normal MMSE > 24 at I month to less than 24 at the 12 month post stroke 
period, giving a crude incidence rate of dementia of 8.4%. 
A retrospective community study of dementia incidence in stroke survivors living 
in the 
community in Minnesota identified 971 individuals who suffered a first 
infarct with no 
evidence of previous dementia (Kokmen, 1996). Dementia incidence 
3 months post-stroke 
was 7%, which was 8.8 times the predicted cornmunity rate. Interestingly they noted 
401 o of 
19 
these cases were Alzheimer's disease which was also much greater than the predicted 
community dementia incidence rate. The increased incidence of dementia in this cohort 
persisted but attenuated to twice the community rate over a 25 year follow-up period. The 
study does not quote which if any diagnostic criteria were employed. 
Tatemichi published a series of papers on post-stroke dementia. From 927 consecutive 
ischaernic stroke admissions, 116 of 726 (16%) testable patients were demented at 10 days 
post-stroke (using clinical judgment only) with a subsequent I year 'incidence of 5.4% and 
10.4% in 60 and 90 year olds respectively (Tatemichi, 1990). Another cohort were assessed 
at 3 months post-stroke using DSM-111-R, 26.3% (66/25 1) were demented compared with the 
community control rate of 3.2%, an odds ratio of 9.4 (95 % Cl 4.2-2 1.1) (Tatemichi, 1992). 
This study did not exclude subjects with pre-stroke cognitive impairment but found that 56% 
of the incident cases were probable vascular dementia and a further 36% were mixed 
Alzheimer's disease and VaD on clinical grounds. Finally, a prospective study of 184 post- 
stroke subjects over 60 years age had a dementia incidence of 8.4 per 100 person years 
compared with 1.3 in community controls, a relative risk of 5.5 (95% Cl 2.5-11.1) 
(Tatemichi, 1994b). 
2.2.4 Conclusions 
Vascular dementia accounts for 10-30% of all dementia cases. The community incidence rate 
is at least 2.5/ 1000 per year in persons at risk, has a male preponderance and rises steeply 
with age. The prevalence is approximately 2% in those aged over 65 years and perhaps as 
much as 15% over 85 years age. The incidence is increased up to nine-fold in the first year 
following ischaernic stroke. 
2.3 Pathology 
Neuropathological studies on VaD highlight a number of key issues. Unfortunately the area 
tends to suffer from a confusing array of terminology. For example the numerous terms 
ascribed to small vessel disease, subcortical ischaemia, Binswangers disease, subacute 
arteriosclerotic encephalopathy and subacute ischaemic leukoencephalopathy are essentially 
describing the same process of bilateral ischaemic damage to the white matter (Roman, 1987). 
As previously discussed there are several subtypes of VaD and studies often benefit from 
subtype recognition in view of basic differences in aetiology. In particular the sudden onset of 
dementia following a cortical stroke due to large vessel disease or cardio-embolisation has 
different characteristics to the insidious onset of dementia from recurrent lacunar infarcts 
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from small vessel disease. Literature reports have so far tended to examine selective hospital 
based cohorts (Brayne, 1993) but more community based data is now emer-ging. 
2.3.1 Neuropathological features 
An important early study raised a number of issues in the definitive pathological changes of 
VaD (Tomlinson, 1970). This report described typical neuropathological changes 'in vascular 
dementia and indicated that larger volumes of infarcted tissue and presence of bilateral lesions 
played an important role in disease expression. An investigation of the validity of DSM-111 
VaD criteria found subjects had suffered bilateral infarcts in 96% cases particularly in the 
basal ganglia and temporal lobes. The volume of infarcted tissue (but not the number of 
infarcts) was proportional to the severity of dementia (Erkinjuntti, 1988). A study examining 
the neuropathology of subjects with only vascular lesions compared findings between 
demented and non-demented individuals, and concluded that infarct volume and number, 
lacunar state and white matter lesions were increased in dementia (del Ser, 1990). Macro- 
infarction involving cortical tissue can lead to dementia as shown in case series (del Ser, 
1990; Hulette, 1997). Such large vessel disease often co-exists with small vessel disease 
(Brun, 1994) and many reports emphasise the role of the latter in vascular dementia. Vascular 
dementia subjects diagnosed by NINDS-AIREN criteria are characterised by diffuse white 
matter changes of arteriosclerosis, spongiosis etat crible and myelin loss (Erkinjuntti, 1996). 
A study comparing non-demented controls, cognitively normal subjects with cerebrovascular 
disease and dementia cases with only cerebrovascular disease (no/minimal AD changes) at 
post-mortem found that microvascular disease was the chief substrate of VaD, consisting of 
subcortical white matter damage, microinfarction and cribriform change: macro-infarction 
was rare in dementia (Esiri, 1997). Similar abnormalities of small infarcts, diffuse white 
matter rarefaction and reduced myelin were found in a group of 40 vascular dementia cases 
(diagnostic criteria not stated) (Englund, 1998). 
2.3.2 Histochernistry and functional neuropathology 
The reduction in cerebral acetylcholine activity is established in Alzheimer's disease but also 
occurs, to a lesser extent, in VaD (Perry, 1977). This finding has been replicated in studies 
which have also shown reduced serotinergic activity. Furthermore, in both these 
neurotransmitter disturbances occur at sites distant to infarcted tissue (Gottfries, 1994; Wallin, 
1989). Recent functional neuroirnaging studies indicate frontal lobe dysfunction in VaD. A 
study comparing normal controls, non-demented stroke subjects and sub-cortical stroke 
subjects with cognitive impairment indicated global cortical glucose metabolism is impaired 
in all groups with sub-cortical disease and deteriorated according to the degree of cognitive 
impairment. In addition sub-cortical infarction was associated with frontal regional 
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hypometabolism (Kwan, 1999). Cortical metabolic dysfunction correlates with the severity of 
subcortical. small vessel disease in VaD (Sultzer, 1995). Memo failure in cognitivelu ry 1.7 
impaired subcortical. stroke subjects correlates with reduction in frontal lobe glucose 
metabolism, whereas in Alzheimer's disease subjects memory failure correlates Nvith 
hippocampal and temporal lobe hypometabolism (Reed, 2000). Frontal lobe hypometabolism 
and hypoperfusion is potentially useful as a diagnostic aide when differentiating between 
Alzheimer's disease and VaD (Nagata, 2000). 
2.3.3 Pathophysiology of small vessel disease 
Key research questions in VaD include the role of white matter disease, the influence of other 
non-vascular pathology and the concept of vascular dementia in the absence of stroke. Central 
to these issues is small vessel disease of subcortical white matter, which is clearly associated 
with vascular dementia (Esiri, 1997; Pantoni, 1996; Wallin and Blennow, 199 1). The 
aetiology of small vessel disease is related to the lacunar hypothesis, reviewed by Bamford 
(Bamford and Warlow, 1988). Essentially pathological luminal narrowing of the 
microvasculature in the subcortex, particularly in the deep perforating vessels, renders the 
white matter vulnerable to ischaernic damage. Reduced or absent flow may lead to a well 
defined array of clinical syndromes referred to as lacunar stroke (Fisher, 1982). Lacunar 
damage is even more frequently asymptornatic (Tuszynski, 1989). Neuropathological proof of 
the lacunar hypothesis has been elusive owing to the low mortality rates immediately 
following lacunar stroke. There is evidence the hypothesis is valid from CT and MRI studies 
of acute lacunar stroke (Boiten and Lodder, 199 1; Lindgren, 2000). The most common sites 
for lacunar stroke from necropsy studies are frontal lobe white matter, putamen, pons, parietal 
lobe white matter, thalamus and caudate nucleus in descending order of frequency (Dozono, 
1991). 
The pathophysiology of small vessel ischaemia is a crucial issue. Abnormal arteriole wall 
structure is certainly implicated. This was described by Fisher who examined the arterial 
lesions underlying 50 lacunes in 4 subjects; note that 36 lacunes were from just I subject 
(Fisher, 1969). In 90% of lacunes, it was associated with an arterial occlusion, usually due to 
44segmental arterial disorganisation"; this consisted of patchy layers of connective tissue 
obliterating the lumen, often exacerbated by haemorrhage within the abnormal vessel wall. A 
different occlusive lesion, fatty atheroma, was found in larger 300-500 micron arteries and 
was associated with larger volume infarcts with a more pronounced neurological deficit. 
Occlusion of a cerebral vessel leads to cellular hypoxia which triggers a chain of events from 
reduced ATP production, free radical production and finally irreversible glial injury; the 
severity of occlusion will influence the spatial and temporal dynamics of cellular injury 
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(Pulsinelli, 1992). In other words, a partial occlusion will theoretically produce cellular 
damage more slowly and in a smaller area than a complete and sudden occlusion. 
The anatomy of the arterial tree supplying the white matter is important. Long tortuous 
arterioles branch out from the main cerebral arteries to supply white matter. Pial arteries on 
the cerebral surface also form perforating arteries; short and medium length vessels supply the 
cortex whilst longer 'medullary' penetrators continue to supply the deep white matter 
(Rowbotharn and Little, 1965). The tissue between the 2 groups of perforators lies in a 
borderzone and is vulnerable to hypoperfusion (De Reuck, 197 1). The perforators appear 
susceptible to hypertensive damage which results in lipohyalinosis, also known as hyaline 
arteriosclerosis or fibrohyalinosis. The arteriolar wall thickens due to deposition of hyaline, a 
material that shows a reddish homogenous appearance when stained with haemotoxylin and 
eosin and is predominantly composed of collagen (Zhang, 1994). The hyalinisation process 
tends to replace smooth muscle and elastic tissue elements within the arteriolar intima and 
media. More extreme hypertensive damage can lead to fibrinoid necrosis where the damaged 
vessel wall undergoes necrosis and is infiltrated by plasma constituents, leading to further 
thickening and luminal narrowing. Fibrinoid necrosis tends to occur in the larger arterioles 
(Brun, 1992) but is rarely cited in the neuropathology studies of vascular dementia which may 
be a reflection of difficulties in studying affected tissue immediately following lacunar 
infarction (or possibly due to inconsistent use of nomenclature). 
Another key factor in small vessel disease may be cerebral autoregulation, the automatic 
process of maintaining constant blood flow to cerebral tissue in spite of changes in perfusion 
pressure. Abnormal autoregulation in the face of hypoperfusion may further impair blood 
flow and oxygen delivery to critically ischaemic white matter. This aspect is discussed further 
in a later section. 
Therefore there are a number of variables determining the extent of ischaemic damage; (a) the 
severity of luminal narrowing in arterioles of varying calibre (b) presence of autoregulation 
and (c) susceptibility of different cell types to hypoxia (neurons > oligodendria > astrocytes). 
It follows that ischaemic damage is probably a spectrum from isolated damage involving a 
few neurons to frank infarction (Ostrow and Miller, 1993). The more severe the ischaemia, 
the more likely it will result in a large area of cellular necrosis, then gliosis and subsequent 
cavity formation and these larger lesions are usually termed lacunes. The ischaemic damage 
may occur within the territory of one deep perforator or between two perforators in the deep 
white matter, depending on the local perfusion and tissue demands of these at-risk sites (De 
Reuck, 1971; Marinkovic, 1985). 
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The morphological hallmarks of small vessel disease are arteriosclerotic perforating arteries, 
myelin loss and pallor, axonal loss, tissue rarefaction or spongiosis and small deep infarcts or 
lacunes (Akiguchi, 1997; Erkinjuntti, 1996; Ostrow and Miller, 1993). There are many 
neuroimaging studies on the associated CT or MRI changes of small vessel disease. These 
radiographic changes are a useful tool in investigating VaD. There is evidence of reduced 
blood flow in deep white matter correlating with the severity of small vessel disease as 
demonstrated on neuroimaging investigations (Kawamura, 1991 a; Kobari, 1990). The clinical 
and pathological correlates of small vessel disease indices on CT and MRI are discussed in 
detail later. 
Binswanger's disease (131)) is a term that receives prominence in the literature with the 
implication of being a separate pathologic entity. Clinical findings include dementia, frontal 
signs, pseudobulbar palsy, gait disturbance (marche a petit pas) and urinary incontinence 
(Roman, 1987). Binswangers' original description actually consisted of neuropathological 
findings in 8 subjects with vascular dementia who developed focal neurological signs: he 
found extensive white matter atrophy without focal infarcts, which he felt made this a distinct 
process from multi-infarct dementia (Binswanger, 1894). However his survey did not include 
microscopic studies in contrast to modem pathological descriptions which have demonstrated 
micro-infarction in Binswanger's disease (Pantoni and Garcia, 1995; van GiJn, 1998). It has 
been suggested that in Binswanger's disease, the majority of small vessel disease occurs in 
the very small arterioles (< 150 micrometres) whereas lacunar infarcts tend to be seen in 
ischaernia of larger vessels (0.4-1.0 nun), thus Binswanger's disease and the lacunar state 
represent the extremes of a pathophysiological continuum (van Swieten, 199 1 a). Many 
authors have confirmed the impression that Binswanger's disease, along with the multitude of 
other associated terms, share the same distinctive and definitive underlying process of small 
vessel disease (Leys, 1999; van GiJn, 1998). 
There is distinct small vessel pathology, cerebral amyloid angiopathy, which is characterised 
by amyloid deposition in the adventitia and media of small arteries and arterioles. These 
changes are classically seen in the cortical vessels and are associated with Alzheimer's 
disease, which contrasts with lipohyalinosis affecting the subcortex and its association with 
VaD (Kalaria, 1997b; Vinters, 1988). However, with the emerging evidence of overlap 
between Alzheimer's disease and VaD, this similarity of arteriolar luminal narrowing may be 
a link between the two processes, i. e. in the causation of cerebral damage. 
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2.3.4 The overlap between Vascular Dementia and Alzheimer's 
disease 
Vascular dementia and Alzheimer's disease are frequently difficult to separate, in both 
clinical and pathological terms. A case series in 1988 observed the high prevalence of small 
vessel disease in neuropathogically verified Alzheimer's disease (Englund, 1988) and an 
epidemiological survey noted the increased incidence of Alzheimer's disease in a post-stroke 
cohort (Kokmen, 1996). The Nun Study was a clinicopathological survey of elderly nuns in 
North America which found that 61 from 102 cases met pathological criteria for Alzheimer's 
disease. For any given level of cognitive deficit, the burden of Alzheimer's disease 
neuropathology was significantly lower in cases with co-existent vascular pathology, inferring 
a lower threshold of Alzheimer's disease pathology for dementia in the presence of 
cerebrovascular disease (Snowdon, 1997). This finding has been replicated in a similar 
studies demonstrating poorer cognitive function in Alzheimer's disease cases with co-existent 
ischaemic changes when compared with pure Alzheimer's disease cases with comparative 
levels of Alzheimer's disease pathology (Esiri, 1999; Heyman, 1998; Nagy, 1997). 
Prospective clinicopathological studies have documented the high rate of mixed pathology 
(approximately one third) in elderly cases of dementia (Holmes, 1999; Xuereb, 2000). 
Vascular pathology was also found in 31% of clinically diagnosed dementia with Lewy 
bodies cases at autopsy (McKeith, 2000). Alzheimer's disease pathology occurred in 55% of 
subjects with clinically diagnosed VaD (Victoroff, 1995). These results suggest that pure 
dementia pathology is not common and dementia is most likely to ensue in individuals who 
suffer a mixture of neuropathology (Holmes, 1999). This theory is further supported by 
results from a study indicating an inverse relationship between the severity of Alzheimer's 
disease and cerebrovascular pathology in a group of predominantly Alzheimer's disease type 
pathology dementia cases (Goulding, 1999). Possible mechanisms for the association between 
Alzheimer's disease and vascular disease have been reviewed by Kalaria, which discussed 
potential common pathophysiology involving the blood-brain barrier, renin-angiotensin 
system and apoptosis, the role of apolipoprotein E and oxidative stress (Kalaria and Ballard, 
1999). Alzheimer's disease -associated cerebral amyloid angiopathy could stimulate the same 
lesions as arteriosclerotic vascular disease. Evidence for the latter theory includes 
experiments on rat aorta which demonstrate that beta-amyloid (a pathological hallmark of 
Alzheimer's disease) interacts with endothelium. to form superoxide radicals which (a) 
directly damage endothelial lining and (b) alters vascular tone by scavenging relaxing factor 
(Thomas, 1996). 
A large community-based, multicentre neuropathological study has recently reported on 
pathological correlates of late-onset dementia in the first 209 subjects (CFAS, 2001). 
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Alzheimer's disease and VaD pathology were the major pathological correlates of cognltl\, e 
impairment but there were no clear thresholds which predicted dementia status. One of the 
striking findings was the high frequency of neuropathology in individuals without clinical 
dementia. Small vessel disease was the most frequent cerebrovascular pathological feature but 
taken alone was not significantly related to dementia status. Only multiple vascular pathology 
was significantly more common in individuals with dementia than those without dementia 
and even then the difference was small (46% vs. 33%). Intermediate burdens of Alzheimer's 
disease pathology did not cause dementia in the face of additional VaD pathology, contrasting 
with the studies discussed above. The study highlights that other factors must determine if 
moderate burdens of Alzheimer and cerebrovascular pathology lead to cognitive failure. 
2.3.5 Conclusion 
Large vessel disease can cause sudden onset of dementia in the early aftermath of cortical 
stroke, typified by large infarct volumes and atherosclerotic disease of large arteries. Small 
vessel disease may lead to a more insidious dementia onset distant from the stroke event. 
Small vessel disease is characterised by arteriosclerosis, small lacunar infarcts, myelin pallor 
and spongiosis. Alzheimer's disease and vascular dementia frequently co-exist but the reasons 
for this overlap are not yet understood. 
2.4 Risk factors 
Risk factor analysis suffers from the problems of vascular dementia nosology. Variation in 
definitions of vascular dementia and risk factors under investigation can lead to design bias. 
Sample size may lead to types I and 11 errors; some studies discussed below have employed 
multiple significance testing, consequently increasing the prospect of chance differences of 
type I error. Vascular dementia is associated with a high mortality rate (Skoog, 1993), thus 
longer intervals in sampling during longitudinal studies run the risk of sampling bias. Despite 
these difficulties there are clear patterns in risk factors. The methodology of individual risk 
factor studies is beyond the scope of this review. Several large prospective cohorts form the 
basis for a number of risk factor reports, notably the Kungsholmen, Hisayama, Honolulu 
Heart Project, Canadian Study on Health and Ageing, Adult Health Study and Atherosclerotic 
Risk in the Community groups (Aguero-Torres, 1999; Lindsay, 1997; Ross, 1999; Ueda, 
1992). 
2.4.1.1 Blood pressure 
Reports on hypertension provide an interesting insight on the pathogenesis of vascular 
dementia. Longitudinal studies in community cohorts conclude hypertension is an 
independent risk factor for VaD (Fujishima and Tsuchihashi, 1999; Hebert and Brayne, 1995; 
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Knopman, 2001; Launer, 2000; Meyer, 2000; Skoog, 1996; Yamada, 1999; Yoshitake, 1995). 
Due to their proven benefit in reducing stroke risk (Amery, 1985; Dahlof, 1991; MRC 
Working Party, 1992; Staessen, 1997b) it is likely that anti-hypertensive treatment will lower 
the risk of vascular dementia. An observational, longitudinal study of anti-hypertensive use 
did reveal reduced risk of incident dementia in particular with diuretic treatment (Guo, 1999). 
More importantly in one of the first intervention trials, anti -hypertensive treatment was 
associated with a lower incidence of treatment (Forette, 1998). 
In the majority ofpost-stroke cross-sectional studies (Barba, 2000; Censori, 1996; Loeb, 
1992; Tatemichi, 1990) and a few poorly designed community surveys (Boston, 1999; 
Kokmen, 1996) (cross -sectional selected sample and retrospective data collection) indicate 
hypertension is not a risk factor. In one post-stroke sample, hypertension lost its significance 
after controlling for age (Gorelick, 1993). Furthermore, some groups report that relative 
hypotension i. e. systolic BP < 135-140 mm Hg is more prevalent in vascular dementia in 
cross-sectional post-stroke (Gorelick, 1993; Pohjasvaara, 1998) and community groups (Guo, 
1996). A key finding in the longitudinal study in Gothenberg is that individuals who develop 
dementia have a higher, pathological blood pressure before the onset of dementia and blood 
pressure declined more rapidly in those who developed dementia (Skoog, 1996). This fits in 
well with the small vessel disease hypothesis. Hypertension can cause arteriosclerosis and 
lipohyalinosis but if hypotension supervenes, white matter ischaernia may follow. 
2.4.1.2 Age 
Community longitudinal (Fratiglioni, 1997; Hebert, 2000; Ross, 1999; Yamada, 1999; 
Yoshitake, 1995) and cross-sectional studies (Kokmen, 1996; Ueda, 1992) conclude that 
increasing age is an independent risk factor for Val). Post-stroke cross-sectional studies 
repeat this finding (Barba, 2000; Desmond, 2000; Gorelick, 1993; House, 1990; Tatemichi, 
1992; Tatemichi, 1993; Tatemichi, 1990). Since age will predispose to neurodegenerative 
processes, the older the subject the more likely a critical threshold for dementia is attained. 
2.4.1.3 Stroke features 
Stroke is usually included in the definition for vascular dementia, thus will obviously appear 
as a risk factor. Community studies have shown that more than one stroke ftirther increases 
dementia risk (Boston, 1999; Yoshitake, 1995). Cross-sectional prevalence studies conducted 
up to 3 months post-stroke report large hemisphere (i. e. large cortical anterior circulation 
syndromes) as an independent risk factor for dementia (Barba, 2000; Censori, 1996; 
Desmond, 2000; Pohjasvaara, 1998; Tatemichi, 1993; Tatemichi, 1990). However 
longitudinal data indicates lacunar stroke (i. e. small subcortical infarcts) is the most common 
stroke subtype in post-stroke dementia (Ross, 1999; Yoshitake, 1995). This is consistent xvith 
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the different pathophysiology and prognosis of stroke subtypes based on the Oxford 
Community Stroke Project classification scheme (Bamford, 1991). Cortical hemisphere 
infarcts are related to large artery atherosclerotic disease resulting Mi large infarct volumes 
and high mortality in the first year, in contrast to lacunar stroke which is related to small 
vessel disease and low mortality rates. 
2.4-1.4 Diabetes mellitus 
Diabetes is an independent determinant for vascular dementia in both community cohorts 
(Boston, 1999; Fujishima and Tsuchihashi, 1999; Hebert, 2000) and post-stroke samples 
(Censori, 1996; Desmond, 2000; Tatemichi, 1993). The odds ratios quoted tend to lie in the 
range 1.4-2.6. Diabetes is also a risk factor for subtle cognitive deficits in abstract reasoning 
and visuospatial dysfunction (Desmond, 1993) whilst impaired glucose tolerance increases 
the risk of asymptornatic lacunar infarction (Kase, 1989) and vascular dementia (Curb, 1999). 
Some post-stroke studies concluded that diabetes was not a risk factor for VaD (Barba, 2000; 
Loeb, 1992; Tatemichi, 1993; Tatemichi, 1990). Diabetes can exert its adverse effect on 
stroke risk by several mechanisms. The risk of large vessel atheroma is increased which in 
turn may lead to anterior circulation infarction. There may be an indirect effect from cardiac 
disease increasing the risk of cardio-embolic disease due to atrial fibrillation and myocardial 
infarction. There is a theoretical risk of small vessel disease as a result of microvascular 
injury (as occurs in retinopathy and renal disease) or from proximal small vessel atheroma. 
2.4.1.5 Cholesterol 
Hyperlipidaernia and elevated low-density lipoprotein cholesterol are risk factors for vascular 
dementia according to longitudinal data (Meyer, 2000; Moroney, 1999) but cross-sectional 
data has not revealed an association (Barba, 2000; Boston, 1999; Carantoni, 2000). The 
mechanisms of cholesterol increasing dementia risk are probably similar to those mentioned 
above for diabetes. 
2.4.1.6 Ischaemic heart disease 
Longitudinal community studies report ischaernic heart disease is a significant risk factor for 
VaD (Fujishima and Tsuchihashi, 1999; Hebert, 2000; Ross, 1999) as well as post-stroke 
surveys (Gorelick, 1993; Tatemichi, 1990). Atherosclerotic disease results in an increase in 
the proportion of cognitively impaired subjects in the population (Breteler, 1994a; Hofman, 
1997). Atherosclerosis, defined by the presence of carotid artery disease and abnormal ankle- 
brachial pressure index, was predictably associated with VaD but also increased the risk of 
Alzheimer's disease with odds ratios in the ranges 1.9-3.2 and 1.3-1.9 respectively (Breteler, 
1994a; Hofman, 1997). Some post-stroke cross-sectional studies did not find an association of 
ischaemic heart disease with VaD (Barba, 2000; Censori, 1996; Kokmen, 1996). 
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2.4-1.7 Education 
Higher educational level is consistently reported as a protective factor against vascular 
dementia in both community and post-stroke studies (Desmondil 2000; Gorelick, 1993; 
Lindsay, 1997; Pohjasvaara, 1998; Pohjasvaara, 2000; Tatemichi, 1992; Taternichi, 1993). 
Education also protects against Alzheimer's disease (Ott, 1995). 
2.4.1.8 Apolipoprotein E genotype 
Apolipoprotein E plays a vital role in lipid transport. The FA allele is a recognised risk factor 
for coronary artery disease and Alzheimer's disease, probably due to alterations in cholesterol 
handling (Frikke-Schmidt, 2001). Apolipoprotein c4 allele frequency can increase in vascular 
dementia with the association being even stronger in homozygotes compared with 
heterozygotes (Hebert, 2000; Kalman, 1998; Katzman, 1997; Slooter, 1997). Some 
investigations have found an interaction between Apo z4 and atherosclerotic disease. Firstly 
the strength of the association with vascular dementia is increased in the presence of carotid 
artery and peripheral vessel atherosclerosis (Hofman, 1997). Secondly the apolipoprotein E; 4 
genotype is associated with the dementia phenotype only in the presence of atherosclerotic 
disease as indicated by white matter lesions (Skoog, 1998b). It has been suggested that the 
interaction between apolipoprotein E4 and peripheral vascular disease attenuates the 
adaptability of the cerebral vasculature during ageing (Kalaria, 1997a). 
In contrast there are a number of studies which have not found an association between 
apolipoprotein F-4 and VaD (Barba, 2000; Bergem, 1997; Bergem and Laninfelt, 1997; 
Burlinson, 1998; Chapman, 1998; Frikke-Schmidt, 2001). These reports include concordance 
studies in twins. Therefore status of the apolipoprotein F-4 allele as a risk factor for VaD is 
controversial. 
2.4.1.9 Smoking 
Several studies report cigarette smoking as a risk factor for VaD (Fujishima. and Tsuchihashi, 
1999; Gorelick, 1993; Shaji, 1996) and a further noted a non-significant trend towards 
increased risk (Pohjasvaara, 1998). Some have not found an association but again these are 
post-stroke samples with methodological weaknesses (Censori, 1996; Kokmen, 1996; Loeb, 
1992). 
It is interesting that some of the traditional atherosclerotic risk factors (smoking, 
hyperlipidaernia, apolipoprotein FA) are not consistently associated with vascular dementia in 
some of these studies. This may reflect the concept of different pathophysiology in vascular 
dementia compared with, for example, coronary artery disease and peripheral arterial disease, 
as previously discussed. 
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2.4.1.10 Atrial fibrillation 
Several cross-sectional post-stroke studies indicate atrial fibrillation Is associated with 
vascular dementia or cognitive impairment (Barba, 2000; Censori, 1996; Ott, 1997). In one 
report the association was not significant after multiple regression analysis (Censori, 1996) 
but a larger community study demonstrated how atrial fibrillation is an independent risk 
factor not only for vascular dementia but Alzheimer's disease as well, even after adjusting 
for stroke (Ott, 1997). Atrial fibrillation increased the risk of poor cognitive performance in a 
study comparing lone atrial fibrillation subjects with sinus rhythm, supporting the hypothesis 
of atrial fibrillation causing silent cerebral infarction and hence cognitive impairment 
(O'Connell, 1998). 
2.4.1.11 Race 
Studies in North America show that VaD risk is increased in non-Caucasian subjects 
(Desmond, 2000; Tatemichi, 1992; Tatemichi, 1993). 
2.4.1.12 Alcohol 
Excess alcohol consumption is an independent risk factor for vascular dementia according to 
longitudinal conununity and cross-sectional studies (Fujishima and Tsuchihashi, 1999; 
Lindsay, 1997; Yoshitake, 1995). 
2.4.1.13 Aspirin 
A community prevalence study reported aspirin use as an independent risk factor for VaD 
(Lindsay, 1997) which is surprising given the proven benefits of aspirin in primary and 
secondary prevention of cerebrovascular disease (Antiplatelet Trialists Collaboration, 1994; 
Collaborative Group of the Primary Prevention Project (PPP), 200 1). The authors suggested 
this finding may be due to Neymans bias, with aspirin prolonging the survival of subjects 
with VaD but a longitudinal survey also found increased risk of VaD with aspirin use (Hebert, 
2000). Both studies used ICD- 10 (good specificity but poor sensitivity) to diagnose VaD. 
Z4.1.14 Homocysteine 
Elevated plasma homocysteine is now a recognised independent risk factor for vascular 
disease as reviewed by Diaz-Arrastia (Diaz-Arrastia, 2000). The pathophysiological 
mechanism remaining unknown but is possibly related to homocysteine metabolites 
producing free radicals and hence endothelial damage. Increased homocysteine level 
correlates inversely with cognitive ftmction (Lehmann, 1999) and is risk factor for small 
vessel vascular dementia (Fassbender, 1999) and Alzheimer's disease (Clarke, 1998). 
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2.4.1.15 Miscellaneous risk factors 
A variety of other risk factors occasionally appear in studies. Positive correlations with 
vascular dementia have been found for renal disease (proteinuria or nephropathy) (Barba., 
2000; Gorelick, 1993), a family history of dementia (Gorelick, 1993), pesticide exposure 
(Hebert, 2000; Lindsay, 1997) rural location (Hebert, 2000) and residing in an area of socio- 
economic deprivation (Whalley, 1995). Protective factors against VaD include western diet 
and vitamin E consumption (Ross, 1999) and shellfish consumption and exercise for women 
(Hebert, 2000). 
2.4.1.16 Orthostatic hypotension 
A prospective study of non-demented stroke subjects found an increased incidence of 
dementia associated with 'hypoxic-ischaemic disorders' after controlling for demographic 
factors, recurrent stroke and baseline cognitive function (Moroney, 1996). This supported the 
hypothesis that cerebral hypoperfusion might be a contributing pathogenetic mechanism in 
the pathogenesis of dementia. Furthermore the association was stronger in older subjects. 
Orthostatic hypotension is more prevalent in post-stroke dementia compared with non- 
demented subjects 3 months post-stroke (Pohjasvaara, 1998). Orthostatic hypotension has 
been reported as an independent risk factor for stroke in a prospective community study 
(Eigenbrodt, 2000). The concept of abnormal blood pressure and heart rate control, or 
Neurocardiovascular Instability, is discussed in more detail below. 
2.4.2 Conclusion 
Age and hypertension are established risk factors for vascular dementia. Diabetes and 
atherosclerotic disease are probably strong risk factors. A number of stroke characteristics 
predisposing to dementia have been suggested. A variety of other risk factors have only been 
intermittently identified, usually in prospective community cohorts. The same risk factors' 
effects appear to be diluted in post-stroke samples. Blood pressure homeostasis has led to 
useful insights in to the pathophysiology of vascular dementia. 
2.5 White matter lesions and neuroimaging 
Neuroirnaging plays a vital role in the diagnosis of dementia. Cerebrovascular disease on CT 
or MRI is usually a requirement in the diagnostic criteria for VaD as previously discussed. CT 
scanning is the the more common form of neuroirnaging but the advent of MRI has enabled 
more detailed analysis of in vivo neuropathological studies of VaD. Interest often focuses on 
the role of white matter lesions. This finding has been referred to as 'leukoaralosis' 
(Hachinski, 1987) and overlaps with the term 'white matter hyperintensities' as seen on MRI. 
In this discussion the term white matter lesions (WML) will be used for consistency. 
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2.5.1 Neuropathology 
Post-mortern studies have identified the pathology of white matter lesions of neuroirnaging. 
White matter lesions reveal demyelination, gliosis, dilated perivascular spaces, lacunar 
infarction and arteriosclerosis (Awad, 1986; Chimowitz, 1992; Fazekas, 1993; Grafton, 1991; 
Gupta, 1988; van Swieten, 1991b). There are differences in the pathology of periventricular 
and deep white matter hyperintensities on MRI (Fazekas, 1993). Neuropathological studies 
indicate that periventricular hyperintensities may have different underlying pathology when 
compared with deep white matter lesions (Roman, 2002). Periventricular lesions are often 
non-ischaemic, with only larger (>5 mm) periventricular hyperintensities having an ischaemic 
basis (Thomas, 2003). Deep white matter lesions are more frequently related to cerebral 
ischaernia (Thomas, 2002). One study suggested that arteriosclerosis was the key initial 
change followed by demyelination, axonal loss and finally perivascular space dilatation as a 
late change (van Swieten, 1991b). 
2.5.2 Risk factors 
Systolic blood pressure, heart disease and peripheral vascular disease were associated with 
WML on CT in a selected group of referrals to a memory clinic (Amar, 1995). Age, heart 
failure and systolic blood pressure below 130 mm Hg were associated with CT WML in a 
sample of geriatric medical patients (Raiha, 1993). 
MRI studies have found that blood pressure, age and stroke history in dementia (Almkvist, 
1992; Inzitari, 1987) and age and diabetes in a post-stroke sample (Schmidt, 1992) were 
predictors of WML compared with normal controls. A history of hypertension (Schrmidt, 
1995; van Swieten, 199 1 a) and a substantial increase or decrease in diastolic blood pressure 
over 20 years (de Leeuw, 1999) are associated with WML in non-demented individuals. Left 
ventricular hypertrophy, an accurate marker of hypertension, is an independent correlate of 
asymptomatic WML (Kohara, 1999). Community based cross-sectional studies concluded 
that age, prior stroke, hypertension (Breteler, 1994c; Longstreth, 1996), lower forced 
expiratory volume (Longstreth, 1996), history of myocardial infarction, factor V11c and 
fibrinogen levels were significant and independent risk factors for WVIL on MFJ (Breteler, 
1994c). 
2.5.3 Clinical manifestations 
Healthy elderly with WML have subtle cognitive deficits compared with individuals without 
WML (Boone, 1992; Breteler, 1994b; Schmidt, 1993; Steingart, 1987). These cognitive 
deficits are principally in executive control and attentional tasks that are typical of subcortical 
VaD. In contrast others have found no association between WML and cognition in healthy 
elderly but did note that WML were preceded by cognitive decline in old age (Garde, 2000; 
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Hunt, 1989). WML are increased in dementia and are more common in VaD than 
Alzheimer's disease (Aharon-Peretz, 1988; Amar, 1995; Barber, 1999; Charletta, 1995). In 
post-stroke samples severity of WML is a correlate of dementia (Liu, 1992; Pohjasvaara, 
2000). However some have found no increase in WML in Alzheimer's disease compared Nvith 
normal controls (Erkinjuntti, 1994; Raiha, 1993). 
A case controlled study has confirmed that gait disorder and urinary incontinence are more 
common in individuals with WML (Tarvonen-Schroder, 1996) as suggested 'in a review 
article (Roman, 1987). 
2.5.4 Conclusions 
WML have similar risk factors compared with stroke indicating a vascular aetiology. This is 
supported by neuropathological correlates. WML are associated with poorer cognitive 
performance in healthy elderly and vascular dementia. However WML can be asymptomatic 
indicating that other factors influence the expression of cognitive impairment. 
2.6 Neurocardio vascular instability 
2.6.1 Normal ageing 
The cardiovascular system is regulated by the autonomic nervous system to maintain an 
appropriate level of perfusion to all organs. There are afferent neural connections from the 
heart and blood vessels to the central nervous system. Central processing leads to an efferent 
outflow of parasympathetic and sympathetic activity back to the heart and vessels (Spyer, 
1992). The system is designed to increase heart rate and peripheral resistance if blood 
pressure falls and decrease these parameters when blood pressure rises. Peripheral 
baroreceptors play a key role in detecting blood pressure changes in the major vessels and 
relay this information to the central nervous system. The speed of this response is known as 
the baroreceptor sensitivity, which may be expressed as the unit change in heart rate per unit 
change in blood pressure. The autonomic nervous system control of the cardiovascular 
system is not thought to qualitatively change in healthy ageing, and this is discussed in more 
detail in Chapter 3. However it is recognised that there are quantitative changes with normal 
ageing. Baroreceptor sensitivity is reduced in healthy aged individuals and the affinity of 
beta-adrenoreceptors for agonists decreases with age (Collins, 1980; Feldman, 1984; Kenny, 
1987; Lipsitz, 1989; Piccirillo, 2001; Shimada, 1986; Spyer, 1992; Veerman, 1994). Despite 
reduced baroreflex sensitivity, it appears that cerebral autoregulation may not deteriorate with 
age (Carey, 2000). 
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2.6.2 The syndrome of Neurocardiovascular Instability 
Abnormal heart rate and blood pressure control is common in the elderly. These abnormalities 
have a number of recognised clinical presentations which include orthostatic hypotension. 
carotid sinus hypersensitivity, vasovagal syncope and supine hypertension. They frequentl-v 
co-exist. This syndrome is referred to as Neurocardiovascular Instability (Kenny and Dey, 
1998). 
Orthostatic hypotension is defined as a reduction in systolic blood pressure of more than 20 
mm Hg or diastolic blood pressure of 10 mnfflg on standing (Anonymous, 1996). Carotid 
sinus hypersensitivity (CSH) is an abnormal response to carotid sinus massage. This has 3 
forms, cardioinhibitory (CICSH) with asystole for greater than 3 seconds, vasodepressor 
(VDCSH) with a greater than 50 mmHg decrease in systolic blood pressure or mixed where 
CICSH and VDCSH co-exist. Vasovagal syncope is a clinical diagnosis of syncope usually 
induced by a precipitating factor or situation which provokes hypotension and/or bradycardia 
sufficiently profound to provoke cerebral ischaenua and loss of neural function. Vasovagal 
syncope is also known as neurocardiogenic syncope and also can be separated into 
cardioinhibitory, vasodepressor and mixed forms (Kenny and Dey, 1998). These hypotensive, 
bradycardic disorders are common causes of dizziness, falls and syncope in the elderly 
(McIntosh, 1993). 
Primary autonomic failure, Multiple System Atrophy and other causes of autonomic failure 
can also lead to orthostatic hypotension and impaired baroreflex sensitivity. Thus 
Neurocardiovascular Instability and autonomic failure, or dysautonomias, are a potential 
cause of hypotensive, bradycardic challenges to the ageing brain and hence ischaemic damage 
to white matter. 
2.6.3 Dysautonornia and stroke 
There are several case series published on transient ischaemic attacks and stroke occurring in 
individuals who suffered from orthostatic hypotension on a background of severe ipsilateral 
carotid stenosis (Dobkin, 1989; Hankey and Gubbay, 1987; Ruff, 198 1). In these cases severe 
hypotensive episodes were temporally connected to cerebral ischaemic damage. A 
clinicopathological series of 145 stroke victims found that 37 cases had no evidence of 
macro-infarction but did have a clear history of hypotensive disorders at the time of stroke 
presentation (Mitchinson, 1980). White matter lesions of small vessel disease have been 
documented in autopsies of patients with severe orthostatic hypotension (Brun and Englund, 
1986; De Reuck and Eecken, 1978; Ginsberg, 1976). 
Small case series have reported a high prevalence of white matter disease on CT and MRI 
studies of individuals with marked orthostatic hypotension (Harrison and Marshall, 1984; 
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McQuinn and O'Leary, 1987). A risk factor analysis for CT white matter lesions in 251 
geriatric patients revealed that orthostatic hypotension was associated with (and supine 
hypotension was an independent correlate for) WML (Raiha, 1993). A case controlled study 
found that systolic hypotension was significantly associated with leukoaraiosis compared with 
normal CT scans (Tarvonen- Schroder, 1996). Orthostatic hypotension in healthy community 
dwelling elderly is associated with severity of lacunes and periventricular hyperintensities on 
MRI (Matsubayashi, 1997). Absence of normal nocturnal dipping in blood pressure and 
excessive dipping in nocturnal blood pressure are both risk factors for white matter disease on 
MRI (Kario, 1997; Tohgi, 199 1). White matter disease is worse in hypertensives (and 
associated with poor cognitive performance) treated with calcium channel antagonists and 
diuretics compared with beta-blocker therapy possibly related to their greater hypotensiN, e 
effect (Heckbert, 1997). Deep white matter disease on MRI correlates with the degree of 
hypotension from CSH or orthostatic hypotension (Ballard, 2000). A study testing the 
hypothesis that borderzone infarcts of differing aetiology would have characteristic patterns 
on diffusion and perfusion weighted MRI did identify a sub-group with normal perfusion 
scans and no evidence of large artery or cardio-embolic disease immediately post-stroke who 
did have evidence of peri-infarct hypotension (Chaves, 2000). This lends support to the 
concept of hypoperfusion causing ischaemia in sclerosed small vessels. 
2.6.4 Dysautonomia and dementia 
Small case controlled studies have demonstrated abnormal parasympathetic function on 
standard autonomic tests in Alzheimer's disease compared with healthy elderly controls 
(Algotsson, 1995; Ehnstahl, 1992; Idiaquez and Sandoval, 1999; Wang, 1994). Impairment of 
sympathetic autonomic function during sleep studies (Aharon-Peretz, 1992; Ferini-Strambi 
and Sn-iirne, 1997; Franceschi, 1986) and on standing (Borson, 1989; Burke, 1994a; Burke, 
1994b; Vitiello, 1993) has also been demonstrated in Alzheimer's disease subjects. Abnormal 
heart rate variability (perhaps reflecting abnormal parasympathetic function) occurs in 
Alzheimer's disease (Aharon-Peretz, 1992). There are very few reports on dysautonomia in 
vascular dementia. A study comparing VaD, Alzheimer's disease and a control group found 
the Alzheimer's disease and control groups had similar autonomic function but the VaD had 
abnormal parasympathetic and preserved sympathetic function (Yamamoto, 1990). 
Orthostatic hypotension is very common in Alzheimer's disease (32-39%), VaD (52%) and 
dementia with Lewy bodies (40%) (Ballard, 1998; Passant, 1997). Orthostatic hypotension 
correlates with middle cerebral artery blood flow and cognitive performance in non-demented 
elderly and the degree of blood pressure reduction in orthostatic hypotension in healthy 
elderly is associated with subsequent cognitive impairment (Elmstahl and Rosen, 1997; Stout 
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and Kenny, 2000). Healthy elderly with orthostatic hypotension have poorer NIMSE and 
visuospatial skills than subjects without orthostatic hypotension (Matsubayashi, 1997). 
Cardio-inhibitory carotid sinus hypersensitivity is markedly increased in Alzheimer's disease 
(28%) and dementia with Lewy bodies (41%) whereas rates in healthy elderly are 
approximately 4% (Ballard, 1998; Wentink, 1993). Vasodepressor CSH is also high in 
Alzheimer's disease (16%) and dementia with Lewy bodies (10%). Elderly subjects with CSH 
have impaired attention and working memory compared with healthy controls (Parry, 1999). 
Hypertension is a known risk factor for VaD and baroreflex sensitivity is impaired in 
hypertension, this relationship being independent of the age (Shimada, 1986). A group with 
VaD due to white matter disease were 'non-dippers' (i. e. absence of normal reduction in 
blood pressure during nocturnal period/sleeping) on 24 hour blood pressure recordings 
compared with controls (Tohgi, 1991) and abnormal circadian rhythm of systolic blood 
pressure is an independent risk factor for MRI white matter lesions (Sander, 2000b). A small 
case series of 6 VaD subjects where evolution of dementia was temporally connected with 
cerebral hypoperfusion revealed marked white matter lesions on CT in 5 out of 6 cases and on 
post-mortern in 3 out of 3 cases (Sulkava and Erkinjuntti, 1987). There are very few 
correlative clinicopatho logical studies but one investigation has shown central noradrenergic 
neurons of the sympathetic system are significantly reduced in Alzheimer's disease but 
unchanged in vascular dementia (Mann, 1982). 
2.6.5 Cerebral blood flow and autoregulation 
During a hypotensive challenge, cerebral blood flow is normally protected by autoregulation. 
Impaired autoregulation may be an integral part of the pathogenesis of white matter disease. 
The results from cerebral blood flow and autoregulation studies over the last 30 years are not 
entirely consistent but do provide some interesting results. Cerebral oxygenation in the frontal 
cortex significantly decreases on standing in healthy elderly (and correlates with attenuated 
diastolic blood pressure rise) but does not change in young controls (Mehagnoul- S chipper, 
2000). However cerebral autoregulation is not impaired in healthy elderly subjects compared 
with young controls (Carey, 2000). Although cerebral blood flow is reduced in hypotension 
due to CSH, this is normally compensated for by intact cerebral autoregulation (Leftheriotis, 
2000). One study found an age related decrease in regional cerebral blood flow in the limbic 
and association cortices and hypothesised this may contribute to normal changes in memory 
in healthy ageing (Martin, 199 1). 
There are contrasting reports on the cerebral blood flow response during orthostatic 
hypotension in individuals with autonomic failure. Some have demonstrated impaired 
cerebral blood flow or a non-significant trend towards impaired autoregulation (Bondar, 
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1997; Lagi, 1994). Others have shown preserved cerebral blood flow and cerebral 
autoregulation (Brooks, 1989; Thomas and Bannister, 1980). One group (Novak, 1998) 
concluded there are three patterns of cerebral autoregulation in orthostatic hypotension - 
normal, extended (i. e. broadened plateau of constant cerebral blood flow for a range of 
cerebral perfusion pressures) and failure of autoregulation. This variety of response is again 
shown in a small series of eleven subjects with orthostatic hypotension where the seven cases 
with symptomatic orthostatic hypotension had abnormal autoregulation in contrast to 
preserved autoregulation in four asymptornatic cases (Wollner, 1979). 
Animal studies have indicated differential autoregulatory behaviour between white and grey 
matter: induced hypotension in newborn dogs produced a selective reduction in cerebral 
blood flow to white matter, initially sparing grey matter (Young, 1982). This is reflected in 
human studies showing cerebral autoregulation is impaired in white matter disease as seen on 
neuroirnaging (Matsushita, 1994; Young, 1982). Cerebral blood flow is reduced in vascular 
dementia when compared with both healthy elderly controls and Alzheimer's disease (Abe, 
1996; Hachinski, 1987; Kawamura, 1991b; Scheel, 1999; Starkstein, 1996). Cerebral blood 
flow is even reduced in asymptomatic subjects with white matter disease on MRI (Meguro, 
1990). Fluctuations in cognitive performance correlate with cerebral blood flow in VaD 
(Meyer, 1988). A small case series reported that white matter cerebral blood flow and oxygen 
extraction fraction was substantially decreased in dementia with small vessel disease but 
white matter cerebral blood flow was more modestly reduced and oxygen extraction fraction 
increased in non-demented individuals who went on to develop dementia I year later (Yao, 
1992). This supports the hypothesis of critically impaired perfusion in small vessel disease, or 
'misery perfusion', as a prelude to white matter damage and dementia. 
Abnormal cerebral blood flow and autoregulation is potentially modifiable. A case series of 7 
individuals with chronic atrioventricular block of 6-36 months duration had symptoms of 
fatigue, poor concentration and memory impairment. Following pacemaker insertion, cerebral 
blood flow and cognitive function improved (Sulg, 1969). Cerebral autoregulation is impaired 
in hypertension but treated hypertensives have intermediate abnormalities compared with 
untreated hypertensives and controls (Strandgaard, 1976). 
2.6.6 Conclusions 
Disorders of blood pressure, heart rate and baroreflex sensitivity are common in dementia. 
Observational studies support the hypothesis that these abnormalities may play a role in the 
pathogenesis of white matter disease and cognitive decline. 
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2.7 Aims and objectives 
This MD thesis will aim to fulfill the following objectives, using a sample of elderly subjects 
with a history of cerebrovascular disease: 
To determine the prevalence of autonomic dysfunction in elderly stroke survIvors 
compared with healthy controls. 
To determine if autonomic dysfunction and blood pressure vanability in elderly 
stroke survivors correlates with white matter disease in a cross-sectional study. 
0 To determine if autonomic dysfunction and blood pressure variability in elderly 
stroke survivors are risk factors for cognitive decline Ma longitudinal study. 
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3 The assessment of cardiovascular autonomic 
function and blood pressure variability 
This chapter will review the physiological basis and utility of cardiovascular autonomic 
function tests employed in this research study. Techniques have evolved over a period of 40 
years, and I will attempt to describe what we can deduce about cardiovascular autonomic 
function from the results of reflex tests and power spectral analysis of heart rate variability. 
The clinical value of these investigations is also discussed. 
I will also review the influence of blood pressure variability on clinical outcomes, in 
particular the relationship between ambulatory blood pressure variability and cerebrovascular 
disease. 
Autonomic research Erequently utilises drugs acting on the cardiovascular system. action of 
the drugs quoted in this section are summarised below. 
Beta-adrenoceptor blocking agents (e. g. propranolol): beta-blockers antagonise the beta- 
adrenoceptors in the heart and peripheral vasculature, thus blocking the action of the 
sympathetic nervous system on the cardiovascular system. 
Atropine: a natural alkaloid that is a highly selective antagonist of acetylcholine at muscarinic 
receptors. The main cardiac effect is increase in heart rate by blocking parasympathetic 
activity at the sinoatrial and atrioventricular nodes. 
Adrenaline, noradrenaline, and phenylephrine: adrenaline and noradrenaline are also known 
as epinephrine and norepinephrine. These are sympathorrUmetics that act on peripheral a- 
receptors to produce vasoconstriction, cardiac 01 receptors leading to increase in heart rate 
and contractility, and peripheral plus cardiacP2receptors that stimulate vasodilatation. 
Adrenaline predominantly acts on a and P, receptors. Noradrenaline mainly acts on a- 
receptors. Phenylephrine has similar vasopressor action with a longer duration of action than 
noradrenaline. 
Guanethidine: this is an adrenergic blocking agent. It is taken up by adrenergic nerve 
tenninals and depletes noradrenaline from nerve terminals causing hypotension. 
Phentolamine: this blocks (x-receptors at both post-synaptic a, and pre-synaptic a2 receptors. 
This leads to postural hypotension and reflex tachycardia. 
Gallamine: a muscle relaxant that leads to muscle paralysis by competitively blocking the 
motor end-plate cholinergic receptor. 
The basic structure of the cardiovascular autonomic nervous system is outlined in Figure 3.1. 
The sympathetic nervous system acts by releasing noradrenaline that leads to peripheral 
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vasoconstriction and increases myocardial contractility and heart rate. The parasympathetic 
nervous system acts by releasing acetylcholine at the cardiac sino-atrial node to increase pulse 
interval i. e. to slow heart rate. 
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Figure 3-1 Cardiovascular autonomic nervous system 
NA, noradmaline: Ach, acetylcholine. 
The brainstem centres involved in regulation of cardiovascular autonomic action are 
illustrated in Figure 3.2. Cardiovascular regulatory areas are located within the brainstem, 
primarily the pons and medulla. Afferent information is supplied from the carotid body and 
aortic arch baroreceptors to the nucleus tractus solitarius. Second order neurones project to 
two sites in the medulla. Firstly cardiac preganglionic neurones which project to the vagus. 
Secondly, GABA-containing neurones (adjacent to the nucleus ambiguus) that project to the 
ventrolateral medulla and then onto the inten-nediolateral cell column that forms part of the 
sympathetic system, and hence projects to the blood vessels and heart. 
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Figure 3-2 Neural circuitry of the baroreflex 
RVLM, rostroventrolateral medulla: NTS, nucleus tractus solitarius: CVLM, caudoventrolateral medulla: ILC, 
inten-nediolateral cell column 
3.1 Cardiovascular autonomic reflex testing 
3.1.1 RR interval and blood pressure response to orthostasis 
Rising from the supine to upright posture elicits a series of cardiovascular reflexes in healthy 
humans. These reflexes are designed to maintain cerebral and systemic perfusion pressure. 
The typical pattern of response is a transient fall in systemic blood pressure, which 
precipitates a rise in heart rate creating a compensatory rise in cardiac output. The subsequent 
increase in blood pressure leads to an overshoot in systemic blood pressure. Finally the heart 
rate slows to allow the cardiac output to decrease; consequently systemic blood pressure 
attains equilibrium. 
This series of haemodynamic changes is controlled by the autonomic nervous system. The 
initial fall in blood pressure is due to peripheral vasodilatation and there is some evidence to 
suggest this may be a cardiopulmonary reflex: local metabolic induced vasodilatation or 
central command mediated cholinergic vasodilatation are other possible contributing effectors 
(Sprangers). The rise in heart rate results from withdrawal of cardiac vagal tone. The rise in 
blood pressure is a sympathetic mediated response, countered by a surge in cardiac vagal 
activity to reduce heart rate. The haemodynamic changes can be measured to give a 
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quan itative assessment of autonomic function. The cardiovascular response to standing is 
depicted in Figure 3.3. 
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Figure 3-3 Blood pressure and heart rate changes on rising from supine to standing position 
The dotted line indicates the moment of rising from supine to standing position. Blood pressure then drops, 
followed by a rise in heart rate then blood pressure rises which leads to decrease in heart rate. 
3.1.1.1 Neural mechanism 
In the course of studying cardiovascular response to isometric exercise, Borst et al observed 
almost instantaneous cardiac acceleration at the start of muscular contraction lasting less than 
one second. The cardiac acceleration was detectable about 0.4 - 0.6 seconds after start of 
muscle contraction, and in conjunction with the work of Freyschuss et al (Freyschuss, 1970) 
they conclude this very rapid response is generated by inhibition of vagal activity (Borst, 
1972). 
The same group explored the mechanisms of initial heart rate response in the first 30 seconds 
of standing. A clear bimodal heart rate response to active standing was observed. Active 
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standing evoked an immediate and rapid heart rate increase, which exactly mirrored heart rate 
change with brief 3 seconds of isometric exercise but was absent during passive tilt (passive 
tilt refers to the patient moving from the supine to upright position whilst resting and secured 
to a tilting table, hence a standing posture is achieved without the subject activating the usual 
sequence of muscle activity). The exercise reflex mediates this increase. This reflex is 
blocked by atropine hence is due to vagal inhibition (Ewing, 1978a; Ewing, 1980b). Afferent 
mechanisms were unclear at that stage (see Isometric Exercise section). The sharp peak in 
heart rate within 3 seconds is followed by another similar magnitude but more gradual peak at 
12 seconds post-stand (the nadir within five seconds does not attain control levels). The 
secondary increase in heart rate leading to the 12 second peak was also witnessed during 
passive tilt and is ascribed to the baroreceptor reflex since it is preceded by a ternporary fall in 
arterial pressure. Again the efferent limb appeared to be mediated by vagal mechanisms. The 
final rapid decrease in heart rate between 12 and 20 seconds is most likely due to reloading of 
arterial baroreceptors. Clearly the heart rate reflex to standing is complex with a number of 
stimuli and afferent mechanisms (Borst, 1982). 
Sprangers (Sprangers, 199 1) concentrated on the cardiovascular changes occurring in the first 
5 to 10 seconds on standing up. It was known that the blood pressure falls abruptly at the start 
of the manoeuvre. Intra-arterial pressure was measured in 10 healthy young adults during 
three manoeuvres; standing, brief strenuous cycling exercise for 3 seconds and passive tilting. 
The cardiovascular changes during standing closely mirrored the cycling exercise transients 
and were quite different to passive tilt. On standing, there was an immediate fall in stroke 
volume (nadir 8% below control level at 2 seconds), an increase in cardiac output (peak of 
24% above control levels at 6 seconds) and a fall in mean arterial pressure (nadir of 25% 
below control levels at 8 seconds). Therefore the calculated total peripheral resistance 
promptly fell by 41% at 8 seconds after the start of standing. Because the circulatory 
transients resembled the changes seen after cycling but not passive tilt, it was hypothesised 
the active part of standing triggers the fall in peripheral resistance. Two subjects also had 
right atrial and oesophageal pressure monitored that demonstrated abrupt rises in right atrial 
pressure of 10 mmHg on standing prior to the fall in peripheral resistance. This was consistent 
with a rise in cardiac filling pressure as a result of muscle contractions displacing blood to the 
thorax. The authors hypothesised the fall in peripheral resistance was most likely to be due to 
the cardiopulmonary reflex, in order to accommodate the shift in circulating volume to the 
thorax. 
The plots of pressure against time in the Sprangers paper depicts a very brief rise in diastolic 
(and to a lesser extent mean arterial) pressure but not systolic pressure that peaks within 2-1 
seconds before decreasing to the nadir levels around 8 seconds. In a study of orthostatic 
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circulatory control in the elderly using the Finapres, this initial very brief rise in pressure is 
found in both systolic and diastolic arterial traces before also decreasing to nadirs at around 8- 
10 seconds (Imholz, 1990a). 
Muscle and baroreceptor afferent nerve activity generated by standing is coordinated in the 
nucleus tractus solitarius. Consequently vagal and sympathetic efferent outflow is adjusted. 
The immediate adjustment, the exercise reflex, generates a very brief cardioacceleration at 3 
seconds and is not part of routine measurement of autonomic function (i. e. is not in the Ewing 
protocol). However subsequent changes from approximately five seconds onwards are 
baroreflex mediated and do form one of the baroreflex tests. In an early description by Ewing, 
the measurement was known as the 30: 15 ratio (Low, 1993a). Ewing et al proposed the 30: 15 
ratio as a test of cardiovagal autonomic function. They studied a group of 22 healthy male 
adults and 25 diabetic patients, 15 of whom had autonomic neuropathy. Subjects were supine 
for three minutes then stood within 5 seconds. In healthy controls and diabetics, R-R interval 
changes tend to reach a trough then peak at a similar number of heart beats following the 
posture change. The trough RR usually occurs at or around the 15 th beat, the peak RR interval 
at or around the 30thbeat, hence the 30: 15 ratio was used to quantify the response. The ratio 
was higher in younger compared with older controls, similar between non-neuropathic 
diabetics and controls but significantly diminished in diabetic patients with autonomic 
neuropathy. The heart rate response was abolished with atropine alone or in combination with 
atropine and propranolol but not with propranolol alone. Therefore the 30: 15 ratio is 
dependent on vagal nerve function (Ewing, 1978b). 
In younger normal controls, the peak and trough heart rates occur around 12 and 22 seconds 
after standing (Wieling). Hence the '30: 15' ratio quantifies the heart rate changes during 
change in posture. The ratio reflects the integrity of cardiovagal function. Ewing proposed 
using the 30: 15 ratio as part of a battery of bedside autonomic function tests (Ewing and 
Clarke, 1982) 
Ewing et al also investigated the autonomic mechanisms underlying the initial heart rate 
changes after standing. Essentially these tests demonstrate that the RR changes after standing 
are under vagal control, with increased sympathetic activity occurring only if the vagus is 
blocked. Atropine has a dual action on the RR changes on standing. Firstly the RR shortening 
decreases and occurs later than the 15ffi beat when compared with non-atropinised controls. 
Secondly the rebound RR lengthening is abolished. There is no dose effect with atropine. 
Addition of Propranolol to atropine further minimises the RR changes. Propranolol alone does 
not alter the pattern of changes but does result in an earlier RR peak lengthening. Therefore 
(1) the heart rate changes on standing are predominantly controlled by vagal activity, with 
initial vagal withdrawal followed by a surge in vagal activity and (2) in the situation of %, a, -, al 
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blocking, sympathetic activity can produce a moderate increase in heart rate on standin 2 
(Ewing, 1980b). Others have also shown atropine significantly reduces but does not abolish 
the RR responses during orthostasis (Julu, 1992). This demonstrates the 30: 15 ratio is highly 
dependent on but not entirely dictated by cardiovagal function. 
There are other influences on the 30: 15 ratio, and a decreased ratio can occur from causes 
other than vagal damage. This pitfall is reflected by a case with isolated sympathetic 
vasomotor failure but intact vagal function. This individual was not able to mount a blood 
pressure overshoot during orthostasis, therefore did not produce a compensatory decrease in 
RR interval: the 30: 15 ratio was greatly diminished but this was not due to vagal damage (van 
Lieshout, 1989). 
Burke et al analysed muscle sympathetic nerve activity (MSNA) in eight healthy adults 
during recumbency, sitting and standing. Note that measurements were usually taken a matter 
of minutes after the change in posture to the sitting or standing position since activity 
involved usually necessitated repositioning the peroneal nerve electrode recording MSNA 
(usually within 2-15 minutes). MSNA was fairly consistent within individuals in the same 
position from one 3 minute period to the next but there were large differences in burst 
incidence (number of bursts/number of heart beats) between individuals. Bursts per minute 
consistently increased from supine to sitting and from sitting to standing positions. Heart rate 
increased on both occasions, with on average a greater increase during sit to stand. Burst 
incidence (bursts per heart beat) also increased from supine to standing position but there was 
no overall change in burst incidence from sitting to standing position. The magnitude of the 
change in burst incidence from supine to sitting was inversely related to the former positions' 
burst incidence (r = -0.76). The results also infer that the increase in sympathetic activity from 
sitting to stable standing position is mainly reflected by tachycardia. For either positional 
change, change in burst incidence was inversely related to change in heart rate (linear 
regression r= -0.8 1) thus heart rate and MSNA increase would complement respective 
activity to generate the desired sympathetic response on postural change. Postural 
compensating mechanisms are discussed and the authors make the point that the large 
variation in MSNA when supine (10 to 83 bursts/100 heart beats) raises questions about how 
those with the lowest MSNA can decrease MSNA and those with the highest activity can 
further increase activity. However sitting and standing are the true resting physiological 
postures and the minimal burst incidence in the sitting position was 42 bursts/I 00 heart 
beats. 
Therefore there is scope to up- and down-regulate MSNA from the midrange but those 
individuals with a high sitting MSNA are probably reliant on heart rate increase to generate 
the required blood pressure response on standing (Burke, 1977). 
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3.1.1.2 Age 
Imholz et al (Imholz, 1990a) observed the heart rate and blood pressure changes occurring in 
40 healthy elderly adults over 70 years of age. There was no younger control group but they 
demonstrated that qualitative changes in orthostatic circulatory responses in the elderly study 
group were no different firorn previous studies of younger adults. Prolonged standing for ten 
minutes to assess steady state responses indicated that, excluding the initial nadir v,, ithin 15 
seconds, the lowest blood pressure values occurred at one minute standing then blood 
pressure gradually increased whilst heart rate remained stationary. 
Age has a strong quantitative effect on the 30: 15 ratio. There is a reduction in the heart rate 
response on standing (Collins, 1980). There is a negative linear influence on the 30: 15 ratio 
with increasing age (Ewing, 1978a; Ewing, 1985; O'Brien, 1986; Vita, 1986; Wieling, 1982). 
Age appears to account for 30% of the variance of the 30: 15 ratio in normal subjects (OBrien, 
1986). One study did not find a relationship for age and log-transforined values of the 30: 15 
ratio in 85 subjects aged from 31-92 years (Clark and Mapstone, 1986). The peak heart rate 
occurred slightly later in a study comparing young and elderly (70-86 years old): the younger 
and older groups' peak RR intervals were recorded at 12 and 14 seconds respectively after 
standing but this difference may have been largely influenced by the increased time to attain 
standing posture (3 ±I vs. 6±I seconds) in the elderly. The same study found the magnitude 
of initial decrease in BP was not different between healthy young and elderly, since in the 
older group the smaller increase in cardiac output, achieved by heart rate increase, was offset 
by a smaller decrease in peripheral resistance on standing (Wieling, 1992). Thus the young 
adapt to standing by a greater RR shortening to counter peripheral blood pooling, whereas the 
attenuated RR shortening in the elderly is compensated by greater peripheral resistance. 
Ziegler et al found postural blood response did not vary with age in subjects aged 15-67 years 
(Ziegler, 1992b). Piha measured systolic blood pressure 30 seconds after standing and this 
index did decline with age (Piha, 1993). 
3.1.1.3 Other influences 
There is no gender effect on the 30: 15 ratio (Ewing, 1985; Gemtsen, 2003; Netten, 1992; 
Wieling, 1982). 
3.1.1.4 Repeatability 
Some investigators advocate adhering to the RR values close to the 15 th and 3 Oth beats for the 
30: 15 ratio. (Ewing, 1978b). However there may be difficulties in achieving a prompt 
standing manoeuvre in individuals with joint disease, muscle weakness, frailty etc. There may 
also be a delayed vagal action with trough and peak RR intervals occurring outside these 
expected times. This drawback leads to considerable indi vidual differences in the RR-33 0: RR 15 
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ratio, which underestimates the true maximum and minimum RR values (O'Brien, 1986; 
Wieling, 1982). Thus the RRmax: RRmin is a superior value to assess vagal activity. Other 
research confirms this approach, with the finding that the shortest RR 'interval occurs in beats 
5- 25, and the longest RR interval between beats 20 - 40 (Ziegler, 1992b). There is no 
significant relationship between resting heart rate and the 30: 15 ratio (Ewing) 
Some investigators take the view that the test range for RRmax: RRmin is too low in older 
individuals aged more than 65 years to allow differentiation between normal and abnormal. 
The difference in heart rate between baseline and peak heart rate within 15 seconds of 
standing provided a greater test range of results and is thought to be a better value for vagal 
investigation (Piha, 1993; Wieling, 1997). Another group (Gerritsen, 2003) have extended 
this concept by taking the difference between mean RR interval I minute prior to standing 
and the minimum RR interval within 15 seconds of standing, and this measure does perform 
better than the RRmax/min in terms of reproducibility and correlation or concordance with 
other autonomic tests. Co-efficient of variation for the RR min was 14% compared with 39% 
(transformed) for the RRmax/min- 
Investigations of the repeatability of the 30: 15 ratio have found conflicting results. In the 
original Ewing paper, co-efficient of variation (CV) for 30: 15 ratio was 5.3% in five young 
controls tested on different days (interval not stated) (Ewing, 1978b). Ewing et al reported the 
individual differences in 18 adults tested on three occasions were only significantly different 
on three out of 52 occasions. However they do not provide any statistical summary of results 
(Ewing, 1980b). Wieling reports repeatability to be high (Wieling, 1997). Another study 
found the between sub ect variation to be the same as within subject variation in a series of 
repeat tests over four weeks. They used a window of ten beats around the 15 th and 3 Oth beats. 
In practice this suggests the test is not suited to follow-up testing to track progress and raises 
doubts on the accuracy of the measurement (Lawrence, 1992b). The within subject 
SD/between subject SD ratio of the 30: 15 ratio is smaller in diabetic patients compared with 
normal controls, and this property improves the tests ability to identify meaningful differences 
between cases (Lawrence, 1992a). Furthermore the 'windowed' 30: 15 ratio had a better 
(lower) within/between subject SD than the exact 30: 15 ratio. 
When describing repeatability, an 'adapted coefficient of variation' is a more appropnate 
method. The adapted CV is obtained by subtracting I from the mean CV, so that the 
relationship between the standard deviation of repeat measurements and the mean of repeat 
measurements is maintained as results approach the no-response unity value (Murray and 
Lawrence, 1993). This technique was not used in earlier studies of repeatability NvIthIn small 
groups of normal cases but nonetheless they both found the CV was approximately 
9% 
(Netten, 1992; O'Brien, 1986). 
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A large group of 177 diabetic patients had repeat autonomic tests separated by at least 3 
months. The authors report the mean 30: 15 ratio remained unchanged. Mean peniod of time 
separating sequential testing is not clear, therefore it is difficult to say if the 30: 15 ratio has 
good repeatability or conversely if it did not respond to any change that may have occurred in 
this particular group. One suspects the latter since the authors infer the follow-up period, ývas 
several years, and secondly many of the subjects already had abnormal responses at their first 
visit (Ewing). 
3.1.1.5 Test methodology 
There is some debate on the ideal test conditions and protocol for assessing the RRmax: 
RRmin. Although the degree of drop in blood pressure may theoretically vary with the time of 
testing, one group found no diurnal variation in the RRmax: RRmin (Wieling). Normal 
practice requires change in posture is from supine to standing upright but the cardiovascular 
responses are comparable when starting from either supine or sitting positions (Ten Harkel, 
1990). However the responses are clearly dependent on the length of the preceding rest period 
before posture change: HRmax can differ by 20% - 32% when comparing rest periods of I 
and 20 minutes (Borst, 1982; Ten Harkel, 1990). Thus test conditions need standardisation. 
Five minutes rest would appear to be sufficient. Imholz compared Finapres performance to 
intra-arterial pressure and found the Finapres overestimated trough systolic pressure by 3 
mmHg and diastolic by 2 mmHg, neither of which were significant. Values at 30 and 120 
seconds tended to be significantly lower in each case, more so for diastolic pressure (Imholz, 
1990b). 
3.1.1.6 Relationship with other cardiovascular autonomic tests 
The 30: 15 ratio appears to be closely associated with total, high and low frequency powers of 
heart rate variability from power spectral analysis (Freeman, 1991). There is poor correlation 
between RRmax/min and the LE ratio derived from heart rate variability during metronomic 
breathing, despite their shared vagal mechanisms. This underlines the different afferent 
mechanisms of the heart rate changes (Wieling). Others have demonstrated weak but 
significant correlations of the 30: 15 ratio with RR interval variation, heart rate response to 
deep breathing and the Valsalva ratio (Vita, 1986). The relative change in heart rate for 
standing is less than that seen during the Valsalva manoeuvre and more than that seen during 
metronomic respiration (O'Brien, 1986). 
Clinical application 
The heart rate response to standing is a simple bedside test of autonomic function. In an carly 
clinical study of a small number of 21 adult diabetic patients, Bennett found three pattems ot- 
response on standing, using data from other cardiac autononuc tests. 
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Normal response with a tachycardia and little or no fall in systolic BP. 
An initial fall in systolic BP which recovered without further increase in heart rate; 
this group had normal overshoot with Valsalva indicating intact vasoconstrictor 
response. 
A third group with a fall in systolic BP which was subsequently partially attenuated 
by a marked tachycardia; this group lacked overshoot for the Valsalva indicating loss 
of vasoconstrictor response and therefore the tachycardia/partial BP recovery was 
achieved via cardiac sympathetic drive. 
One case had profound hypotension and no tachycardia, indicating severe combined 
sympathetic and vagal failure (Bennett, 1975). 
Ewings' original 30: 15 paper described the value of the test in identifying diabetic patients 
with autonomic neuropathy. All 15 diabetic patients with neuropathy had a 30: 15 ratio less 
than 1.03, less than both the healthy controls and non-neuropathic diabetic groups (Ewing, 
1978b). One of the more common clinical uses is in diabetic patients where the 30: 15 ratio is 
a sensitive test for neuropathy (Ziegler, 1992a). The American Diabetes Association do not 
mention the 30: 15 ratio in their report of Standardized Measures in Diabetic Neuropathy 
(Anonymous, 1995). The American Academy of Neurology do recommend the heart rate 
response to standing as a test of cardiovagal function (AAN, 1996a). They summarise the test 
as being sensitive, specific and reproducible (in contrast to Lawrence et al (Lawrence, 1992a; 
Lawrence, 1992b)), as well as simple, safe and cost-effective. One author does not advocate 
the 30: 15 ratio because of its complex physiology and ill-defined confounding variables 
(Low, 1993a). There are studies indicating the 30: 15 ratio is not a sensitive test for diabetic 
autonomic neuropathy, and certainly not as sensitive as heart rate variation during deep 
breathing. Mackay et al (Mackay, 1980) assessed 287 diabetic patients; the 30: 15 ratio 
equivalent was abnormal in 57% cases with autonomic symptoms but sensitivity improved to 
90% when detecting the combined groups of borderline abnormal (between 1.5 and 2 SD of 
control values) and frankly abnormal (less than 2 SD control). However repeat tests remained 
abnormal in 90% cases when repeated within a year. 
Dyrberg et al (Dyrberg, 198 1) also report poor sensitivity for detecting autonomic neuropathy 
in a cohort of 75 diabetic patients compared to 28 controls. The diabetic patients were split 
into 3 groups according to duration of diabetes. Other autonomic tests demonstrated 
increasing frequency of abnormal results with increased length of diabetes but the 30: 15 ratio 
did not show any differences when compared with control values (1.14) or within the diabetic 
groups (diabetes up to 9 years 30: 15 = 1.14,10-19 years 30: 15 = 1.15,20-40 years 30: 15 
1.10). 
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Normal blood pressure response to standing remains a matter for debate. A consensus 
statement on definition of orthostatic hypotension in 1996 stated a cut-off of >20 mmHg 
systolic and >I 0 mmHg diastolic drop in blood pressure as abnormal. No reference was made 
to associated symptoms (AAN, 1996b). Wieling et al report a systolic fall of > 40 mmHg and 
diastolic fall of > 25 mmHg as abnormally large changes on standing (Wieling, 1992). 
Conclusion 
In the first 30 seconds after standing, sympathetic and parasympathetic activity produce 
distinctive patterns of RR and blood pressure response. Peripheral resistance falls 
immediately to accommodate sudden thoracic filling therefore blood pressure falls. There is a 
bimodal peak in heart rate due to vagal withdrawal, with the second peak the larger and more 
important of the two. Combined cardioacceleration and MSNA output rescue the falling blood 
pressure, creating a blood pressure overshoot. This is buffered by vagally driven heart rate 
slowing. The RRmax/RRmin ratio (otherwise known as the 30: 15 ratio) reflects vagal 
integrity. Blood pressure drop is dependent on a number of factors. RRmax/RRmin declines 
with age. Clinical utility is debateable and reproducibility is moderate at best. 
3.1.2 The Valsalva Manoeuvre 
The Valsalva manoeuvre is a respiratory manoeuvre that tests baroreflex sensitivity. It is 
named after Antonio Maria Valsalva (1666-1723). The Valsalva manoeuvre is performed by 
forced expiration at a constant pressure for a fixed time whilst at rest. By ensuring a small air 
leak in the expiratory apparatus, the glottis remains open during expiration to ensure that the 
connection between mouth and airway remains continuous. The physiological changes 
required for forced expiration increases intrathoracic and intra-abdominal pressure. 
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Figure 3-4 The haemodynamic consequnces of the Valsalva manoeuvre 
'Valsalva' block represents the duration of forced expiration with an open glottis. The tachogram 
depicts the 
pattern of blood pressure and heart rate changes. 
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This produces a sequence of changes in heart rate and blood pressure dictated by the 
autonomic system reacting to the cardiovascular stress that results from the pressure increase. 
The haemodynamic response to the Valsalva manoeuvre is depicted in Figure 3.4. 
3.1-2.1 Heart rate response 
As the blood pressure falls during forced expiration, the heart rate quickens in order to 
improve cardiac output. This tachycardia reaches a maximum just after the end of forced 
expiration. This may be expressed by the minimum RR interval. When blood pressure 
rebounds shortly after the end of forced expiration, heart rate slows leading to a maximum RR 
interval. This maximum usually occurs within 30 seconds of the start of the procedure. Heart 
rate then moderately increases to settle back to a rate similar to that at baseline. The ratio of 
maximum: minimum RR intervals during the manoeuvre is known as the Valsalva ratio 
(Levin, 1966). The heart rate changes are shown in the lower panel of Figure 3.5. 
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Figure 3-5 Blood pressure phases and heart rate response to the Valsalva manoeuvre 
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3.1.2.2 Blood pressure response 
The blood pressure changes follow a pattern split into 4 phases (Hamilton,, 1936) that are 
shown in the upper panel of Figure 3.5. The following description includes physiological 
observations made by Greenfield et al (Greenfield, 1967) from direct recordings of arterial 
pressures in 8 normal subjects who underwent renal angiography. Valsalva manoeuvre was 
performed with expiratory pressure of 40 mmHg for 25 seconds. 
IA very transient rise in blood pressure within 2-3 seconds, a mechanical effect due to 
the rise in intrathoracic and intra-abdominal pressures that compresses the aorta. Stroke 
volume (SV) and aortic cross-sectional area do not change (Greenfield, 1967). Total 
autonomic blockade does not alter arterial pressure transients of phase 1, confirming its 
mechanical basis (Korner, 1976). 
Ile A fall in blood pressure, early in phase 11. The rise in intrathoracic pressure impedes 
venous return, affecting cardiac output therefore blood pressure gradually falls in Ile. Wexler 
et al (Wexler, 1968) recorded abrupt decrease to near zero in inferior vena cava (IVC) flow 
from the start of straining until the end of straining in four subjects. In this experiment, 
straining was for 20-30 s, and on some occasions IVC flow moderately increased towards the 
end of straining. The drop in systolic blood pressure was partially cushioned by a tachycardia 
dependent on vagal withdrawal. There is another reaction to the fall in blood pressure in terms 
of sympathetic function which creates a biphasic pattern of early and late phase 11 (Ile and 
llý. Greenfield (Greenfield, 1967) found a rapid decrease in SV and arterial pressure but a 
25% increase in peripheral vascular resistance 
ill A moderate rise in blood pressure, late in phase 11. An intact autonomic system 
recognises the preceding deterioration in blood pressure and the ensuing sympathetic outflow 
produces a small rise in blood pressure predominantly by increasing peripheral arterial 
resistance (up to 50% greater than control values at end strain) and also acting on the 
capacitance beds (Greenfield, 1967). This will usually return the blood pressure to 
approximately baseline levels in normal subjects. Wexler recorded a brief period of increased 
IVC flow velocity immediately after release of strain (Wexler, 1968). In a review, Eckberg 
described increases in efferent sympathetic neural outflow to limb muscles, plasma 
epinephrine and total peripheral resistance in phase Ill (Eckberg, 1980). 
III A drop in blood pressure. This is the sudden fall in blood pressure, which is a 
mechanical effect due to fall in intrathoracic pressure that occurs immediately after cessation 
of forced expiration. This only lasts 1-2 seconds. Sudden augmentation of left ventricular 
afterload may contribute to the drop in blood pressure that principally results from sudden 
expansion of the great vessels (Eckberg, 1980). Greenfield noted a reduction in peripheral 
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resistance but stroke volume did not change. Total autonomic blockade does not alter arterial 
pressure transients of phase 111, confirming its mechanical basis (Komer, 1976). There is an 
additional burst of sympathetic activity causing a further increment in heart rate (Eckberg, 
1980). 
IV The final rise in blood pressure. This is the peak blood pressure attained during the 
blood pressure overshoot which normally occurs within the 15 seconds after termination of 
forced expiration. During phase IV, venous return, stroke volume and cardiac output return to 
normal, against a backdrop of elevated peripheral arterial pressure. Hence blood pressure rises 
above control values in phase IV. Greenfield found stroke volume and arterial pressure rose 
rapidly to control values after 6-9 beats, peripheral vascular resistance fell to control values 
within 3 beats of release and aortic area increased. Maximal SV was achieved in the range of 
6-15 beats post-release (Greenfield, 1967). 
The calculation of blood pressure changes for each of these phases is depicted in Figure 3.6. 
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Figure 3-6 Blood pressure measurements for phase I to phase IV of the Valsalva manoeuvre 
3.1.2.3 Neural mechanism 
The bradycardia occurring during the post-expiratory phase is mediated by parasympathetic 
neural activity via the vagus. However it is not clear if the tachycardia is predominantly 
due 
to sympathetic drive or vagal withdrawal (Bennett, 1976). Spodick et al (Spodick, 1974) 
demonstrated a significant beta-adrenergic component to fluctuation in heart rate in the 
first 
three phases. Beta-blockade slowed the heart rate during early strain, end strain and early 
in 
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phase IV. However there was no difference in the post-release bradycardia. Overall the RR 
interval changes followed the same qualitative course despite beta-blockade. 
One group found the Valsalva ratio did diminish with atropine but was not abolished: 
furthermore there was no significant response to low-dose atropine, unlike the RR variability 
during deep breathing (Rothschild, 1987). Another report noted the Valsalva ratio is non- 
significantly reduced after atropinisation, adding weight to the view that the Valsalva ratio is 
not purely reliant on cardiac vagal function (Julu, 1992). 
Bennett et al (Bennett, 1976) described the Valsalva manoeuvre as a test of baroreflex 
function: individuals with abnormal RR and blood pressure response also had decreased 
baroreflex sensitivity using the phenylephrine technique. Lack of normal BP overshoot 
indicated an efferent lesion with loss of vasomotor function. 
The sympathetic system is thought to mediate the increase in systemic blood pressure in 
phase 4. It is generally assumed to result from vasoconstriction but a group of healthy normal 
controls demonstrated responses in two groups, either forearm vasoconstriction or forearm 
vasodilatation, whilst all had normal Valsalva ratios i. e. no evidence of autonomic 
neuropathy. Some diabetics also had post-manoeuvre forearm vasodilatation with no other 
evidence of neuropathy. In contrast those with orthostatic hypotension also had post- 
manoeuvre forearm vasodilatation plus abnormal heart rate variability (Bennett, 1979). 
W- Komer et al investigated the impact of autonomic blockade on the four phases. Phase 11 mean 
arterial pressure was greatly diminished, and phase IV overshoot was abolished by total 
autonomic block (using atropine, propranolol and guanethidine), confirming their reliance on 
autonomic modulation. Physiological parameters were studied in greater detail during 30 and 
45 seconds of expiratory pressure, and these measurements concentrated on the parameters 
during the final 10 seconds of expiration i. e. phase 11. The impact of atropine and propranolol 
(cardiac autonomic blockade) and then with the addition of guanethidine to block sympathetic 
vasoconstriction (total autonomic blockade) was assessed. Mean arterial pressure increased 
with increasing expiratory pressure (10 to 30 mmHg), but this was largely abolished by 
cardiac autonomic blockade (atropine and propranolol), and additional sympathetic 
vasoconstrictor block with guanethidine led to a large decrease in arterial pressure. Heart rate 
increase was severely restricted to the same extent with atropine and propranolol alone or 
with the addition of guanethidine. Rise in total peripheral resistance increased with greater 
expiratory pressure, this change was not affected by atropine and propranolol but was 
abolished by guanethidine. Overall the experiment indicated the complex afferent input and 
the variable role of pathways according to expiratory pressure (Komer, 1976). 
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Sandroni et al conducted a detailed investigation of the components of the Valsalva 
manoeuvre and came to several conclusions regarding blood pressure changes (Sandroni, 
1991). 
1) The BP changes in the Valsalva manoeuvre, detect adrenergic vasoconstrictor failure 
with more sensitivity than orthostatic BP recordings: adrenergic failure leads to a 
reduction in III in patient groups with orthostatic hypotension (established and 
borderline) and sympathetic sudomotor failure. Those worst affected patients had 
more severe falls of BP at Ill plus absent phase IV. 
2) Alpha-adrenergic blockade led to a reduction in 11 but increased IV blood pressure. 
The former suggests Ill is due to alpha-adrenergic activation but IV reflects the effect 
of cardioacceleration in response to preceding fall in BP. 
3) Beta-blockade with propranolol markedly reduced blood pressure at IV, with a 
smaller reduction in phase 11 again consistent with the theory that IV is more 
dependent on cardioacceleration and 11 is more dependent on peripheral adrenergic 
function. 
4) In summary, Ill is more dependent on peripheral sympathetic innervation whereas IV 
is produced by cardiac sympathetic innervation. 
Another detailed investigation provided further insight to the complex blood pressure changes 
of the Valsalva manoeuvre, this time using healthy controls and examining muscle 
sympathetic nerve activity (MSNA) during the test phases (Smith, 1996). 
1) There was a highly significant correlation between straining and increases in MSNA 
during straining, and with the phase IV BP elevation 
2) There was a highly significant correlation between peak MSNA and the change in 
blood pressure from phase III to IV, suggesting this increase in BP is secondary to 
MSNA activity (seemingly at odds with Sandroni et al (Sandroni, 199 1)) 
3) The times to return to baseline systolic blood pressure, sympathetic activity and the 
occurrence of the first post-straining sympathetic burst correlated significantly with 
the intensity of straining (measured using different expiratory pressures of 10,20 and 
30 mmHg) 
4) There was no significant RR variation using an expiratory force of 10 mmHg; R-R 
variation became progressively larger with pressures of 20 and 30 mmHg 
5) Aortic cross-sectional area, which was highly reproducible within the 4 cases 
examined, tended to decrease during straining below control levels and then increased 
above control levels after the forced expiration 
They conclude that (i) MSNA is proportional to straining level and is a function of the artenal 
baroreflex, and (ii) arterial blood pressure elevations estimate sympathetic nerve activity and 
reflect integrity of the arterial baroreflex. They hypothesise that changes in baroreceptor 
activity are more important than absolute levels, and that baroreceptor outflow may reset to 
preceding pressure transients that last only seconds. 
There are some pathological studies indicating the type of neural damage underlying 
abnormal Valsalva ratio response. Diabetics (who unfortunately did not have ante-mortem 
autonomic function testing) were found to suffer loss of autonomic nerve fibre density with 
demyelination and occasional axonal degeneration (Low, 1975). Abnormal blood pressure 
responses (progressive fall in BP throughout phase 11 and lack of overshoot in phase IV) were 
found to have different substrates according to the underlying clinical syndrome. Cases with 
pure autonomic failure or parkinsonism with sympathetic neurocirculatory failure had 
evidence of loss of myocardial sympathetic nerve terminals whereas multiple-system atrophy 
cases had evidence of intact sympathetic terminals and absent nerve traffic (Goldstein, 1997). 
A normal VR taken alone should not be viewed as a marker of baroreflex integrity, since RR 
variation can occur in patients with complete but isolated sympathetic failure (van Lieshout. 
1989). 
Some investigators have commented on 'square wave responders' referring to the abnormal 
BP pattern in a small number of cases: the BP remains high throughout the straining phase 
and the overshoot is absent (Zema, 1980). But this square wave response can change to a 
normal sinusoidal. response by changing from the recumbent to sitting position (van Lieshout, 
1989). Robertson et al reported reductions in left ventricular end-diastolic and end-systolic 
volumes of around 10% and left atrial diameter by 3 0% but in cardiac failure there was 
proportionately less decrease in left atrial dimension (Robertson, 1977). In keeping with 
Levin's hypothesis, the square wave response may be a result of larger intra-cardiac blood 
volume in certain individuals (Levin, 1966). Square wave response is mostly reported in 
patients with congestive cardiac failure (Eckberg, 1980). 
3.1.2.4 fvAm Age 
As Low has discussed, there are conflicting results with regard to the influence of age on the 
VR (Low, 1990). Studies of healthy normal controls have not find any relationship between 
age and VR (Benarroeh, 1991; Ewing, 1985; Vita, 1986). Levin found a small non-significant 
decrease in VR with age but only assessed middle-aged groups (Levin, 1966). A larger study 
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of 425 normal controls aged 9-79 did show a significant negative correlation between age and 
VR (plus a weaker clinically irrelevant association with BMI) (Gelber, 1997). Generally 
though the majority view is that the Valsalva ratio does decline with age (Clark and 
Mapstone, 1986; Smith, 1984; Smith and Smith, 1981). Low's discussion and summary of 
published studies on the effect of age on VR suggests the inconsistencies are due to lack of a 
standardised protocol for the manoeuvre. The studies with negative findings tended to be 
studies with smaller numbers, more compacted age range or using the supine position. From 
his own cohort of 155 subjects, there was a significant inverse relationship between age x and 
VRy (Low, 1990). 
2.27- O. Olx R=0.5 p<0.001 
Smith et al's (Smith and Smith, 198 1) healthy cohort of 174 adults aged 16 - 89 years gave 
the following best-fit relationship, which explained 18% of the total VR variance 
Valsalva ratio = 2.156 - (0.009125 x age in years) 
Gender and smoking did not influence VR. Subsequent analysis showed that a curvilinear 
model gave a better fit for variation in VR with age and another linear regression analysis was 
performed on the natural logarithm of the ratio minus one (Smith, 1984) 
Ln (ratio - 1) = 0.2188 - (0.0145 x age in years). 
Some authors cast doubt on the usefulness of the Valsalva ratio in older patients. One author 
concluded the test range for the VR in cases aged over 65 years is too small to differentiate 
normal from abnormal heart rate control (Piha, 1993). Others feel that elderly and those with 
neurological disorders cannot perform the Valsalva manoeuvre adequately well to make the 
test valid (de Jong-de Vos van Steenwijk, 1997). 
The change in systolic blood pressure to phase Ile becomes increasingly negative with age but 
this does not affect phase IV (Denq, 1998). 
3.1.2.5 Other influences 
Gender has no influence on the VR (Baldwa and Ewing, 1977; Benarroch, 199 1; Gelber, 
1997; Smith and Smith, 198 1). In a review, Low summarised other important influences as 
position of the subject, expiratory pressure, duration of effort, inspiratory volume and 
medication (Low, 1993a). The height of the systolic BP overshoot in phase IV is proportional 
to left ventricular ejection fraction (Zema, 1980). Gender has no effect on the phase Ile or 
IV 
systolic blood pressure responses but higher resting blood pressure exaggerates the trough of 
Ile (Denq, 1998). 
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3.1.2.6 Repeatability 
The literature contains a variety of methods of calculating the Valsalva ratio. Unfortunately 
there is no consensus on the ideal method of calculating the Valsalva ratio. The more 
common methods for ascertaining the Valsalva ratio are as follows: 
1) Mean ratio of three successive Valsalva manoeuvres (Baldwa and Ewing, 1977. 
Ewing, 1985). 
2) The largest value from two (Levin, 1966) or three Valsalva manoeuvres (Low, 19 75 
Sandroni, 1991; Vita, 1993) 
3) Mean of a pair of Valsalva ratios (Bennett, 1976; Lawrence, 1992b) 
4) Until two reproducible responses are obtained (Low, 1993a) 
5) One VR is required in the clinical practice, according to Mustonon et al (Mustonen, 
1989). This report noted the difference between the first VR and the mean VR of 3 
efforts was small and not statistically significant in a group of 75 diabetics and 48 
controls 
6) The mean of the maximum and minimum values, calculated Erom the mean of each 
extreme value plus the 2 intervals either side, are used for the ratio (Schumer, 1988). 
The Valsalva ratio was not significantly related to the resting heart rate in a study of 135 
subjects aged 16-69 and this finding has been replicated elsewhere (Ewing, 1985; Smith and 
Smith, 1981; Ziegler, 1992b). 
Different techniques have been used to measure repeatability. Levin (Levin, 1966) simply 
measured the mean difference between ratios, which was 0.10 for the VR or 5 %. He also 
noted that increasing the expiratory pressure increases variation in VR. Baldwa et al (Baldwa 
and Ewing, 1977) investigated 12 normal young adults (on 10 occasions over 2 months) and 7 
middle-aged adults (5 occasions over one week). The mean, within-subject SD and between- 
subject SD variation of the Valsalva ratio was 1.49,0.17 and 0.18. The mean was lower, 
within-subject SD the same and between-subject SD results smaller in the middle aged group 
compared with the young adult group. In other words, repeatability was similar between the 
two groups but the test range did not allow as good a discrimination between subjects in the 
older group. The authors felt this represented adequate reproducibility although one could 
argue these results do not confer very good reproducibility. Smith et al (Smith and Smith, 
198 1) performed Fisher's intrapair correlation coefficient in assessing repeatability of the VR 
in 20 healthy subjects aged 20-87 years mean age 40 years. Valsalva ratio was repeated after 
intervals of 3-8 months. There was a moderate level of correlation; r= +0.61, p<0.01. Smith 
58 
perfon-ned another study on repeatability, this time using a group of 19 healthy adults and 19 
diabetic patients on two clinic visits (interval not stated). Coefficient of variation for healthy 
subjects was 15.4% but 10.5% in the diabetic group (Smith and Smith, 198 1). 
The Valsalva ratio had satisfactory repeat variability (subject mean 1.92. between subject SD 
0.38, within subject SD 0.17), and also had the best 'within subject/between subject' ratio 
(0.45) compared with the 30: 15 ratio and deep breathing tests of RR variation in a group of 10 
normal controls (Lawrence, 1992b). There were similar results in a group of II diabetic 
subjects but with a small deterioration in within subject/between subject ratio (subject mean 
1.74, between subject SD 0.3 1, within subje. -e-SD 0.18, ratio 0.57) (Lawrence, 1992a). The 
same group of investigators argue the adapted co-efficient of variation should be quoted in 
studies and report this measure demonstrates a strong relationship with the 'Nk, ithin 
subject/between subject' SD ratio (Murray and Lawrence, 1993). The issue is that co-efficient 
of variation of the test should have a direct relationship between the SD of repeat 
measurements and the mean of measurements, which does not hold true for the 'unadapted' 
CV for the Valsalva ratio. Using a similar mathematical approach but adding log 
transformation, one group felt that day-to-day reproducibility was poor for the Valsalva ratio 
and was certainly the worst of a range of autonomic tests (Ziegler, 1992b). 
This ideal method (adapted co-efficient of variation) is not widely used but if we do take the 
opinion that some value can still be derived from the basic CV, some worthwhile results were 
reported on autonomic testing at different centres over three test dates within 18 months. This 
report indicated, by virtue of similar CV results, that the Valsalva ratio is reliable and 
reproducible and benefited from a large number of cases (Schumer, 1988). 
The tachycardia ratio was investigated by Baldwa et al. This is the shortest RR interval during 
the manoeuvre divided by the longest RR interval before the man0euvre starts. 
Reproducibility (within-subject SD = 0.043) was actually better than the traditional Valsalva 
ratio, even allowing for the smaller mean tachycardia ratio of 0.75, compared to 1.49 for the 
Valsalva ratio. Between-subject variation was 0.05 for the tachycardia ratio (Baldwa and 
Ewing, 1977). 
3.1-2.7 Test methodology 
Eckberg (Eckberg, 1980) reviewed methods employed in Valsalva manoeuvre studies and 
highlighted the lack of standardisation. Straining is initiated after maximal, full or normal 
inspiration. Mouth pressure is usually 40 mmHg but varies from 30 to 60 mmHg. Duration of 
Straining is often 15 seconds but also varies from 10 to 30 seconds and occasionally longer. 
Post-straining respiration is rarely controlled but can have a critical effect on reflex changes. 
Eckberg comments on the multiple regulatory mechanisms and receptors contributing to a the 
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reflex changes. Net heart rate changes are primarily influenced by central reactions between 
arterial baroreceptors, chemoreceptors and cardiopulmonary receptors. The prolonged nature 
of the reflex means that late pressure changes depend on 'peri -reflex' events and not just the 
'pre-reflex' stimulus itself 
Position has an important influence on the Valsalva ratio. Most authors recommend 
performing the manoeuvre in the sitting position and blowing into a mouthpiece for 15 
seconds aiming to maintain a pressure of 40 mmHg (Baldwa and Ewing, 1977; Denq, 1998; 
Ewing, 1985; Low, 1975; Ten Harkel, 1990; Weston, 1996a; Ziegler, 1992b). Twenty 
seconds (Gelber, 1997; Parati, 1989; Schumer, 1988) or ten second periods (Bennett, 1976; 
Levin, 1966; Smith and Smith, 1981; Vita, 1993; Vita, 1986; Zema, 1980) have been used 
elsewhere. One review suggests the subject should be recumbent and also recommends that 
the maximum RR value used should occur within 30 seconds of commencing forced 
expiration (Low, 1993a). However the magnitude of the BP fall during straining and 
subsequent overshoot of phase IV are smallest in the recumbent position and increase with the 
change to sitting and standing position (Ten Harkel, 1990). In those cases who lack BP 
overshoot in phase IV, it has been recommended to use the highest BP in the first 15 seconds 
after completion of expiration (Wieling and Karemaker, 1999). The Valsalva ratio is 
significantly increased in the standing position compared with the supine and sitting positions 
because of the increase in maximum heart rate. This study also showed that the period of 
preceding rest (from I to 20 minutes) did not influence the Valsalva ratio or blood pressure 
changes. The greatest source of poor repeatability is variation in respiratory pattern and cases 
should be instructed on breathing pattern before and after forced expiration (Lawrence, 
1992b). Normal tidal breathing pattern pre-manoeuvre will enhance the Valsalva ratio which 
is reduced if the subject takes a maximum inspiration pre-strain, but in practice this can be 
difficult to control (Levin, 1966). 
The expiratory pressure has a critical influence on the Valsalva ratio. A wide ranging 
exploration of the factors affecting Valsalva manoeuvre variables formed the following 
conclusions (Benarroch, 1991). 
* Maximal changes in Ill and IV correlated with duration of expiration at low (20 
mmHg ) and high (50 mmHg) expiratory pressures (consistent with the theory these 
responses are sympathetically mediated) (Komer, 1971). Similar results were 
produced by Levin but without a significant correlation (Levin, 1966). 
Valsalva ratio correlated with duration of expiration only at the higher 50 mmHg 
pressure, probably because at lower pressures intrathoracic blood volume can buffer 
arterial pressure flux 
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In general there were stronger correlations between the magnitude of expiratory 
pressure and blood pressure/heart rate changes than with duration of expiration (e., -),. 
Valsalva ratio correlation r= +0.63). 
Overall the literature suggests that expiration for 10 seconds is effective and 15 seconds is 
optimal. Heart rate and blood pressure changes should always be viewed in tandem. For 
example there may still be a normal Valsalva ratio in the presence of cardiovagal damage if 
sympathetic activity produces cardioacceleration in phase 11. 
Levin also found a significant positive correlation between duration of strain and VR, from 8 
to 14 seconds (Levin, 1966). Low's group, in a study setting normative data (Denq, 1998), set 
the following useful inclusion criteria when evaluating the shape of the blood pressure cur%-e: 
Expiratory pressure at least 30 mmHg and 10 seconds 
2) Reproducible Valsalva manoeuvre BP curve, defined as maximal and minimal 
systolic blood pressures that differ by less than 10 mmHg between recordings 
3) Absence of flat top blood pressure curve (in other words absence of a curve 
resembling the expiratory waveform) 
The blood pressure is best measured using a continuous non-invasive device such as the 
Finapres. The difference between intra-arterial and Finapres blood pressures tends to be 
small: in a study of 15 hypertensive adults with a mean age of 50 years, for systolic, mean and 
diastolic blood pressures the mean differences were I±9.6,9 ± 6.8 and 4±6.1 mmHg 
respectively. Furthermore the Finapres faithfully reproduced patterns in the change of blood 
pressure during the Valsalva. The device tended to underestimate intra-artenial pressure 
during the control phase and over-estimate during phase 2, probably related to the changes in 
flow and diameter of vessels during the procedure (Imholz, 1988). The good correspondence 
between finger and intra-arterial BP during resting and active phases of the Valsalva 
manoeuvre was also shown in a study of 17 subjects (Parati, 1989). This study calculated 
baseline BP from a 20 second before the manoeuvre. 
The interaction between the Valsalva manoeuvre and isometric exercise was examined in a 
small study of 5 males with mild untreated hypertension and 4 normal subjects. Essentially 
the blood pressure changes remain unchanged if sustained muscular exercise occurs during 
VM but heart rate changes are attenuated. Although there were similar qualitative changes. 
the quantitative changes indicate that strenuous muscular activity should be avoided 
dunng 
testing (Ewing, 1976b). 
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3.1-2.8 Relationship with other cardiovascular autonomic tests 
Like other RR measures in the course of developing autonomic neuropathy, the vagally 
mediated Valsalva ratio tends to deteriorate before the sympathetic -mediated blood pressure 
measures of isometric exercise and orthostatic hypotension (Ewing, 1985). The Valsalva ratio 
may not detect subtle early autonomic dysfunction: a group of insulin dependent diabetics had 
normal bedside tests of autonomic function but definite decline in heart rate variability on 
spectral analysis (Weston, 1996a). The same group did reveal a reduction in baroreflex 
sensitivity from both Valsalva manoeuvre and spectral analysis techniques (Weston, 1996a). 
In another study, the Valsalva ratio did correlate strongly with total, high and low power of 
short term power spectral analysis of heart rate variability (Freeman, 199 1) but others have 
found poor or absent correlation between the Valsalva ratio and spectral analysis or bedside 
autonomic tests (Vita, 1986; Ziegler, 1992b). There was a weak correlation with the 30: 15 
ratio (r = +0.32, p< 0.01) (Vita, 1986). Some studies have shown good agreement between the 
Valsalva ratio and expiration/inspiration (E/1) ratio of metronomic respiration in detecting 
autonomic neuropathy but repeatability of the Valsalva ratio is not as good as the E/I ratio 
(Smith, 1984; Smith and Smith, 198 1). 
Parasympathetic damage according to the Valsalva ratio and other RR measures is associated 
with loss of normal blood pressure diurnal rhythm. Mechanisms may differ according to 
absence or presence of sympathetic damage, with attenuation of the nocturnal decline or 
decrease in daytime blood pressure respectively (Carvalho, 2000). 
3.1.2.9 Clinical application 
In repeat tests at least three months apart in 237 diabetic subjects, the Valsalva ratio did show 
a moderate but significant decrease from 1.50 to 1.43. This is in contrast to no change seen in 
heart rate variation during deep breathing and standing, and may reflect the greater test range 
of the Valsalva ratio in diabetes (Ewing, 1985). A study of 75 diabetic patients at varying 
stages of neuropathy indicated the Valsalva ratio can detect neuropathy but is not as sensitive 
as the heart rate variation during metronomic respiration (Dyrberg, 198 1). In general, diabetic 
patients have reduced Valsalva ratio (Low, 1975). Smith (Smith, 1984) observed the Valsalva 
ratio to perform well in detection of diabetic neuropathy. In 18 patients with abnormal 
Valsalva ratios, 16 had abnormal 'gold standard' metronomic respiration heart rate variation 
but 5 patients with normal or borderline Valsalva ratio had abnormal metronomic respiration 
sinus arrhythmia. In diabetic subjects, those with symptomatic autonomic neuropathy had a 
significant reduction in Valsalva ratio compared with non-diabetics but there was no 
difference between asymptomatic diabetics and normal controls (Rothschild, 1987). They also 
comment that the Valsalva ratio retains its quantitative properties with more seN, ere autonomic 
dysfunction. The Valsalva ratio ranked as one of the best Ewing battery tests in detecting 
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cardiovascular autonomic neuropathy in diabetics with peripheral neuropathy (Ziegler, 
1992a). Correlation coefficients with resting heart rate variation in 100 diabetic patients, who 
had varying degrees of autonomic neuropathy, were +0.659 (p<0.001) for the Valsalva ratio 
and +0.727 (p<0.00 1) for the tachycardia ratio (the tachycardia ratio is the shortest RR 
interval during the manoeuvre divided by the longest RR interval preceding the manoeuvre) 
(Baldwa and Ewing, 1977). 
The Valsalva ratio is used in both the Ewing autonomic battery of cardiovascular tests and 
Low's Composite Autonomic Scoring Scale (Ewing and Clarke, 1982; Low, 1993b). Both of 
these batteries are essentially a series of autonomic reflex tests with each test contributing to a 
summative score that reflects overall autonomic function. Ewing's battery and Low's scale 
are used in clinical practice in autonomic laboratories. 
The Valsalva manoeuvre can also be used to assess baroreceptor reflex sensitivity, by using 
the ratio of the change in blood pressure to RR interval in phase 4 i. e. the slope of the linear 
regression between systolic blood pressure and subsequent RR interval. This value bore a 
good correlation with the phenylephrine method (r = +0.91) whilst avoiding the difficulties of 
cannulation and drug administration (the phenylephrine method is the gold standard for 
measuring baroreceptor sensitivity, and measures unit change in RR interval as blood pressure 
is increased by phenylephrine injection) (Palmero, 198 1). The slope method was compared to 
a new baroreflex sensitivity index method where the difference between maximal and 
minimal RR intervals and systolic blood pressure was used to calculate a ratio. This technique 
showed good agreement with the slope method (Bland Altman method, p<0.05) and 
acceptable test-retest repeatability (between II and 24% intra-subject variation) that was the 
same as the slope method (Kautzner, 1996). 
Other information on cardiovascular function can be deducted from the Valsalva manoeuvre. 
One report found the phase IV systolic blood pressure overshoot measured using a bedside 
sphygmomanometer can provide a semi-quantitative estimate of left ventricular function and 
in so doing, is better than traditional clinical signs and chest radiograph (Zema, 1980). 
Valsalva ratio also changes in heart failure: Valsalva ratio was lower in cases with higher left 
ventricular end-diastolic pressure and radiographic evidence of heart failure (Levin, 1966). 
3.1-2.10 Conclusion 
The Valsalva ratio is a well established test of cardiac vagal and sympathetic function. The 
mechanically mediated changes in blood pressure at initiation and termination of forced 
expiration provoke changes in autonomic neural activity. Subsequent blood pressure changes 
are largely due to sympathetic nerve firing. Heart rate changes, particularly the increase in R-R 
interval during blood pressure overshoot are mainly influenced by vagal activity. Howcver the 
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responses from the two autonomic limbs are closely intertwMed. The Valsalva ratio is 
reasonably sensitive in detecting vagal damage. Correct technique is critical in obtaining valid 
results and the ratio is sensitive to the duration and pressure of forced expiration: expiration at 
40 mmHg for 15 seconds in an upright position is likely to yield satisfactory results. However 
repeatability may be moderate at best. The majority of research has used diabetic patients, and 
the literature provides sufficient evidence to show the Valsalva ratio can reliably detect 
autonomic neuropathy. 
3.1.3 Heart rate response to deep and metronomic respiration 
Variation in heart rate with respiration is one of the simplest cardiovascular autonomic tests. 
The fluctuation in RR interval is closely tied to respiratory movement. RR intervals vary at 
high frequency, usually mirroring respiratory frequency. The cardiovagal nerve forms the 
efferent limb of the reflex. The fluctuation of heart rate with respiration is depicted in Figure 
3.7. 
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Figure 3-7 Variation in heart rate with respiration 
HR, heart rate: Resp, respiration 
3.1.3.1 Neural mechanism 
Animal models demonstrate a proportional relationship between cardiac vagal efferent 
activity and respiratory heart period variations in experimental conditions (Katona and Jih, 
1975). In other words, fluctuations in cardlovagal activity are mirrored by changes in the 
magnitude of sinus arrhythmia. A near linear relationship has been shown in humans 
(Eckberg, 1983; Pfeifer, 1982) but some conclude that linear coupling is only true for vagal 
traffic below baseline levels (Eckberg, 1988). 
There are three potential mechanisms behind the variation in heart rate with respiration. 
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0 Pulmonary stretch receptors, in the lungs or chest wall, initiating a reflex response on 
lung inflation 
An indirect effect from blood pressure flux (secondary to respiratory movements) 
stimulating arterial baroreceptors which influence heart rate 
0 There appears to be a direct interaction between respiratory and cardiovascular 
centres in the medulla. 
The importance of each component has remained controversial (Low, 1990). 
Inspiration leads to activation of pulmonary stretch receptors, impulses then travel via the 
vagus to inhibit the respiratory centre: this is the Hering Breuer respiratory reflex. The 
respiratory centre has a net inhibitory effect on the cardioinhibitory centre, and vagal activity 
changes to allow an increase in heart rate. Pulmonary receptors may be less important in 
humans though. 
Increased venous return during inspiration appears to have two effects. Firstly the Bainbridge 
reflex is a cycle originating in the right atrium due to distension, which triggers vagal 
afferents acting on the nucleus solitarius. This brainstern centre then influences vagal 
efferents and alters sinoatrial firing to accommodate increase in venous return. Secondly atnal 
stretch acts on mechanoreceptors near the sinoatrial node, sending vagal afferent messages to 
the vasomotor centre which activates sympathetic efferents supplying the sinoatrial node to 
increase heart rate (Brooks, 1966). 
Levy et al (Levy, 1966) used an animal model to demonstrate the probability of direct 
respiratory neuron activity influencing cardiac autonomic centres. Venous return did not vary 
during respiratory cycle, the right atrium was continuously drained by gravity, the arterial 
pressure was held constant and the lungs were collapsed with hill ligated. Oscillation in heart 
rate was still observed. This was predominantly vagal in origin but there was a residual 
oscillation after vagal nerve section, about one-third of that seen with intact vagi. With intact 
vagi, cardiac acceleration commenced towards the end of (but just within) the expiratory 
phase, i. e. prior to the onset of detectable muscle activity. Overall, appreciable cardiac 
acceleration only began with the onset of inspiration. Peak heart rate was attained at one-third 
of the interval toward the next inspiratory effort. 
Other observations on the relationship between heart rate and respiration include those of 
Mecher et al indicating a baroreflex component (Melcher, 1976). During inspiration, vagal 
efferent activity is curtailed but this relationship is lost during artificial ventilation (Joels and 
Samueloff, 1956; Katona, 1970). 
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Figure 3-8 Respiratory activity and RR interval variation during metronomic respiration 
C02 and flow panels indicate respiratory activity. Inspiration leads to increase in heart rate then expiration leads to 
decrease in heart rate. 
Wheeler and Watkins (Wheeler and Watkins, 1973) are widely credited for first advocating 
heart rate variation during deep metronomic breathing as a test of cardiovascular autonomic 
neuropathy. The phenomenon of RR variation with respiration was known within the 
physiology literature, as discussed above. Wheeler and Watkins compared heart rate variation 
during deep breathing at six to eight breaths per minute whilst supine after 20 minutes rest in 
nine diabetics with symptoms of advanced autonomic neuropathy, 15 insulin treated diabetics 
without complications and 25 healthy subjects. There was a striking reduction in heart rate 
variation in the neuropathy group, all had <6 beats per minute variation whilst the other two 
groups all had much greater beat-to-beat variation. Atropine was given to one healthy subject 
which abolished the normal respiratory sinus arrhythmia but propranolol had no clear effect, 
so from this n=I test, loss of vagal tone was proposed as the cause of reduced heart rate 
variation in autonomic neuropathy. 
Further work confirmed RR variation is virtually abolished after atropine but there is no 
additional effect with beta-adrenergic blockade using propranolol. There is no significant 
effect on RR variation with alpha-adrenergic blockade but there is a significant reduction in 
RR variation with sympathetic stimulation using isoproterenol (Pfeifer, 1982). There is a 
significant atropine dose response on RR variation (Rothschild, 1987). Therefore in the 
resting supine individual, parasympathetic activity is the driving mechanism behind RR 
variation. 
The pattern of respiration imparts a strong influence on the quantity and timing of cardiovagal 
firing. R-R intervals increase as respiratory interval increases and, to a lesser extent, increasing 
tidal volume increases RR interval. The fluctuation in RR interval is achieved by both 
prolongation of maximum and (less marked) shortening of minimum RR interval. The phase 
angle of RR and respiratory interval Is a stnctly linear relationship - in other words, the 
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difference in onset of inspiration and RR interval change is closely correlated. 
Cardioacceleration is synchronous with inspiration at typical respiratory frequencies between 
0.15 to 0.25 Hz, but there is a phase lag for very long breathing intervals when supine: this 
trend can reverse in the upright position with a phase lead at slow respiratory rates (Saul, 
1989). Hirsch demonstrated the linear relationship between RR and respiratory intervals holds 
true for most of the normal physiological range but there is a 'comer frequency' at very slow 
respiratory rates (Hirsch and Bishop, 198 1). There is a 'system resonance' at 5-6 respirations 
per minute when the variation in RR interval is at its greatest (Angelone and Coulter, 1964. 
Pfeifer, 1982). 
Cardiodeceleration begins in expiration at all breathing intervals, but late in expiration at 
normal respiratory frequencies of around 0.2 Hz and progressively earlier in expiration as 
frequency decreases (Eckberg, 1983). Respiratory pattern and depth will therefore influence 
heart rate variation. In particular tidal volume, can adversely affect repeatability (Lawrence, 
1992b). Position is also important when recording heart rate variation. Bennett et al reported a 
significant difference in RR variation in diabetics with and without intact vagal function 
during metronomic respiration; this disparity weakened with subjects in supine breathing at 
normal rates and lost significance in a standing position (Bennett, 1977). 
The relationship between respiration and heart rate variation is discussed in more detail in the 
section on Heart Rate Variability (3.2.4.1). 
3.1.3.2 Repeatability 
Studies of heart rate variation during metronomic respiration use either the ratio of maximum 
to minimum RR intervals or the difference in maximum to minimum heart rate. As a result of 
the physiological link with expiration and inspiration, these are often labelled the E/I ratio (or 
I/E ratio) and E-I difference. 
Ewing and colleagues (Ewing, 198 1) compared the predictive value and reproducibility of 
different methods of quantifying RR interval variation in three groups of diabetic patients; 
normal, parasympathetic neuropathy and combined sympathetic and parasympathetic 
neuropathy. During metronomic respiration for one minute, the heart rate difference between 
maximum and minimum heart rates and the standard deviation of RR intervals over five 
minutes of quiet breathing performed best at demarcating between different severities of 
autonomic dysfunction. Max-min heart rate differences did not show any significant 
differences in repeat tests in 6 tests per individuals (54 subjects) over two days testing. 
Max- 
min heart rate and max/min heart rate ratio strongly correlated (r = +0.97, p not stated). 
Max- 
min heart rate differentiated with the highest significance during sitting and standing 
compared with lying but the analysis does not constitute a true inter-method comparison and 
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in effect the performance is very similar. Max-min heart rate was also independent of resting 
heart rate. The authors recommend the max-min heart rate difference (ideally whilst sitting or 
standing) as the ideal routine clinical test of RR variation. The standard deviation of RR 
intervals during five minutes quiet breathing was of sirffllar value and suitable for research 
purposes. 
Max-min heart rate difference had good repeatability in a cohort of ten young adults and 
diabetic patients, with no significant difference in the mean of max-min heart rate differences 
from 5 respiratory cycles. In addition, a method of maximal respiration gave equivalent 
results to timed inspiration-expiration of five seconds each (Hilsted and Jensen, 1979). 
In the course of establishing databases for RR variation in large groups of healthy normal 
cases, heart rate variation during deep breathing produced a skewed distribution. Therefore 
logarithmic transformation was performed for further analysis (O'Brien, 1986; Wieling, 
1982). Ziegler et al (Ziegler, 1992b) also suggested that to obtain a log normal distribution for 
the E/I ratio, the calculation log (x- 1) should be perfon-ned. 
Many reports comment on the relationship between heart rate during rest and deep, 
metronomic respiration. There may be a weak but significant correlation between resting 
heart rate and E/I ratio in metronomic respiration (Wieling, 1982; Ziegler, 1992b), other 
investigators have not found a relationship (Smith, 1982). There are contrasting results for the 
relationship between resting heart rate and E-1 difference: significant inverse according to 
Ziegler et al and Smith et al (Smith and Smith, 198 1; Ziegler, 1992b) and none according to 
Ewing et al (Ewing, 1985). Multiple correlation analysis has shown a negligible contribution 
to heart rate variation in metronomic respiration from basal heart rate (OBrien, 1986). 
The co-efficient of variation during a solitary deep breath was 6% (range 2-9 %) for the ratio 
of maximum/minimum RR intervals but 16 % (range 7-28 %) for the heart rate difference in a 
group of six healthy 20-35 year old males (O'Brien, 1986). Another study results indicate a 
similar CV of 12.9 % for the heart rate difference in a series of 10 tests over a2 month period 
in 13 non-nal subjects (Ewing, 1985). Using the log(x-1) transformation, Ziegler found a 
standard deviation factor of 1.19 and 1.32-1.33 for controls and diabetics respectively (E-1 
difference or E/I ratio) (Ziegler, 1992b). 
Although the difference in results in a group of 34 healthy normal controls (aged 19-85) for 
E-I difference over a mean retest interval of 0.96 years was small (2.12 ± 4.08 ), it was still a 
significant difference. This infers that single tests may not be suitable for serial or follow-up 
observations (Braune, 1996). But within-subject variability is lower than between-subject 
variability in both normal controls and diabetic patients, for both the E-I difference and 
EI 
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ratio, confirming that the test has value (Lawrence, 1992a; Lawrence, 1992b). The co- 
efficient of variation for E-I difference in these studies is shown in the following table. 
Table 3-1 Co-efficient of variation for heart rate variation during metronomic respiration 
Group Co-efficient of variation for E-1 difference 
Supine Sitting 
Normal (n=10) 28.6%* 16.1% 
Diabetic (n=25) 19.6% 17.7% 
A Murray 1993 (Murray and Lawrence, 1993). (Data derived from published figures for standard deviation and 
mean, differs from above figure*: CV = SD/mean) 
The 'raw' values for the E/I ratio have a much lower co-efficient of variation. But the same 
group have highlighted the disadvantage of calculating a CV when the test does not show 
proportional relationship between the standard deviation and the mean as the response 
decreases, as is the case for the E/I ratio (and other ratios of RR intervals). They advocate the 
use of the adapted CV, which is derived by subtracting I from the actual values for RR 
interval ratios - this results in a proportional relationship between the mean and standard 
deviation as the response diminishes. There is a strong relationship between the adapted CV 
and the SD ratio i. e. the within subject SD divided by the population SD (normal subjects r 
+0.63, diabetic subjects r= +0.91) (Murray and Lawrence, 1993). 
Reproducibility for the E-I difference, measured by RRmax - RRmin, was considered 
moderate at 40% (Gerritsen, 2003). Smith et al's study used a different technique - the Fishers 
intrapair correlation co-efficient. Reproducibility of E-1 difference for deep breathing, 
repeated at intervals of 3-8 months in 20 healthy subjects, was highly significant: r= +0.68, 
p<0.0 I (Smith and Smith, 198 1). 
3.1.3.3 Age 
There is a significant decline in RR variation during metrononuic respiration with increasing 
age (Clark and Mapstone, 1986; Ewing, 1985; Lawrence, 1992b; Masaoka, 1985; Smith and 
Smith, 1981; Vita, 1986; Wieling, 1982; Ziegler, 1992b). Multiple regression analysis 
indicated age contributed around 30 % of the variation in heart rate variability (O'Brien, 
1986). Low supplies a univariate regression model documenting the significant 
decline in E/I 
ratio y (beats per minute) for each year of age x (Low, 1990) 
37.17 - 0.36x R=0.7 p<0.001 
Smith and Smith (Smith and Smith, 198 1) perfon-ned multiple regression on 
logarithmic- 
transformed metronomic respiration max-min heart rate differences 
(in y), to obtain the 
following best fit relationship 
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ln y=4.764 - (0.01918 x age in years) + (0.0173 x mean RR inten-al) 
These two variables accounted for 47 % of In y variance. 
3.1.3.4 Other influences 
Two studies show no gender effect on RR variation in metronomic respiration (Low, 1990; 
Smith and Smith, 198 1; Ziegler, 1992b) but one study has shown a gender effect in the E-1 
difference (maximum RR - minimum RR) with a male and female medians of 207 and 163 
ms respectively (Gerritsen, 2003). There does not appear to be any diurnal variation (Bennett, 
1978; Wieling, 1982), although RR variation is more reproducible in the morning: coeff-Icient 
of variation was II- 12% in the morning but 17-2 1% in the afternoon for non-nal and diabetic 
adults (Bennett, 1978). 
One study has demonstrated moking history does not affect metronomic respiration max-min 
heart rate difference but variation in the max-min heart rate difference significantly increases 
with decreasing resting heart rate (Smith and Smith, 198 1). Masouka observed duration of 
diabetes significantly decreased max-min HR variation in insulin-treated but not non-insulin 
dependent diabetic patients. This may have been related to the shorter duration of diabetes in 
the NIDDM cohort (Masaoka, 1985). 
3.1.3.5 Test methodology 
Heart rate variation during metronomic respiration is usually assessed by instructing the 
subject to take six deep breaths, one every ten seconds, for one minute. Inspiratory and 
expiratory phases are five seconds each. This protocol is quoted in the Ewing battery (Ewing 
and Clarke, 1982) and has been widely used elsewhere (Clark and Mapstone, 1986, Netten, 
1992; Staessen, 2001; Ten Harkel, 1990; Vita, 1986; Wieling, 1982; Ziegler, 1992b). Mackay 
et al demonstrated maximal heart rate variation during metronomic respiration occured at a 
respiratory frequency of 6.3 ± 0.6 breaths per minute in adults aged 20-29 years and 5.5 ± 0.3 
for age range 30-43 years. The resonant frequency (i. e. respiratory frequency producing the 
largest variation in RR interval variation) was significantly lower for diabetic patients with 
autonomic neuropathy. There was a two to three-fold increase in heart rate variation as 
breathing frequency decreased to the resonant frequency. The relationship was linear after 
logarithmic transformation of respiratory frequency. At very low breathing rates slower than 
the resonant frequency, heart rate variation decreased in a non-linear fashion. 
Diabetic 
patients with autonomic neuropathy had a clinically small but significant reduction 
in 
resonant ftequency (Mackay, 1983). These observations are similar to the work of Angelone 
et al (Angelone and Coulter, 1964). 
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Sundkvist et al (Sundkvist, 1979) were the first to modify the variation in heart rate to the EI 
ratio, where E/I = mean value for longest RR intervals during expiration / mean % alue for 
shortest RR intervals during inspiration. 
Variations on respiratory cycle number and frequency include: 
1) A solitary deep breath (O'Brien, 1986; Smith, 1982). Bennett and colleagues 
(Bennett, 1978) reported that there was no difference in heart rate variation for a 
single deep breath and six breaths over a minute (40.2 vs. 43.8 bpm) for normal 
adults but for diabetic patients the single deep breath evoked a significantly larger 
change in heart rate than six repeated deep breaths (20.1 vs. 13.5, p<0.00 1). 
2) Smith reported an age-related E/I ratio normal range for a solitary deep breath, which 
outperformed a mean E/I ratio because (a) it is not affected by resting heart rate and 
(b) in practice reduced the false-positive and false-negative results (Srnith, 1982). 
3) Six deep breaths per minute on two occasions; the higher of the two max-min HR 
difference averages was used for analysis (Masaoka, 1985). 
4) Five breaths per minute for six minutes, using the last five minutes for analysis 
(Rothschild, 1987). 
5) Six respiratory cycles per minute for about two minutes with the mean heart rate 
variation of 10 cycles (Mackay, 1980) 
6) The mean max-min heart rate difference fromfive cycles performed at six cycles per 
minute (Smith and Smith, 198 1) 
7) Eight cycles, the mean of the five largest responses used for analysis (Low, 1990) 
8) Six respiration cycles over one minute with the average of breathing cycles two to 
four used for analysis. This study also demonstrated that reproducibility improves in 
the sitting position compared with the supine position, probably because of more 
variable respiratory behaviour when supine (Lawrence, 1992b). 
Lawrence et al have shown that within-subject variability (and within/between subject 
standard deviation) improves using multiple respiratory cycles than one solitary breath. 
Mustonen et al (Mustonen, 1989) have reported no significant difference in the E/I ratio when 
comparing the means of the I't to 3 rd and I" to 6th respiratory cycles in both controls and 
diabetic subjects, which may be useful in subjects who are unable to complete the normal 
protocol. 
There is no influence of preceding rest duration upon RR variation (Ten Harkel, 
1990). RR 
variation is less apparent during standing and improves in the supine position (Bennett, 
1977) 
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but others found a non-significant reduction in RR variation in the sitting and standing 
position compared with the supine position (Ten Harkel, 1990). Ewing's observations 
favoured sitting or standing position for optimising performance of the max-Min heart rate but 
without any clinically meaningful differences between results in the three positions (Ewing, 
1981). 
Netten et al devised a software program for autonomic analysis, and found no difference in 
results between testing with an computerised program or using a conventional ECG (Netten, 
1992). 
3.1.3.6 Relationship with other cardiovascular autonomic tests 
The correlations between E-I difference and orthostatic changes in heart rate (r = +0.17) or 
RRmax/RRmin (r = +0.14) are poor (Wieling, 1982). This emphasises the differing 
physiological mechanisms that determine each response. Ewing et al examined correlation 
between reflex cardiovascular autonomic tests in 61 diabetic patients, with normal and 
abnormal autonomic function. Max-min heart rate difference gave the following correlation 
coefficients in the lying position: Valsalva ratio r= +0.41 (p<0.001), 30: 15 ratio r= +0.51 
(p<0.001), isometric handgrip change in DBP r=+0.36 (p<0.01), postural blood pressure fall 
in SBP r= -0.32 (p<0.0 1) (Ewing, 198 1). RR variation in deep breathing is more sensitive 
than the Valsalva ratio in detecting diabetic autonomic neuropathy (Dyrberg, 198 1; 
Rothschild, 1987). It is also superior to the 30: 15 ratio (Mackay, 1980). However heart rate 
variation from a solitary deep breath tends to be less than that seen during standing or the 
Valsalva manoeuvre (O'Brien, 1986). Amongst the autonomic tests of heart rate variation, the 
E-I difference or E/I ratio appears to have the best reproducibility (Smith and Smith, 198 1; 
Ziegler, 1992b). 
The E-I difference of maximum- minimum RR intervals agreed moderately well with spectral 
analysis low and high frequency powers, baroreflex sensitivity (correlation co-efficients 
+0.49 to +0.52) and standard deviation of normal RR intervals (SD NN, percentage 
concordance 63%) (Gerritsen, 2003). Bennett and colleagues reported the correlation between 
the post-Valsalva manoeuvre bradycardia and heart rate variation (single breath) was 
significant in diabetics but not significant in normal adults (Bennett, 1978). 
3.1.3.7 Clinical application 
The relationship between respiration and vagal activity is used as a tool to investigate the 
integrity of parasympathetic fimction. The deficit in RR variation in diabetics is due to 
decreased parasympathetic activity and not increase in sympathetic activity (Rothschild, 
1987). Dyrberg et al in a comparison of detection of diabetic cardiac neuropathy with tests of 
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RR variation, found metronomic respiration to be the most sensitive test compared with the 
Valsalva ratio, 30: 15 ratio and heart rate response to exercise (Dyrberg, 198 1). 
in a study of 261 diabetic patients aged 11-76 years, the rates of abnormal heart rate vanation 
during metronomic respiration were as follows: 
Table 3-2 Peripheral neuropathy and autonomic neuropathy in diabetes 
Stage of peripheral neuropathy in Type I and 11 Abnormal E-1 Abnormal E/I ratio diabetic patients difference (%) N 
0 none 9.6 8.7 
I subdinical 25.0 26.7 
2a symptomatic, no autonomic symptoms 47.2 52.8 
2b symptomatic, + autonomic symptoms 100 100 
D Ziegler 1992 (Ziegler, 1992a) (%) = percentage of abnon-nal cases in each stage 
Similar high sensitivity was shown in a study of 287 diabetics aged 20-49 years. E-I 
difference was abnormal in 62 out of 64 cases with the following autonomic symptoms: 
postural hypotension, diarrhoea, gustatory sweating, upper gastrointestinal atony, bladder 
atony, unexplained cardiorespiratory arrest. Of the 62 cases, 54 were clearly abnormal (>2 SD 
of control values) and 8 were borderline abnormal (between 1.5 and 2 SD control values). 
Serial tests less than 12 months apart were consistently abnormal in 97% cases. Thirty percent 
of subjects with peripheral neuropathy had abnormal E-1 difference (Mackay, 1980). Earlier 
Sundkvist et al demonstrated the value of E/I ratio in detection of autonomic neuropathy, one 
of the first papers to use the ratio as opposed to the heart rate difference. The paper could be 
criticised for making the assumption that those with sensory neuropathy had autonomic 
neuropathy without using a proven diagnostic test for the latter. Ten out of 18 diabetics with 
sensory neuropathy and nine of II patients with absent ankle reflexes had E/I ratios less than 
IA0, in comparison to only two of 25 controls (Sundkvist, 1979). 
Diabetic patients with symptoms of autonomic neuropathy have reduced RR variation during 
deep breathing compared to normal controls but similar (less exaggerated) changes occur in 
asymptornatic diabetics (Dyrberg, 1981; Mackay, 1980; Pfeifer, 1982; Rothschild, 1987). 
Ewing et al have also shown a progressive deterioration in max-min heart rate difference in 
diabetic groups without autonomic neuropathy (19.0 bpm, standard error of the mean (SEM) 
1.7), to isolated parasympathetic neuropathy (13.5 bpm, SEM 2.1) to combined sympathetic 
and parasympathetic neuropathy (11.0 bpm, SEM 1.6, group difference p<O. 0 1) (Ewing, 
198 1). A similar pattern across diabetic subgroups was shown by Smith (Smith, 1982) but on 
this occasion using a single deep breath. Sundkvist reported the E/I ratio outperfon-ned the 
Valsalva ratio in detection of detection of autonomic neuropathy in diabetic patients. 
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Abnormal E/I ratio (<1.09) occurred in 77 % of diabetics with symptomatic autonomic 
neuropathy (based on questionnaire) but in the same group, only 40 % had an abnormal 
Valsalva ratio (<I -18). The same tests were abnormal in 54 % and 29 % of diabetics with 
peripheral neuropathy only. These results were somewhat surprising since subgroup mean 
values showed incremental decrease from control to peripheral neuropathy to autonomic 
neuropathy for both E/I ratio and Valsalva ratio (Sundkvist, 1982). 
The heart rate response to metronomic respiration was recommended as a measure of 
cardiovagal function by the American Academy of Neurology, with satisfactory specificity, 
sensitivity and reproducibility (AAN, 1996a). 
Impaired parasympathetic function may have an impact on circadian blood pressure control. 
Parasympathetic failure preceded sympathetic failure in a group of patients with familial 
amyloid polyneuropathy. In those with combined failure, diurnal blood pressure variation was 
absent by virtue of diminished daytime blood pressure levels: however in those with isolated 
cardiac parasympathetic damage, there was an intermediate degree of diminished diurnal 
variation (Carvalho, 2000). Mechanisms may include disruption of cardiac baroreceptor 
afferents. 
3.1.3.8 Conclusion 
Respiration modulates heart rate via baroreceptors and mechanoreceptors sending afferent 
traffic to the brainstem and via direct central neural connections between respiratory and 
cardiac centres. Efferent signals reach the heart via the vagus nerve. Metronomic respiration 
can provide a measure of cardiovagal ftinction. Heart rate variation during respiration is 
quantified using the difference between or ratio of maximum and minimum heart rates. The 
heart rate difference may be advantageous in terms of ability to differentiate patient groups 
and independence of resting heart rate. Depth and rate of respiration need to be controlled. 
Age and position of the subject also influence heart rate variation. Repeatability is generally 
moderate but will deteriorate in poorly controlled conditions. Heart rate variation during 
metronomic respiration is a useful test in identifying and quantifying cardiovascular 
autonomic neuropathy. 
3.1.4 Isometric exercise 
Isometric exercise tests cardiovascular sympathetic function. The individual performs 
isometric activity, such as handgrip, for a short period (usually three minutes). The change in 
blood pressure from baseline (before activity) to the end of activity is measured. Blood 
pressure increases in healthy individuals. 
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Neural mechanism 
Donald and colleagues (Donald, 1967) published a review of literature describing the 
physiology of isometric exercise. Much research had been carried out on dynamic exercise 
but they commented on the importance of static, or isometric exercise, in older humans. 
Elderly adults may have curtailed dynamic exercise through general frailty but continually 
perform isometric exercise throughout the lifespan on a daily basis. The haemodynamic 
response to static exercise was first investigated by Lindhard in 1920 (Lindhard, 1920) who 
tested subjects hanging by their hands, with their arms bent, from an overhead beam. He 
found that oxygen uptake increased after exercise and hypothesised that during isometric 
exercise the blood flow through muscles was occluded by the mechanical compression of the 
tensed muscle fibres. In the 1930's experiments by Asmussen and Hansen (Asmussen and 
Hansen, 1938) found that cardiac output, heart rate and blood pressure all substantially 
increased during isometric exercise but after cessation of strain, blood pressure and heart rate 
declined rapidly whilst cardiac output and oxygen uptake underwent further rises before a 
gradual return to baseline. A series of experiments throughout the 1950s and 1960s 
concentrated on the observation of Gaskell in 1877 (Gaskell, 1877) that blood supply to a 
contracting muscle is a compromise between two forces. Firstly, the increase in blood flow to 
exercising muscle that triggers dilatation of local vessels. Secondly, the occlusive force of 
contracting muscle mechanically compressing the same local vessels. 
Blood flow to isometrically contracting muscle may actually be cut off at sub-maximal 
muscle capacity, probably by a nipping effect between shortening and stationary fibres. Early 
experiments suggested the effort provoking this effect may be as little as 20% of maximal 
voluntary contraction (MVC) but later reports indicate the figure is nearer 70% for the 
forearm. Muscle tissue benefits from increased blood flow at around 33% MVC. 
The increase in flow is directed exclusively at active muscle. Inactive muscle does not attract 
higher flow rates, nor do muscles in other resting limbs. Therefore Donald hypothesised that 
the increase in blood pressure during isometric exercise infers vasoconstriction in inactive 
limbs (Donald, 1967). Even relatively small muscle masses experiencing isometnc exercise 
can provoke marked increases in blood flow and it appears the fatigue encountered is due to 
insufficient blood flow to contracting muscle. The increase in blood pressure therefore has the 
Physiological benefit of maintaining blood flow in active (contracting) muscle by overconung 
resistance in local vascular beds. 
Lind et al reported the rise in blood pressure was due to increased cardiac output generated by 
an increase in heart rate (Lind, 1964). Unexpectedly Lind found no substantial change in 
peripheral vascular resistance with isometric exercise. Stroke volume did not change at 10- 
20% MVC but was consistently reduced at 50% MVC, and the latter was associated 1xith a 
75 
pronounced tachycardia. Subsequently it was found that in older subjects who were less able 
to mount an increase in heart rate, the rise in blood pressure was similar to younger adults but 
generated by either increase in stroke volume or peripheral vascular resistance. At low muscle 
contraction forces, blood influx to isometrically contracting muscle is sufficient for metabolic 
requirements. Beyond approximately 15% MVC, demand will outstrip supply leading to the 
sensation of fatigue during prolonged contraction 
The pressor response generated by muscle mass is largely dictated by the MVC specific for 
that muscle group, i. e. the same response is obtained by 30% WC for either forearm or le-g 
contractions (Freyschuss, 1970). Pressor response will still occur during isometric exercise 
even if performed simultaneously with dynamic exercise, despite substantial cardiovascular 
commitment to dynamic requirements. Pain is a common feature of isometric exercise. 
However this develops after the pressor response is initiated and the rate of blood pressure 
rise is not greatly influenced by the severity of discomfort. Therefore pain is not the primary 
stimulus for increment in blood pressure (Donald, 1967). 
In his 1967 review, Donald (Donald, 1967) identified the three potential stimuli for the 
cardiovascular reflexes observed during isometric exercise: humoral (metabolic substances in 
the systemic circulation), central autonomic drive or neural reflex. At that point, experimental 
evidence was lacking but early indications were against humoral factors. The debate 
continued in the 1970s and 80s. 
Freyschuss (Freyschuss, 1970) conducted a series of extensive investigations on isometric 
exercise in a small number of adult subjects. Heart rate and blood pressure response occurred 
rapidly at around 10- 15 seconds after start of contraction (and were independent of respiratory 
events and right atrial pressures), suggestive of a neurally mediated mechanism. Both heart 
rate and blood pressure increase in isometric exercise, in contrast to the non-nal inverse 
relationship between heart rate and blood pressure (Figure 3.9). Such dissociation between the 
usual counter-regulatory forces suggested separate control centres and pathways taking part in 
the response. Overall normal baroreflex function appeared to be inhibited. Beta-adrenergic 
blockade did not affect these observed reactions but atropine diminished cardioacceleration, 
indicating a contribution from vagal withdrawal towards the tachycardia. Phentolamine, a 
moderate adrenergic blocking drug which has a greater action on circulating adrenergic 
mediators and lesser action on sympathetic nerve impulses, only resulted in a modest 
attenuation of the normal blood pressure rise when given alone. This indicates peripheral 
sympathetic activity contributes to the pressor response. Following blinded neuromuscular 
blockade to prevent volitional muscle contraction, increases in heart rate of 47-76 % (a\-erage 
64 %) control values and blood pressure at 37-75 % (average 55 %) control values were still 
obtained. Therefore central command was suggested to play a role in the normal responses. 
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An increase in venornotor tone was also observed, and could contribute to the Increase in 
perfusion pressure by cardioacceleration and rise in systermc vascular resistance. Magnitude 
of pressor response was not correlated to MVC. 
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Figure 3-9 Isometric exercise for three minutes: systolic, diastolic and heart rate response 
Animal models were used by Coote et al (Coote, 197 1) with nerve root stimulation of animal 
hind-limb muscles in four situations: different stimulation intensity, with gallamine to abolish 
muscle contraction, following limb afferent nerve section and finally under ischaemic 
conditions by vascular occlusion. Increasing stimulus intensity led to increasing 
blood 
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pressure rise, with a lag of 2-3 seconds. Abolition of muscle contraction with gallan-ýne 
resulted in no pressor response despite stimulation, indicating the pressor response is a neural 
reflex initiated in the contracting limb. Non-muscle (articular nerves, vagus) afferent nerve 
section did not affect the pressor response, indicating the reflex originates in the contracting 
muscle. The pressor response was potentiated by occlusion of the arterial supply to the 
contracting muscle, suggesting the response is in some way influenced or generated by 
metabolic receptors. 
In an extension of this work using animal models, arterial and venous occlusion of exercising 
muscle prolonged the pressor response beyond the period of exercise, providing finiher 
support for some form of ischaernic metabolite stimulating the pressor response from within 
exercising muscle. Complete section of dorsal roots receiving muscle afferents abolished the 
pressor and heart rate response. Selective nerve blocking experiments provided evidence that 
the isometric exercise response is mediated by fibres within groups III and IV (i. e. small 
myelinated fibres and um-nyelinated fibres) (McCloskey and Mitchell, 1972). 
In contrast, Goodwin (Goodwin, 1972) supported the role of central command from the 
results on human studies. Vibration stimulus to muscle afferents was used to provide reflex 
stimulation of muscle contraction at lower levels of central command. Muscle contraction 
force (controlled with tension gauges visible to the subject) was kept constant before and after 
addition of vibration stimulus. They observed smaller pressor response and heart rate 
increases with the addition of vibration stimulus at a set contraction force. In other words, 
lower levels of central command were associated with reduced blood pressure and heart rate 
increases during isometric exercise. 
Hultman and Sjoholm. (Hultman and Sjoholm, 1982) observed cardiovascular response to leg 
isometric exercise in six young male adults, firstly under 20% maximum voluntary 
contraction and then non-voluntarily using percutaneous electrical stimulation (such that 
central command was apparently not involved). The cardiovascular responses were not 
significantly different between experiments: heart rate increased by 40% and systolic and 
diastolic blood pressure by 30% and 50% on both occasions. They conclude that muscular 
activity alone is sufficient to generate the cardiovascular response to isometric exercise, 
whilst adding that central command may not be without importance. 
In a comparison of 61 normal and 126 age matched diabetic subjects, the systolic blood 
pressure increase was similar but the mean diastolic increase was significantly less in the 
diabetic group. There was a significant correlation between the MVC and rise in blood 
pressure both in the normal and diabetic subjects (Ewing, 1974). 
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In a complex series of experiments, Eldridge et al (Eldridge, 1985) used animal models in 
various conditions of anaesthesia, decortication and decerebrate conditions, with electrical or 
pharmacological movement stimulation and under spontaneous actual motion or fictive 
locomotion (locomotor activity in the motor nerves during paralysis). Among the findings, the 
pressor response to exercise was no different during fictive locomotion despite the absence of 
muscular contraction or limb movement and the lack of change in metabolic rate. This 
provided some support for central command driving the cardiovascular response to exercise 
and the hypothalamus appeared to be the signal source. 
Activation of chemically sensitive muscle afferents during isometric exercise stimulates 
muscle sympathetic nerve activity (MSNA) but this effect is only significant during the 
second minute of exercise. MSNA is peripheral nerve traffic producing vasoconstriction - for 
a review of this topic see Wallin 1988* (Wallin and Fagius, 1988). Additionally, MSNA 
further increases during post-handgrip muscle ischaemic whereas heart rate returns to normal. 
During isolated biceps involuntary muscle contraction, MSNA does increase but heart rate 
does not. In contrast biceps voluntary muscle contraction does increase heart rate but, in the 
early phase prior to established muscle ischaemia, does not increase MSNA (and in fact 
MNSA actually drops in the first minute of handgrip). This series of observations indicates 
that central command causes tachycardia but does not increase, and instead appears to inhibit 
MSNA. Secondly, that chemically sensitive muscle afferents are responsible for the rise in 
MSNA. In sustained handgrip at 30% MVC, the excitatory influence on MSNA prevails in 
the mid to latter stages and significantly increases. The dissociation of heart rate and blood 
pressure trends during these experiments underlines the likelihood of the two responses being 
governed by different mechanisms (Mark, 1985). Figure 3.10 depicts the changes in blood 
pressure, heart rate and MSNA during isometric exercise. 
These findings have been replicated with further evidence of the differential effects of the 
muscle chemoreflexes and central command on sympathetic and parasympathetic response 
(Victor, 1987). Mild non-ischaemic exercise stimulates withdrawal of vagal tone and the 
resultant rise in heart rate increases blood pressure: central command is responsible for this 
reflex. The arterial pressure increases in proportion to exercise intensity and rise in heart rate. 
Sustained strenuous or ischaernic exercise stimulates muscle chemoreflexes but this response 
is relatively delayed until the ischaernic exercise has created the metabolites that excite the 
afferents. Therefore there is a lag before the metabolite-induced increase in MSNA that 
augments blood pressure increase already created by heart rate changes. The sympathetic 
Outflow will be directed at non-exercising skeletal muscle and the heart (Victor, 1987). 
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Figure 3-10 isometric exercise: blood pressure, heart rate and NISNA changes. 
Heart rate increases rapidly early during exercise then blood pressure steadily increases, mirrored by increasing 
MSNA. The three dataplots are for three different levels of isometric exercise: baseline activity (squares), 10% 
mean voluntary contraction (circles) and 30 mean voluntary contraction (triangles) 
MAP, mean arterial pressure: MSNA, muscle sympathetic nerve activity: BL, baseline 
Victor et al (Wallin, 1987) examined the relationship between MSNA and venous 
noradrenaline levels during isometric exercise in 16 normotensive and 15 untreated 
hypertensive patients. There was a small but non-significant elevation of MSNA in 
hypertensive patients compared with normotensives when expressed as MSNA bursts per 
minute but no difference when expressed as the product of bursts per minute and burst 
amplitude. Both groups showed minor elevations of MSNA in the first minute then similar 
and significant increases in the second minute. Hypertensive patients had a significant 
increase in noradrenaline after 2 minutes exercise which was significant but without 
subsequent change. Normotensive patients only showed increase in noradrenaline in recovery 
period but this was not significant. Individual changes in MSNA were correlated to changes 
in plasma noradrenaline during the first minute (r = +0.6 1, p<0.05) and second minute of 
handgrip (r = +0.44, p<0.05) despite the difference in the shape of the curve, with 
noradrenaline lagging MSNA. The increase in noradrenaline was relatively small but it's 
likely the plasma level may underestimate true noradrenaline response due to 
Pharmacokinetic properties. 
Other workers found MSNA response proportional to the level of muscle contraction force. 
Seals et al (Seals, 1988) examined heart rate, mean arterial pressure and MSNA responses to 
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isometric handgrip in 8 young adults at 15%, 25% and 35% MVC over 2.5 minutes. Pressor 
response was proportional to exercise intensity. The non-fatiguing 15% MVC produced a 
small but significant increase in pressure and heart rate but no increase in MSNA. They 
conclude at such light loads, the arterial pressure response is mainly due to vagal withdrawal 
and hypothesise that muscle perfusion in exercising muscle is adequate such that substantial 
rise in pressure from sympatho-excitation is not necessary. At 25% and 35% MVC, the first 
response was again increase in heart rate in proportion to intensity of exercise but reaching 
maximal level after 1.5 minutes without further rise in the final minute. The second 
contribution to arterial pressure rise came from increase in MSNA level which did not change 
significantly until the first minute of exercise but the continued to increase markedly in the 
final 1.5 minutes in an exercise-intensity dependent fashion. Thus at fatiguing exercise levels, 
the pressor response is generated by first by cardioacceleration from vagal withdrawal and 
then later by vasoconstriction from peripheral sympathetic traffic. In the final minute, 
increase in arterial pressure was very closely correlated with MSNA (r = +0.99, p<O .0 1). 
This concept was refined by Seals et al (Seals, 1993) by measuring the response until the 
maximum of endurance time. Handgrip contraction at 20%, 40% and 60% maximum 
voluntary contraction force was sustained until exhaustion, which occurred at 495,140 and 73 
seconds respectively, with 20 to 25 minutes between tests. Perceived effort was similar in the 
12 healthy young adults assessed. When measured as a percentage of maximum endurance 
time, systolic pressure was no different at the three contraction intensities. Diastolic pressure 
was lower only at the latter phase of 20% contraction force when compared with 40 % and 60 
% contraction force experiments (P<0.05). The rate of cardioacceleration rose in proportion to 
contraction force but then after 20% of maximum endurance time the rate of heart rate 
increase was similar for the three contraction intensities. Final peak heart rates were 
significantly different and related to contraction force. MSNA were similar at 40 % and 60 % 
contraction force throughout endurance time. The rate of MSNA rise and final peak level 
obtained were lower at 20% contraction force (p<0.05). In summary, findings indicated that at 
sub-maximal isometric contraction, MSNA is influenced by contraction force at low forces. 
But contractions above 20% MVC stimulate peak levels of sympathetic outflow. 
Ewing and Borst reported strong voluntary muscle contraction causes cardiac acceleration 
very quickly after onset of isometric exercise - within 0.4 to 0.6 seconds. They also reported 
that firstly cardioacceleration is due to sudden vagal inhibition, secondly is largely 
independent of heart rate and contracting muscle mass and thirdly is only mildly influenced 
by the strength of muscle contraction. There is a large degree of cardioacceleration variation 
between subjects (Borst, 1972; Ewing, 1974). Smith et al (Smith, 1976) in a review of the 
integrated mechanisms of cardiovascular response during exercise, summansed the origins of 
81 
tachycardia during exercise. They hypothesised on additional factors contributing to the 
tachycardia, in a time-dependent manner. The increase in heart rate starts very promptly 
within a few seconds and this initial response is due to vagal withdrawal. After 8- 10 seconds 
sympathetic impulses to the heart can contribute to tachycardia. Continued exercise may 
increase circulating catecholamines which act as a final contributor to cardioacceleration, 
probably at least 30 seconds after exercise initiation 
A recent study has shown that during isometric exercise, there is a significant increase in the 
(absolute and normalised) low frequency component of HRV as well as a significant decrease 
in the (normalised) high frequency component, suggesting a combined sympathetic and 
parasympathetic mechanism to the cardio-acceleration. The authors appear to make an 
assumption that the sympathetic component is 'muscle metabaloreflex' driven, since this 
reflex stimulus was continued post-exercise by occluding circulation to the exercising limb 
and the low frequency component remained elevated in this phase, only returning to baseline 
levels when the occlusion was removed. In contrast, the high frequency component returned 
to normal immediately post-exercise (and during circulatory occlusion) when heart rate also 
recovered to baseline levels - this infers an arterial baroreflex response mediated by vagal 
efferents which has a greater net effect on heart rate than sympathetic activity (lellamo, 
1999). 
Diastolic arterial pressure correlates more closely with MSNA than systolic pressure (Sundlof 
and Wallin, 1978). Watson et al (Watson, 1980) observed a significant correlation between 
diastolic pressure and plasma norepinephrine (r = +0.62, p<0.05) but not for systolic pressure 
during exercise (r = +0.28, ns). At rest sympathetic traffic is very low, hence capacity to 
reduce sympathetic activity in response to rising pressure is much less than ability to increase 
sympathetic activity when arterial pressure falls (Eckberg, 1988). 
*MSNA occurs in bursts, normally increases when blood pressure drops and in normal 
conditions is almost absent when blood pressure rises. MSNA usually occurs homogeneously 
without significant regional differences within individuals but activity differs markedly at rest 
between individuals. MSNA is mostly determined by diastolic pressure and often features a 
respiratory periodicity. MSNA is mostly involved in the instantaneous stabilization of blood 
pressure and not the control of mean resting blood pressure (Wallin and Fagius, 1988). 
3.1.4.2 Age 
Following linear regression, there was a significant relationship between age and Isometric 
exercise diastolic blood pressure response, but this was a positive correlation suggesting 
increasing diastolic blood pressure with age (Freeman, 1991). Another study tested 124 
healthy normal subjects aged 20-90 years and found that age did not influence the 
diastolic 
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response to handgrip (Mustonen, 1989). The lack of a relationship between age and the 
diastolic blood pressure response to handgrip has been shown in other studies using 
correlation techniques (Vita, 1986; Ziegler, 1992b). 
Another study confirmed that age does not influence the blood pressure response during 
handgrip (note this investigation used the mean arterial blood pressure). The underlying 
absolute increase in MSNA was the same for older and younger subjects but since there was a 
higher basal rate of MSNA, the percentage increase in MSNA was significantly smaller in 
older subjects. The increase in heart rate was significantly smaller in older subjects from an 
early stage during handgrip. Plasma noradrenaline levels increased by a similar percentage 
value in young and old but the absolute basal and peak values were higher in the older group 
(Ng, 1994). 
3.1.4.3 Other influences 
This is one test of autonomic function where there is a clear sex difference. Smaller diastolic 
blood pressure response occurs in females (Ewing, 1974; Mustonen, 1989; Ng, 1994; Vita, 
1986). This is related to typically lower force of MVC in females which leads to a smaller 
blood pressure rise than males (Ewing, 1974). 
3.1.4.4 Repeatability 
There is substantial retest within-subject variation in blood pressure results for isometric 
exercise in healthy individuals over I year, calling into question its value as a means to 
monitor the course of autonomic dysfunction. The heart rate response is more consistent 
(Braune, 1996). 
From a study of same day reproducibility, the coefficient of variation was 18.6 % in 21 
subjects tested using the Finapres and 36.9 % in a smaller group of 8 tested using manual 
sphygmomanometry (Mustonen, 1989). Parati et al also indicate that reproducibility is poor. 
In a group of adults aged 20-61 years, handgrip was performed on six occasions at 'intervals of 
30 minutes with intra-arterial pressure measurement. The group average mean arterial 
pressure coefficient of variation was 22.2%, individual range 12.8 to 32.3% (heart rate CV 
24.6%, individual range 11.9% to 49.1 %) (Parati, 19 8 5). 
Another study gave equivocal results. Firstly they quote a range of reproducibility in 5 non-nal 
cases, from mean diastolic increase and SD of 37 ±4 to 25 ± 10 mm Hg respectively, which 
indicates poor reproducibility. In contrast, in 25 normal and diabetic cases, the square of the 
deviation of the difference in diastolic blood pressure rise between subjects was 
approximately seven times that within subjects (F = 7.39, P< 0.01), indicating good 
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reproducibility (Ewing, 1974). In his review however, Low states the blood pressure change 
during isometric exercise is of limited sensitivity and specificity (Low, 1993a). 
There was no significant difference between control and diabetic cases, with standard 
deviation factors of intra-individual. variation of 1.46 and 1.37 respectively (Ziegler, 1992b). 
3.1.4.5 Test methodology 
The following methods for isometric exercise, using handgrip for exertion, have been used in 
studies. Diastolic blood pressure response is the preferred outcome except where indicated. 
1) 50% of maximum voluntary contraction for 2 minutes (Braune, 1996) 
2) 40% MVC sustained until exhaustion, mean artenal pressure quoted (Ng, 1994) 
3) 40% MVC for 90 seconds (Parati, 1989; Parati, 1985) with average blood pressure 
measured in the last 10 seconds of the test and 10 seconds immediately preceding the 
test. 
4) 30% MVC for as long as possible up to a maximum of 5 minutes (with BP measured 
using manual sphygmomanometry) (Ewing, 1974; Ziegler, 1992b). Interestingly the 
maximum blood pressure was similar no matter how long subjects maintained MVC, 
with times ranging from 2 to 5 minutes. Blood pressure was measured 3 to 4 times 
per minute during testing, the change in blood pressure taken as the difference 
between the last reading and the means of 3 baseline readings. 
5) 30% MVC for 4 minutes, assessing the diastolic blood pressure increase (Freeman, 
1991). 
6) 30% MVC for 3 minutes, suggested in a review (Low, 1993a) and used in some 
studies (Mustonen, 1989; Netten, 1992). 
7) 30 % WC for 5 minutes, or at least 3 minutes (Vita, 1986). 
8) When manual sphygmomanometry is used, blood pressure is usually recorded at 
minute intervals, and one group suggested to only record at the third minute since the 
response is significantly higher at this stage compared to the first and second minutes 
(Mustonen, 1989). 
In a comparison of young and old subjects, mean ages 25 and 64 years respectively, 
endurance times for 40% MVC and perceived effort as well as post-exercise perceived pain 
were no different between the two groups (Ng, 1994). In other words the test was equally 
well-tolerated in both these age groups. 
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Two groups report on Finapres performance during isometric exercise testing. Thirteen cases 
had simultaneous intra-arterial (radial) and Finapres blood pressure monitoring during 90 
second handgrip: this study indicated the Finapres provides a reasonably accurate estimate of 
the quantitative change in blood pressure during isometric exercise. The average discrepancy 
in systolic and diastolic pressure change was respectively 4.6 ± 4.1 and 2.1 ± 1.2 mmHg. 
Finapres always reproduced the qualitative changes resulting from handgrip (Parati, 1989). 
Ziegler et al found the Finapres offers clear benefits compared with results obtained using 
sphygmomanometry; the latter was inconsistent because of difficulties in obtaining the final 
blood pressure during exercise (Ziegler, 1992b). 
The interaction between handgrip isometric exercise and Valsalva was examined by Ewing 
and colleagues (Ewing, 1976b) by performing concurrent tests in a small group. Essentially 
neither test had an over-riding influence on the other. But if a Valsalva manoeuvre took place 
towards the end of exercise, blood pressure response to exercise was exaggerated and heart 
rate was moderately reduced, therefore it is advised to avoid a Valsalva manoeuvre during 
isometric exercise testing. 
3.1.4.6 Relationship with other cardiovascular autonomic tests 
In the Ewing battery, there is a weak but significant correlation with heart rate response to 
deep breathing only, with no significant correlation with the Valsalva ratio, 30: 15 ratio or 
blood pressure response to standing (Vita, 1986). The change in low frequency power spectral 
analysis on moving from supine to an upright position is a poor predictor of diastolic blood 
pressure increase during isometric exercise (Freeman, 199 1). 
3.1.4.7 Clinical application 
Isometric exercise is often used as part of a battery of clinical autonomic fimction tests. The 
test was included by Ewing in his protocol and was also advocated by a consensus conference 
of the American Diabetes Association on diabetic neuropathy (Anonymous, 1988; Ewing and 
Clarke, 1982). A repeat consensus conference involving the American Diabetes Association 
and American Academy of Neurology did not include isometric exercise in their suggested 
cardiovascular autonomic tests and other groups have not recommended the test for routine 
clinical use (AAN, 1996a; Anonymous, 1995). 
Nonetheless, there is a considerable body of literature on the clinical value of isometric 
exercise in evaluation of sympathetic ftinction. In one study, 22/124 diabetic subjects had an 
abnon-nally low (<2 s. d. for normal mean value) diastolic blood pressure change: the presence 
of abnormal blood pressure response was not related to duration of disorder, method of 
treatment, control or the presence of microvascular disease. This study also found no 
significant differences in heart rate response between non-nal and diabetic subjects. They 
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concluded the test was useful for the detection of autonomic dysfunction in diabetics (ENN-ing, 
1974). In a review, Low (Low, 1993a) suggested defining a normal response as an increment 
in diastolic blood pressure of 16 mnfflg or more, with 11 -15 mmHg as a borderline response. 
Although isometric exercise has been shown to be a useful test of efferent adrenergic arterial 
vasoconstriction, care is required in the interpretation of results. There is one unusual example 
of a moderate increment in blood pressure in an individual known to have sympathetic failure 
with intact vagal control: the presumed mechanism was vagal withdrawal leading to 
cardioacceleration and hence increase in cardiac output (van Lieshout, 1989). 
3.1.4.8 Conclusion 
Isometric exercise is a test of cardiovascular autonomic reflexes that normally causes a 
tachycardia and rise in blood pressure. The tachycardia is multifactorial in origin. Early va-aal 
withdrawal is an important component: increases in efferent cardiac sympathetic impulses and 
circulating catecholarnines probably also contribute. The blood pressure rise has dual origin - 
early cardioacceleration-related rise in cardiac output and most importantly a delayed increase 
in peripheral muscle sympathetic nerve activity to non-exercising muscle that produces 
vasoconstriction. MSNA correlates with the force of contracting muscle i. e. is effort 
dependent. The whole purpose of this haemodynamic adjustment is to maintain and increase 
perfusion to isometrically-exercising muscle. The reflex is triggered by a combination of 
afferent neural traffic from ischaemic skeletal muscle and signals from central command 
areas that control voluntary muscle movement. 
Opinion is divided on the value of isometric exercise as a clinical tool for evaluation of 
cardiovascular autonomic function, with generally a smaller body of experience in the 
literature. There is no agreement on ideal test protocol and repeatability can be poor. However 
the test can show differences in autonomic function between groups - 
3.1.5 Cold pressor test 
The cold pressor test measures the blood pressure response to cold sensory stimulus. The 
hand is immersed in an ice water bath for up to 2 minutes. The rise in blood pressure from 
baseline to the final period of immersion is recorded. The normal response is a rise in systolic 
or diastolic blood pressure of 10- 15 mmHg and 10 mmHg respectively. Systolic and diastolic 
pressure rises of more than 20 and 15 mmHg are abnormal. Subnormal responses may be seen 
in cases with damage to efferent sympathetic vasoconstrictor function (Wieling and 
Karemaker, 1999). 
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3.1-5.1 Neural mechanism 
Victor et al (Victor, 1987) examined effects of the cold pressor test M 25 healthy young 
adults. Arterial pressure, heart rate and MSNA all significantly increased during cold pressor 
test. Similar to isometric exercise, normal cold pressor response results in the absence of the 
usual inhibitory effect of increasing blood pressure on sympathetic outflow. Heart rate rise 
started early within 30 seconds, peaked in the first minute, then declined in the second nuinute 
and the response was blocked by propranolol, indicating a cardiosympathetic basis. There was 
no correlation between MSNA and heart rate. MSNA was significantly higher at the end of 
the first minute and peaked in the second minute. MSNA strongly correlated with mean 
arterial pressure increase (r = +0.86, p<0.01). Mean arterial pressure was maximal in the 
second minute of immersion and the increase was not affected by propranolol. Peak 
norepinephrine level did not occur until the end of the first minute of the recovery period: 
there was a significant correlation between MSNA and norepinephrine levels but the large 
change in MSNA compared with small differences in norepinephrine levels. Therefore cold 
pressor elicits an early increase in cardiac sympathetic drive (possibly due to painful stimuli) 
and a later increase in peripheral muscle sympathetic activity which dictates the blood 
pressure response (possibly driven by cutaneous afferents). 
Stancak et al (Stancak, 1996) observed cardiovascular changes during a4 minute cold pressor 
test in 20 young male healthy adults. Systolic and diastolic blood pressure rises were evident 
in the first minute, maximal at the end of the second minute, and then stabilised with a 
marginal decrease in the third and fourth minutes. Heart rate rise was maximal at the end of 
the first minute but then attenuated from second to fourth minute such that third to fourth 
minute heart rate was not significantly higher than basal heart rate. In the rest phase 
immediately following cold pressor, heart rate actually decreased to a level below that of pre- 
test control period but systolic and diastolic pressure remained at a level intermediate to test 
and pre-test control phases. 
Kregel et al and Fagius et al (Fagius, 1989; Kregel, 1992) confirmed the cold pressor test is a 
powerful activator of muscle nerve sympathetic activity (MSNA). The cold pressor test 
usually leads to a prompt rise in bursts of MSNA during immersion followed by a slow 
decrease in bursts during emersion. The level of MSNA correlates well with the rise in blood 
pressure with a stronger correlation for systolic than diastolic changes. The test itself 
produces a reversal of normal baroreflex function since an increase in blood pressure usually 
reduces MSNA. The blood pressure response is proportional to the level of reported 
discomfort but is not entirely governed by pain since an equivalent electrical painful stimulus 
(although of a different nature) does not elicit the same changes (Fagius, 1989). Another 
study also reports only weak correlations between pain and cardiovascular changes during 
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cold pressor test (Stancak, 1996). This suggests the response is likely to be dependent upon 
combined input from peripheral pain and cold receptors. 
The lack of response in peroneal nerve skin sympathetic nerve activity (SSNA) indicates 
different regulatory mechanisms controlling MSNA and SSNA. Sundlof et al reported 
diastolic arterial pressure correlates more closely with MSNA than systolic pressure, in 
contrast with studies mentioned above (Sundlof and Wallin, 1978). 
Ng et al (Ng, 1994) reported the cold pressor test only produces an increase in MSNA with 
noxious skin cooling. At seven degrees centigrade there was an initial dip in MSNA followed 
by a steady increase, whereas at zero degrees centigrade the rise in MSNA was instantaneous. 
In both cases peak MSNA occurs after 2.0 - 2.5 minutes immersion, and is 2-3 x basal levels 
in the case of zero degrees C. Non-noxious skin cooling at temperatures between 14-28 
degrees C actually decreases or has no net effect on MSNA. There is a small immediate 
tachycardia on immersion at all temperatures but twice as great at zero degrees C: the 
mechanism is not clear but may be due to arterial baroreflex inhibition (Kregel, 1992). 
The previous studies indicate that in the last 20 years many investigators have examined the 
role of MSNA in cold pressor response. But as early as 1965, Greene et al demonstrated that 
cold pressor response can have differing mechanisms between individuals. Eight 
normotensive and 10 hypertensive adults had direct arterial pressure, pulmonary artery 
pressure and cardiac output measured during cold pressor at 4"C. Most patients responded 
with a significant increase in blood pressure. Although most subjects produced an increase in 
total peripheral resistance, an increase in cardiac output generated the pressure rise in 5 cases. 
In another three cases, there was a combined cardiac output and peripheral resistance change 
behind the pressor response. Increase in pulmonary artery pressure was a third observed 
mechanism behind the pressor response (Greene, 1965). 
3.1.5.2 "ACI Age 
In a group of 15 insulin dependent diabetics with autonomic neuropathy, age just failed to 
reach the level of significance for a negative correlation with cold pressor response (Freeman, 
1991). 
Cold pressor induced changes in mean arterial pressure did not differ between 15 old and 
young subjects (mean ages 64 and 25 years respectively). The older group had higher baseline 
and peak MSNA levels but at one minute the percentage increase in MSNA was not 
significantly different between young and old groups. Then at I '/2and 2 minutes, the 
percentage increase in MSNA was greater in the younger group. The baseline and peak 
noradrenaline levels were significantly higher in the older group but the percentage increase 
in noradrenaline was not different between the groups (young 69%, old 65%). The modest 
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rise in heart rate was not influenced by age (Ng, 1994). Overall the study indicated 
sympathetic neural reactivity to stress does not increase with age in healthy humans. 
This question was addressed by Pascualy et al (Pascualy, 1999) who compared plasma 
catecholamine responses to cold pressor test in three healthy groups; 19 young adults mean 
age 25 years, 28 early aging adults mean age 70 years and 8 advanced age adults mean age 84 
years. Catecholarnines were sampled at every 5 minutes after immersion in ice water for I 
minute. Blood pressure was measured by automated arm sphygmomanometer after every 5 
minute blood sample, unfortunately not utilising continuous blood pressure measurement. 
Basal noradrenaline was higher, increased to a greater degree but returned to basal level at a 
similar time point in the oldest age group compared to early aged and young adults. 
Noradrenaline levels were much higher in the advanced aged group compared with early 
aging group. Basal epinephrine levels displayed a trend towards elevation in younger adults 
compared with early aging adults but were significantly higher in the advanced aging 
compared with early aging group. However advanced aging adults were the only group to 
demonstrate an epinephrine response to cold pressor test (increase at 5 nuinutes, normalising 
at 10 minutes). In summary advanced aging exaggerates the modest effects of early aging on 
basal sympathetic nervous system activity and greatly enhances the norepinephrine response 
to cold pressor stress. Advanced aging appears to result in epinephrine rise during cold 
pressor test not seen in younger people. The authors indicate sampling times may not capture 
early rise and clearance of catecholarnines in the younger groups. 
3.1.5.3 Other influences 
Hypertensive individuals appear to have an exaggerated pressor response during cold stimulus 
compared with normotensives. Greene et al made this observation but noted that although the 
absolute change in pressure was greater, the percentage change relative to control values was 
exactly the same between groups (Greene, 1965). 
3.1.5.4 Repeatability 
Reproducibility was examined in a group of 48 healthy normal subjects by Fagius et al 
(Fagius, 1989). Group results were very similar, but there were up to seven-fold intra- 
individual differences on tests repeated the same day and up to five-fold on tests separated by 
up to 3 days. Thus the cold pressor test may not be reliable as a quantitative clinical test. 
Parati et al (Parati, 1985) also conclude reproducibility is not good. Eight individuals repeated 
60 second ice water immersion for six occasions at intervals of 30 minutes, measunng mean 
intra-arterial pressure. Mean arterial pressure coefficient of variation averaged 17.2% 
(range 
8.2 to 34.7%) for the group (heart rate CV 44.2%, range 18.1 to 158.1 %). They hypothesised 
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variability is a reflection of the complexity behind central processing that governs the pressor 
response. 
3.1.5.5 Test methodology 
Period of immersion has ranged from one (Fagius, 1989; Freeman, 1991; Parati, 1989; Parati, 
1985), 21/2 (Ng, 1994) and three minutes. Significant blood pressure changes are evident after 
one minute and continue, peaking around the 2.0-2.5 minute mark (Kregel, 1992). The quoted 
temperature has ranged from 0- VC (Ng, 1994), two (Fagius, 1989) to four (Freeman, 199 1) 
degrees Celsius. Although many investigations use diastolic blood pressure change, some 
investigators use the systolic pressure response or mean arterial pressure (Freeman, 199 1; No. 
1994). A limited number of studies quantify time period for obtaining blood pressure 
readings: one study calculated changes using a 20 second period in the one minute prior to the 
test for baseline values and then the final 10 seconds of the immersion phase and another 
suggested similar 10 seconds pre-test and final test phase averages (Parati, 1989; Parati, 
1985). 
The Finapres is a suitable device to record blood pressure during the cold pressor test. In a 
group of 14 individuals, the Finapres blood pressure values gave an accurate estimate of 
blood pressure values when compared to the gold standard of radial intra-arterial values. The 
mean discrepancy between methods for systolic and diastolic pressures were 4.6 ± 4.1 and 2.1 
± 1.2 mm-Hg respectively. When considering the sign, there was a significant difference in the 
discrepancy for systolic pressure, +43 ± 4.5 mmHg (p<0.0 1) but not diastolic pressure, +0.1 
± 2.5 mmHg (Parati, 1989). 
Although the cold pressor test is viewed as a test of efferent sympathetic function, caution 
may be required in drawing this conclusion. One case report of a patient with known 
sympathetic failure but intact vagal control still produced a normal rise in blood pressure 
during the cold pressor test, probably by a mechanism of vagal withdrawal. This enabled an 
increase in heart rate, producing a rise in cardiac output unopposed by reflex vasodilatation 
(van Lieshout, 1989). 
3.1-5.6 Relationship with other cardiovascular autonomic tests 
The postural change in low frequency spectral power, seen as a marker of sympathetic 
function, did not bear any relationship to cold pressor systolic pressure changes (Freeman, 
1991). 
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3.1.5.7 Clinical application 
Wieling et al comment that, in their experience, the cold pressor is the most useful test of 
efferent sympathetic pathways, since isometric tests are hampered by limited sensitivity and 
specificity (Wieling, 1997). 
3.1-5.8 Conclusion 
Cold cutaneous stress provokes increase in blood pressure and heart rate. The blood pressure 
rise is created from increase in MSNA activity, circulating catecholamines and tachycardia. 
The proportional contribution can vary according to age. The tachycardia is a combination of 
cardiosympathetic activity and vagal withdrawal. There is no conclusive evidence of the 
impact of ageing on numerical blood pressure response to cold cutaneous response. Individual 
reproducibility is moderate at best, limiting clinical value of cold cutaneous stress in 
evaluation of sympathetic efferent function. 
3.2 Heart rate variability 
3.2.1 Terminology 
Heart rate variability is a term applied to a number of techniques in the literature. Broadly 
speaking, these fall into three groups. Firstly the classic 'bedside' cardiovascular autonomic 
reflexes describe heart rate variability over very short intervals in response to metronomic 
respiration, orthostasis and the Valsalva manoeuvre. In the last two decades, computerised 
analysis of heart rate variability led to development of two other techniques, time domain and 
frequency domain analysis of heart rate variation. These two methods quantify oscillation in 
heart rate over longer periods, usually minutes to hours. The following discussion focuses on 
heart rate variability in the frequency domain, a method used in this investigation. 
3.2.1.1 History 
Beat to beat variability in blood pressure was first documented in the 18'hcentury by Stephen 
Hales during the first measurement of arterial pressure (Hales, 1733). In the 1960's Hon and 
Lee reported reduced heart rate variability was a marker of foetal death (Hon and Lee, 1965). 
Value as an adverse prognostic marker in adults was first shown in the 1970s when Wolf et al 
(Wolf, 1978) reported reduced variability associated with long-term mortality after 
myocardial infarction. 
3.2.2 Measurement 
Beat-to-beat variability in cardiovascular variables reflects the interplay between perturbation 
to cardiovascular homeostasis and the stimulated response of the cardiovascular regulatory 
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systems (Appel, 1989). Cardiac autonomic control loops are subject to many influences, 
which can interact amongst themselves. Such interaction of the influencing components is 
termed coupling and can lead heart rate, peripheral vascular resistance and blood pressure to 
demonstrate non-linear dynamic responses. Features of such non-linear systems include (a) 
small changes creating striking, non-proportional effects and (b) the non-linear system cannot 
be understood by individual component analysis, because of the coupling phenomenon. 
Breakdown of this complex array of mechanisms is a feature of Pathological states 
(Goldberger, 1996a). Despite these difficulties, a mathematical model of the interplay 
between RR interval, blood pressure and peripheral resistance was proposed by de Boer 
(deBoer, 1987). This model does reproduce the characteristics of RR and blood pressure 
variability and its accuracy was improved by modifications by Whittam et al (Whittam, 
2000). 
3.2.3 Frequency domain 
Spectral analysis is the process of segregating a signal into its constituent sine waves, by 
mapping out the different frequencies to represent the strength of each sine wave, or harmonic 
component (long term heart rate variability studies). The power spectrum presents the squared 
amplitude of the sine waves as a function of frequency i. e. x axis is the frequency, y axis is 
square of the sine wave amplitude. This is the power spectral density for the heart rate 
variability power spectrum. 
For heart rate variation, these frequencies are less than I Hz in humans. The spectrum is 
divided into bands of interest. These bands are not arbitrary: research over the last 25 years 
indicates the bands reflect activity in distinct limbs of the cardiovascular autonomic system 
and other feedback loops in response to haemodynamic perturbation. The power of a 
frequency band is represented by the area under the curve. The number of bands of interest 
depends on the length of heart rate recording. Longer recordings improve ability of spectral 
analysis to identify slower heart rate variation. In other words prolonged heart rate recordings 
are required to detect very low frequency bands. 
Stationarity is theoretically an ideal requirement for frequency domain analysis. Stationarity 
means obtaining a state where all other biological systems, bar those under investigation, are 
held constant. In effect stationarity is not obtainable in normal research conditions, even 
during fairly short periods of heart rate assessment (Malliam, 1994). Nonetheless it is an 
important principle of heart rate variability study to minimise variation in conditions. 
In a five minute recording, the two bands of interest are the high frequency and low frequency 
spectral powers (HF and LF). The high frequency is mediated by the parasympathetic nerN'ous 
system which is able to rapidly react to cardiovascular perturbation within a fe, %v seconds, thus 
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generating the most rapid fluctuations in human heart rate activity. Sympathetic autonomic 
response is more sluggish, requiring around 10 to 20 seconds to generate a measurable 
response to cardiovascular perturbation (Rosenblueth, 1934). Even slower frequencies exist 
and require prolonged heart rate recording for accurate delineation (Malik, 1996). These 
slower frequencies are grouped into very low and ultra low frequencies (VLF and ULF). In 
prolonged heart rate variability studies, VLF and ULF powers dwarf high and low frequency 
powers. In spite of this disproportionate importance, physiological correlates of ULF and 
VLF are surprisingly less well understood than high and low frequency powers. Nonetheless 
ULF and VLF power are still useful when considering clinical applications of heart rate 
variability. ULF and VLF have been referred to as non-respiratory powers (less than 0.04 Hz) 
since they do not appear to be altered by changes in respiratory pattern; they are said to be 
persistent during short term recording (Novak, 1993). This thesis concentrates on obtaining 
low and high frequency individual power bands as well as the 'total' power band. It is 
recognised that total power is influenced by VLF and ULF power bands, despite the short five 
minute recording chosen for study. Understanding the components of the low and high 
frequency power bands is particularly useful when assessing the neural reflexes governing 
short term heart rate and blood pressure variability. Mechanisms governing low and high 
frequency powers are discussed in greater detail below. 
The transition from a five minute recording of ECG and blood pressure data to the production 
of RR interval and systolic blood pressure spectral powers is a highly complex mathematical 
process which is beyond the scope of this review. 
In brief, the concept is based on identifying harmonic components of heart rate variations, 
which yield peaks in the Fast Fourier Transformation (FFT) power spectrum. In practice, the 
FFT spectra are often a highly split pattern with power scattered over a broad band with no 
clearly discernible peaks. In situations where there is a lack of distinct hannonic components 
after FFT, results can still be comparable to other methods of spectral analysis (Adelmann, 
1999). If 24 hour recordings are analysed by spectral methods, taking the mean values of 
multiple five minute segments over 24 hours yields the same results as continuous spectral 
analysis over 24 hours whilst offering a simpler processing method (Rottman, 1990). 
Limitations of Fast Fourier Transformation to calculate power spectra are the (a) deterministic 
nature of algorithm used, (b) applicability only to periodical phenomena, not strictly true in 
this situation, (c) need to window and (d) difficulty in defting with certainty the relative 
component power (Pagani, 1986). 
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3.2.3.1 Editing 
Ectopic data produce non-sinus R waves that require removal from the recording before 
power spectral analysis. This is necessary to remove the noise in a recording and allow more 
accurate reflection of true autonomic activity acting on the sinus node. Artefacts often appear 
in ECG recordings due to change in body position, poor ECG electrode-skin contact or 
muscle movement. Despite the very best recording and training techniques, a proportion of 
records from a study will not be suitable for processing due to artefacts (Liao, 1996). Even 
with only very small amounts of ectopic data (less than I %), heart rate variability 
measurement can be significantly hampered (Storck, 200 1). Furthermore variation in editing 
methodology can lead to substantially different frequency domain results (Salo, 2001). Some 
groups stipulate minimum percentage of RR intervals are normal sinus beats(NN intervals), 
for example 80% for Rottman et al (Rottman, 1990). The cut-off figure needs to yield 
consistent results whilst permitting a large residual fraction of RR intervals to allow 
meaningful analysis. 
3.2.3.2 Repeatability 
Some studies are optimistic, reporting consistent results for low frequency and high frequency 
over 2 months with reliability co-efficients of 0.68 to 0.77 under free respiration and 0.75 to 
0.82 during metronomic respiration (Sinnreich, 1998). In a comprehensive report, Pitzalis 
demonstrated short term frequency domain measurements possess different degrees of 
reproducibility (over 2 weeks and 7 months) according to experimental conditions. Total 
power was reproducible only at rest (Intraclass correlation coefficient, ICC 0.75), high 
frequency power only during metronomic respiration (ICC 0.65) but low frequency power 
was reproducible during rest, metronomic respiration and tilt (ICC 0.60 to 0.77) (Pitzalis, 
1996). Intraclass correlation co-efficients for three concurrent ECG recordings (i. e. one 
experiment with simultaneous triplicate ECG recording) yielded intraclass correlation co- 
efficients of 0.63 to 0.78 for low frequency, 0.72 to 0.91 for high frequency but only poor to 
fair results for fractional power and LF: HF. These latter results are alarmingly poor for a 
situation that should exclude natural variation over time and suggests either poor recording 
quality or poor interobserver agreement in editing technique (Ahmed, 1994). Other reports 
indicate reproducibility of frequency domain measures of heart rate variability is not good 
because inter-individual variation is high (Lord, 1997; Malik, 1996; Whittam, 2000). 
Patient groups with impaired autonomic function such as post-myocardial infarction exhibit 
less heart rate variability therefore more reproducibility (Kautzner, 1995; Stein, 1995). 
Longer-ten'n measures of frequency domain (ULF and VLF) demonstrate better 
reproducibility. This may be related to varying conditions over 24 hours with a larger number 
of situations, thereby including a larger number of modifications and thus homogenising this 
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spectral power. This could viewed as analogous to 'regression to the mean' for that 
individuals' heart rate variability (pitzalis, 1996). 
3.2.4 Physiological correlates 
3.2.4.1 High frequency heart rate variability 
The most rapid fluctuation in heart rate is mediated by the vagus nerve with a periodicity that 
matches the respiratory rate. In normal conditions this is around 0.20 Hz with a range between 
0.15 and 0.40 Hz. Synchronicity between respiratory and heart rate variation was addressed in 
section 3.1.3.1 (Metronomic respiration as an autonomic reflex test) and additional issues are 
now discussed. 
Respiratory activity has a mechanical effect on the intra-thoracic vessels and heart which 
stimulates vagal outflow to moderate cardiac output. Respiratory activity mechanically 
modifies arterial blood pressure which then leads to similar high frequency heart rate 
fluctuation, and not vice versa (Bernardi, 1989; deBoer, 1987; Peters, 1988a; Peters, 1988b; 
Saul, 1991). Under 'pure vagal conditions', the phase lag (the difference between respiratory 
activity 'input' and heart rate 'output' frequencies) is close to zero at all frequencies, such that 
heart rate increases during inspiration (suppression of cardiac vagal activity) and decreases 
during expiration (Eckberg, 1983; Saul, 1991; Saul, 1989). In addition to the mechanical link, 
there may be direct neuronal connections between high level respiratory and cardiac 
autonomic centres (Saul, 1991). 
The vagus provides the efferent arni of this circuit (Eckberg, 1983; Katona and hh, 1975). 
Katona et al (Katona, 1970) isolated single and multiple cardiovagal efferent nerve fibres in 
anaesthetised dogs, and described the following outcomes. 
Vagal firing substantially diminished or was abolished during natural inspiration 0.5 
seconds before the respiratory nerve commenced firing, and resumed activity 
immediately after cessation of inspiratory nerve firing (a similar conclusion was 
reached by Saul et al (Saul, 199 1) who also observed that inspiration inhibits 
sympathetic activity). Vagal firing decreases to increase heart rate as a response to the 
fall in left ventricular output during inspiration (Peters, 1988b). 
Vagal firing increased as blood pressure rose and vice versa: time interval was 
usually 60 to 80 ms but with a range of 55 - 140 ms 
Rapid blood pressure changes were followed by more gradual changes in vagal firing, 
with a longer latency to respond to drops in blood pressure compared with a rise in 
pressure 
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0 RR interval was closely related to vagal firing 
Katona and Jih isolated the vagus nerve of anaesthetised dogs. The nerve strands ývere 
manipulated by cooling and re-warming in the presence of autonomic pharmacologic 
blockade. Results demonstrated how the respiratory sinus arrhythmia, in other words the high 
frequency variation, is very closely proportional to vagal activity in animals (Katona and Jih, 
1975). The sino-atrial node responds as a low pass filter to fluctuations in either sympathetic 
or parasympathetic tone (Berger, 1989). 
Other animal models provide further proof of change in vagal firing with the respiratory 
cycle. These experiments entailed direct vagal firing measurement in decerebrate cats or 
conscious dogs, and utilised autonomic blockade to characterise the response. Atropine 
virtually abolishes high frequency power (Akselrod, 1985; Akselrod, 198 1; Billman and 
Dujardin, 1990; Chess, 1975; Rimoldi, 1990). In the presence of hypotensive drugs that 
stimulate sympathetic reactivity, low frequency is enhanced and high frequency decreases 
(Pagani, 1986). 
Katona et al (Katona and Jih, 1975) reported high frequency variation in heart rate variability 
is proportional to cardiovagal impulses in conscious dogs. Pomeranz et al (Pomeranz, 1985) 
replicated these results in humans. Pomeranz demonstrated that atropine administration 
greatly diminishes the high frequency component of power spectral analysis in humans. High 
frequency peak was practically abolished by atropine in both the supine and standing 
positions with no impact after beta blockade. Standing or passive tilt leads to diminution of 
HF power (Pagani, 1986; Pagani, 1991; Pitzalis, 1996; Pomeranz, 1985; Sanderson, 1996; 
Yokoi and Aoki, 1999). Propranolol alone has no effect on HF but adding atropine reduces 
HF power (Ahmed, 1994). Others have also shown near complete abolition of HF with 
atropine with minimal additive effect after propranolol (Jokkel, 1995). Beta-blockade alone in 
the supine state can increase high frequency power (Jokkel, 1995; Pagani, 1986). 
Ahmed et al investigated the impact of different sympathetic stimuli on frequency domain 
power spectral analysis. Exercise and isoproterenol significantly reduced FEF, tilt produced a 
non-significant decrease and epinephrine had no effect (Ahmed, 1994). Fouad (Fouad, 1984) 
used atropine in human subjects to show how parasympathetic activity is proportional to RR 
interval variation in quiet resting conditions, and this relationship was not affected by beta- 
blockade. Psychological stress from mental arithmetic or interview decreases high frequency 
whereas isometric exercise surprisingly may not have any effect (Pagani, 199 1). 
There clearly is a relationship between respiratory activity and RR variation and the studies 
discussed above indicate this is a very close linear relationship. This stance is contested by 
other workers who have obtained results indicating vagal cardiac nerve firing is not directly 
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proportional to the (high frequency) respiratory sinus arrhythmia (Eckberg. 1988; Kollai and 
Mizsei, 1990). Kollai and Mizsei (Kollai and Mizsei, 1990) investigated the respiratory sinus 
arrhythmia in 29 healthy young adults. They found that parasympathetic cardiac activitV 
could be further reduced by atropine during inspiration i. e. vagal firing was not zero during 
normal inspiration. They termed the difference between maximum and minimum RR intervals 
as the respiratory sinus arrhythmia (RSA) and the parasympathetic control (PC) as the change 
in RR interval after complete parasympathetic blockade by atropine. There was a significant 
but only moderate correlation between PC and RSA (r = +0.6 1, p <0.00 1). They also found 
close associations between RSA and respiratory cycle length (r = +0.69, p<0.00 1) and RSA 
and tidal volume (r =- +0.89, p<0.001). Parasympathetic control and respiratory cycle length 
were not significantly correlated (r = +0.24), PC and tidal volume were loosely related (r = 
+0.46). Following multiple linear regression, the strength of correlation for RSA improved 
when including three variables: PC, respiratory cycle length and tidal volume (R = 0.93, 
adjusted r' = 0.84). Saul et al (Saul, 1989) found proportionality between the respiratory and 
heart rate frequencies is seen in the normal operating range but does not hold true at very low 
frequencies. 
Controlled or metronomic respiration is used to augment parasympathetic activity and 
stimulate the high frequency power. The effect tends to plateau at 6 to 10 breaths per minute 
(Brown, 1993; Novak, 1993; Pagani, 1986; Pagani, 1991; Sanderson, 1996). The relationship 
is mostly dependent on rate of respiration but larger tidal volumes also increase high 
frequency power (Brown, 1993). High frequency power is sometimes termed the respiratory 
frequency in view of the physiological link to respiratory rate but clearly at low respiratory 
rates the 'high' frequency will move into the low frequency band when respiratory rate is less 
than 0.15 Hz. The gain in high or respiratory frequency power spectra is significantly greater 
at the lowest breathing frequencies i. e. around 6 to 10 breaths per minute compared with 15 to 
24 breaths per minute (Brown, 1993). Metronomic respiration concentrates the respiratory 
high frequency power at the same frequency but during spontaneous breathing rates, the 
respiratory power can be spread over a wide frequency band (Saul, 1989). If the rate is similar 
to spontaneous respiration, the effect on HF and LF can be small or negligible (Pitzalis, 1996) 
and higher respiratory rates actually diminish both powers (Bernardi, 2000; Sanderson, 1996). 
One report states very slow respiratory rates (less than 0.15 Hz) can also diminish vagal 
activity (Saul, 1991). Thus, the body of evidence indicates respiratory rate is clearly important 
in modulating high frequency but there is also evidence demonstrating no significant 
differences in the heart rate variability results whether the respiratory rate was fixed to a 
metronome at a physiological rate or not (Goldberger, 1996b; Kim, 1997). In states such as 
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heart failure where heart rate variation is generally diminished, metronomic respiration can 
still increase high frequency power (Arrowood, 1995; Sanderson, 1996). 
Heart transplant recipients are thought not to develop cardiovagal re-innervation. Indeed 
atropine does not alter high frequency after transplantation but metronomic respiration does 
increase low and high frequencies post-transplant (Lord, 1997). Oscillations in RR interval 
with respiratory manoeuvres in heart transplant patients are usually approximately 5% of that 
seen in controls,, with a larger relative influence of tidal volume (Bernardi, 1989). This effect 
may be mediated by sinus node/myocardial wall stretch or possibly even persistent 
intracardiac ganglia. 
High frequency power is more of a representation of the variation in modulating activity of 
the cardiovagal nerves rather than a direct measure of cardiovagal impulses. An increase of 
high frequency power is reflecting an increase in modulations of cardiovagal activity. For 
example in resting conditions when vagal activity can fluctuate normally, high frequency 
power will be present and will increase during vagal manoeuvres such as deep breathing 
(Pagani, 1986). However, completely opposing physiological conditions will both lead to an 
absence of HF components. Saturated vagal outflow, such as occurs when increasing blood 
pressure with phenylephrine, will lead to a slow heart rate that cannot vary at all at high 
frequencies under these physiological conditions (Cerati and Schwartz, 199 1). Therefore 
despite very high vagal activity, high frequency power is reduced (Goldberger, 1994). With 
the opposite condition of parasympathetic blockade, the heart rate will be fast with no vagal 
activity but again, the ability for high frequency fluctuation is absent and high frequency 
power is abolished. Thus completely different levels of vagal activity produce the same 
absence of high frequency power (Malik and Camm, 1993). Saul et al reported lack of change 
in high frequency power despite assumed changes in vagal activity during baroreflex stimuli 
in humans (pressor and hypotensive drug infusions). This report hypothesises high frequency 
power is unlikely to correlate with mean vagal activity (Saul, 1990). Animal models lend 
support to this theory: high frequency component increased greatly during modulation of 
vagal activity by oscillating stimulation frequency or magnitude compared to constant 
frequency vagal stimulation (Hedman, 1995). 
Goldberger's (Goldberger, 200 1) investigation results informed a model whereby heart rate 
variability increases as parasympathetic activity increases until a plateau or saturation point is 
attained. Thereafter heart rate variability decreases as parasympathetic activity further 
increases. There is marked inter-individual variation in the relationship between heart rate 
variability, perhaps explaining the inconsistencies in some studies on heart rate variation 
physiology. This also creates a situation where we may not fully appreciate if observed inter- 
individual differences in HRV are due to true differences in autonomic effects or alternatively 
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a different relationship between HRV and autonomic effects, depending on where the 
individual is studied on the ascending-descending response limb of heart rate variability. 
Kollai's (Kollai and Mizsei, 1990) work has also shown inter-individual variation for the 
relationship between respiratory cycle length and RSA. Slow breathing usually increases RR 
interval but can decrease the interval in others. In the majority of subjects, reduced minimum 
and increased maximum RR contributed to the increase in RSA amplitude caused by slow 
breathing (type A/Z). In some subjects, the same procedure induced large decreases in 
minimum RR and very small/negligible changes in maximum RR (type A). For another small 
group, changes were exactly the opposite (type Z). Kollai hypothesises the variation in 
reaction is due to different levels of resting parasympathetic activity. For type A, the average 
cardiovagal activity was likely to be high and near saturation, thus there was little scope for 
increased firing during expiration but further vagal withdrawal during inspiration could yield 
a large change in RR interval. In type Z, the vagal firing could be near its floor level during 
inspiration at basal respiratory rates but there was a large potential for increased vagal firing 
during expiration at slower respiratory rates. Two hypotheses regarding the saturation effect 
are (a) that intense acetylcholine release into the sinus node means that enzymatic degradation 
is outstripped or alternatively (b) there is loss of phasic respiratory changes in vagal nerve 
firing during the experimentally increased blood pressure. 
It can be seen that many of the mechanisms behind heart rate variability are still contested 
with the conflicting nature of some results. Sleight suggests inconsistent experimental 
evidence may relate to derangement in baroreflex sensitivity in certain subjects, which in 
itself is be an important component of RR variability (Sleight, 1995). 
There is further evidence that high frequency spectral power is not solely dictated by vagal 
activity. Indeed, some have clearly shown dissociation between heart rate variability and 
parasympathetic activity. Goldberger et al used phenylephrine as a vagal stimulant as a result 
of baroreflex. stimulation: the bradycardia reflected increasing vagal activity but there was a 
simultaneous decrease in high frequency power (Goldberger, 1994). Denervated hearts of 
transplant patients still display some high frequency power although this is less than 8% 
control subject levels, with a greater influence from tidal volume (Bemardi, 1989). Heart 
transplant patients' respiration-related oscillations in heart rate are hypothetically triggered by 
myocardial wall stretch. In normal subjects, atropine has a strong suppressive effect but does 
not abolish high frequency power (Eckberg, 1983; Katona and Jih, 1975; Saul, 199 1) and this 
non-autonomic component of high frequency variability is closely related to the rate of 
change of lung volume or respiratory airflow (Saul, 1991). Exercise is known to reduce vagal 
activity and at moderate exercise rates, high frequency power decreases but at very high 
exercise rates the proportion of high frequency power increases, consistent with the theory of 
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a non-autonomic mechanism contributing to this power (Bernardi, 1990). This non-neural 
component of high frequency accounts for a small fraction of high frequency power in 
healthy subjects but the proportional representation can increase in states such as heart failure 
(EI-Omar, 2001). 
3.2.4.2 Low frequency heart rate variability 
The components of low frequency heart rate variability have been extensively debated in the 
literature. Some workers argue that low frequency predominantly represents sympathetic 
effects on the heart (Malliani, 1994; Malliani, 1991) but the consensus view is that low 
frequency probably represents both vagal and sympathetic input to heart rate variability 
(Akselrod, 1985; Stein and Kleiger, 1999), and the relative sympathetic/parasympathetic 
contribution will vary according to physiological conditions. A model has been proposed 
which incorporates dual Parasympathetic and sympathetic action generating low frequency 
RR variation as a result of feedback (Bernardi, 1994; deBoer, 1987; Sleight, 1995; Whittam, 
2000). 
The origin of the low frequency variability in heart rate appears to be due to the delay in 
sympathetic feedback loops. The numerous factors influencing heart rate variability lead to 
noise but feedback from fluctuation in peripheral vasomotor tone amplifies the noise around 
0.1 Hz, creating the low frequency peak (deBoer, 1987). Step by step, this theory starts with 
the assertion that respiratory movement alters venous return to the heart which leads to 
arterial blood pressure flux. Consequently baroreceptor stimulation leads to efferent 
autonomic activity: fast vagal firing within I second and slower sympathetic firing over 3 to 
10 seconds. The slower sympathetic response is out of phase with the former fast oscillations. 
This is not buffered by the system. Instead a new oscillation is generated which is also sensed 
by the baroreceptors, producing a slow i. e. low frequency oscillation around 0.1 Hz. This 
model is supported by experimental evidence demonstrating how both vagal and sympathetic 
limbs are required to produce low frequency waves (Bernardi, 1994). The product of this 
sequence of interactions is sympathetic-mediated low frequency RR variation (Sleight, 1995). 
Another hypothesis is that a central neural oscillator creates the low frequency peak, since 
there are oscillations in central cardiorespiratory neurons, low frequency fluctuation persists 
during apnoeic states and opposite effects on baroreceptors produce the same increase in low 
frequency (Janig, 1985; Malliani, 1991). Overall, the consensus opinion is probably that low 
frequency heart period oscillation is generated by baroreceptor-sensed blood pressure 
fluctuation (Bemardi, 1994). 
The low frequency oscillation is normally centred on 0.1 Hz. It is not fixed to a certall, 
frequency and can vary between approximately 0.04 to 0.13 Hz. Animal experiments 
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demonstrate an increase in low frequency after sympathetic stimulation through 
pharmacological hypotension but this increase is abolished by pharmacological ganglionic 
blockade or arterial baroreceptor denervation (Furlan, 1990; Pagani, 1986; Rimoldi, 1990). 
However the blood pressure low frequency spectral density is maintained in spite of bilateral 
stellectomy (Pagani, 1986). This indicates the role of cardiac sympathetic nerves in the 
generation of low frequency. 
In Akselrods' original description of heart rate variability in conscious dogs (Akselrod, 198 1). 
autonomic manipulation revealed the following results: 
Combined parasympathetic and beta blockade abolished all powers with no heart rate 
variation 
Sympathetic blockade alone partially diminished LF power 
Parasympathetic blockade plus vasodilatation to stimulate sympathetic activity 
increased LF power 
B eta- sympathetic blockade plus increasing arterial pressure with a vasoconstrictor to 
reflexly increase parasympathetic activity increased low frequency power, 
confirming the parasympathetic input to this frequency domain. 
Pomeranz (Pomeranz, 1985) found similar results in humans. At rest atropine reduced low 
frequency spectral power by approximately 84% with no additional affect from propranolol. 
The act of standing greatly increased low frequency around tenfold. Whilst standing, atropine 
followed by propranolol produced incremental decreases in low frequency. Propranolol alone 
also reduced low frequency power. This investigation concluded parasympathetic activity 
alone produces low frequency at rest but both parasympathetic and sympathetic limbs 
influence low frequency when upright. 
Ahmed et al (Ahmed, 1994) investigated the impact of different sympathetic stimuli on low 
frequency. Only tilt produced a significant increase in low frequency. Epinephrine led to a 
modest rise whilst isoproterenol and exercise led to non-significant reductions in low 
frequency (the latter two with significant decreases in the fractional low frequency power): 
the sinus node also reacts differently to sympathetic action mediated by neural effects and 
circulating beta-agonists. These findings underline the pitfalls in drawing conclusions on 
sympathetic activity based on the low frequency power. Others have also shown increase in 
low frequency during passive tilt (Pagani, 1986; Pagani, 1991; Pitzalis, 1996). Low 
frequency: high frequency ratio was not altered by cardiac sympathectomy during supine rest 
(Lipsitz, 1990) but the ratio was significantly reduced during tilt testing (Tygesen, 1997). 
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Metronomic breathing, compared with spontaneous respiratory rate, tends to reduce low 
frequency power (Ahmed, 1994; Novak, 1993; Pagani, 1986; Pagani, 1991 . Pitzalis, 1996). 
There is a small reduction in low frequency power when respiratory rate increases from 
intermediate to fast rates (Brown, 1993). Where slow metronomic respiration has increased 
low frequency power, some authors suggest this is the result of respiratory frequency moving 
into the low frequency range, rather than a simple rise in the localised 0.1 Hz peak (Brown. 
1993; Novak, 1993; Sanderson, 1996). In the resting state, MSNA varied with respiration in 
ten normal subjects. Maximum activity occurred at end expiration and minimum activity 
usually at end inspiration (Eckberg, 1988). Respiratory related fluctuation in MSNA has been 
shown elsewhere (Saul, 1990). 
Low frequency power may be greater in males (Sinnreich, 1998). High frequency component 
in absolute tenns does not show any gender effect but when expressed as a percentage of total 
power may be greater in females (Sinnreich, 1998). 
One may expect that studies examining muscle sympathetic nerve activity could clarify the 
debate on sympathetic activity's role in the low frequency peak. In fact they reveal 
contrasting outcomes. One reports a significant correlation between low frequency and 
MSNA amplitude using normalised units but no association between bursts of MSNA per 
minute and low frequency (Pagani, 1997). Another has failed to show a positive correlation 
between MSNA and low frequency power (or LF: HF) in either control or heart failure 
patients. In fact low frequency power was inversely related to MSNA in heart failure patients 
(Notarius, 1999). But a revealing study by Saul et al (Saul, 1990) reported that in the resting 
supine state, MSNA or norepinephrine levels did not correlate with low frequency power but 
there were weak correlations during sympatho-excitatory states, i. e. falling arterial pressure 
using the vasodilator nitroprusside. There were no correlations when sympathetic activity 
decreased during rising arterial pressure. Generally there were marked inter-individual 
variations in the association between MSNA and low frequency heart rate variability. 
Conditions that increase sympathetic activity such as orthostatic stress and stressful interview 
increase low frequency power (Pagani, 1986; Pagani, 199 1; Sanderson, 1996). However 
results from studies using exercise as a sympathetic stimulus provide conflicting results; low 
frequency power can substantially diminish during exercise (Bernardi, 1990; Perini, 1990) or 
modestly (and non-significantly) increase during isometric exercise (Pagani, 1991). 
Furthermore in heart failure states, which is known to cause sympathetic arousal, low 
frequency power is actually reduced (Mortara, 1994; Sanderson, 1996; Saul, 1988) with 
failure to increase on standing (Sanderson, 1996). Reduction of sympathetic activity during 
for example sleep is associated with reduced low frequency. At rest cardiac norepinephrine 
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spillover in heart failure patients does not correlate with low frequency (nor LF: IV ratio) 
(Tygesen, 2001). 
Heart transplant patients are thought not to develop vagal re-innervation but may sprout 
sympathetic cardiac neural connections therefore provide a potential model of pure 
sympathetic cardiac innervation (Bernardi, 1995). In the post-transplant setting, intracoronary 
tyran-ýine (releases noradrenaline only from intact pre-synaptic nerve terminals) produced RR 
interval changes proportional to low frequency component. These results do provide further 
evidence that low frequency power is directly related to sympathetic activity (Lord, 1997). 
Jokkel et al (Jokkel, 1995), using the autoregressive technique for power spectral analysis, 
demonstrated similar near-abolition of low frequency with atropine with minimal additive 
effect from beta blockade but propranolol alone actually increased low frequency perhaps 
due to cardiac vagal nerve stixnulation (Kollai, 1994). Other studies report reduced low 
frequency power with chronic beta blocker use (Ahmed, 1994; Pagani, 1986). 
Caution is required when making assumptions about correlating low frequency power to 
autonomic nerve activity, in the same manner that applies to high frequency power. The low 
frequency power is expressing the ability of the autonomic nervous system to modulate heart 
rate variation. If the sympathetic nerves to the heart are at saturation level, there will be little 
scope for the sympathetic nerves to cause low frequency fluctuation and low frequency power 
will be diminished. Therefore sympathetic activity is high but low frequency power is low. 
This underlines the need to interpret findings in the context of the physiological setting 
(Malik and Camm, 1993). 
3.2.4.3 Sympathovagal balance 
Expressing the balance of sympathetic and parasympathetic activity using the ratio of low to 
high frequency power has been an attractive tool in the field of cardiovascular autonomic 
research (Malliani, 1991). Theoretically, activities such as exercise which lead to increased 
sympathetic activity increase the value of the LF: BF ratio and the converse applies during 
vagal stimulation such as metronomic respiration. Some reports do indicate the ratio can 
describe changes in autonomic activity that absolute values do not fully reflect but also report 
poor reproducibility of the ratio (Pitzalis, 1996). Unfortunately experimental results have not 
always validated the concept of 'autonomic balance' using the LF: 14F ratio (Lord, 1997; Saul, 
1990; Tygesen, 200 1). One review adopted a sceptical tone regarding the physiological basis 
of LF: HF ratio as a marker of sympathovagal balance (Eckberg, 1997). 
Another method of expressing the relative modulating activity of autonomic limbs is 
reporting the low or high frequency in normalised units (Malik, 1996; Malliani, 1994; Pagan,, 
1986; Pagani, 1991). This is the individual power spectral density (low or high) divided by 
103 
the sum of low and high frequency powers. The values can indicate a change in the apparent 
sympathovagal. balance during reflex tests in the absence of change In the absolute values for 
low or high frequency (Pagani, 1986; Pagani, 199 1). There may be some benefit in 
normalised units reflecting the proportional changes in autonomic balance during baroreflex 
stimuli since there is a better correlation with MSNA and normalised low frequency power 
than with absolute low frequency power (Pagani, 1997). However normalised units do not 
actually offer any more information than the LF: HF ratio (Hojgaard, 1998) and naturally 
suffer the same weaknesses as LF: HF in not honestly portraying neural activity (Lord, 1997). 
For example, in the process of adjusting sympathetic tone to lower levels, the LF: HF did not 
decrease with prolonged supine rest but did decrease with beta blockade. Therefore the ratio 
does not always reflect changes in sympathovagal balance and LF: HF does not correlate well 
with MSNA (Hojgaard, 1998; Saul, 1990). Additionally, the LF: 1-1F ratio may behave 
differently according to the nature of the sympathetic stimulus. Tilt and isoproterenol 
significantly increased the ratio whereas exercise and epinephrine led to small non-significant 
increases (Ahmed, 1994). 
3.2.4.4 Measurement and recording 
Stationary conditions are vital for frequency domain analysis. Stable environment and 
physiology will produce a steady state autonomic state which will enhance the interpretation 
of power spectra. Stationarity does not prevent the subject from performing any manoeuvre 
but requires remaining in the same condition throughout the short term recording - for 
example resting in quiet conditions, subjected to tilt, or a drug infusion. 
Activities such as reading, mental arithmetic or manipulation of respiratory rate will affect 
heart rate variability results. Reading silently or aloud decreases RR variability and increases 
low frequency, with similar but larger shifts towards low frequency during silent and aloud 
mental arithmetic (Bernardi, 2000). The respiratory high frequency power is lower in the 
upright position than supine (Saul, 1989). Ideally autonomic stimulation by physiological 
challenge should be incorporated into clinical HRV studies, since one recording in the supine 
position will not reveal the system's ability to show regulatory capacity (Karemaker, 1997). 
3.2.4.5 Conclusion 
Power spectral analysis of heart rate variability over five minutes can provide data reflecting 
cardiovascular autonomic modulation. The high frequency power spectra predominantly 
arises from vagal activity. Both sympathetic and parasympathetic activity modulate low 
frequency power spectra. Power spectral data are easily affected by environmental factors and 
also demonstrate potential for inconsistent responses between individuals. 
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3.2.5 Short term blood pressure variability 
Beat-to-beat variation in blood pressure can be recorded by intra-arterial monitors or non- 
invasively using the Finapres or the ambulatory version, Portapres, which records 
measurements over 24 hours. These devices employ Penaz's volume clamp technique; this is 
a pressure measuring device that fixes finger volume at a preset level by using a fast 
servosystem and autocalibration procedure. Combined with an infrared photoplethysmograph, 
the system can measure digital intra-arterial pressure. The non-invasive devices can 
overestimate intra-arterial systolic pressure at brachial artery level of the arterial tree but this 
is a relatively minor aberration (Omboni, 1993). 
Like heart rate, there are similar variations in blood pressure oscillations with respiration 
(Figure 3.11). These variations are linked with the heart rate variations in terms of underlying 
physiology. The high frequency component of blood pressure variability depends on the 
neurally-mediated beat-to-beat RR changes (deBoer, 1987). As respiratory frequency slows, 
systolic (and diastolic) frequency slows with the maximum frequency power at the same 
frequency as respiratory and RR interval maximal powers (Novak, 1993). Vagal activity 
provides the neural driving mechanism with no significant contribution from sympathetic 
activity (Saul, 199 1). Abolition of RR variability by ganglionic blockade does not remove all 
high frequency blood pressure variability indicating that mechanical factors are also important 
detenninants on this component (Rimoldi, 1990). 
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Figure 3-11 Heart rate and blood pressure variation during metronomic respiration 
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3.2.5.1 Low frequency blood pressure variability 
This frequency range may be generated by a system resonance in the baroreflex control of 
peripheral vascular tone implying that peripheral vasomotor activity, and not heart rate, 
governs low frequency blood pressure variability: the delay in baroreflex feedback amplifies 
frequencies around the LF 0.1 Hz band (Akselrod, 1985; Bernardi, 1994; deBoer, 1987). The 
low frequency fluctuation is generated by variation in sympathetic discharge to peripheral 
vasculature, produced by resonant interaction between fast vagal and slow sympathetic 
response baroreceptor stimulation (Sleight, 1995). Both parasympathetic and sympathetic 
activity is involved in the generation of low frequency blood pressure waves. Simultaneous 
sympathetic stimulation with peripheral sympathetic blockade to the vasculature abolished the 
low frequency response, but similar provocation with intact neural network led to increased 
low frequency component indicating the role of peripheral sympathetic activity in generating 
the low frequency (Rimoldi, 1990). Although bilateral ablation of the stellate ganglion in 
animals reduces RR low frequency, it does not affect blood pressure spectra (Pagani, 1986). 
3.2.5.2 Ageing, gender and frequency domain analysis 
The qualitative nature of heart rate variability persists in older age, but there is evidence of a 
quantitative decline in frequency domain measures of heart rate variability with increasing 
age (Sinnreich, 1998). Low frequency power may be greater in males (Sinnreich, 1998). High 
frequency component in absolute terms does not show any gender effect but when expressed 
as a percentage of total power may be greater in females (Sinnreich, 1998). 
3.2.6 Clinical applications 
It is clear that power spectral analysis of RR and BP variation offers a useful tool to assess 
cardiovascular autonomic function. However this has not yet translated into clinical practice. 
The problems are (Wieling, 1997): 
Unproven value in assessment of the individual patient, despite ability to differentiate 
autonomic function between large groups 
e Lack of long tenn reproducibility 
Lack of clinical utility: power spectral analysIs is a very sensitive for detecting early 
autonomic impairment but at present there is no effective treatment for autonomic 
failure. 
Reduction in vagal activity provides a therapeutic target for high risk groups. Angiotension 
converting enzyme (ACE) inhibitors actions include an increase in parasympathetic acti\, ity 
after myocardial infarction (Bonaduce, 1994) and chronic cardiac failure (BInkley, 1993), and 
there is some evidence that benefits include a reduction in sudden death (Cohn, 199 1). 
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Angiotensin 11 appears to decrease vagal activity (Townend, 1995; Valle, 1998). Therefore 
ACE inhibitors (which inhibit production of angiotensin 11) may mediate improved outcome 
via alteration in autonomic activity. Beta adrenergic blockers' benefits are thought to be the 
product of peripheral action but lipophilic versions may also modulate vagal activity via 
central beta- I receptors (Coats, 1992). Physical training up-regulates cardiovagal and reduces 
sympathetic activity in patients with cardiac failure, which may be the basis for its beneficial 
effects (Coats, 1992). 
3.3 Ambulatoty blood pressure variability 
Blood pressure is constantly fluctuating. Behavioral factors and arterial baroreflexes are two 
of the most important influences on blood pressure variability (Parati, 1996; Watson, 1980). 
Three methods exist for recording fluctuation. The invasive intra-arterial technique and non- 
invasive finger arterial pressure measuring device provide continuous recordings of beat-to- 
beat blood pressure. Ambulatory oscillometric blood pressure monitors provide non- 
continuous recordings, taking intermittent readings on a regular basis, usually at intervals 
ranging from 10 minutes to one hour. The continuous methods benefit from good accuracy 
whereas the latter method is more acceptable to patients and is the standard technique in 
routine clinical settings. 
There are three important themes arising from blood pressure variability studies in the last 20 
years (Parati and Mancia, 2001). 
e Knowledge of the physiological mechanisms underlying fluctuation in blood pressure 
(from continuous recordings) 
0 How certain pathological states can alter blood pressure variability 
0 Data regarding the importance of blood pressure variability as a risk factor for end- 
organ damage and cardiovascular outcomes 
Some aspects of physiological mechanisms in beat-to-beat variability are covered in the 
section on Heart Rate Variability above. The following discussion concentrates on the role of 
abnormal blood pressure variability in end-organ damage, with emphasis on cerebrovascular 
disease. 
The literature uses a variety of terms to describe different modes of blood pressure variability 
with occasionally some inconsistencies. Unfortunately there is no statement regarding 
definitions and nomenclature of the various techniques. Here blood pressure variability will 
be discussed in terms of 
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Long term variability: the standard deviation of non-continuous ambulator. y blood 
pressure recording 
Short term variability: the beat-to-beat variability of continuous blood pressure 
recording, using either time domain or frequency domam techniques 
0 Pulse pressure: the difference between systolic and diastolic blood pressure 
Diurnal variation: the difference between means of day and night blood 
pressure from 24 hour recordings 
3.3.1 General characteristics of blood pressure and its 24 hour 
variation 
There is a well-recognised alerting response when blood pressure is measured in a clinical 
setting by a doctor (Mancia, 1983a). Ambulatory blood pressure results are lower than office 
recordings. The difference varies from 513 mmHg in non-notensives to around 26/16 in 
untreated hypertensive patients. There is an age related rise in mean ambulatory blood 
pressure results. Men have elevated mean ambulatory recordings, with systolic pressure 
approximately 4 to 6 mmHg and diastolic 5 to 6 mmHg higher than women. 
Difficulties in teasing out the relative strengths of systolic, diastolic and mean blood pressure 
plus pulse pressure are highlighted by their inter-dependence. In the PIUMA study 
(Verdecchia, 200 1), mean ambulatory blood pressure correlated with pulse pressure and 
diastolic pressure (r = +0.28 and +0.95 respectively). However diastolic pressure did not 
correlate with pulse pressure (r = -0.06). Using only office blood pressure in 9431 subjects 
aged 65 years and older, systolic blood pressure correlated significantly with diastolic 
pressure (r= +0.50, p<0.0 1) but the relationship was modest compared to middle-aged 
populations. Pulse pressure had a weak and slightly U-shaped correlation with diastolic 
pressure: less than 80 mmHg DBP, r= -0-21 and above 80 mmHg r= +0.10 (both p<0.00 1). 
There was a strong correlation (r = +0.82) between systolic and pulse pressure (Glynn, 2000). 
Long term variability is greater than short term blood pressure variability. Absolute values of 
blood pressure variability increase as mean blood pressure increases but the percentage 
variability (as a proportion of the mean) can be similar between different blood pressure 
categories. Blood pressure variability reduces during sleep, presumably due to reduction in 
activity level (Mancia, 1983b; Veerman, 1996). 
Majahalme et al (Majahalme, 1996) noted that in terms of predicting future blood pressure, 
continuous invasive blood pressure recording can only explain a fraction of the varance of 
future blood pressure (generally less than 50%), whether measured with ambulatory or 
repeated casual readings. Despite this, invasive 24 hour ambulatory recordings correlate 
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reasonably well with follow-up blood pressure and are clearly better than casual office 
readings in this respect. 
3.3.2 Choice of blood pressure parameter 
Continuous and non-continuous blood pressure measurement can yield data for systolic, 
diastolic and mean blood pressure. All of these values have been used in variability studies. 
Unfortunately there does not appear to be any consensus statement or position view indicating 
a preference. A theme emerging from the literature in the last 10 years is that stroke and 
coronary events differ in how they are best predicted by different parameters of blood 
pressure. Furthermore, lowering of systolic and diastolic pressure or pulse pressure may have 
a discordant effect on cerebrovascular and cardiac outcomes (Millar and Lever, 2000). 
It is well established that isolated systolic hypertension is common in the elderly: up to 30% 
of people over 60 year's age have elevated systolic pressure over 160 mmHg (Psaty, 1992; 
Staessen, 1990). Even 'borderline' isolated systolic hypertension with values between 140 to 
160 mmHg has a strikingly high prevalence of 18% in people aged over 65 years and carries 
significantly increased long term risk of cardiovascular disease (HR 1.47,95% Cl 1.24 to 
1.74) and death from cardiovascular disease (HR 1.57,95% 1.24 to 2.00) (Sagie, 1993). 
Diastolic pressure tends to fall from the seventh decade onwards, in contrast to systolic 
pressure which displays a consistent linear rise throughout the ages (Franklin, 1997a). 
Systolic hypertension is probably now regarded as a more important determinant of 
cardiovascular risk than diastolic pressure (Neaton and Wentworth, 1992). The literature 
emphasises the importance of systolic pressure above that of diastolic pressure and when 
compared directly, higher systolic pressure usually carries greater risk than diastolic values 
(Anonymous, 1997; Kannel, 1996; Khattar, 1999; Psaty, 2001). 
Mean arterial pressure is seen as an estimate of vascular resistance but there are three reasons 
why this assumption can be unreliable in older people (Franklin and Weber, 1994). Firstly, 
the plateau in mean pressure after age 50 to 60 years can lead to an underestimate in mean 
arterial pressure, since vascular resistance continues to rise with age. Secondly mean arterial 
pressure is usually calculated using a factor of 0.33 of the pulse pressure but the pulse wave 
contour changes with age such that a factor of approximately 0.5 is more appropriate. Thirdly 
as diastolic pressure declines in older age, the calculated mean pressure will further 
underestimate the true vascular resistance. 
The rise in systolic pressure with age has two origins. Increased vascular resistance 
contributes to the change but the more important component is probably increased input 
impedance, which is generated by large artery stiffness and early pulse wave reflection 
(James, 1995; Messerli, 1983). 
109 
It could be argued that since systolic blood pressure is such an important determinant of 
outcome in the elderly, systolic variability is likely to be a more useful parameter than mean 
or diastolic blood pressure variability. The literature contains reports using any combination 
of systolic, diastolic or mean pressure which can make comparison problematic. Systolic, and 
to a lesser degree, mean blood pressure appear to be more frequently quoted in the literature 
than diastolic. One could speculate this is a result of diastolic pressure producing fewer 
significant results than systolic blood pressure. 
3.3.3 Long term variability 
3.3.3.1 Definition 
This is the standard deviation of intermittent mean levels, usually from non-continuous 
recordings over prolonged periods (typically 24 hours). The frequency of sampling is 
important, since less frequent measurements reduce power to accurately reflect variability. If 
the sampling interval is 15 minutes or less, the standard deviation is not significantly different 
to continuous recordings. Intervals greater than 20 minutes will result in loss of ability to 
define short term blood pressure changes (Bevan, 1969; di Rienzo, 1983). It is important to 
bear in mind that similar standard deviation values can arise from radically different types of 
blood pressure variation (deBoer, 1987). 
The long term variability may be summansed as a total, 24 hour figure. However blood 
pressure fluctuation can differ between daytime active periods to resting nocturnal periods, 
and it is often helpful to quote separate figures for the two phases. Further refinement by 
calculating the coefficient of variation (standard deviation / mean blood pressure) adjusts for 
the increasing variation in blood pressure with higher mean values. One group advocate their 
index of variation which is the standard deviation of 24 hour blood pressure/square root of 
mean blood pressure, and this measure is said to have the advantage of being independent of 
mean blood pressure (Prattichizzo and Galetta, 2002). 
Often studies investigate the role of blood pressure variability using correlation or regression 
but in terms of defining abnormal levels of variability, more than 15 mmHg (daytime systolic 
variability) is an appropriate cut-off value based on population studies (Sander, 2000a). 
Similar values are used in other studies (Mancia, 1983b; Verdecchia, 1996). 
3.3.3.2 Mechanism 
Watson et al (Watson, 1980) used continuous intra-arterial BP recording to investigate factors 
determining arterial pressure in 26 mild-moderately hypertensive patients under controlled 
physical activity levels as hospital inpatients. Systolic pressure and its variability were 
significantly correlated at all times (sleep r= +0.56, p <0.05; bed rest r= +0.73, p <0.01; 
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waking r= +0.64, p <0.001) but diastolic pressure and variability were only correlated during 
bed rest (r = +0-71, p <0.01). Systolic variability increased w1th age (r = +0.42, p<0.05) but 
this association was no longer significant when allowance was made for increase of pressure 
with age. There was a non-significant tendency for variability to decrease with the leanness 
index (height3 /weight). In other words, variability tended to increase with obesity. No 
relationship was observed between variability and circulating catecholarnines. 
In subjects with untreated hypertension of mild to moderate degree, long term variability has 
an inverse correlation with baroreflex sensitivity (Mancia, 1986; Parati, 1995a; Watson, 
1980). Thus loss of the buffering mechanism of baroreflex sensitivity leads to greater swings 
in blood pressure. Baroreflex sensitivity can fluctuate in the course of a day, and therefore 
blood pressure variability can increase not only with the ageing effect but also from hour to 
hour. 
3.3-3.3 End organ damage 
Increasing long term variability is associated with organ damage, independent to the mean 
blood pressure level. Two early studies indicated end-organ damage correlates with the 
standard deviation of 24 hour blood pressure (Parati, 1987; Pessina, 1985). Frattola et al 
(Frattola, 1993) assessed the comparative value of short and long term variability from 24 
hour beat-to-beat intra-arterial recordings in 73 patients mean age 53 years, over 7 years 
follow-up. Scoring criteria for end-organ damage were based on left ventricular hypertrophy 
changes on ECG, cardiac enlargement on chest radiograph, retinal changes of hypertension 
and left ventricular mass index from echocardiogram. End-organ damage was significantly 
associated with long-term variability but was not influenced by short term variability. 
Pickering et al (Pickering and James, 1994) found that daytime diastolic BP variability is an 
independent risk factor for cardiovascular morbidity in mild hypertension. Palatini et al 
(Palatini, 1992) have also shown greater degrees of target organ damage (left ventricular 
hypertrophy and retinal damage) in patients with higher daytime blood pressure variability in 
addition to the known risk with increasing pressure. 
Reasons for long term variability having greater impact on outcomes than short term ('within 
half hour') variability include (a) they represent a larger proportion of overall variability than 
short fluctuations (Mancia, 1983b) and (b) they represent the historical blood pressure values 
more closely (antihypertensives may lower mean blood pressure but do not greatly alter long 
term BP variability) (Mancia, 1989). 
Blood pressure variability has been linked with arterial wall damage. Carotid intima thickness 
was significantly related to 24 hour non-invasive ambulatory systolic blood pressure 
variability (Mancia, 2001; Mancia, 1996). Longitudinal studies indicate increasing systolic 
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blood pressure variability independently predicts progression of intima media thickness 
(Sander, 2000a). From an initial cohort of 424 patients aged over 55 years who had 
neurological disorder excluded during hospital admission, 286 cases were followed up with 
repeat carotid Duplex ultrasonography. A significant and linear relationship was found 
between intima media wall thickness (IMT) progression and initial systolic blood pressure 
variability (r = +0.52, p<0.01). Following multivariate linear regression, daytime systolic 
variability was the best predictor of IMT progression, followed by mean systolic pressure, age 
and pack years of smoking. There was an interaction with diurnal variation: those with 
excessive daytime systolic variability and reverse of diurnal variation had the worst IMT 
progression, and those with low daytime variability and normal diurnal variation experienced 
the least IMT progression 
Most of the studies indicating an association between increasing blood pressure variability 
and cardiovascular morbidity or mortality have used non-invasive techniques (Pickering and 
James, 1994; Verdecchia, 1996). Early data tended to be cross-sectional. More recently 
longitudinal studies provide evidence that increasing long term variability is a true 
independent predictor not only for organ damage, but cardiovascular mortality as well. There 
were 67 cardiovascular deaths amongst a group of 1542 patients followed over a mean period 
of 8.5 years (Kikuya, 2000). Daytime systolic blood pressure variability was a significant and 
independent predictor of cardiovascular mortality. Night-time systolic variability carried a 
similar but less significant risk. Sander et al (Sander, 2000a) also found increased risk of fatal 
and non-fatal cardiovascular events in patients with raised blood pressure variability, defined 
as systolic SD more than 15 mmHg (RR 1.87,95% CI 1.08 to 3.20, p<0.0 1). 
Until recently, most studies had concentrated on studying blood pressure variability in patient 
cohorts, in particular hypertensive groups. Sega et al (Sega, 2002) investigated blood pressure 
variability and end organ damage in the general population. In 1648 people, left ventricular 
mass index positively correlated with 24 hour systolic and diastolic variability, with 
regression coefficients 0.57 (95% CI 0.29 to 0.85, p <0.001) and 0.70 (95% Cl 0.36 to 1.04, p 
<0-00 1) respectively. However in multivariate analysis, the basic standard deviation of 
systolic and diastolic BP were no longer significantly correlated with left ventricular mass 
index (LVMI) but the group used another measure of variability, the individual residual 
variability. Fast Fourier Transformation of the 72 measurements over 24 hours revealed two 
cyclic components accounting for most of the variability. These components were tested for 
their ability to fit the systolic blood pressure profile in each subject. Then the sum squared of 
the differences between the observed and fitted profile was taken as reflecting the variability 
unexplained by the cyclic components in each case i. e. the individuals' residual variability. 
This measure did positively correlate with LVMI in multivariate analysis, and persisted after 
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adjustment for gender, age and 24 hour average blood pressure values. The study also 
demonstrated a positive correlation with 24 hour mean blood pressure and LVML The 
individual residual variability may represent the erratic component of blood pressure 
variability, which may be pivotal in the effect on target organs. 
Palatini has argued that ambulatory blood pressure does not hold that great an advantage over 
carefully performed serial 'office' readings (Palatini, 2002). However, there are studies 
confirming that target organ damage correlates more closely with mean 24 hour blood 
pressure and its variability than with office blood pressure measurement (Appel and Stason, 
1993; Khattar, 1999; Ohkubo, 1997; Parati, 1987; Perloff, 1983; Verdecchia, 1996; 
Verdecchia, 1998). In hypertensive patients, left ventricular hypertrophy is more closely 
correlated with 24 hour ambulatory readings than by clinic blood pressure. Secondly, 
treatment induced regression of left ventricular hypertrophy is significantly related to 
reduction in ambulatory readings but does not correlate with office blood pressure readings 
(Mancia, 1997). 
It would seem fair to say that ambulatory blood pressure parameters are able to predict 
outcomes more accurately than serial office readings. It is widely acknowledged that 
ambulatory blood pressure recording has cost, time and technical implications in comparison 
to office blood pressure measurement. Presently it is recommended the advantages of 
ambulatory measurement are best applied (1) in research settings where the extra degree of 
accuracy is particularly important and (2) in clinical settings only in certain selected patients 
(Prasad, 1996). White coat hypertension is the obvious example, but other common uses 
include investigation of anti-hypertensive drug side-effects, analysing 24 hour blood pressure 
control and assessing behavioural influences on blood pressure where this affects treatment 
e. g. employment related hypertension (O'Brien, 2000; Prasad, 1996; Prasad, 1995; Staessen, 
1999a). Selective use of ambulatory blood pressure recording may change in the future as we 
learn more about its value in managing blood pressure in patient groups. 
3.3.4 Short term variability 
This variable can only be obtained from continuous blood pressure recordings. Short term 
variability was given prominence by Mancia in the early 1980's (Mancia, 1983b). It refers to 
the mean variation in beat-to-beat blood pressure over short periods. Mancia et al's form of 
reporting is the average of 48 standard deviations taken from each 30 minute mean blood 
pressure in a 24 hour recording. However, short term variability appears to have less clinical 
value in predicting cardiovascular outcomes in comparison to long term variability (Frattola, 
1993). 
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Frequency domain analysis of short term continuous blood pressure recording is covered in 
the section on Heart Rate Variability. Hypotheses regarding the autonomic neural control of 
blood pressure have developed from experimental manipulation of blood pressure variation. 
These responses alter the blood pressure variation power spectrum which is known to display 
certain characteristics according to autonomic activity (Parati, 1995b). 
Short 5 minute non-invasive continuous blood pressure measurement yielded data of 
prognostic value in post-stroke patients (Dawson, 2000). Mean arterial pressure variability 
gave an odds ratio for death/dependency at 30 days after stroke of 1.32 (p < 0.03) for every I 
mnfflg increase in variability measured within 3 days of cerebral infarction. In a logistic 
regression model, mean and diastolic blood pressure variability were significant Independent 
predictors of death/dependency at 30 days post-stroke. The highest quartile of mean and 
diastolic blood pressure variability had worse outcomes than the lower groups. 
When measuring a broad band of frequencies, blood pressure variation follows a I/f 
distribution: the lower the frequency of blood pressure variability, the greater its power and 
contribution to greater variance (Parati, 1996). Hence slow frequency variation is the 
predominant fluctuation in longer blood pressure recordings. Some consider the very slow 
day-to-night fluctuation as one of the most important blood pressure variabilities. Circadian 
variation in blood pressure is now discussed in more detail. 
3.3.5 Diurnal variation 
3.3.5.1 Definition 
A circadian variation in blood pressure was first noted by Bevan in the late 1960s and Millar- 
Craig in 1978 (Bevan, 1969; Millar-Craig, 1978). The presence of circadian variation was 
debated in the following years (Watson, 1980) but O'Briens' work published in 1988 
(O'Brien, 1988) appears to have confirmed the presence of a diurnal variation and provided 
further stimulus for continuing investigation of this phenomenon. 
Normal individuals experience a reduction in blood pressure during sleep. Blood pressure 
follows a circadian pattern due to variation in physical and mental activity and possibly 
autonomic and hormonal mechanisms (Pickering, 1982; Ziegler, 1976). 
Diurnal variation may be expressed in three ways. 
Absolute change: awake - asleep values 
Percentage change: night/day x 100% 
Percentage dip: day-night/day x 100% 
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The latter two methods are considered preferable since they account for the increase in 
diurnal variation with increasing blood pressure between subjects 
To differentiate between abnormal and normal circadian variation in blood pressure, the terms 
'non-dipper' and 'dipper' were coined (O'Brien, 1988). A cutoff value of 10% gained 
popularity. Dippers had a greater than 10% reduction from day to night period whereas non- 
dippers blood pressure varied by less than 10%. This is a somewhat arbitrary definition. In 
some early reports, diurnal variation was thought to be normally distributed (Staessen, 1992) 
but a much larger study indicates that the distribution does deviate from normality, 
particularly for normotensive subjects but not for hypertensive cases (Staessen, 1997a). 
Reversal of the normal diurnal rhythm i. e. absence of any reduction in nocturnal blood 
pressure may be a more useful definition than assigning an arbitrary cutoff value. This was 
bome out in Staessen et al's (Staessen, 1997a) assessment of ambulatory recordings from an 
international database of 4765 normotensive and 2555 hypertensive patients aged 10 to 99 
years. In normotensive subjects, the 95hpercentiles for systolic and diastolic pressure were - 
0.3/4.1 mmHg for the nocturnal fall and 99.7%/98.3% for the night-day ratio. In all subjects 
the systolic/diastolic nocturnal fall and corresponding ratios are shown in Table 3.3. Of all 
subjects, 3.2% had systolic and diastolic ratios of 100% or more. 
Table 3-3 Normal values for diurnal variation in ambulatory blood pressure 
Noctumal change, mean (mmHg) Ratio, mean 
Systolic pressure -16.7 11.0 87.2 ± 8.0 
Diastolic pressure -13.6 8.1 83.1 ± 9.6 
From Staessen 1997 (Staessen, 1997a) 
There are two prominent difficulties in assessing diurnal variation. Firstly reproducibility is 
poor (Mancia, 1997; Palatini, 1994). Secondly a variety of times have been used to define day 
and night (or awake and asleep) periods (Staessen, 1997a; Verdecchia, 1994). There is also 
the issue of non-continuous monitors affecting sleep pattern due to intermittent cuff inflation. 
Cuff activation overnight disturbs sleep in up to2/3of patients: consequently systolic pressure 
can increase momentarily up to 10 mmHg as a result of cuff activation (Davies, 1994; 
Palatini, 1992). Conversely actual activity in the night especially nocturnal urination can 
'falsely' elevate the night-time blood pressure and result in the misclassification of people as 
non-dippers. Modest increases in night-time blood pressure associated with waking to 
micturate effectively increased the systolic non-dipping status by 25% and diastolic non- 
dipping status by 50% (Perk, 2001). Therefore accounting for participants' nocturnal actiNity 
improves the accuracy of results. 
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3.3.5.2 Time interval for diurnal variability 
Many studies use fixed time periods based on the complete 24 hour period, for example 07: 00 
to 22: 00 and 22: 00 to 07: 00. The principal difficulty is that blood pressure substantially and 
rapidly changes between the hours of 06: 00 to 09: 59 and 20: 00 to 23: 59 (Fagard, 1996; 
Staessen, 1991; Van Hoof, 1989). Studies using the 10: 00 to 20: 00 and 00: 00 to 06: 00 fixed 
interval avoid these transitional periods influencing the awake and sleep blood pressure 
levels. Therefore they are closer to diary derived values (see Reproducibility). Staessen and 
colleagues have adopted these narrow fixed time periods in many of their studies (Staessen, 
1992; Staessen, 1997a; Staessen, 1996; Staessen, 1999b; Verdecchia, 1998). 
3.3.5.3 Aetiology of abnormal circadian rhythm 
Certain secondary causes of hypertension are more likely to lead to reversal of diurnal 
rhythm, for example renal artery stenosis, glornerulonephritis, diabetic nephropathy and 
phaechromocytorna (Middeke and Schrader, 1994). Advanced cardiovascular autonomic 
neuropathy, for example in primary autonomic failure, diabetes and Shy Drager syndrome, 
are also associated with non-dipping status (Pickering, 1990; Vagaonescu, 2000). Heart rate 
variability markers of autonomic function are diminished in hypertensive non-dippers 
(Kohara, 1995). A report by Kario (Kario, 1997) gives some indication of normal autonomic 
diumal variation becoming disturbed, and possibly underlying the loss of normal blood 
pressure diurnal variation. The study uses unconventional markers of heart rate variability and 
performs multiple correlations but indicates that sympathetic activity may be lower at night in 
extreme dippers, and lower during the day in non-dippers. Another report suggested 
disordered autonomic function alters nocturnal decrease in blood pressure, but in this case 
found a rise in sympathetic tone overnight (Dodt, 1997). 
Kario's group continued their work with an interesting insight into dipping status from 
passive tilting (Kario, 1998). Extreme dippers experienced a significant increase in blood 
pressure with tilt i. e. orthostatic hypertension, in contrast to non-dippers who suffered a drop 
in blood pressure during tilt i. e. orthostatic hypotension. They hypothesise that the upright 
position during the day may drive the abnormal circadian rhythm, by virtue of mcreasing 
blood pressure in extreme dippers and decreasing blood pressure in non-dippers. 
Unfortunately this cross-sectional study is unable to determine cause and effect in the 
sequence of changes. 
3.3.5.4 End organ damage 
Non-dippers have more end-organ damage in terms of left ventricular hypertrophy, small 
vessel cerebrovascular disease and renal damage (Kario, 1996; O'Brien, 1988, Palatini, 1992. 
Sander, 2000b; Verdecchia, 1994; Verdecchia, 1990). Stroke is more common in non-dipping 
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hypertensive patients (O'Brien, 1991b). There are some negative studies, but meta-analysis 
provides further evidence that reduced diurnal variation is independently associated with 
cardiovascular events (Staessen, 1997a). 
In placebo treated participants of the Syst-Eur trial, the night-time systolic blood pressure 
(00: 00-06: 00) more accurately predicted cardiovascular end-points than the daytime level, 
and ambulatory parameters predicted outcomes over and above office blood pressure levels. 
However, ambulatory levels were non-significant predictors of outcomes In the treatment 
group. Most importantly they found the relative hazard ratio with a 10% higher systolic night- 
to-day ratio was 1.41 (95% CI 1.03 to 1.94, p=0.03) (Staessen, 1999b). 
An important finding in the study of diurnal variation is the risk of increased lacunar or ývhite 
matter cerebrovascular disease in patients with an excessive fall in blood pressure ovemight, 
the so-called 'extreme dippers' (Kario, 1996; Shimada, 1992). Such findings support the 
hypoperfusion theory of small vessel cerebrovascular disease. Extreme dippers also have 
greater long term BP variability (Kario, 1996). 
Data from a longitudinal study following intra-arterial ambulatory blood pressure recordings 
reported a significantly higher incidence of cardiovascular events or death in patients with 
less than 10% dip in nocturnal blood pressure and in patients with smaller nocturnal decreases 
in both systolic and diastolic pressure (Khattar, 1999). 
3.3.6 Pulse pressure 
This is often included in discussing blood pressure variability since pulse pressure informs 
about the blood pressure variation occurring within the cardiac cycle, from systole to diastole 
(Parati and Mancia, 200 1). Stroke volume, major artery wall stiffness and the speed of 
reflected waves are the variables that determine pulse pressure. Studies mostly of 
hypertensive patients with concomitant coronary artery disease, conclude pulse pressure can 
increase end-organ damage and affect cardiovascular outcomes (Parati and Mancia, 200 1). 
There is a linear increase in systolic blood pressure from 30 years old through to the middle of 
the ninth decade but diastolic pressure declines after the age of 60. Hence pulse pressure rises 
steeply in old age, and the rate of increase in pulse pressure significantly increases with 
higher midlife systolic pressure (Franklin, 1997a). A possible scenario of a synergistic 
relationship between hypertension and large artery stiffhess emerges. The age related 
decrease in diastolic pressure is a result of increasing major artery stiffhess. The decline in 
capacity of the elastic reservoir results in greater dispersion of stroke volume in systole, a 
situation compounded by reduced elastic recoil and these factors combine to the fall in 
diastolic pressure. Pulse pressure is more closely correlated with end-organ damage when 
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measured by ambulatory methods than with office blood pressure (James, 1995; Khattar, 
1997; Verdecchia, 1998). 
3.3.6.1 End-organ damage 
.: p-, 
James et al (James, 1995) reported a significant correlation between media-lumen ratio and 
pulse pressure that was independent of age, systolic and mean pressure and BP variability (r 
+0.56, p z-- 0.00 1). This indicates a role for pulse pressure in alteration of resistance vessels' 
structure. 
Franklin et al (Franklin, 1999) reported coronary artery disease (CAD) risk is positively 
associated with increasing pulse pressure, and neither systolic nor diastolic pressures were 
superior to pulse pressure in predicting CAD risk. There was a far greater increase in CAD 
risk with increments in pulse pressure and static systolic blood pressure than with increments 
in systolic pressure but stable pulse pressure. Therefore in older age there was an inverse 
relationship between CAD risk and increasing diastolic pressure. These observations support 
the hypothesis that CAD risk is more related to the pulsatile stress caused by large artery 
stifffiess during systole than the steady-state stress due to small-vessel resistance during 
diastole (Nichols, 1986). Other studies provide further evidence that elevated pulse pressure 
increases the risk of myocardial infarction (Madhavan, 1994). Cross-sectional studies indicate 
an association between pulse pressure and left ventricular mass (Pannier, 1989). 
Cross-sectional studies found an association between pulse pressure and carotid intima media 
thickness (a marker of atherosclerosis), which was actually greater than that for systolic blood 
pressure (Franklin, 1997b; Zanchetti, 1998). In a longitudinal study following intra-arterial 
ambulatory blood pressure recording, mean pulse pressure and systolic (but not diastolic) 
pressure were significantly correlated with left ventricular mass index and markers of carotid 
artery atherosclerosis. After stepwise regression, the mean pulse pressure was the strongest 
independent predictor of left ventricular mass index and carotid intima media thickness 
(Khattar, 1997). Carotid intima thickness is not only significantly related to pulse pressure, 
but also to fluctuation in pulse pressure as measured by its standard deviation (Mancia, 200 1; 
Mancia, 1996). 
Other studies report that the cardiovascular morbidity associated with increasing pulse 
pressure is independent of systolic and diastolic pressure (Benetos, 1997; Verdecchia, 1998). 
Data from the PIUMA study in Italy (Verdecchia, 1998), a cohort of 20 10 untreated 
hypertensive patients followed up for a mean of 3.8 years, demonstrated ambulatory pulse 
pressure was a potent independent predictor of cardiovascular risk. Across the tertiles of mean 
24 hour pulse pressure, the rates of cardiovascular events were 1.19,1.81 and 4.92 per 100 
person years, and 0.11,0.17 and 1.23 for cardiovascular mortality (p < 0.0 1). The authors 
did 
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note the additional predictive value of ambulatory compared to office blood pressure was not 
clear-cut in the category of cardiovascular mortality. Further PIUMA data analysis reý-ealed 
that for each 10 mmHg increase in 24 hour pulse pressure, there was an independent 35% 
increase in cardiac event risk (95% CI 17 to 55%) but mean blood pressure did not contribute 
to risk (Verdecchia, 2001). Another longitudinal study using intra-arterial ambulatory blood 
pressure recording found a significantly higher pulse pressure in tiMe to first cardiovascular 
event or death in 688 patients with hypertension (Khattar, 1999). 
3.3.7 Repeatability 
Blood pressure variability tends to be only moderately reproducible at best. This is probably 
due to variation in activities from day to day, and reproducibility does improve when 
conditions are closely controlled. Gerin et al (Gerin, 1993) performed one 4 hour recording of 
ambulatory BP on consecutive days (daylight hours), with measurements at 5 minute 
intervals. They note better results than other reproducibility studies but correlation 
coefficients are still only moderate. 
Table 3-4 Reproducibility of blood pressure variability (Gerin et al 1993) 
Systolic blood pressure 
_ 
Diastolic blood pressure 
Mean level 0.86** 0.76** 
Standard deviation 0.52* 0.63** 
RMSSD 0.60** 0.49* 
From Gerin et al 1993 (Gerin, 1993). RMSSD = root mean square of successive differences 
*p < 0.01 **p < 0.001 
3.3.7.1 Mean ambulatory blood pressure 
Frequency of sampling influences reproducibility. A minimum frequency of twenty minutes 
in the day period results in satisfactory reproducibility (Palatini, 1994). Mean ambulatory 
blood pressure is significantly more reproducible than office blood pressure measurement in 
older patients both with and without hypertension (Fotherby and Potter, 1993). Coefficient of 
variation for mean pressure in tests separated by 4- 10 weeks is approximately 4- 6% 
(Robinson, 1995; Weston, 1996b). 
Duration of monitoring influences results from intra-arterial recording, with marked 
differences between short periods of several hours and the standard 24 hour period. Some 
reports conclude 6 hours is adequate to describe the mean value (di Rienzo, 1983) whereas 
others state at least 12 hours recording are required to achieve results similar to the 24 hour 
mean (Di Rienzo, 1985). Clearly the inclusion of the sleep period will decide how closely 
sbort recordings mirror 24 hour averages. 
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3.3-7.2 Day-night variation 
Reproducibility of the circadian variation in blood pressure is poor (Staessen, 1992). Fixed 
time technique that uses all hours in a 24 hour period has two disadvantages. Firstly it can 
lead to large swings in non-dipper status by broadening the duration of the night period. 
Secondly it will reduce week-to-week reproducibility (Wong Chung, 199 1). 
Three statistical techniques for calculating the circadian variation were evaluated using data 
from 32 young healthy volunteers on two occasions at least 4 weeks apart (Weston, 1996b). 
Mean blood pressure was reproducible with a coefficient of variation of 4.7%. Fixed times 
(07: 00 to 22: 00 and 22: 00 to 07: 00) returned systolic and diastolic day-night differences CVs 
of 52 and 59% respectively. This only marginally improved using diary based day-night 
periods to 40% and 41% but there was a moderate improvement using cusum analysis, with 
CVs of 24.6% and 2 8.1 %. 
A similar examination of performance but using additional 'narrow' fixed time periods was 
performed in older hypertensive patients. The results for the gold standard diary technique 
and the narrow fixed time period are shown in Tables 3.5 and 3.6. 
Table 3-5 Comparison and reproducibility of day and night mean systolic blood pressure 
assessed by flxed time (10-20: 00 and 00-06: 00) and diary method (Robinson et al 1995) 
(Robinson, 1995) 
Day Night 
Visit I Visit 2 Sdd CV Visit I Visit 2 Sdd CV 
Fixed time 132 (17) 133(14) 10.3 7.8 113(19) 113(19) 8.2 7.2 
Diarv 13207) 13105) 8.1 6.2 114(19) 112(18) 7.1 6.3 
Sdd, standard deviation of the within subject differences: CV, coefficient of variation 
Table 3-6 Comparison and reproducibility of diurnal variation in systolic blood pressure assessed 
by fixed time (10-20: 00 and 00-06: 00) and diary methods (Robinson et al 1995) (Robinson, 1995) 
visit I Visit 2 Sdd CV 
Diumal SBP change (mmHg) Fixed time 18.8 (9.9) 19.7 (13.8) 10.3 53.2 
Diary 17.6 (8.4) 18.7 (10.8) 7.0 38.6 
Diumal SBP change Fixed time 14.4 (7.0) 14.9 (10.0) 7.2 49.0 
Diary 13.5(5.9 14.4 (7.8) 
_ 
5.2 37.0 
.... -F- 
Adapted from Robinson T 1995(Robinson, 1995). Values are mean (standard deviation) in mmHg unless 
otherwise stated. Sdd, standard deviation of the within subject differences: CV, coefficient of variation 
It can be seen from Table 3.5 that the two methods gave comparable average systolic Nalues 
for the day and night period. Whilst CV was not as quite as good as diary-derived tIme period. 
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degree of reproducibility was similar for the two methods. From Table 3.6, both fLxed time 
and diary methods for reporting diurnal systolic variation had poor reproducIbIlItY. 
Reproducibility was not substantially improved by cusum-derived techniques (Robinson, 
1995). 
3.3-7.3 Long term variability 
One report indicates that for blood pressure variability i. e. standard deviation of mean to be 
reproducible, sampling frequency in daytime needs to be a minimum of 20 minutes (Palatini, 
1994). 
3.3.8 Age and blood pressure variability 
Variability tends to increase with age (Bertinieri, 2002; Mancia, 1983b; Parati, 1997a; Parati, 
1995a). In a small study of eight elderly subjects (mean age 64 years) and eight young 
subjects (mean age 24 years), 24 hour long term variability was significantly higher in old 
than young subjects, but there was no difference for diastolic blood pressure variability. Other 
studies clearly shown a decrease in baroreflex sensitivity with age, and one in particular found 
the marked increase in baroreflex sensitivity at night in young subjects was not observed in 
older subjects (Parati, 1995a). This effect is likely to be related to firstly, increasing large 
artery stiffness that results in larger pressure fluctuation at a set stroke volume, and secondly 
the reduction in baroreflex sensitivity with age (Parati, 1997b; Parati, 1995a). 
Parati et al (Parati, 1997b) examined the pattern of changes affecting systolic blood pressure 
variability in the elderly compared with middle aged controls. Continuous non-invasive finger 
pressure monitoring was used to produce spectral bands for heart rate and blood pressure 
variability. In contrast to the global decrease in heart rate variability affecting all power bands 
in the elderly group, their blood pressure power spectra changes were concentrated in the very 
low frequency range with little age difference for the low and high frequency bands. 
Franklin hypothesises there are three phases in the linear increase of systolic blood pressure 
with age (Franklin, 1997a). A gradual increase in diastolic pressure in early to middle age 
suggests a key role for increasing vascular resistance. Diastolic pressure is steady during the 
sixth decade and mean arterial pressure displays an asymptotic leveling but pulse pressure has 
an increased slope: these factors point towards increased vascular resistance and large artery 
stiffness gaining in a parallel fashion. Finally the drop-off in diastolic pressure in older age 
indicates the predominance of large artery stiffness driving the associated rise in systolic 
pressure. 
There is a weak but significant inverse correlation between the nocturnal decrease 
in diastolic 
blood pressure and age (r = -0.14, p=0.006) from a population study of 
399 subjects 
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(Staessen, 1992). The probability of being a non-dipper increased 2.8 times (95% 2.0 - 4.0) 
from 30 to 60 years and 5.7 times (95% CI 4.4 - 7.4) from 60 to 80 years (Staessen, 1997a). 
These findings may be due to age-related changes in the circadian sleep-wake rhythm (e. g. 
increase in night-time wakefulness) and autonomic changes with age (Prinz, 1990). 
3.3.9 Blood pressure variability and stroke 
Increasing blood pressure is clearly established as a risk factor for stroke disease and other 
cardiovascular events (Kannel, 1996; MacMahon, 1990). Higher blood pressures are 
particularly associated with increasing incidence of small vessel disease, i. e. lacunar 
infarction and white matter hyperintensity, when comparing hypertensive patients ýý-ith 
normotensive control subjects (Breteler, 1994c; Liao, 1996; Longstreth, 1996). This 
association extends to subjects who have normal range blood pressures (DeCarli, 1995). 
Historically the main interest in addressing stroke risk has concentrated on average blood 
pressure but in the last decade, blood pressure variability has grown in importance as a 
predictor of outcomes in cerebrovascular disease. Ambulatory blood pressure appears to have 
advantages over clinic blood pressure in stroke disease, not only in predicting stroke 
incidence but in the evaluation of secondary risks encountered by stroke survivors. 
MRI abnormalities in the elderly are associated with elevated mean ambulatory blood 
pressure and diminished circadian variation (Kawamoto, 199 1). In a cross-sectional study, 
Sander et al (Sander, 2000b) found a significant correlation between systolic (but not 
diastolic) circadian blood pressure variation and the extent of white matter lesions. 
Multivariate linear regression found systolic circadian blood pressure variation and age as the 
only significant factors contributing to white matter lesion burden. This study indicated blood 
pressure variation was more important than mean level. 
Kukla et al (Kukla, 199 8) studied 118 patients older over 55 years old, 61 with a hi story of 
lacunar infarction and 57 controls. Thirty-three patients had MRI and 85 CT imaging, with 
number of lacunae recorded by visual inspection. Non-invasive ambulatory blood pressure 
monitoring was performed at 15 minute intervals over 24 hours. Daytime and nighttime were 
classed as 06: 00 to 22: 00 and 22: 00 to 06: 00 respectively. Circadian variation was defined as 
average percentage change of nighttime/daytime blood pressure. Patients with lacunar 
infarction had higher mean blood pressures, an increase in daytime systolic blood pressure 
variability and a decrease in diurnal variation. Following logistic regression, age, reduced 
systolic diurnal variation, mean daytime systolic pressure and history of hypertension were 
significantly related to the presence of lacunar infarction. 
Goldstein et al (Goldstein, 1998) studied 144 healthy individuals aged 55 to 79 years old. 
Non-invasive ambulatory blood pressure monitoring obtained measurements randomly three 
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times per hour in waking hours and hourly overnight. MRI images were rated visually using 
an in-house scale of zero to four. Significant associations with increasing white matter 
hyperintensity burden were found for awake and asleep systolic levels, awake diastolic levels. 
awake systolic variability (long term i. e. standard deviation) and for reduction in circadian 
rhythm for both systolic and diastolic pressure. 
One study did not find a significant correlation between blood pressure variability and small 
vessel disease but suffers from small numbers (12 and 13 in each group) and use of a non- 
validated white matter rating scale (Marti-Fabregas, 200 1). Diurnal variation is diminished in 
the acute post-stroke phase (Kario and Shimada, 1994). 
A study by Kario et al (Kario, 1996) included 131 hypertensive patients older than 60 years, 
with non-invasive blood pressure measurement sampling every 30 Minutes for 24 hours and 
MRI films rated by number of lacunae and severity of periventricular hyperintensities. Both 
measures of 'silent' cerebrovascular disease were substantially greater in the extreme dippers 
and non-dippers compared with patients with normal diurnal variation. 
The Atherosclerosis Risk in Communities is the only study that has examined the relationship 
between pulse pressure and cerebrovascular small vessel disease (Liao, 1997). Blood pressure 
values were obtained from the mean of the second and third office readings in 1920 adults 
aged 55 to 72 years. White matter lesions on a 1.5T MRI scan were rated on a scale from 0 
(none) to 9 (severe) but the authors did perform some post-hoc reclassification into 4 groups, 
since ratings of 4 or more were rare, and a binary system (0-3, >3) was used for calculating 
odds ratios. White matter lesion severity was significantly and positively associated with 
systolic blood pressure and pulse pressure, and weakly associated with diastolic pressure. 
Following subgroup analysis, these trends were most evident in African Americans (49% of 
the total cohort) compared with European Americans. 
However, one large epidemiological study (Benetos, 1997) measuring office pulse pressure in 
over 19,000 men aged 40 to 69 years reported slightly contrasting results, using a different 
cerebrovascular outcome measure. In subjects with normal or elevated mean arterial pressure, 
increased pulse pressure was a strong predictor of general and cardiovascular mortality 
affecting in particular the coronary circulation, but no significant risk occurred with respect to 
stroke mortality. Furthermore, the interaction between mean pressure and pulse pressure %vas 
usually additive but in older subjects this changed to a significant negative interaction. The 
main conclusion with respect to cerebrovascular disease was that mean blood pressure was a 
significant predictor of cerebrovascular mortality but increased pulse pressure did not carry 
significant risk for the cerebral circulation. 
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From the Systolic Hypertension in the Elderly Program (SHEP) study of 4736 elderly patients 
with isolated systolic hypertension (Domanski, 1999), higher pulse pressure was associated 
with an increase in systolic and decrease in diastolic pressure. In a multivariate analysis for 
each 10 mmHg increase in pulse pressure there was an 11% (95% CI 1% - 22%, p=0.028) 
increase in stroke risk. The authors discuss how pulse pressure is a surrogate for conduit 
vessel stiffness, which mechanistically is linked to stroke by potentiating carotid artery 
disease and contributing to small vessel disease. 
Results from ambulatory blood pressure studies have led to the idea of aJ curve relationship 
between blood pressure level and stroke risk in elderly people (Kario and Pickering, 2000a). 
A sub-analysis from the Systolic Hypertension in the Elderly Program and an observational 
study of treated hypertensives found increased cardiovascular risk with lower diastolic blood 
pressure (Somes, 1999). Kario (Kario and Pickering, 2000b) links these results and another 
study reporting lower hazard ratio of stroke with higher blood pressure in those patients with 
tight carotid stenoses (0.52,95% CI 0.19 - 1.40 (Silvestrini, 2000)), to support the hypothesis 
that in some individuals, a higher blood pressure is protective by maintaining cerebral 
perfusion. 
Another strand in this argument is that silent myocardial ischaemia can increase in extreme 
dippers when treated with anti-hypertensive drugs (Pierdomenico, 1998). Such patients may 
benefit from ambulatory blood pressure monitoring to guide anti-hypertensive use (Kario and 
Pickering, 2000b). At this point, it is worth re-iterating meta-analysis results to confirm the 
value of intervention in the majority of patients with high blood pressure. Anti -hypertens i ve 
treatment clearly reduces stroke, major cardiovascular events and heart failure in the elderly, 
but the same study also highlighted no treatment benefit for cardiovascular death and a non- 
significant excess of all-cause death in the treatment group (Gueyffier, 1999). 
Most recently Kario et al (Kario, 200 1) report increased stroke incidence with abnormal 
diurnal variation in a large, prospective study. This study followed 575 Japanese patients for a 
mean of 41 months. Non-invasive blood pressure monitoring sampled every 30 minutes for 
24 hours, and 361 patients had MRI scans which provided data on silent cerebral ischaemic 
lesions (lacunes < 15 mm). Again they demonstrate that reverse dippers (i. e. day-to-night 
systolic pressure <0%) and extreme dippers (day-to-night systolic pressure >20%) had a 
significant excess of silent cerebrovascular disease on MRI. Furthermore abnormal circadian 
rhythm displayed a J-shaped curve for stroke incidence. Reverse dippers had the worst stroke 
incidence (22%), and extreme dippers the second worst incidence (12%) when compared ývith 
nortnal dippers (6%). Haemorrhagic stroke was significantly higher in reverse dippers 
whereas there was a tendency for more ischaen-iic stroke as percentage dip increased. Dipping 
status was revealed as an independent predictor of stroke incidence following Cox regression 
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analysis. Their discussion suggests excessively low nocturnal blood pressure could be 
particularly important with respect to the hypothesis of hypoperfusion and cerebral damage. 
However they also note that 55% of strokes in the extreme dippers occurred between in the 
morning period from 06: 00 to 12: 00 hours. Other prospective studies demonstrate non- 
dipping pattern is an independent predictor for cardiovascular disease (Verdecchia, 1994). 
Kario's cut-off of > 20% diurnal variation in blood pressure constituting 'extreme dipping' is 
an arbitrary choice. In the international database study (Staessen, 1997a), the 5h systolic and 
diastolic percentiles in the normotensive population were -30.2 and -25.2 mmHg respectively, 
which translated to percentage falls of 23.4% and 31.3%. These values are logical choice, 
based on a very large study of normal adults. 
3.3.10 Pulse pressure, diastolic pressure and cardiovascular 
risk -aJ shape curve? 
There is a continuing debate in the literature on the nature of the curve describing the 
association between the principal blood pressure measures i. e. systolic and diastolic values 
and various cardiovascular outcomes. Some of these papers are described below, with most of 
the data obtained from office blood pressure measurement and not ambulatory recordings. 
Data from the Medical Research Council (MRC) Mild Hypertension Trial was examined 
using an empirical linear model (office blood pressure measurement) (Millar and Lever, 
2000). Results suggest lower diastolic pressure has different effects on the cerebral and 
coronary circulation. Stroke risk increased progressively with increasing diastolic pressure but 
aJ shape curve was obtained for coronary events, with perhaps the lowest risk at 70 to 90 
mmHg below which coronary risk increases. The authors suggest coronary risk is best 
predicted by pulse pressure whereas stroke risk is best predicted by mean pressure. 
There is further evidence that pulse pressure may not be the optimal predictor for 
cerebrovascular events. In a large population study, pulse pressure predicted cardiovascular 
but not stroke mortality (Benetos, 1997). Similar data comes from the Progetto, lpertensione 
Umbria Monitoraggio Arnbulatoriale (PIUMA) (Verdecchia, 2001) longitudinal study of 
2311 hypertensive subjects, using 24 hour ambulatory blood pressure. Pulse pressure but not 
mean pressure independently predicted coronary events, whereas mean pressure (and not 
pulse pressure) independently predicted stroke events. For each 10 mmHg increase in mean 
pressure, cerebrovascular event risk increased by 42% (95% CI 19 to 69%). An intervention 
study, the European Working Party on Hypertension in the Elderly (EWPHE) (Amery, 1985), 
demonstrated a similar pattern. Stroke was independently predicted by mean BP (HR 1.91, 
95% Cl 1.05 to 2.18) but not pulse pressure (HR 1.10 95% Cl 0.90 to 1.36). Coronary events 
were not predicted by mean BP (HR 1.09 95% Cl 0.77 to 1.35). A Japanese cohort had a 
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similar significant risk of stroke with increase in mean blood pressure but not with increasing 
pulse pressure (Ohkubo, 200 1). 
In contrast, a meta-analysis of EWPHE, Syst-Eur and Syst-China studies found that pulse 
pressure did predict both cerebral and coronary events after adjusting for mean pressure. 
However this effect was mainly confined to the two studies that recruited patients with 
isolated systolic hypertension (Blacher, 2000). In the SHEP study, both mean pressure and 
pulse pressure were significant predictors of stroke, but the risk was proportionately higher 
for a set increase in mean pressure compared with pulse pressure (20% and II% respectively. 
for each 10 mmHg pressure increase) (Domanski, 1999). 
Large scale population based studies have commented on the possibility of a J-shaped curve 
for the relationship between blood pressure and adverse outcomes. An Italian study recruited 
3858 people aged 65 years or older who presented to the GP for any reason. They found that 
systolic but not diastolic pressure was associated with total and cardiovascular mortality: 
impact on stroke was not addressed (Alli, 1999). A population based cohort of 6927 
inhabitants of Rotterdam found the risk of stroke was linearly related to both increasing 
systolic and diastolic pressure. However in treated hypertensives, a J-shaped curve existed for 
both systolic blood pressure and diastolic blood pressure for stroke events with a statistically 
significant increase in risk in the lowest diastolic pressure category (Voko, 1999). A meta- 
analysis of eight studies investigating isolated systolic hypertension (treated or untreated) 
inpatients older than 60 years was performed by Staessen at al (Staessen, 2000). They 
revealed risk of death was directly associated with systolic blood pressure and inversely 
associated with diastolic blood pressure (but the latter finding did not apply to stroke 
incidence in isolation). Glynn et al (Glynn, 2000) did not examine stroke outcome but do 
report that both systolic and diastolic pressure provide independent prognostic information on 
risk of cardiovascular and total mortality, but the association of diastolic pressure is largely 
explained by the confounding effects of frailty and co-morbidity. Additionally pulse pressure 
appeared to be the best single blood pressure parameter as a marker of mortality risk. Ohkubo 
et al (Ohkubo, 1997) also found that the association of the lowest quintile of ambulatory 
blood pressure values with increased mortality was related to deaths due to malignancy i. e. 
that concurrent illness lowered the blood pressure and not that the low blood pressure was the 
Primary event with regard to cause of death. 
There are consistencies and contrasting results from large-scale longitudinal studies. Khattar 
et al (Khattar, 1999) reported a linear relationship between diastolic pressure and stroke 
events but a plateau effect was observed in lower diastolic pressures with respect to coronan" 
events. Intervention trial data has been used to discount the theory of a J-shaped cun, e 
(Rodgers, 1996). A definitive study from the Cardiovascular Health Study in North America 
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highlighted the influence of cohort selection on the relationship between systolic, diastolic 
and pulse pressure and cardiovascular events (Psaty, 200 1). They examined a population 
cohort of 4902 men and women aged 65 years and above. In this cohort there was no 
suggestion of a J-shaped relationship for any blood pressure parameter and cardiovascular 
disease. All three measures alone were directly associated with the risk of incident myocardial 
infarction and stroke. For stroke the hazard ratios were 1.34 for systolic (95% CI 1.21 to 
1.47), 1.29 for diastolic (L 17 to 1.42) and 1.21 for pulse pressure (L 10 to 1.34). Systolic 
pressure was the best predictor for stroke but any two of the three parameters improved the 
model fit: for myocardial infarction, pulse pressure did not improve the fit of the model 
including systolic pressure alone. Psaty comments that pulse pressure is not commonly 
employed by clinicians and holds no advantage over the traditional systolic and diastolic 
measures of blood pressure (Psaty, 200 1). Countering this assertion, Glynn argues that 
systolic and diastolic contribute independent information and the best single measure of blood 
pressure to predict mortality is pulse pressure (Glynn, 2000). 
Aortic stiffness, the main determinant of pulse pressure, is an independent predictor of fatal 
stroke in hypertension. In 1715 hypertensive patients, pulse wave velocity remained a 
significant predictor for fatal stroke after controlling for other cardiovascular risk factors: 
pulse pressure was a significant predictor in univariate analysis but lost significance after 
adjusting for age (Laurent, 2003). The authors hypothesise aortic stiffness may mediate its 
adverse effect by increasing pulse pressure which generates stressful cyclic stretching. 
Subsequent arterial re-modeling is associated with carotid atherosclerosis, risk of plaque 
rupture and white matter lesion burden. 
Age is an important factor in the interplay between blood pressure parameters and stroke risk. 
A cohort of 126 hypertensive Japanese patients who suffered a stroke had ambulatory blood 
pressure data available from one year preceding stroke incidence (Makino, 2000). Blood 
pressure data was compared with age- and sex-matched hypertensive patients who remained 
free of stroke. Mean blood pressure and pulse pressure was higher in the stroke group aged 
less than 70 years but there was no difference in these values for the stroke patients aged over 
70 years. The authors note this is an unusual finding and discuss how the older stroke patients 
may not be representative of more typical patients. 
Bilateral severe carotid stenosis constitutes a subgroup of stroke patients for whom blood 
pressure lowering can have adverse consequences. The linear risk for stroke from increasing 
systolic or diastolic pressure held true for the UK-TIA, European Carotid Surgery and North 
American Symptomatic Carotid Endarterectomy Trials when considered as one group 
(Rothwell, 2003). Increasing pulse pressure only held a significant positive linear relationship 
in the UK-TIA trial. However the group with bilateral > 70% stenosis changed the association 
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to a significant negative relationship between stroke risk and pulse pressure (HR 0.43,95% 
Cl 0.20 to 0.91, p =- 0.02), systolic pressure (HR 0.41, p=0.02) or diastolic pressure (HR 0.58 
p=O. 19). Compared with patients with both stenoses < 70% , the relative hazard of stroke in 
patients with bilateral > 70% stenoses was 2.54 at systolic pressures of 130 to 149 mmHg and 
5.97 at systolic pressures less than 130 mm-Hg (both p: ý 0.001). The mechanism is probably 
linked to impaired cerebral perfusion and loss of normal cerebral autoregulation with tight 
bilateral stenoses (Kistler, 1984). Rothwell et al (Rothwell, 2003) also highlighted that 
patients with unilateral stenosis are not exposed to the same risk (in line with their much 
lower prevalence of impaired cerebral perfusion, 5%) and secondly that severe bilateral 
stenosis is uncommon with a prevalence of approximately I to 2%. 
Another issue in this debate is the timing and vigour of blood pressure lowering after stroke. 
In spite of the strength of the overall association for hypertension and stroke risk, blood 
pressure reduction should proceed gradually. Rapid systemic blood pressure reduction may 
challenge the already compromised cerebral autoregulation beyond its limits. Transient 
ischaernia or infarction could follow, leading to worse outcomes in those treated cases 
(Staessen and Wang, 2001). 
3.3.11 Blood pressure variability and cognition 
Belleli et al (Bellelli, 2002) stratified 34 elderly (mean age approximately 75 years) into three 
groups according to MMSE score and found that increasing values of 24 hour BP variability 
were significantly associated with lower cognitive performance. Systolic Hypertension in 
Europe (Syst-Eur) Trial patients' blood pressure variability was measured by the standard 
deviation of six office BP readings over three visits (Birkenhager, 2002). From 2902 patients, 
64 developed dementia. Blood pressure variability tended to be positively correlated with the 
dementia risk. Each 5 mmHg increase in systolic BP variability was associated with a 15 % 
higher risk of dementia (95% CI 0.90 to 1.47) and each 2 mmHg increase in diastolic BP 
variability was associated with a 17% higher risk (95% Cl 0.96 to 1.42). 
An uncontrolled study of 88 Japanese patients mean age 71 found an association between 
blood pressure variability and the Ravens Coloured Matrices Test which assesses judgment 
through visual information processing (Kanemaru, 200 1). 
3.3.12 Blood pressure variability in atrial fibrillation 
There are few studies examining the impact of atrial fibrillation (AF) on ambulatory blood 
pressure. Some question the validity of using ambulatory blood pressure monitoring in atrial 
fibrillation because of technical factors that make measurement problematic and introduce 
larger margins of error compared with sinus rhythm (Stewart, 1995). But office 
sphygmomanometry-based blood pressure readings can also be inconsistent in AF due to the 
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erratic nature of Korotkov sounds in AF (Sykes, 1990). Ambulatory monitoring should 
provide an advantage by producing an average of multiple measurements. A study by Lip et 
al (Lip, 1996) proved the feasibility of ambulatory recording in AF. There was a high 
percentage of successful recordings at 80%, a figure not too different to sinus rhythm. 
Furthermore the first measurement on the ambulatory recorders matched the mean of M, o 
manual blood pressure measurements for systolic (but not diastolic) pressure. Another report 
suggests that validated monitors have a satisfactory frequency response to provide an 
adequate measurement (OBrien, 1990). 
There is evidence that accurate inforination can be obtained by ambulatory blood pressure 
monitoring in atrial fibrillation. From 42 patients undergoing cardioversion for atrial 
fibrillation, 22 completed before and after 24 hour ambulatory blood pressure recordings 
(Olsen, 2002). In the group of 22,12 reverted to sinus rhythm whilst 10 remained in atrial 
fibrillation. There were no significant differences in mean systolic and diastolic levels for 
both sinus rhythm and atrial fibrillation groups before and after cardioversion. Blood pressure 
variability and repeatability attained similar levels in both in both groups (SD/mean). 
3.3.13 Conclusions 
Blood pressure is an important risk factor for cardiovascular outcomes. Ambulatory blood 
pressure monitoring provides information about the variation in blood pressure (1) between 
measurements over a period of 24 hours and (ii) between day and night periods. Long-term 
variability and circadian variation are independent prognostic markers for cerebrovascular 
disease. Increasing long-term variability significantly increases white matter lesions, 
atherosclerotic disease and mortality. Reversal of the normal dip in blood pressure from day 
to night period is associated with cerebrovascular disease; some investigators have found an 
association between exaggerated drop in nocturnal blood pressure and white matter disease. 
One could hypothesise these markers could affect cognitive function in elderly stroke 
survivors. 
Increasing blood pressure is firmly established as a risk factor for stroke. Systolic blood 
pressure bears the strongest relationship for adverse outcome. Increasing diastolic blood 
pressure is usually associated with increasing cardiovascular disease. Some studies indicate 
low diastolic blood pressure carries higher risk than intermediate levels, but this is not a 
universal finding and may be explained by severe co-morbidity associated with the lo"Aest 
levels of diastolic blood pressure. However in patients with severe bilateral carotid stenosis, 
decreasing blood pressure does exacerbate cerebral damage. A similar mechanism could drive 
the white matter disease since cerebral white matter flow may be critically impaired in the 
arteriosclerotic conditions. 
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4 Methodology 
4.1 Case selection 
The purpose of case selection was to find elderly patients living in the local area that had 
suffered a stroke and were able to attend for a series of hospital-based investigations. Cases 
were selected from the Cognitive Function After Stroke (COGFAST) Study. COGFAST is an 
observational and longitudinal study of cognitive function in older stroke patients. The key 
purpose of COGFAST is to determine the neuropathological substrate of post-stroke 
dementia. Patients have an annual neuropsychometric assessment and in those cases who give 
consent for brain tissue donation, key neuropathological changes will be interpreted in the 
light of emerging post-stroke cognitive deficits. 
Cases were recruited from patients presenting to hospital. Collaborative links were 
established with consultants in Geriatric Medicine with special interest in Stroke Medicine. 
Systems to screen hospital stroke admissions were established: in most cases hospitals had 
existing stroke registers that provided patient demographic details. Cases aged 75 years and 
over were identified and approached to determine willingness to participate in COGFAST. At 
a later date, those cases consenting to COGFAST were asked to participate in the 
cardiovascular and MRI investigations. This secondary process was enabled to a large degree 
by study personnel obtaining further information on patient suitability for the study from the 
initial screen that provided cognitive function and physical health data. Thus information 
influencing inclusion criteria was obtained in a series of stages. There were minor variations 
in the process according to hospital site owing to differences in content of different stroke 
registers and information available to study investigators. The main study inclusion and 
exclusion criteria will be described. Then a summary of the selection process according to 
each hospital stroke register will be discussed. 
4.1.1 Inclusion criteria 
4.1-1.1 Age 75 years old and above 
The minimum age for incident stroke was set at 75 years. The primary aim of COGFAST is to 
investigate the neuropathology of late-onset dementia; therefore by definition the study 
required older persons who have survived a stroke. Cut-off age was influenced by the aim of 
obtaining tissue donation for neuropathological studies. An older cohort meant that a smaller 
number of patients were required to obtain the required number of brain tissue donations for 
the main study purpose. 
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4.1.1.2 Stroke 
The subject has suffered a stroke according to World Health Organisation criteria as "rapidly 
developing clinical signs of focal (or global) disturbance of cerebral function9 with symptoms 
lasting 24 hours or longer or leading to death, with no apparent cause other than of vascular 
origin" (Hatano, 1976). The diagnosis was confirmed by a consultant physician (with an 
interest in stroke medicine) responsible for the local hospital's stroke register. Both infarcts 
and haemorrhagic strokes were included. Cases with subarachnoid haemorrhage were 
excluded from the study. The presence of a patient on the stroke register was relied on as a 
measure of certainty of stroke diagnosis. In other words it was assumed that a person had 
suffered a stroke, according to the WHO definition, if the collaborating hospital had assigned 
a diagnosis of stroke. A large number of individuals were involved in case selection. Inter- 
rater reliability analysis was not feasible. However all patients were assessed at some stage by 
a consultants with a special interest in stroke. All hospitals used the Oxfordshire Community 
Stroke Project (OSCP) classification scheme (Bamford, 1991). This is a purely clinically 
based classification system, relying entirely on stroke symptoms and signs at the time of 
maximal deficit from the presenting event. Using the OCSP system, the stroke is assigned to 
one of four groups. 
Lacunar stroke (LACS) 
0 Pure motor stroke, pure sensory stroke, sensori-motor stroke or ataxic hemiparesis. 
Total anterior circulation infarcts (TACS) 
The following signs in combination 
9 New higher cerebral dysfunction e. g., dysphasia, dyscalculia, visuospatial disorder 
Homonymous visual field defect 
Ipsilateral motor and/or sensory deficit of at least two areas of the face, arm and leg. 
If the conscious level is impaired and formal testing of visual fields or higher cerebral 
function is not possible, a deficit should be assumed 
Partial anterior circulation infarcts (PACS) 
Patients could fulfil any one of the following three criteria 
9 Only two of the three components of the TACI syndrome 
Higher cerebral dysfunction alone 
A motor or sensory deficit more restricted than those classified as LACI e. g. confined 
to one limb or to face and hand but not involving the whole limb 
Posterior circulation infarcts (POCS) 
Any of the following cnteria. 
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" Ipsilateral cranial nerve palsy with contralateral motor and/or sensory deficit 
" Bilateral motor and/or sensory deficit 
" Disorder of conjugate eye movements 
" Cerebellar dysfunction without ipsilateral long tract deficit 
" Isolated homonymous visual field defect 
The classification scheme is quick and practical, simple to apply in trained operators and does 
not require any formal investigations. It has moderate interobserver agreement (K ý-- 0.4,95 % 
confidence interval 0.39 to 0.68) (Lindley, 1993). The four groups have distinctive features, 
most importantly in natural history (Bamford, 1991). Each group has theoretically distinct 
pathophysiological mechanisms and does in practice provide an indication of stroke cause 
(Lindgren, 1994; Mead, 2000b; Tei, 1999). Total anterior circulation infarcts result from 
occlusion of the middle cerebral artery, either by embolism or thrombosis. Partial anterior 
circulation infarcts are usually due to embolic occlusion of branches of the middle cerebral 
artery. Lacunar infarction is usually due to thrombotic occlusion of the deep perforators 
(arising from the middle cerebral artery) that supply deep hemispheric structures. The OCSP 
classification can successfully predict the site of infarct in those with a visible lesion in 
approximately three quarters of patients (Mead, 2000a). The OCSP classification does have 
limitations. If the ischaemic lesion changes in the initial post-stroke phase, the clinical signs 
can change leading to a change in classification category. For example a large vessel partial 
occlusion may initially present with only limb weakness and appear as a lacunar stroke but if 
the occlusion becomes complete, the full cortical deficit becomes apparent and is revealed as 
a total anterior circulation infarct. Conversely partial anterior circulation infarcts that rapidly 
improve may only present as a lacunar stroke if clinical assessment is delayed. Accurate 
categorisation is highly dependent on clinical skills - inter-rater reliability for signs such as 
visual field assessment can be poor. 
The OSCP classification was obtained from original hospital case notes. The opinion of the 
most senior doctor trained in stroke medicine was used to classify each case. If there was a 
discrepancy between two or more senior clinicians' classification, the judgement of the author 
was used to classify the case: training in stroke assessment took place during clinical training 
including certification in National Institute of Health stroke scale (Brott, 1989). The 
judgement decision was based on degree of effort to all ascertain all possible stroke deficits, 
optimal timing (usually early during admission at time of maximum deficit) and the 
individuals' experience in stroke medicine. 
4.1.1.3 Physical health 
The subject had to be in good physical health. They had to be independently mobile and 
Physically capable of completing cardiovascular autonomic tests and the MRI scan. If a 
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Barthel Index score was available, a score of 10 and above was required: initially this was set 
as an inclusion criterion but not all hospital stroke registers were able to provide this 
information. In most cases, a pragmatic decision on individual's suitability was taken during 
either during case screening at the initial COGFAST assessment or at the second phase of 
consent by the autbor. 
4.1.2 Exclusion criteria 
4.1.2.1 Co-morbidity 
Any cases with significant cardiac, respiratory, renal or liver failure were excluded. Similarly 
any cases with significant chronic illness that resulted in shortened life-expectancy were 
excluded. Cases with any active malignant disease were excluded. Significant visual 
impairment led to exclusion from the study, since poor vision would interfere with cognitive 
assessment. 
4.1.2.2 Cognitive function 
All subjects with dementia were excluded. Some cases were excluded on this basis on the 
initial hospital case register screen where there was sufficient information available on 
cognitive function. Otherwise the subject was interviewed usually with a next of kin and the 
Mini-Mental State Examination (MMSE) completed during screening for COGFAST at the 
sub ects home (Folstein, 1975). The subject was excluded if the MMSE was less than 24 and 
had dementia according to DSM IV criteria (American Psychiatric Association, 1994). 
The MMSE is a 30 point test of cognitive function conducted by interview. The MMSE was 
originally devised to differentiate organic from functional organic disorder and was able to 
quantify serial change in cognitive perfonnance. It is now widely used as a screening tool and 
measure of cognitive change. The scale has been comprehensively reviewed: test-retest 
reliability co-efficient was 0.89, and an amalgamation of test-retest and inter-rater reliability 
co-efficients was 0.83 (Tombaugh and McIntyre, 1992). The questions mostly require verbal 
responses with some written responses. The MMSE assesses orientation to time and place (10 
points), registration of three words (3 points), attention and calculation (5 points), recall of 
three words (3 points) language (8 points) and visual construction (I point). It is a simple and 
relatively quick assessment of cognitive function originally intended to differentiate organic 
from functional disorders and to monitor clinical change. It is widely used as a general 
screening tool for cognitive function but may not detect frontal lobe dysfunction. As 
previously discussed, it was devised at a time when the concept of dementia was modelled on 
Alzheimer's disease and is not ideally suited to detecting some of the neuropsychological 
deficits typical of vascular dementia. 
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DSM IV criteria for vascular dementia are as follows (American Psychiatric Association. 
1994). 
" Memory loss 
" Impairment in at least one other higher cortical function e. g. aphasia, apraxia, 
agnosia, executive function 
" Decline in social or occupational functioning 
" Focal neurological signs and symptoms or laboratory evidence of cerebrovascular 
disease 
" Exclusion of delirium 
These criteria were checked at the initial phase of case screening by trained interviewers. 
4.1.2.3 Trial parficipation 
At the request of collaborating physicians, any patients who were actively engaged in other 
drug trials or clinical studies were not approached for COGFAST, at the request of 
collaborating clinicians and in order not to burden patients with numerous clinical study 
commitments. 
4.1.3 Hospital stroke registers and screening 
The information held on each stroke register slightly varied between hospitals, as did the 
protocol (as agreed with local investigators) for contacting cases to obtain consent for the 
study. However, once basic contact information was obtained, the case selection process did 
follow a common format. The investigators contacted all candidates by telephone or letter to 
explain the study and request an appointment to visit the person's home with a next of kin 
present. At the home interview, an MMSE was performed and the study was explained in 
detail. Written information on the study was provided. At this stage, consent was sought to 
recruit to COGFAST. The neuroPsychometric schedule was performed at subsequent 
domiciliary visits. The protocol of neuropsychological tests is described in detail below 
(section 4.4). The cases consenting to COGFAST were contacted by telephone at a later date 
to discuss the cardiovascular and MRI investigations. Those cases willing to discuss these 
investigations were seen at home to explain the cardiovascular and MRJ tests in detail. 
Candidates were assessed regarding suitability for investigations, with respect to physical 
health and ability to complete the schedule. Safety regarding the MRI scan was checked using 
the standard protocol used by the Nuffield Hospital where scanning took place. This was a 
series of questions to ask the candidate if there was any history of accidental injury with 
metallic objects to soft tissue or surgical procedures for implantation of soft tissue metallic 
prostheses e. g. cardiac valves, arterial clips or stents, cochlear implants. If any such injury or 
implantation could not be confidently excluded, then the candidate was excluded from the 
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MRI scan study. If there were no contra-indications to MR1 and consent was obtained, the 
subject was given dates for firstly the cardiovascular autonomic assessment and secondly the 
MRI brain scan. The MRI scanning protocol is discussed in detail in below (section 4.3). 
Subjects were given written information regarding the tests with contact details for study 
personnel. 
4.1.3.1 Freeman Hospital 
This hospital site had a computerised stroke register. COGFAST investigators received a list 
of all stroke cases from research staff at Freeman Road Hospital on a monthly basis. The only 
information available at this stage was basic demographic data. The cases were all contacted 
by telephone to arrange an initial COGFAST screening. 
4.1.3.2 Queen Elizabeth Hospital, Gateshead 
The computerised stroke register was screened by the author to identify cases. This register 
held information on cognitive function in some instances, which enabled some cases to be 
excluded from COGFAST at this stage. The register also included a Barthel index score for 
some individuals, therefore some cases were excluded from the cardiovascular study at this 
stage by virtue of impaired physical function. All other potential cases were initially 
contacted by letter signed by the local hospital consultant staff. This letter briefly introduced 
the study and stated COGFAST investigators would contact the person at home. This served 
as a means of introducing the third party of the COGFAST investigators and helped to satisfy 
Caldicott guidance (Department of Health, 2000). These regulations cover a number of uses 
of patient data. With regard to research, one of the primary aims was to ensure that access to 
patient data was controlled by the consultant responsible for their care and to ensure that the 
patient had the opportunity to refuse any contact from third party agencies. The letter briefly 
describes the nature of the study and gave the support of the consultant staff. Patients were 
asked to respond only if they did not wish to be contacted. 
4.1.3.3 North Tyneside General Hospital 
Local research staff screened their computerised hospital stroke register to supply details of 
cases. They excluded any people who were or had taken part in local research trials. A letter 
signed by the individual's hospital consultant introduced the study prior to contact from 
COGFAST. 
4.1.3.4 South Tyneside Hospital 
The stroke register consisted of paper copies of all stroke cases. When the site was enlisted to 
the study, the previous year's stroke admissions were screened by me to identify candidates. 
Subsequently candidates were prospectively identified by the stroke specialist nurse based on 
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site. The information available included discharge destination and co-morbidity. Therefore 
some cases were excluded from consideration for the cardiovascular study at this stage. A 
letter from the local hospital consultant introduced the study to candidates who Nvere then 
contacted by the COGFAST team. 
4.1.4 Consent process 
Ethical approval was sought for the study via the Local Research Ethics Committee for 
Newcastle Hospital Trust and Gateshead Hospital Trust. The first stage of approval in 
Newcastle regarded recruiting individuals to the neuropsychological and MRI part of the 
study. Chairman's action was sought for the cardiovascular protocol - this was obtained at a 
later stage, after recruitment for COGFAST had commenced. 
For the Gateshead area, alterations were made to the screening and recruitment process at the 
request of the hospital stroke physicians. The major change was a letter of introduction to 
each candidate from the hospital consultant and author. The letter briefly explained the nature 
of the study and gave the candidate an opportunity to decline participation. 
Consent for the cardiovascular and MRI study occurred in two phases. The first phase was 
consent for the neuropsychological tests. Candidates were contacted by telephone to arrange 
an appointment at the individual's home address. Some candidates refused to participate 
during this initial discussion. Where unable to make telephone contact, a letter was sent to the 
candidate with a request for a meeting. A next-of-kin was also present at this initial meeting 
with the COGFAST investigator at the candidate's home. The purpose of the study was 
explained and the nature of the tests involved. Candidates were given written information 
about the study and given an opportunity to consider participation, with a second interview 
arranged if more time was required to make a decision. The consent forms required the 
signature of participant and next-of-kin. The 'assent' obtained from the next-of-kin was 
required to satisfy ethical standards in a study where over the course of time some cases 
would develop significant cognitive impairment whilst Participating in research tests . The 
next contact with consenting candidates occurred when the clinical assistant performed the 
neuropsychometric schedule in the subject's home. The schedule could be performed over 
two days if required due to subject fatigue. The schedule is described below (section 4.4). 
The second phase of consent was my responsibility. Subjects were contacted by telephone to 
ask if they were interested in participating with cardiovascular and MRI investigations. If so, 
a meeting was arranged at their home address to discuss these tests in more detail. At this 
meeting the nature and purpose of the tests were explained, and written information provided. 
The subject's ability to complete the cardiovascular schedule was assessed. An outline of the 
investigation protocol was explained to the candidate. General points covered were the 
136 
problems with memory decline in stroke survivors and the need to investigate what causes the 
underlying brain damage mechanisms that lead to dementia. The risk of post-stroke dementia 
was discussed in broad terms in order not to create distress but that made it clear this was a 
significant problem requiring investigation. 
Safety of the investigation protocol was discussed. All of the autonomic and blood pressure 
tests did not pose any health risk, except for carotid sinus massage. It was made clear that 
participation would entail a number of time-consuming hospital visits. 
The consent process included an explanation of carotid sinus massage in the investigation of 
carotid sinus hypersensitivity. The subject was informed of the studies' role in examining 
how abnormalities of heart rate and blood pressure control may play a part in worsening 
cognitive function; such changes may be amenable to treatment. Carotid sinus 
hypersensitivity was explained as a potential treatment target. Carotid sinus massage was 
therefore a useful investigation but this test entailed a risk of TIA or stroke, quoted as 
occurring in approximately I in 1000 cases according to published data (Davies and Kenny, 
1998). Carotid sinus massage would only be performed in cases where any carotid artery 
stenosis was less than 50%. This information could be obtained from any previous carotid 
Doppler scan. If this was not available then a carotid scan would be arranged as part of the 
study protocol. It was made clear to candidates they may wish to participate in the study of 
autonomic function tests and MRI scanning without performing the carotid sinus massage 
study. The requirement for a blood test as part of the study was discussed. 
The MFJ safety checklist was completed to exclude any cases from MR1 scanning if there 
was a history of soft tissue metallic foreign body or prosthesis. As part of the consent process, 
it was explained that the MRI scan lasted for approximately 22 minutes and was a different 
process to the CT brain scan that subjects would have experienced at the time of the stroke. In 
particular the noise and claustrophobic nature of the scanner was discussed, noting that the 
radiographers were in constant communication with patients and the scan could be stopped at 
any time at the request of the patient if too distressed to continue. 
The following points were emphasised during the consent process 
9 The cardiovascular tests were purely for the purpose of research- The information 
obtained would not be routinely relayed to primary or secondary care physicians, 
unless a previously unidentified and treatable problem was observed. It was noted 
that, apart from the carotid sinus massage and ambulatory blood pressure tests, in 
general the autonomic function tests were unlikely to influence routine clinical care. 
e The decision to participate or not would in no way influence their health care. 
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The only risk entailed carotid sinus massage as previously discussed. In terms of any 
discomfort involved, we were requesting a blood sample. The ambulatory blood 
pressure recording required wearing a blood pressure cuff around the upper arm for 
24 hours including overnight. It was explained that the automatic cuff inflation may 
interfere with sleep in around half of users and can cause some discomfort during 
inflation. 
* All travel would be arranged by the COGFAST research team, at no expense for the 
candidate. Individual taxis were arranged for each study investigation. 
e The individual was free to withdraw from the study at any stage, without having to 
provide any explanation. 
If consent was obtained, the subject was asked to sign individual consent forms for the 
cardiovascular and MRI tests. 
4.1.5 Carotid duplex scanning 
Carotid duplex scan results were required in those individuals who consented to CSM. The 
hospital radiography department was contacted to provide any information on previous 
carotid scanning and if available a copy of the full report was obtained. If there was no 
previous carotid scan, a duplex scan was arranged as part of the research study. A trained and 
experienced ultrasonographer performed a standard duplex scan of the carotid arteries to 
provide information on flow and plaque characteristics in the same manner as a routine 
clinical investigation. The scan report documented severity of any stenosis and the nature of 
atheromatous plaque in the extracranial carotid arteries plus flow characteristics in the 
vertebral arteries. If carotid scanning revealed evidence of carotid artery stenosis greater than 
50 % or unstable plaque (soft, mixed, ulcerated, thrombosis) then carotid sinus massage was 
not performed. 
4.2 Clinical research tests 
Subjects attended the Falls and Syncope Service at the Royal Victoria Infinnary in Newcastle 
upon Tyne for the cardiovascular investigations - There were 
four sections - 
* clinical history and examination 
0 heart rate variability 
0 autonomic function tests 
* ambulatory blood pressure monitor 
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These sections will be described in detail below, and these methods apply to the 
investigations described in chapters 5 to 13. 
4.2.1 Clinical history and examination 
The subject was interviewed to check current health status and document medical history. 
Any relatives or carers in attendance were given the opportunity to assist with the history with 
the permission of the subject. The purpose was to record significant cardiovascular co- 
morbidity. The presence of conditions was rated as yes, no or possible. Efforts were made to 
record the response as yes or no; possible was only used if there was a strong indication of a 
clinical condition that was not proven by subsequent events. If the subject's response 
suggested a possible condition but on further inquiry cast doubt on the likelihood of a 
condition, then the response was rated as 'no'. For example if the subject thought they had 
angina but the chest pain did not fit the typical pattem of pain, there were no confirmatory 
investigations and they were not on appropriate medication, then this was rated as no. The 
following information was sought, with a brief description of the main question. 
Hypertension. Do you take tablets for blood pressure? Have you ever had high blood 
pressure? 
" Myocardial infraction. Have you ever suffered a heart attack? Have you ever had 
severe chest pain and had clot-buster treatment in hospital? 
" Angina. Have you been told you have angina, or ever suffered chest pains on 
exertion? 
" Atrial fibrillation. Have you had problems with an irregular heart rhythm, needed 
treatment with digoxin or been told that you have atrial fibrillation? 
" Cardiac failure. Have you been told you have heart failure or needed treatment with 
water tablets? 
" Peripheral vascular disease. Have you suffered leg pain/cramp on exercise? Does this 
come on at a typical distance and get better with rest? 
" Diabetes mellitus. Are you diabetic? 
" Asthma. Do you have asthma? Do you use inhalers? 
" Chronic obstructive pulmonary disease. Do you have chronic bronchitis or 
emphysema? 
" Rheumatic fever. Did you have rheumatic fever as a youngster? 
Hypothyroidism. Do you have an underactive thyroid, or take thyroxine tablets? Have 
you ever required treatment for thyroid problems? 
Hyperthyroidism. Have you ever had an overactive thyroid? 
Stroke. How many strokes have you suffered? 
Transient ischaernic attack. Have you ever suffered a mini-stroke or TIA? 
An enquiry was made for current fitness or any recent illness, and other significant chronic 
illness not previously covered. Current drug treatment and dose was noted. 
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Examination 
Height and weight were recorded in metres and kilograms respectively. A brief cardiovascular 
examination recorded presence of elevated jugular venous pressure, added heart sounds or 
murmurs and ankle oedema. Added sounds on chest auscultation were noted. Blood pressure 
was measured using a sphygmomanometry with the subject semi-supine after a resting period. 
Pressures were recorded to nearest 2 mmHg and the disappearance of Korotkov V was taken 
as the diastolic pressure. 
4.2.1.2 Clinical scales, reliability and validity 
Clinical scales or instruments require assessment to ensure they perform in a reliable manner 
and produce results that accurately reflect the variable being measured. This process of testing 
reliability and validity is psychometnc assessment. These concepts are summarised below 
(Bowling, 1998). 
Reliability equates to the reproducibility and consistency of the tool. Reproducibility and 
repeatability seem to be used in an almost interchangeable manner in the literature. 
Reproducibility is the ability to produce a copy of or representation of the original form and 
repeatability is the ability to say or do over again, recite or to form an imitation of a previous 
action. Reliability informs the observer on the homogeneity of the tool and its resistance to 
random error. Reliability takes several forms; test-retest reliability, inter-rater reliability and 
internal consistency. Validity similarly has a number of facets. 
4.2.1.2.1 Test-retest reliability 
Assessing the stability of a measure over a period of time. Repeated measures are perforined 
over a time period where one would not expect the tool to change. Different statistical tests 
are required according to the nature of data. Cohen's kappa may be used for nominal data, 
weighted kappa for ordinal data and Pearson's correlation coefficient for continuous data 
(Altman, 199 1). However it has been argued that correlation is not appropriate for assessing 
agreement over time for a tool where intuitively one expects a good degree of association 
(Altman, 199 1). Therefore the Bland and Altman method of confidence intervals to assess the 
size of the difference between scores is often preferred to correlation (Bland and Altman, 
1986). Correlation could still be strong without giving an acceptably good reproduction of 
score. Difference between methods is plotted against the mean of each paired measurement to 
give a visual representation of the difference between methods. The mean and standard 
deviation of differences can then be plotted and a one sample t-test of the differences against 
zero will inform if the mean difference is significantly different from zero. The mean 
difference is a representation of the average bias when comparing methods. The standard 
deviation shows how well the methods agree for an individual and this value should give a 
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range of values which cover the agreement between methods i. e. ±2 SD gives the 9- 0 50, " limits 
of agreement. 
4.2.1.2.2 Inter-rater reliability 
The ability of a tool to give the same score when applied by two or more raters testing the 
same population sample. Again kappa tests can be used. Kappa values less than 0.40 indicate 
poor agreement, 0.40-0.59 fair, 0.60-0.74 good and 0.75-1.00 excellent agreement. 
Correlation techniques have also been used but with the same weaknesses as above, so again 
the Bland and Altman method may be a better choice. 
4.2.1.2.3 Internal consistency 
A scale usually consists of a series of items that focus on a particular facet. Internal 
consistency is the ability of particular items to reflect only their intended facet and not the 
other dimensions of the object being measured. Methods include certain forrns of correlation 
analysis and Cronbachs alpha. Cronbachs alpha is an estimate of reliability based on all 
possible correlations between all items within the scale. It depends on average correlation 
between items and the number of items in the tool. A minimum level for Cronbachs alpha has 
been suggested as 0.70, which implies that 70% of the measured variance is reliable and 30% 
is due to random error. 
4.2.1.2.4 Factor structure 
Questions within a tool may be aimed at different dimensions and may not necessarily 
correlate with each other or the total score. Factor analysis is a process of measuring how 
questions or items group together in measuring the dimensions (i. e. which items best account 
for the variance), and how consistently they do so. It will inform how items influence each 
other. Factor analysis is utilised in scale development to identify items that do or do not 
correlate with the object under assessment. Factor analysis is also used to confirm that 
questions tap into the intended factor and are not associated with other factors. Thresholds 
exist for factor analysis to suggest which factor should be retained in the tool; these are called 
eigenvalues and >1.5 is commonly used. 
4.2.1.2.5 Validity 
Validity takes different forms described below and they are not mutually exclusive. Internal 
validity is that which applies to the population under study, external validity is how applicable 
the tool is to the general population. 
4.2-1.2.6 Face validity 
A common-sense verdict of a scale: do the questions appear relevant and clear, according to 
subjective opinion? 
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4.2.1.2.7 Content validity 
Again subjective but usually a judgement by expert panel if the tool is considered to assess all 
relevant dimensions of what is being measured in a balanced manner. 
4.2.1.2.8 Criterion validity 
Criterion validity is the satisfactory accuracy of a measure in comparison with a gold 
standard, or proxy measure if a gold standard does not exist. It is the correlation between the 
toot under assessment and the gold standard criterion measure. It can take two forms, 
confirmation of correct measurement of criteria which is concurrent validity, and ability to 
correctly predict longitudinal developments of criteria which is predictive validity. 
4.2.1.2.9 Construct validity 
Construct validity is a comparison between old and new measures to demonstrate 
measurement of the same construct, particularly useful when there is no gold standard. There 
are two parts; convergent validity informs about agreement with related variables and 
discriminant validity requires that the construct is not associated with unrelated variables. 
4.2.1.2.10 Sensitivity 
The ability of a tool to correctly partition the objects it sets out to identify, i. e. the ability to 
detect all true positives. Sensitivity describes the proportion of positives that are correctly 
identified by the test. Also the ability to reflect true change in the object under measurement. 
4.2.1.2.11 Specificity 
The ability of the tool to refute objects under assessment that do not meet the criteria to be 
considered a true positive i. e. the ability to minimise false positives. Specificity describes the 
proportion of negatives that are correctly identified by the test. 
The neurological deficit was rated with the Scandinavian Neurological Stroke Scale 
(Scandinavian Stroke Study Group, 1985). This scale was chosen (a) for relevance in 
assessing functional recovery in stroke survivors months after the incident event (b) 
reasonable validity and (c) prior training in use by the author at the Stroke Research Unit at 
Gateshead Hospital, therefore familiarity was useful. 
The scale was devised by the Scandinavian Stroke Study Group with the aim of being easy to 
use and to be of functional significance to patients (Scandinavian Stroke Study Group, 1985). 
Therefore it avoided items like visual field and sensory function which are difficult to assess, 
and chose items which are relevant to those patients making a long term recovery from stroke. 
It is a nine item scale with an ordinal scoring system for each item, with four items selected in 
the initial stage as a prognostic index, and a seven item long term score for rating recovery. 
The Scandinavian Neurological Stroke Scale has good interobserver reliability, with one 
142 
study reporting weighted kappa values between 0.688 to 0.912, and high correlation bem'een 
2 observers (r = +0.954) (Lindenstrom, 1991). The scale does have high predictive value for 
neurological status and mortality 3 months post-stroke (Scandinavian Stroke Study Group, 
1987; Scandinavian Stroke Study Group, 1988). The scale does have limitations , for example 
inter-rater reliability can dip to moderate levels as previously mentioned. One item is based 
on gait and is thus a measure of disability and not impairment. 
Extrapyramidal signs are frequent in old age, common causes being Parkinson's disease and 
associated Parkinsonian syndromes, dementia with Lewy bodies and cerebrovascular disease. 
Parkinsonian signs were recorded using a modified version of the Unified Parkinson's 
Disease Rating Scale (MUPDRS) (Fahn S, 1987). Inclusion of the MUPDRS was an attempt 
to quantify extrapyramidal signs in the cohort, in consideration of potential neuropathological 
investigations. Secondly it could highlight clinical changes of importance in subjects who 
cognitively decline. The MUPDRS does not have any proven validity in this context but 
pragmatically seems a logical tool. It contains the following parts from the motor section of 
the UPDRS - facial expression, tremor at rest, action tremor, rigidity, arising from chair, 
posture, gait and bradykinesia. To the author's knowledge, there is no tool specifically 
designed to measure extrapyramidal signs in cerebrovascular disease. 
The electrocardiogram was recorded using the standard 12 leads. The ECG was calibrated 
such that I millivolt led to a 10 mm. deflection. The paper speed was 25 mm/s. 
4.2.2 Cardiovascular autonomic tests 
For the purpose of the autonomic function tests, all subjects were asked to refrain from 
smoking and caffeine ingestion on the day of the investigations and to avoid food on the 
morning of the tests. Caffeine within tea and coffee potentially has a sympathormmetic effect 
which may confound autonomic function testing. All investigations were performed between 
the hours of 09: 00 and 13: 00 since there may be some diurnal variability in postural 
autonomic test results. All testing took place in a warm room. Environmental noise was 
minimized and subjects were left alone in quiet surroundings during heart rate variability 
recording since extraneous noise that leads to auditory stimulation may influence heart rate 
variability, probably by increased sympathetic activity. 
A ten minute rest phase was allowed before investigations commenced with the subject 
supine and not engaged in conversation. This achieved optimal resting state condition for 
heart rate variability studies. The same sequence was followed for all the clinical autonomic 
tests. All sections of the investigation protocol were interspersed with a2 minute rest phase. 
This was a practical compromise to allow completion of a lengthy testing schedule and aý'oid 
subject fatigue. Preceding rest time does not significantly affect response to Valsalva 
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manoeuvre or metronomic respiration but may influence the RR and blood pressure response 
to standing (Ten Harkel, 1990). 
The testing equipment was explained to the patient. The model is schematically shown in 
Figure 4.1. The subject was in the supine position with the arm comfortably supported by 
pillows. FinapreSTM (for FINger Arterial PRESsure) and its portable equivalent, PortapreST ' 1. 
machine were used to acquire instantaneous blood pressure (Ohmeda Finapres, Wisconsin, 
USA and Portapres, TNO-Biomedical Instrumentation, Amsterdam). This is a non-invasive 
blood pressure monitoring device to record beat-to-beat changes in arterial pressure. It has 
clear advantages over the intra-arterial method which is invasive and affects autonomic tone 
(Wieling and Karemaker, 1999). 
The system was designed by Penaz in the early 1970s (Penaz, 1973). The principle Is a cuff 
pressure controlled by a feedback system so that the vascular volume is 'clamped' to a preset 
value. The feedback is provided by a plethysmograph signal in a closed loop system. The 
inflatable finger cuff pressure is controlled by an electropneumatic system acting on a signal 
from the integral photoelectric plethysmograph. During the start procedure, the cuff pressure 
is raised to a level whereby the arterial compartment is compressed to about one-third of its 
normal volume. This represents the clamped value. Fluctuation in vascular volume (from 
changes in intravascular pressure) triggers automatic adjustment in cuff pressure. Therefore 
the intravascular pressure is continuously tracked. The principle was ftniher developed by 
Wesseling and coworkers to produce the FinapreSTm device. One of the most important 
improvements was the Physiocal procedure. This checks and adjusts the set-point of the 
volume clamp during operation. The equipment package includes the finger-cuff attached to a 
small box on the wrist that contains the fast-acting pressure device to adjust cuff pressure, and 
a main unit containing air-pump, electronics and computer hardware. 
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Figure 4-1 RR interval and blood pressure acquisition equipment 
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The performance of finger arterial pressure monitoring has been extensively reviewed by 
imholz and colleagues who collated data from 15 years experience and 43 research articles 
(Imholz, 1998). These articles compared performance of finger arterial pressure monitoring 
(Finapres or Portapres) with intra-arterial (or non-invasive but intermittent) blood pressure 
measurement. Accuracy of the finger devices ranged from -48 to +30 mmHg for systolic, -20 
to +18 mmHg for diastolic and -13 to +25 mmHg for mean arterial pressure. However when 
weighted for the number of subjects, pooled accuracies were -0.8 mmHg (SD 11.9) for 
systolic, -1.6 mmHg (SD 8.3 mmHg) for diastolic and -1.6 mmHg (SD 7.6 mmHg) for mean 
arterial pressure. Weighted accuracy of finger blood pressure measurement was within the 5 
mmHg limit of the American Association for the Advancement of Medical Instruments 
(AAMI) but precision was too low for systolic and mean pressure and did not meet the AAMI 
limit of within 8 mmHg SD (AAMI, 1992). Subdivision of studies according to reference 
blood pressure, setting and device revealed no significant differences in mean or standard 
deviation. For measuring beat-to-beat differences, PortapreSTM is able to duplicate qualitative 
changes accurately. There is usually no significant quantitative difference in diastolic or mean 
pressure when compared with invasive techniques. There are significant differences in 
systolic pressures but these are usually not clinically relevant i. e. they are small in comparison 
to the magnitude of response. Omboni has found that for systolic pressures, there are no 
significant differences between finger and intra-arterial frequency domain power spectral 
analysis, but there were significant over-estimation of low and mid-frequency bands in the 
finger trace (Omboni, 1993; Veerman, 1994). 
The appropriate finger cuff size was selected to achieve a close fit around the digit. Attention 
was paid to maintaining a warm environment and occasionally local wamung techniques 
were used to improve capture of the systolic pressure wave (Imholz, 1998). The middle finger 
was the default choice but in the event of poor systolic waveform, the index or ring finger was 
tried. Right hand digits were used for testing but if no satisfactory waveform was achieved on 
the right hand, the left hand was tested. Attempts to keep the finger device at heart level were 
made as far as possible during changes in posture for the cardiovascular reflex tests (Imbolz, 
1998). 
4.2.2.1 Heart rate variability 
Heart rate variability studies were performed using a5 minute ECG recording using limb lead 
I with the subject supine in quiet resting conditions. The subject was left to breathe 
spontaneously at their own free rate and depth. The ECG was recorded using commercial 
software, sampling at 1000 Hz. Systolic blood pressure was recorded using the FinapreST", or 
PortapreSTM, with the physiocal operating to provide intermittent calibration. Five minutes of 
ECG and systolic pressure waveform data were digitized and stored on computer for 
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subsequent offline analysis (Labview and DAQ 1200, National Instruments. Newbury). The 
program identified R wave peaks to produce RR interval data, and the peak systolic pressure 
following each sinus beat. Non-sinus and ectopic beats were removed automaticallý- then 
manually if necessary, using an R wave detection software package. The programme inserted 
an R wave by linear interpolation for missed or ectopic beats (Clayton, 1995). 
From the ECG recording, a fixed point for comparative purposes is identified on the R wave, 
termed the fiducial point. Good quality recordings with high signal-to-noise ratios are 
required for reliable fiducial point identification. The software program recognises each 
sequential R wave and generates a series of inter-beat intervals. If there is an unexpected 
variation in the R wave interval, set at >30%, the software generates an interpolated R wave 
based on the variation observed in the preceding four R waves. This automatic process is 
augmented by visual inspection of the softwares' R wave identification: if there is a mis- 
identification of R wave activity the observer can generate additional or remove inappropriate 
R wave intervals on a 'best fit' basis. The options available on the software menu are shown 
in Table 4.1. 
Table 4-1 R wave interpolation in CRISP 
R wave change required Interpolated R wave label 
From normal to ectopic Ectopic 
From ectopic to nonnal Not ectopic 
From normal to incorrectly detected Not R wave 
Incorrectly detected to normal R wave 
Reproduced from CRISP User Manual (Whittam, 1998b). 
Manually interpolated beats are only possible within boundaries set by software algorithms 
(Whittam, 1998b). The final edited sequence of RR intervals is saved on disc. The data is fed 
to another program which applies Fast Fourier Transformation to generate a power spectrum 
of heart rate variation. A locally developed computer program, ALPHA, was used to produce 
RR interval power spectra (Whittam, 1998a). 
Similarly systolic pressure waveform was inspected to identify any peaks that were not true 
systolic pressure waves, and these values were replaced by an interpolated value. The 
program automatically interpolated systolic pressure values during the interruption to 
recording due to physiocal operation. Power spectral analysis of the edited recording, after 
fast Fourier transformation, provided values for heart rate and blood pressure variability as a 
total value and in the low and high frequencies, according to international guidelines (Task 
Force of the European Society of Cardiology and the North American Society of Pacing and 
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Electrophysiology, 1996). The boundaries for total, low and high frequency bands were 0 to 
0.405 0.04 to 0.15 and 0.15 to 0.40 Hz respectively. Recordings with significant non-sinus 
activity (at a level set by the software programme or after review by investigators) were 
deemed unsuitable for power spectral analysis and excluded from the results. 
Combined RR interval and blood pressure measurement can facilitate measurement of 
baroreflex sensitivity. For this study, baroreflex sensitivity was determined by a validated 
technique of synchronisation of RR interval and systolic pressure spectral data (Lord, 1998). 
The program calculated magnitude squared coherence (MSC) between the heart rate and 
blood pressure variabilities in the 5 minute recording and calculated the alpha index of 
baroreflex sensitivity where MSC exceeded 0.5 (Clayton, 1995). Spectral index baroreflex 
sensitivity has been compared with the gold standard phenylephrine technique and 
demonstrates acceptable agreement, with correlation co-efficients ranging from +0.78 to 
+0.94 (James, 1998; Piccirillo, 2001; Robbe, 1987). 
4.2.2.2 Cardiovascular autonomic reflex tests 
Clinical bedside autonomic tests similar to the protocol described by Ewing (Ewing and 
Clarke, 1982) were perfon-ned next with the beat-to-beat RR interval and blood pressure 
response continuously recorded using an ECG and FinapreSTM or PortapreSTM . RR interval, 
systolic and diastolic blood pressure data were digitised and stored on computer for off-line 
analysis. RR interval and blood pressure measurement was performed using a locally 
developed software programmes based on Labview (Labview and DAQ 1200, National 
Instruments, Newbury) and software running on the Neuroscope (Medifit Instruments Ltd, 
UK). The programs displayed RR interval and systolic and diastolic blood pressure on 
computer screen, along with markers for the start/finish of each autonomic reflex test. 
Initially the data was analysed using the TONE program on the Neuroscope TM package. Then 
a Labview-based program was developed (Regional Medical Physics Department, Royal 
Victoria Hospital, Newcastle upon Tyne). The Labview programme allowed removal of non- 
sinus activity from the stored data with interpolations if required for the calculation. 
Recordings with excessive movement artefact or non-sinus activity were excluded from 
analysis. Where mean values were used to provide a blood pressure result, the standard 
number of beats required was set at 20. Where artefact and non-sinus beats affected the 20 
beat set of RR intervals, a minimum of ten beats were required for data to be included in 
analysis. 
4.2.2.2.1 Heart rate response to orthostasis 
The 30: 15 ratio was obtained from RR measurements during a change in posture from the 
supine to standing position (Ewing, 1978b). Cardio-acceleration due to hypotension on 
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standing, followed by compensatory cardio-deceleration due to a rebound in blood pressure 
level led to a trough then peak in RR interval. The shortest and longest RR intervals occur at 
approximately the 15 th beat and 3 Oth beats respectively (Ewing, 1978b): however a technique 
was employed such that the true minimum and maximum RR intervals occurring in the 
predicted pattern following standing were selected (Wieling, 1982). Strictly speaking, this 
value is the RRmax/RRmin and is now the recommended method for quantifying heart rate 
changes on standing (Wieling, 1997). However throughout this text, the term 30: 15 ratio is 
used for simplicity and to improve differentiation from other RR interval ratios. 
4.2.2.2.2 Blood pressure response to orthostasis 
Blood pressure change during standing was calculated as the change from the mean blood 
pressure for the 20 beats immediately prior to standing, to the first blood pressure nadir that 
was clearly identified in the period immediately after standing. If there was a clear 
paradoxical rise in blood pressure without any typical nadir, then that peak blood pressure in 
the same period was used in the analysis. 
4.2.2.2.3 Isometric exercise 
Isometric exercise was performed by asking the subject to rise from the supine to a sitting 
position on the couch, and to remain in that sitting position for 3 minutes. The subject had to 
retain the sitting position without external help, thus producing an isometric exercise stimulus 
(Donald, 1967). This test replaced the isometric handgrip exercise since it was easier for 
elderly subjects to follow instructions. The blood pressure response was taken as the 
difference between the mean diastolic values for the 20 beats immediately prior to sitting and 
the 20 beats immediately prior to the end of the sitting exercise. 
4.2.2.2.4 Valsalva manoeuvre 
A Valsalva manoeuvre was performed by the subject blowing into a tube connected to a 
manometer. The barometric pressure was shown on a visual scale to the subject and they were 
instructed to blow at approximately 40 mmHg for 15 seconds, then to remain silent and still in 
the subsequent recovery phase. The Valsalva ratio was taken as longest RR value in the 15 
seconds following forced expiration divided by the shortest RR value at the end of the forced 
expiration phase (Ewing and Clarke, 1982). For inclusion the minimum expiratory time was 
10 seconds and there had to be a recognisable expiratory pattern in the respiratory waveforrn 
and change in RR interval consistent with a typical response. This procedure was performed 
on three occasions: the largest ratio (Sandroni, 1991) and the best blood pressure response 
(shallowest point systolic value of three phase Ile troughs, and highest point systolic value of 
three phase IV peaks) were used for statistical analysis (Low, 1990). 
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4.2.2-2.5 Cold pressor test 
The cold pressor test was performed in addition to the standard Ewing tests. The subject 
immersed the left hand in iced cold water for one minute (Fagius, 1989). The diastolic blood 
pressure response was calculated using the 20 beats prior to immersion and 20 beats during 
the final phase of immersion. A minimum immersion of 45 seconds was required for 
inclusion. 
4.2.2.2.6 Heart rate response to metronomic respiration 
Metronomic respiration was performed by instructing the subject to take six deep timed 
breaths over one minute. This sequence would produce six pairs of RR interval peaks and 
troughs. For statistical purposes, the maximum divided by the minimum RR interval produced 
the E/I ratio (Pfeifer, 1982). Secondly, RR intervals were converted to instantaneous heart 
rates, which allowed calculation of the absolute change in heart rate from inspiration to 
expiration, the E-I difference. The mean of E/I ratios and E-I difference were used for 
analysis, with a minimum of three consecutive cycles of RR data required for inclusion. A 
typical respiratory pattern in conjunction with typical sinusoidal RR interval change was 
necessary for correct identification of peaks and troughs. 
4.2.2.2.7 Carotid sinus massage 
Carotid sinus massage was performed in the supine position for 5 seconds on the right then 
left carotid sinus (Brignole, 200 1). This investigation was only performed if there was no 
evidence of significant carotid stenosis on Doppler scanning (i. e. less than 50 % stenosis) in 
the stroke cases and the subject had given informed consent following a discussion of the 
potential risks of carotid sinus massage. Two values were obtained following carotid sinus 
massage. The cardio-inhibitory response was the value of the peak RR in the 30 seconds 
immediately after commencing carotid sinus massage. The vasodepressor response was the 
difference between the mean systolic blood pressure for 20 beats prior to CSM and the nadir 
blood pressure in the 30 seconds after carotid sinus massage. 
4.2.3 Spirometry 
The test procedure was demonstrated to the subject. The subject inspired deeply to maximum 
capacity then started expiration through the mouthpiece of the spirometer tubing with a tight 
seal to avoid leakage. The subject was encouraged to continue expiration at maximum force 
for six seconds or for as long as tolerated. A minimum of two forced expirations were 
required until a consistent trace was obtained. The forced expiratory volume was recorded at 
one second post-expiration and the forced vital capacity at six seconds post- expiration. Values 
were recoded to the nearest 0.05 litre. 
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4.2.4 Ambulatory blood pressure monitoring 
Spacelabs Ambulatory Blood Pressure Monitor 90207 was used for ambulatory blood 
pressure recording (Spacelabs Medical, Inc, Redmond, Washington, USA). The monitor uses 
oscillometric techniques to record systolic, diastolic and mean blood pressure plus heart rate. 
The automatic measurement interval was set at 30 minutes from 07: 00 to 22: 00 and 60 
minutes from 22: 00 to 07: 00. Cuff size was chosen according to arm circumference. By 
convention the cuff was attached to the non-dominant arm to minimise normal physical 
activity affecting blood pressure measurement. It has been shown that the non-dominant arm, 
which is the left in over 90% of cases, under-estimates blood pressure obtained by 
simultaneous ambulatory blood pressure recording in the right arm, which is the limb most 
consistently used for office blood pressure readings (O'Shea and Murphy, 2000). However 
this was not a predominant concern for this research project where variation within the group 
was of primary concern, rather than comparison with clinical office measurement. The centre 
of the inflatable bladder was positioned over the brachial artery using the marker on the cuff. 
Tubing was placed under clothing to allow a change of clothing without disturbing the 
recording equipment. A test blood pressure measurement was performed to ensure the 
equipment was functioning correctly and make the subject aware of the procedure. Consent 
for the recording to proceed was confirmed after the test reading to ensure the subject was 
prepared to complete the 24 hour monitoring, in view of the discomfort experienced during 
cuff inflation. Subjects were instructed not to move the arm during cuff inflation, to keep the 
arm at heart level during measurement and requested to keep the equipment dry. Subjects 
were also informed that in the event of a regular automatic recording failing, the monitor 
would automatically retry measurement within two minutes, but if this failed the next cuff 
inflation would occur at the pre-programmed interval. Recording commenced between 10: 30 
and 13: 30 i. e. after completing the autonomic test protocol. Subjects were supplied with 
written instructions regarding the monitor plus a contact number in event of difficulties 
(O'Brien, 2000). The subject was instructed to inactivate the monitor and remove the 
equipment after a period of 24 hours. 
The Spacelabs 90207 has been validated for use according to the British Hypertension Society 
Protocol (Fotherby, 1995; O'Brien, 1991 a). The monitor achieved grade B for both systolic 
and diastolic blood pressure according to British Hypertension Society (BHS) criteria (good 
agreement, recommended for clinical use). It also passed the assessment protocol of the 
Association for the Advancement of Medical Instrumentation (AAMI) which states that test 
devices should not differ by more than 5 mmHg from the mercury measurement, with a 
standard deviation of less than 8 mmHg. O'Brien's validation study (O'Brien, 1991 a) 
included subjects aged from 15 to 86 years. Iqbal et al (Iqbal, 1996) performed a validation 
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study in older subjects aged 60 to 90 years. Only diastolic blood pressurewas satIsfact0ril". 
recorded in all body positions and at all pressures according to BHS and AAMI standards. At 
higher blood pressure levels, systolic accuracy deteriorated, especially at blood pressures 
greater than 200 mnfflg. 
The machine has the following measurement ranges 
0 Heart rate 
0 Systolic pressure 
0 Diastolic pressure 
40 to 180 beats per minute 
70 to 285 mniHg 
40 to 200 mmHg 
* Mean arterial pressure 60 to 240 mnfflg 
Measurement time is typically 35 to 50 seconds. Cuff pressure will initially inflate to 165 
mmHg but if this is not able to capture the systolic pressure, the cuff will inflate to 
approximately 30 mmHg above the previous systolic pressure, to a maximum of 300 mmHg. 
Data from the ambulatory monitor was downloaded via dedicated cable to the hard drive on a 
computer where data could be accessed using Spacelabs software, the Ambulatory Blood 
Pressure Report Management System 9012 1. This program allowed data retrieval, editing and 
printing. The software program automatically edited measurements. It rejected artifact that 
resulted in non-physiological blood pressure measurement from, for example, patient 
movement, heart rate arrhythmia or equipment malfunction. Values outside the following pre- 
set automatic edit limits were excluded from analysis 
9 Systolic BP 70 - 240 mniHg 
Diastolic BP 40 - 150 mnfflg 
o Pulse pressure 20 - 150 nunHg 
Manual editing was not performed. Subjects were excluded from further analysis if there were 
less than 15 readings in the 24 hour period (Staessen, 1997a). 
Definition of day and night periods was according to 'narrow' fixed time period (Staessen, 
1991). The day period was fixed at 10: 00 to 20: 00 and night period was 00: 00 to 06: 00. The 
morning and evening intervals were excluded from the analysis. This approach allows 
standardisation of awake and asleep periods which can improve ability to make comparisons 
between studies (Fagard, 1997). These periods were adopted by Staessen et al (Staessen, 
1997a) in the meta-analysis of circadian variation of ambulatory blood pressure. The method 
does tend to overestimate night blood pressure levels from actual asleep values and 
underestimate day blood pressure levels compared with awake values. However fixed time 
methods that exclude the morning and evening phases from the daytime and night-tinie 
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periods are closer to the actual asleep and awake pressures than fixed time periods that 
include the full 24 hours in the two periods (Fagard, 1996). The narrow fixed time period is 
poorly reproducible but so are the other methods for defining day and night periods. 
Furthermore using set time period avoids inaccuracy from time diaries which are not always 
completed by participants (Robinson, 1995). For inclusion in separate day or night analyses, a 
minimum of 10 measurements in the day or 5 in the night period were required, and both for 
circadian variation analysis (Staessen, 1997a). 
The long term variability of ambulatory blood pressure was defined as the standard deviation 
of the mean level for either the 24 hour period, day or night period (Mancia, 1983b). The 
circadian variation was defined as the percentage decrease in blood pressure from the day 
period: (day pressure - night pressure) / day pressure x 100%. Pulse pressure was the 
difference between mean values for systolic and diastolic blood pressure. 
4.3 Magnetic resonance imaging 
MRI brain scans were performed using a 1.5 Tesla GE Signa scanner (General Electric 
Medical systems, Milwaukee, WI). Imaging was performed on a different day to 
cardiovascular investigations, with the aim of scanning within 4 weeks of cardiovascular 
tests. Scanning was performed at the Nuffield Hospital, Newcastle upon Tyne, with a member 
of the study group on hand to provide assistance regarding check-in and transport. The MRI 
checklist for contra- indications was repeated on-site by trained and experienced radiographers 
who briefed the subject on scanning time and conditions: any possibility of contra- indication 
resulted in exclusion from MR1 scanning. Subjects were warned in particular about the noise 
generated by MRI equipment and possibility of claustrophobia from the enclosed space and 
head brace. The neck and head were secured in a restraint to reduce the risk of movement 
during scanning, and all metallic personal objects removed from clothing. Communication to 
radiography staff was maintained by a two-way transmitter such that instructions and 
reassurance were provided by radiographers to subjects, and vice versa for any problems 
encountered by subjects. 
4.3.1 MRI scanning protocol 
The scanning sequence took 22 minutes. The protocol contained a series of imaging 
modalities to optimise extraction of structural information on different tissues and 
pathologies. Information was principally sought on whole and regional brain volumes, 
discrete cerebrovascular lesions and white matter lesions. The protocol included the intention 
to repeat MRI after an interval of 2 years to investigate change in structure. The scans are 
summarised in Table 4.2. 
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Table 4-2 Summary of MRI protocol in COGFAST 
Technique Technical data Uses Examples 
T, weighted images 3- 
dimensional Fast Spoiled 
Gradient (FSPGR), 
whole brain, coronal 
plane 
Fluid-attenuated 
inversion recovery 
(FLAtR), whole brain, 
axial 
TR= 12 ms, TEc = 4.2 
ms, TI=650 ms, 
256xI92 matrix, 1.6 
mm thickness, flip 
angle= 15 * 
TR= 10,000 ms, TE = 
125ms, Tl= 2ý 1 OOms, 
5mm slice thickness, 
0.3mm interslice gap 
Cerebral structure, 
regional volumes and 
location of white matter, 
grey matter and (CSF) 
boundaries 
White matter lesions 
Medial temporal 
lobe atrophy. Voxel- 
based morphometr-_ý 
Visual rating of 
WMH (Scheltens 
Scale) 
Variable echo, whole TR= 2,740 ms, TE White matter lesions Visual rating of 
brain, axial. Proton 12/84.2 ms, slice WME (Scheltens 
density and T2-weighted thickness = 5mm, Scale) 
interslice gap=0.3mm 
TR, repetition time; TI, inversion time; Tec, Echo time; WMH, white matter hypenntensity. 
As discussed in Chapter 2, white matter lesions visible on brain imaging are important in the 
pathophysiology of cognitive impairment. This creates the need for careful evaluation and 
rating of brain imaging results. Rating scales have evolved to provide uniform interpretation 
of scans. In this study, we have used established rating scales and developed a novel score to 
investigate the relationship of cardiovascular variables and cognitive function with imaging 
abnormalities. 
4.3.2 Visual rating of white matter lesions 
There are a number of rating scales but none have been validated in morphological studies, 
(including the Scheltens scale) and most do not rate severity of brain atrophy (Scheltens, 
1998). In a comparison of thirteen white matter hyperintensity rating scales, the potential for 
inconsistency between scales highlighted the risk of contrasting results in the pathological and 
clinical correlates of the process (Mantyla, 1997). The scales were applied to 395 post-stroke 
patients in Finland. Agreement was investigated using Goodman-Kruskal measures of 
association. Agreement for deep white matter hyperintensity was at best 80% but at worst 
18%. The Scheltens scale demonstrated the best agreement with two other scales. Agreement 
between scales was even worse for periventricular hyperintensities, at best 88% received the 
same grade but at worst only 0.4%. Clearly the probability of obtaining similar grades, order 
of severity and distribution of lesions can vary widely depending on the scale employed. 
The Scheltens scale was used in our study. Scheltens et al designed a rating scale to assess the 
location and severity of signal hyperintensities on T2-weighted magnetic resonance imaging 
in the early 1990s (Scheltens, 1993). This formed an extension to a previous scale (by 
Fazekas) which was disadvantaged by lack of detail on anatomical distribution or extent of 
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white matter damage. The Scheltens scale has the advantages of taking the number of lesions 
into account, providing regional information and including separate scores for basal ganglia 
and infratentorial lesions. The Scheltens score involves a visual rating of the _MRI films using 
T2 weighted images to identify areas of increased signal intensity compared to brain tissue 
and cerebrospinal fluid. The appearance is then rated on a numerical ordinal scale to provide a 
semi -quantitative rating of signal hyperintensities, based on size and firequency of 
hyperintensities. There are four brain regions identified in the system. 
Periventricular hyperintensifies (PVH): continuous confluent areas of high signal intensitY 
adjacent to anterior or posterior horns of the lateral ventricles ('caps') and along the lateral 
ventricles ('bands'). A three grade 0-2 scale is used for PVH, maximum score 6. 
00= absent 
01=<5 mm 
02=> 5mm and < 10 mm 
0 PVH greater than 10 mm are rated as DWMH. 
Deep white matter hyperintensities (DWMH): hyperintensities in the deep and subcortical 
white matter, divided into frontal, temporal, parietal and occipital regions. If the lesions were 
directly adjacent to the ventricles, they were rated separately from periventricular 
hyperintensities. A seven grade 0-6 scale is used for DWMR, maximum score 24. 
0. No lesions 
1. <3mm, n<5 
2. <3mm, n>5 
3.4-10 mm, n<5 
4.4-10 mm, n>5 
5.11 mm, n>I 
6. confluent 
Basal ganglia hyperintensities. Divided into caudate nucleus, putamen, globus pallidus, 
thalamus and internal capsule regions. Seven grade 0-6 scale, maximum score 30. 
Infra-tentorial hyperintensities. Divided into cerebellum, mesencephalon, pons and medulla 
regions. Seven grade 0-6 scale, maximum score 24. 
Scans were rated blindly and by consensus by three trained and experienced raters. 
The scale has been validated in ten-ns of providing good observer reliability. Inter- and mitra- 
observer agreements of the Scheltens scale were compared to the Fazekas scale and the neýv 
scale gave good agreements for deep white matter (reproducibIlIty as standard devIation of 
raters agreement as % of scale range 6.1-5.6%), basal ganglia ( 4.3-4.4%) and infratentorial 
(2.9-3.8%) region hyperintensities compared to poor to reasonable agreements for the 
Fazekas 
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scale (periventricular 9.5-12.3%, DVVM 11.8-15%, kappa 0.34-0.74). There was no advantage 
over the Fazekas scale when rating periventricular hyperintensities using Scheltens scale 
(12.6-15.3%) (Scheltens, 1993). This report does use different methods for assessing the two 
scales. In an overview of visual rating scales, the European Task Force recommended 
Scheltens scale whilst recognising the lack of knowledge regarding radiological-pathological 
validation studies (Scheltens, 1998). 
4.3.3 White matter volume 
The deficiencies of visual rating scales indicate a need for more accurate methods to measure 
white matter lesion volume. Manual segmentation of white matter lesions will provide an 
accurate volumetric measure but is subjective and time-consuming requiring a neuroanatomy 
expert. Automatic segmentation of white matter hyperintensities provides the benefits of 
accuracy and avoids the lengthy process of manual/semi-automated techniques. Automated 
image processing software was developed in-house, employing code written with Matlab (the 
Mathworks Inc, Massuchusetts, USA) and Statistical Parameter Mapping (SPM99, Wellcome 
Department of Cognitive Neurology, Institute of Neurology, London, UK; 
http: //www. fil. ion. ucl. ac. uk) routines. The technique has been validated by comparison with a 
manual/semi -automated segmentation process of measuring white matter lesion volume. 
Comparing the automated and semi-automated segmentation techniques, the mean difference 
in white matter lesion volume was 0.53 SD 3.4 mL (Firbank, 2003). This level of agreement 
compared favourably with a comparison of two expert humans using a semi-automated 
contouring technique where a SD of 2.83 ml was obtained (Grimaud, 1996). The method is 
now described in brief 
FLAIR images were analysed to quantify white matter hyperintensities. Following transfer to 
computer, images were converted to analyse white matter lesion formation using MRIcro then 
segmented using code written in Matlab (the Mathworks Inc., Massuchusetts, USA) as 
previously described (Firbank, 2003). FLAIR images were spatially nonnalised to the TI- 
weighted Montreal Neurological Institute template, which approximates Talairach space 
(Talaraich, 1988), using a 12 parameter affine transformation and non-linear iterations 
(Ashbumer and Friston, 1999). Images were re-sampled to a voxel size of 2x2x2 mm 3 using 
bi-linear interpolation. Automatic segmentation via cluster analysis produced grey matter, 
white matter, cerebrospinal fluid and a fourth partition of skull, fat, muscle and voxels "'ith a 
high degree of partial voluming (Ashbumer and Friston, 2000). The brain extract function of 
SPM99 (Anonymous, 2000) created a brain mask to remove non-brain regions from the 
original FLAIR images. The masked FLAIR images were then segmented slice-by-slice usiil(-, 
a threshold automatically determined from the histogram of pixel intensities. White matter 
hyperintensities were identified as those pixels with intensity greater than 1.45 times that of 
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the modal pixel intensity. All segmented white matter hyperintensities were visually inspected 
and any non-brain structure removed by manual editing. To assess the distribution of A-11 ite 
matter hyperintensities in cortical areas, a region of interest map (created in MNI space) was 
transformed onto the FLAIR image of each subject. The percentage of white matter 
hyperintensities in the brain was calculated by dividing the volume of segmented WMH by 
the volume of the brain as determined from the SPM99 segmentation (Asbbumer, 1997). 
images with movement artifact that precluded volumetric assessment were excluded from this 
analysis. 
4.3.4 Discrete infarcts 
Infarct rating used a locally developed scoring system (based on the NINDS-AIREN cnteria). 
Larger cerebrovascular lesions were identified using Ti -weighted images reconstructed in the 
axial plane. Scans were rated blindly by two raters trained in MRI white matter assessment. 
The location, size and volume were determined from hard copies of MR images. Side of 
lesion was recorded in each case. Lesions greater than 3mm in diameter and with signal 
characteristics similar to that of cerebrospinal fluid were considered as infarct. Cortical and 
white matter region infarcts were grouped into frontal, parietal, occipital and temporal lobes. 
For these regions, size was rated on largest diameter in the following four categories: 3-9 mm, 
10-29mm, 30-49mm and >50mm. Subcortical regions were putamen, caudate nucleus, globus 
pallidus, thalamus and internal and external capsules. Two size categories, 3 -9 mm and > 10 
mm, were employed for subcortical sites. 
4.4 Neuropsychometric investigations 
The aim of the neuropsychometric protocol is to measure the intellectual and emotional 
deficits occurring in the study population. The principal aim of COGFAST is to reliably 
diagnose those individuals who develop dementia and correlate clinical deterioration with 
neuropathological changes. Dementia is defined as global intellectual impairment, 
operationalised as memory loss and impairment in at least one other domain of higher cortical 
function (aphasia, apraxia, agnosia, executive functioning) with decline in social or 
occupational functioning: delirium and possible non-organic causes of cognitive loss should 
be excluded (American Psychiatric Association, 1994). It is equally important to characterise 
more subtle change in intellectual function. One of the key aims of the COGFAST is to 
describe the intellectual domains that deteriorate in vascular-based cognitive impairment in 
comparison to dementias of other (neurodegenerative) pathology. The tools chosen need to 
chart neuropsychometric function over a period. With this in mind, a protocol was devised. 
When i-neasuring cognitive impairment in the elderly, several issues should be borne in mind. 
The test battery should include tools that address a basic minimum of cognitive domaills: 
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attention and orientation, learning and memory, language, motor, visuospatial and executi%"c 
functions. Intellectual function declines with age in normal elderly individuals. Therefore 
normative data from a similar age group is required to make comparisons. Intellectual decline 
may occur in an individual but they remain within normal range of scoring, because of 
preceding high intellectual capacity. Two methods assist making an adjustment for premorbid 
ability. Education or occupation reflects the person's intellectual capacity. Standardised 
reading tests or tests of crystallized intelligence (vocabulary, general knowledge) also infon-n 
about previous ability, since they are less affected in earlier stages of organic cognitiN, e 
decline (Jutagir, 1998). Test results should assist investigators in categorising likely cause of 
cognitive decline. 
Memory function can be divided into primary (short term) and secondary (long-term). 
Primary memory: temporary storage of material in memory for periods up to 30 
seconds. This is often referred to as working memory, a central executive system. It 
utilises and integrates circuits in particular the articulatory loop system and 
visuospatial scratch pad. 
Secondary memory: the longer term storage of memory. There are different theories 
on the subdivision of secondary memory, a common one is as follows: 
Implicit memory: non-declarative memory. This is the subconscious 
processing e. g. conditioning, priming, that provides a platform for overall 
function in the environment 
Explicit memory: declarative memory. This is further subdivided into (a) 
semantic memory, which is the process of internally representing knowledge 
of words, facts and concepts of the environment and produce mental models 
(b) episodic memory, the catalogue of autobiographical experience and the 
timing of events. 
4.4.1 Mini-mental State Examination 
This is a widely used measure of cognitive function, applied in everyday practice and clinical 
research. It is a simple test of cognitive function. The original report suggested three purposes 
(Folstein, 1975): a means of differentiating organic from functional cognitive disorder, the 
ability to quantitatively estimate the severity of cognitive impairment and finally to document 
serial change in function. The MMSE was not intended to be used as a diagnostic test 
(Folstein, 1975). 
158 
4.4.1.1 Requirements 
A trained interviewer requires around 5-10 minutes to complete the test, which is based 
around response to verbal questions with some tests of motor function and language and 
visuospatial skills involving pen and paper. 
4.4.1.2 Scoring system 
The maximum score is 30. There are five subsections: orientation, registration, 
attention/calculation, recall and language. A score of <24 indicates significant cognitive 
impairment. The threshold has evolved through research findings and is widely accepted in 
community surveys (Tombaugh and McIntyre, 1992). Traditionally, significant clinical 
change is suggested from a change of >4 points, but it is a non-linear rating scale. The 
influence of educational level has been widely debated in the context of whether educational 
level represents a psychometric bias or risk factor for cognitive decline (probably through 
association). It may act in both dimensions. 
4.4.1.3 Validity and reliability 
The original paper assessed 206 patients with psychiatric disorders. There were correlations 
of 0.78 with Weschler adult intelligence scales for IQ. Test-retest reliability was 0.89 and a 
combination of test-retest and inter-rater reliability was 0.83 (Tombaugh and McIntyre, 
1992). 
Internal consistency has reached Cronbach's alpha levels of 0.96 in medical patients but is 
lower in community surveys with a score of 0.77 in a community survey of 4917 adults aged 
18 to 85+. Test-retest reliability can be poor, for example in patients with delirium where 
cognition is fluctuating or in control subjects where the ceiling effect and limited test range 
limits correlation coefficient abilities. Some items in particular are a cause of poor reliability 
in terms of methodology and scoring system. Generally small longitudinal changes in score 
should be interpreted with caution (Tombaugh and McIntyre, 1992). 
From Tombaugh's review of 25 studies assessing criterion validity, in 70% of studies an 
MMSE of less than 23 was associated with dementia in at least 79% of subjects but this figure 
can drop when the mean score is high, for example in community surveys with a higher 
proportion of normal subjects. Specificity is very dependent on the population characteristics, 
varying from good specificity for community studies to poor specificity where other types of 
Psychiatric patients are included in the cohort (46-62% specificity). 
Correlation co-efficients with a range of representative cognitive screening tests generally 
range between 0.70 and 0.90 for intelligence and memory tests. In Folsteins' original paper, 
correlation coefficients with Wechsler Adult Intelligence Scale were +0.78 for the verbal 
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scale and +0.66 for the Performance Scale (Folstein, 1975). The ceiling effect with the 
MMSE limits its relationship in some studies. 
4.4.1.4 Clinical utility 
The MMSE does fulfill its intended aim of a brief screening tool to quantitatively assess 
severity and measure change in cognitive impairment. As discussed above, there are flaws in 
its use as a diagnostic tool. Lack of ability to test right hemisphere function and mild language 
impairment are recognised flaws. However its strengths of simplicity, widespread use and 
proven validity are clear. Tombaugh and McIntyre (Tombaugh and McIntyre, 1992) 
recommended the MMSE for use as a screening tool but it should not be used as the sole 
criterion for diagnosing dementia, or if the individual was of low educational ability or not 
fluent in English. Scores can be surnmarised as follows: cognitive impairment, none = 24-30, 
mild = 18-23, severe = 0- 17. However weaknesses in assessing serial change have been 
highlighted in a brief re-examination of test-retest reliability. Cognitive drug studies have 
used mean improvements of 1.3 as indicating worthwhile drug efficacy but Bowie et al 
(Bowie, 1999) demonstrated that for an individual, the confidence intervals of aI point 
improvement from 20 to 21 could actually reflect a decrease to 19 or an increase to 23. Forty 
Old Age Psychiatry specialists administered the MMSE to dummy subjects with a set 
response but the range of scores obtained was 14 to 27.1, mean 18.5 (95% CI 17.2-19.2). 
4.4.2 CAMCOG 
This is a test of global cognitive function, derived mainly from section B of the Cambridge 
Examination for Mental Disorders of the Elderly (CAMDEX) (Roth, 1986). Its purpose was 
the diagnosis and measurement of dementia, although it is worth bearing in mind the original 
paper concentrates on the tests' ability to separate organic mental disorder i. e. both dementia 
and delirium, from depressed and healthy normal subjects. It is a pen and paper test 
completed by trained interviewer and interviewee. There are sub-sections devoted to 
assessment of particular cognitive domains: memory, executive function, language 
comprehension, language expression, attention, praxis and abstract thinking. 
4.4.2.1 Requirements 
The test is lengthy and usually takes 20-30 minutes for completion. A booklet is used which 
contains images used to assess reading, copying and perceptual ability. It is reasonably well 
tolerated by patients. In a validation study of 462 community-living people aged 77-96,44 
did not complete the schedule (I I unexplained missing data, 33 frail/refused/too cogniti\, ely 
impaired). In the 418 who completed the test, 46 had missing individual items on CAMCOG 
(Huppert, 1995). 
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4.4.2.2 Scoring system 
The maximum score was originally 106. A slightly modified version has been reported N'6th a 
total score of 105 (Leeds, 2001). There are eight subsections: orientation, language, memorY, 
praxis, attention, abstract thinking, perception and calculation. The test incorporates the 
MMSE for means of comparison but not all MMSE items are included in the CAMCOG total 
score. The range of scoring for the total score is responsive to high performing individuals 
and tends to avoid the ceiling effect. Orientation and calculation subscores can be susceptible 
to ceiling effects (Huppert, 1995). 
4.4.2.3 Validity and reliability 
In the original paper, inter-rater reliability was quantified using the phi coefficient, where 
+1.0 is the best possible score. The value was +0.90 (+1.0 to +0.30) for the cognitive section 
and Pearsons correlation coefficient was +0.97 (p<0.00 1). Test-retest reliability was not 
assessed. Validity was assessed by comparison with Blessed's dementia score (Blessed, 1968) 
and a clinical rating of severity of dementia (although it is not clear exactly which clinical 
rating scale was employed). Both of these other instruments showed close correlation with the 
eight cognitive subscales (no coefficients quoted, p<0.000) (Roth, 1986). There are significant 
associations of total CAMCOG for age, gender, educational level and social class differences. 
Age is highly correlated with total score and subscores. For these reasons, cut-off diagnostic 
points should be treated with caution, depending on the age of subjects under investigation. In 
Huppert's study (Huppert, 1995), CAMCOG was stated to correlate with MMSE: Spearman's 
co-effleient +0.79 with all CAMCOG items, +0.67 excluding MMSE items (no p value 
quoted). 
4.4.2.4 Clinical utility 
Cut-off score of 79/80 yielded 92% sensitivity and 96% specificity for the diagnosis of 
organic disorder (either dementia or delinum). The MMSE section of the CAMCOG yielded 
sensitivity of 94% and specificity 85% for organic mental disorder. It has been validated in 
stroke survivors, and elderly populations (Huppert, 1995; Kwa, 1996). Roth's paper (Roth, 
1986) indicated CAMCOG is able to discriminate between individuals at the high end of the 
ability range. 
A Dutch study of 129 patients 3 months post-stroke observed the majority (88%) of stroke 
patients can complete the CAMCOG at this stage of their recovery (Kwa, 1996). The main 
reason for failure was severe aphasia, indicated by an Aphasia Severity Rating Scale of 0-3 
(from the Boston Diagnostic Aphasia Examination). Moderate aphasia (Aphasia Severity 
Rating Scale 4-5) resulted in only a few missing items and no increased risk of dementia 
according to total CAMCOG score. Therefore the CAMCOG appears feasible in stroke 
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patients but the authors note that they were only able to interview 52% of the initial selection 
of 252 patients. The missing cases included many who were likely to have more severe 
dysphasic problems. Thus the utility of CAMCOG will be limited in stroke patients. 
4.4.3 Cognitive drug Research Assessment System 
(COGDRAS-D) 
This is also known as CDR (Computerised Dementia Research) battery. it was originally 
intended to examine the effects of drugs on cognitive function (Simpson, 199 1). Previousl, ', 
test batteries measuring reaction time, vigilance and memory required considerable time to 
complete (> I 1/2hours), substantial interviewer training and could lack sensitivity. The CDR 
battery was designed as a relatively quick and sensitive test that can be applied after minimal 
training (Ritchie, 1995). 
4.4.3.1 Requirements 
The protocol takes around 30 minutes to complete. The researcher uses a computer with 
visible screen to present a series of numerical and pictorial images. Standard instructions are 
read to the subject. The interviewee responds by pressing YES and NO buttons clearly 
marked on a separate box. Testing can be suspended if the subject is distracted. Quality of 
response can be measured by time to react or by proportion of correct responses. The 
interviewee needs adequate vision and the use of one hand; no keyboard skills are required. In 
some studies, subjects have refused to perform tests because of poor eyesight (Simpson, 
1991). 
4.4.3.2 Content and scoring system 
The protocol can be refined to suit the clinical aims. The primary value of the CDR battery is 
to assess the patients' powers of selection, evaluation, quality of working memory and the 
ability to respond to stimuli or information. There are a number of subsections. 
Simple reaction time (SRT). The word YES is displayed intermittently at varying intervals 
(1.0-2.5 s) in the centre of the screen on 30 occasions. The subject has to press the YES 
button as soon as the image is displayed. The time taken to respond is recorded. The reaction 
time can be quantified by the mean, median or standard deviation (the latter a measure of 
fluctuation). In healthy populations the mean approximates to the median. Results reflect 
alertness, attention, concentration and the primary stage of memory processing. 
Number vigilance. A number is displayed constantly just to right of centre screen. Random 
digits are displayed just left of centre at the rate of 80 per minute. The subject has to press the 
YES button every time the digits match. Response is quantified usually by percentage of 
correct reactions or by the mean of the reaction time: number of false alarms and SD (for 
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fluctuation) of reaction time may also be used. This tests intensive vigilance, sustained 
attention and ability to ignore distraction 
Choice reaction time (CRT). Y-ES or NO are displayed at varying intervals (1 -2.5 seconds) 
in the centre of the screen. The subject has to correctly respond with the same YES -NO 
button. Mean (or median) time to react is used, and SD can again reflect fluctuation. This 
section tests the same domains as SRT plus stimulus discrimination and response 
organisation. 
Memory scanning/numeric working memory. Three digits are presented singly at Intervals 
of 1.2 seconds. The subject has to memorise the digits and then press YES or NO when 18 
digits are serially presented if they match one of the original three digits. The sensitivity index 
(SI) is a dimensionless value of the quantity of correct responses. The index is a non- 
parametric technique where +I indicates a perfect score, 0 is by chance alone and -I indicates 
all responses were incorrect. In most cases the SI is between 0 and +1. Alternatively mean (or 
median) time to react can be analysed. NWM assesses the sub-vocal rehearsal of digit 
sequences and the articulatory loop sub-system of working memory. 
Spatial working memory. A simple 2 dimensional picture of a house with 9 windows is 
presented. Four of the windows are lit. The subject has to memorise this image, then respond 
with YES or NO when the same house re-appears but with a single, randomly lit window, 
depending on whether it matches one of the original lit windows. Response can be measured 
by the percentage of correct answers or percentage accuracy at rejecting incorrect matches, or 
the sensitivity index which is amalgamated from all responses. Also mean (or median) time to 
react. This test assesses episodic memory i. e. ability to temporarily retain spatial information 
using the visuospatial sub-loop of working memory. 
Picture recognition. Fourteen pictures are shown for a second time interspersed with 14 new 
ones in random order. The subject presses YES or NO for each picture depending on a match 
for the original 14 pictures. Sensitivity index and reaction time are recorded. This assesses 
episodic secondary non-verbal visual recognition and the ability to discriminate novel from 
previously presented material. 
Face recognition. The same as picture recognition, but using faces instead. 
lintnediate word recall. Twelve words appear on screen over a set time. Afterwards the 
subject is asked to recall all 12 words. Score is based on number of correct words, intT-Lisions 
(words from previous lists) and errors. This tests ability to store and recall verbal information. 
There is clearly overlap in the battery and a principal component analysis combined with a 
Varimax rotation yielded five factors shown in Table 4.3 (Wesnes, 2000). 
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Table 4-3 Principal component analysis of COGDRAS-D 
Factor CDR value 
Speed of memory processes picture and word recognition speed 
numeric and spatial working memory speed 
Quality of episodic memory immediate and delayed word recall accuracy 
word and picture recognition accuracy 
Power of attention simple and choice reaction time 
digit vigilance detection speed 
Continuity of attention digit vigilance detection accuracy 
choice reaction time accuracy 
digit vigilance false alarms 
tracking error 
Quality of working memory numeric and spatial working memory accuracy 
Wesnes KA Psychopharmacology 2000 (Wesnes, 2000). 
4.4.3.3 Validity and reliability 
The CDR battery was compared with MMSE and Kew cognitive tests in a validation study 
(Simpson, 199 1). Ten patients were unable to perform number vigilance tasks but all other 
CDR tests could be completed by the 22 controls and 23 patients with dementia. Immediate 
word recognition, delayed word recognition, delayed picture recognition, memory scanning 
and choice reaction tasks were significantly impaired in dementia patients and number 
vigilance was non-significantly lower in dementia. Age was significantly higher in the 
dementia group so a secondary analysis was performed by excluding younger controls and 
older dementia cases, and similar differences in performance were obtained. Immediate and 
delayed word recognition, delayed picture recognition, memory scanning and choice reaction 
time correlated with the MMSE (sensitivity scores, range of correlation coefficient r +0.53 to 
+0.65, p<0.00 1; reaction times r -0.57 to -0.68, p<0.00 1). There were similar correlations 
with the Kew Test of memory, aphasia and parietal function. Correlations with a measure of 
behaviour and everyday skills, the Stockton Rating Scale were weaker for example CRT r 
0.50, p<0.05, but most were still significant. Test-retest reliability was performed in 26 
subjects; results are reported using only correlation co-efficients, with values ranging from 
+0.53 (p = 0.0079) for memory scanning sensitivity to +0.93 (p < 0.000 1) for choice reaction 
time. 
A validation study was performed on 98 subjects split into five groups; 'worried well', 
depression, dementia, minimal cognitive impairment and other brain disorders (Nichol L 
1995). The dementia group scored least well, 'worried well' the best and the minimal 
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cognitive impairment group had intermediate scores. Other diagnoses had a wide spread of 
scores in keeping with the heterogeneous nature of diagnoses. The depressed group perfon-ned 
less well than 'worried well' but to a small non-significant degree and much better than the 
dementia group. Generally the minimally impaired had accuracy scores at an intermediate 
level between worried well and dementia but reaction times were similar to the dementia 
group. This interesting finding points to the importance of speed of memory performance. 
The authors discuss how this dissociation between accuracy and speed may represent a desire 
by patients with minimal cognitive impairment to sacrifice speed in the quest for accuracy. 
Alternatively there may be early deficits in speed of recognition and processing which may 
herald cognitive decline. The CDR battery has established sensitivity in assessing cognitive 
change in the elderly and inpatients with dementia (Simpson, 1991). In a criterion validity 
study, MMSE score correlated with CRT (r = -0.542, p=0.04), spatial working memory (r 
0.938, p=0.01) and word recognition (r - -0.949, p=0.01). However this was a small study 
of 15 young patients and the test schedule had to be modified due to patient fatigue. There 
were no significant associations between CDR battery and IQ test but the latter was taken 
from historical records of only six patients and not at the time of testing (Keith, 1998). 
CDR battery was able to measure change in cognition during oxygen administration in 
healthy young adults but this study did not run other gold standard tests of cognition, so 
cannot be viewed as a validation study (Moss, 1998). Similar weaknesses are found in a 
comparison of cognitive function in young and old dentists with regard to the effects of 
mercury exposure but the CDR battery was shown to be straightforward to use (Ritchie, 
1995). CDR was able to detect an improvement in working and long-term memory in healthy 
middle aged volunteers in response to Gingko biloba (Wesnes, 2000). 
4.4.4 Cornell scale for depression in dementia 
The scale measures depressive symptomatology in depression. Its value lies in obtaining 
information from an informant since the patient is often not able to provide reliable answers 
to traditional depressive scale questionnaires (Alexopoulos, 1988). 
4.4.4.1 Requirements 
The scale is completed by an interviewer questioning both carer (20 nuinutes) and patient (10 
minutes). The carer needs to have a reasonable knowledge of the patients' day-to-day 
behaviour and changes that may have occurred. Response is based on the week prior to 
interview. 
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4.4.4.2 Scoring system 
A 19 item scale, divided into five subsections: mood related signs, behavioural disturbance, 
physical signs, alteration in circadian function and ideational disturbance. Each of the 19 
items can score 0 for absence of positive signs, I if mild or intermittent and 2 for seN, ere 
symptoms. Greater than 10 points indicates significant depression. 
4.4.4.3 Reliability and validity 
The original paper examined 26 subjects. Inter-rater reliability studies yielded a kappa 
statistic of 0.67 i. e. good. Internal consistency yielded a Cronbach's alpha score of 0.84. 
Validity was satisfactory when compared with research diagnostic criteria. 
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5 Characteristics of the cohort 
5.1.1 Demographic data 
The assessment period ran from July 2000 to March 2002. All COGFAST participants from 
Freeman Hospital, Queen Elizabeth Hospital, North Tyneside Hospital and South Tyneside 
General Hospital were screened. During this period, the total number of candidates recruited 
to COGFAST was 190. Ninety-seven people consented to participation in the cardiovascular 
study. Fifty-four (56%) were female and 43 male. The average age was 80.7 SD 4.2 years, 
range 75.0 to 93.0 years (interquartile range 77.5 to 83.0 years). Further clinical 
characteristics are described below. 
5.1.2 Cerebrovascular lesion 
All stroke subtypes were included in the study, with the exception of subarachnold 
haemorrhage. Table 5.1 records the numbers in each group according to the Oxford 
Community Stroke Project (Bamford, 1991). The difference between OCSP population data 
and this cohort regarding stroke subtype are discussed in a later section. 
Table 5-1 Oxfordshire Community Stroke Project stroke classification 
Stroke subtype Hemisphere Total 
left right unknown 
Total Anterior Circulation 2 2 0 4 
Partial Anterior Circulation 25 14 1 40 
Lacunar 11 17 1 29 
Posterior Circulation 4 3 11 18 
Unclassified 4 0 2 6 
Total 46 36 15 97 
Allocation of stroke subtype and affected hemisphere was based on retrospective review of 
clinical findings in combination with clinical CT brain report. The left hemisphere partial 
anterior circulation stroke group contains two cases with dysphasia with no CT lesion, 
assumed to have suffered left hemisphere events. The 'unknown' column contains stroke 
cases labelled as partial anterior, lacunar stroke and unclassified cases but casenote review did 
not allow identification of side of either clinical symptoms or acute CT lesion. The 
unclassified' group had insufficient clinical data in casenotes to confidently allocate stroke 
subtype. Four of these had CT evidence of an acute left hemisphere lesion. 
There were 18 cases with clinical evidence of posterior circulation stroke: three had right- 
sided limb symptoms, four had left-sided limb symptoms and ten did not have lateralising 
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signs. A minority of the posterior circulation stroke group had visible acute lateralising CT 
lesions. 
Table 5.2 contains data on CT appearance (from casenote radiology reports) in relation to the 
OSCP stroke subtype. 
Table 5-2 CT appearance and stroke subtype 
CT abnormality OSCP subtype 
TACS PACS LACS POCS Unclassified 
Large cortical/subcortical 
Medium/small cortical/subcortical 1 22 22 
Deep hemisphere 
Brainstern or cerebellar 
6 11 
7 
None 10 16 
Large cortical/subcortical; involves large area or more than one cortical lobe. Medium/small cortical/subcortical; 
involves only one lobe (frontal, parietal, temporal, occipital) or specifically described as small. Deep hemisphere; 
basal ganglia, internal capsule, periventricular lesions, thalamus, subthalamus, hypothalamus. 
Thirty-nine percent of cases did not have a visible CT lesion that was consistent with the 
acute cerebrovascular syndrome. All of the total anterior circulation syndrome cases had a 
visible lesion which was usually a large cortical infarct. Just over half the partial anterior 
circulation stroke cases had an appropriate medium or small CT lesion involving the cerebral 
cortex whilst a quarter did not have a visible acute lesion. The vast majority of the lacunar 
syndromes either had an acute deep hemisphere lesion or no visible acute lesion. Sirrularly 
most of the posterior circulation stroke syndromes had an appropriate lesion in the brainstem 
or cerebellum, or no visible lesion. Of the two posterior circulation stroke cases with a 
medium/small cortical/subcortical lesion, one was an occipital infarct. There were no primary 
intracerebral haemorrhages seen on CT scanning. Two cases were reported as haemorrhagic 
infarction. The first had a partial anterior circulation stroke, with a left hemisphere medium- 
sized cortical lesion. The second haemorrhagic infarction case had a lacunar-type stroke with 
a right deep hemisphere lesion on CT scan. The total number of cases in Table 5.2 is 95: two 
are excluded because they had a delayed MRI scan instead of CT imaging. 
5.1.3 Clinical characteristics 
The median interval from stroke to cardiovascular assessment was 251 days, interquartile 
range 197 to 321 days. This interval was more than a year in 18 cases. 
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Table 5-3 Clinical characteristics of study population 
History Percentage 
Congestive cardiac failure 19 
Myocardial infarction 19 
Angina 21 
Myocardial infarction or angina 27 
Hypertension 68 
Atrial fibrillation 24 
Peripheral vascular disease 12 
Asthma 16 
Chronic obstructive pulmonary disease 17 
Asthma or Chronic obstructive pulmonary disease 24 
Diabetes mellitus (type 11) 6 
Hypercholesterolaernia, 23 
Hypothyroidism 12 
Hyperthyroldism 
Table 5-4 Smoking and alcohol habits of study population 
Habit Usage Percentage 
Smoking Never 28 
Ex-smoker 14 
Current 58 
Alcohol/units per week None 49 
1-10 37 
11-20 9 
21-50 4 
>50 1 
Additional data on cholesterol status were available from fasting blood tests performed on 91 
of the participants. Sixty-six percent had fasting total cholesterol levels > 5.2 mmol/l, slx 
percent did not have blood cholesterol levels performed. Therefore a total of 76% cases had a 
prior history of hypercholesterolaernia or elevated fasting cholesterol. 
Cardiorespiratory abnormality on examination was infrequent. Only two percent had elevated 
jugular venous pressure, ankle oedema was present in 22% and on chest auscultation nine 
percent had expiratory wheeze and five percent had inspiratory crackles. Cardiac murmurs 
were present in 16% and carotid artery bruits in 14%. Inter-rater reliability of such clinical 
169 
Table 5-5 Frequency of previous cerebrovascular events 
Event Total number Percentage 
TtA 0 83 
1 10 
21 
3 3 
4 3 
Stroke 0 80 
1 14 
2 2 
3 1 
Table 5-6 Drug prescription rates in study population 
Drug Percentage 
Beta blocker 28 
Thiazide diuretic 39 
Loop diuretic 17 
ACE inhibitor or Angiotensin 11 blocker 21 
Calcium channel blocker 22 
Diltiazem 6 
Other hypertensive agent I 
Nitrate 13 
Nicorandil 2 
Amiodarone I 
Digoxin 12 
Warfarin 21 
Antiplatelet 70 
SSRI 9 
Tricyclic agent 5 
Other sedative drugs 6 
Oral corticosteroid 4 
Inhaled beta-2 agonist 6 
Anti-epileptic 6 
Insulin 2 
Oral hypoglycaernic I 
Thyroxine 11 
Statin 21 
.. 
Oxy utynin 6 
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signs is usually very poor - these data are presented for the sake of completeness but cannot 
be used in data analysis. 
Table 5-7 Examination findings of study population 
Parameter Mean ± standard deviation (n=97) Range 
Height m 1.62 ± 0.10 1.43,1.96 
Weight kg 67.0 ± 12.7 38.7,108 
Body mass index 25.4 ± 3.7 17.6,36.9 
Systolic blood pressure / mmHg 150.2 ± 24.0 106,220 
Diastolic blood pressure / mmHg 83.2 ± 11.8 56,110 
Forced expiratory volume / litre* 1.71 ± 0.66 0.35,3.15 
Forced vital capacity / litre* 2.37 ± 0.83 0.70,4.00 
FEV/FVC 0.71 ± 0.09 0.50,0.97 
MUPDRS (range 0-32) 2.40 ± 3.08 0,13 
Total SNSS (range 0-58) 55.7 ± 3.3 45,58 
Long-term SNSS (range 0-48) 45.7 ± 3.3 35,48 
MTJPDRS, Modified Unified Parkinson's Disease Rating Scale: SNSS, Scandinavian Neurological Stroke Score: 
*n = 92 for lung volumes 
Eighty-four percent of cases had a modified UPDRS score < 5, only four percent scored 10 or 
more and the interquartile range was 0 to 3 (maximum score 32). Interquartile range for the 
total and long-term Scandinavian Neurological Stroke Scale scores were 54 to 58 (maximum 
score 58) and 44 to 48 (maximum score 48) respectively. 
5.1.4 Investigations 
Table 5-8 ECG characteristics 
ECG abnormality Number 
Sinus rhythm 76 
Atrial fibrillation 21 
Q waves None 70 
Inferior 19 
Anterior 5 
Not applicable (BBB) 3 
Left ventricular hypertrophy None 83 
Present 11 
Not applicable _(BBB) 
3 
BBB, bundle branch block 
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Table 5-9 Neuropsychological parameters 
Cognitive teof st Number Mean ± SD or median QQR) Range 
MMSE 97 27.8 3.1 23,30 
CAMCOG total 97 85.0 8.5 61,99 
GDS 93 4.0 ± 3.1 0,14 
Cornell 94 3.9 ± 3.4 1,6 
CDR Number scanning/ seconds 94 516 (478,603) 0,759 
CDR choice reaction/ seconds 94 632(537,836) 434,3149 
CDR choice reaction SD/ seconds 94 163 (110,253) 56,2442 
CDR memory/ seconds 
. 
93 1126 (962,1415) 654,10017 
MMSE, Mini-Mental State Examination: CAMCOG, Cambridge Cognitive Examination: GDS, Geriatric 
Depression Scale: CDR, Computerised Dementia Research battery 
Table 5-10 Ambulatory blood pressure recording 
Ambulator y blood pressure Mean SD Range 
24 hour Number of measurements 34.0 6.5 9,47 
Systolic (mmHg) 137.6 ± 14.8 104,182 
Diastolic (mm. Hg) 72.9 ± 8.1 58,94 
Pulse pressure (mm. Hg) 64.7 12.8 38,106 
Day Number of measurements 17.6 3.8 6,29 
Systolic (mmHg) 141.3 16.0 103,181 
Diastolic (mmHg) 75.6 9.1 53,99 
Pulse pressure (mmHg) 65.7 13.7 37,104 
Night Number of measurements 5.7 1.2 0,7 
Systolic (mmHg) 129.4 16.1 99,181 
Diastolic (mm. Hg) 66.8 8.9 48,86 
Pulse pressure (mmHg) 62.5 13.0 36,102 
5.1.5 Discussion 
Exact figures for number screened for the study are not available since candidates for the 
study were initially assessed by local hospital staff. Therefore the total number of stroke 
admissions who were candidates for COGFAST was not collated by investigators. This 
arrangement was part of the initial agreement with local COGFAST collaborators. Caldicott 
guidelines also influenced the procedure since potential candidates for the study were not 
revealed to the COGFAST team without permission from the patient. It is clear the cases 
identified for the study are a highly selected group, even without the benefit of accurate 
numbers of candidates at each stage of the selection process. 
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Allocation of cases to OCSP stroke subtype was performed retrospectively. All stroke patients 
were assessed by a consultant with expertise in Stroke Medicine during their admission and 
usually allocated a subtype. However these data were occasionally missing and therefore 
subtype allocation was Performed on a 'best estimate' basis using available clinical data. In 
some cases senior assessment occurred after improvement of clinical signs; consequently 
opinion between clinicians on subtype could differ. The OSCP classification should be based 
on 'the clinical pattern at the time of maximum deficit' (Bamford, 199 1). It has been shown 
that interobserver agreement for the OCSP classification using neurology-trained clinicians 
can vary from moderate to good (Lindley, 1993). All these factors suggest that whilst the data 
on stroke classification is based on best available information, they may lack a degree of 
accuracy. 
From Table 5.2 it can be seen that CT appearance does match the stroke subtype for the 
majority of cases. This is in line with published data indicating the OSCP classification 
system predicts the site of infarct in approximately three-quarters of patients (Mead, 2000a). 
From the data in Table 5.2,56 patients had a visible acute infarct: 43 (77%) had a CT lesion 
appropriate to the clinical syndrome in keeping with Mead et al's results (Mead, 2000a). 
Three total anterior circulation stroke cases had a large cortical, 22 partial anterior circulation 
stroke had a medium/small cortical/subcortical, II lacunar stroke cases had a deep 
hemisphere and 7 posterior circulation stroke cases had a brainstem/cerebellar lesion. It 
should be borne in mind that rating of OCSP subtype and CT lesion were performed by the 
author and not blinded. It is likely this favourably influenced the match between clinical and 
radiological reports. However, the important message is that retrospective data collection was 
reasonably accurate in indicating the infarct type and size. Furthermore the absence of an 
acute lesion on CT in 39% of cases is similar to the much larger study of Mead et al. Thirty- 
five percent of stroke patients did not have a visible acute lesion on imaging in this series of 
1012 patients (Mead, 2000a). This radiological comparison seems favourable when it is 
considered that Mead's study had the benefits of expert neuroradiology opinion and a small 
proportion of patients had more sensitive MRI scans. 
Clearly there were high rates of co-morbidity within the study group. Some of these 
conditions are known to affect autonomic function - diabetes, myocardial infarction and 
congestive cardiac failure are more obvious examples. However exclusion of all significant 
co-morbidity was not a viable option. In order to obtain a reasonable number of candidates, 
there had to be some allowance for other pathology. Furthermore the aim of the study is to 
examine the natural history of post-stroke patients and the evolution of cognitive decline. 
Exclusion of all co-morbidity would lead to a study group not representative of the typical 
Population at risk. Thus results would be hampered by the caveat of highly selected cases. 
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There is some confirmation from stroke incidence surveys that the cohort here is 
representative in terms of co-morbidity rates. The German cohort in Erlangen (100,330 
inhabitants studied over 4 years) had a history of hypertension in 57%, diabetes in 25%, 
current smoking habit in 13% and history of cardiac disease 54% (Kolominsky-Rabas, 200 1). 
Diagnostic criteria for hypertension included self-reported history or levels above 160 mnfflg 
for systolic and 95 mmHg for diastolic blood pressure. Diabetes prevalence Nvas probably 
higher because they included elevated fasting blood glucose but it is not clear if all cases had 
such a test. Cardiac disease included history of coronary artery disease, congestive cardiac 
failure, arrhythmia or valvular heart disease as one category. For the Italian cohort in the 
Belluno province (211,389 inhabitants studied over I year), 54% had a history of 
hypertension, 24% atrial fibrillation, 21% coronary artery disease, 18% diabetes mellitus, 
18% current smokers, 9% hypercholesterolaernia, 14% peripheral vascular disease and 13% 
previous TIA (Lauria, 1995). The Russian cohor-t in Novosibirsk (158,234 inhabitants over I 
year) had a history of hypertension in 82%, angina in 46%, atrial flutter/fibrillation in 16%, 
cigarette smoking in 35%, TIA in 11%, diabetes in 9% and congestive heart failure in 5% for 
cerebral infarction and haemorrhage of all ages (Feigin, 1995). In the Oxfordshire 
Community Stroke project, 52% had a history of hypertension, 38% ischaemic heart disease, 
25% peripheral vascular disease, 13% atrial fibrillation and 10% diabetes mellitus (244 cases 
of first ever stroke) (Sandercock, 1989). Thirteen percent of patients with stroke were diabetic 
in the community prevalence survey by O'Mahony et al (O'Mahony, 1999). In the Greek 
Arcadia Stroke Registry incidence study, risk factors were hypertension in 81%, diabetes 
mellitus in 29%, coronary artery disease in 20%, atrial fibrillation in 34%% and TIA in 17% 
(Vemmos, 1999). 
The best comparison of co-morbidity for this cohort of stroke patients comes from a study by 
Rodgers et al (Rodgers, 2004). A total of 329 first-ever strokes occurred in a cohort of 4440 
subjects aged over 65 years followed for five years. Crude prevalence rates for stroke risk 
factors from this study are shown in Table 5.11 
When compared with Rodgers study, the stroke patients in our study had very similar 
prevalence rates for gender, congestive cardiac failure, coronary artery disease (MI or 
angina), peripheral vascular disease, left ventricular hypertrophy, diabetes and regular alcohol 
consumption. History of hypertension and presence of atrial fibrillation were much higher, 
and TIA slightly higher in our cohort. This is unlikely to be solely related to the slight age 
difference between the studies, 80.7 ± 4.2 years in our study vs. 78.6 ± 6.3 years in Rodgers et 
al (Rodgers, 2004). Reasons for the discrepancy probably could include ascertaim-nent method 
and selection bias in our study but it is difficult to say with certainty what led to these 
differences. Smoking was almost twice as common in our study, and this may be related to 
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our method of direct questioning compared with reference to GP records for the Rodgers 
study. 
Table 5-11 Crude prevalence rates of risk factors and adjusted hazard ratios for first-ever stroke, 
Rodgers et al 
Risk factor Stroke 
_ 
Hazard ratio (95% Cl) 
% Yes (n=329) % No (n=4022) 
Male 46.8 45.8 1.28 (1.02-1.59) 
Transient ischaemic attack 12.5 5.5 2.18 (1.57-3.04) 
Hypertension (history/treatment) 45.6 33.0 1.68 (1.35-2.09) 
Atrial fibrillation (ECG) 9.7 4.6 2.12 (1.47-3.06) 
Current smoker 28.2 20.7 1.79 (1.39-2.32) 
Left ventricular hypertrophy (ECG) 13.7 9.9 1.38 (1.01-1.90) 
Regular alcohol 53.0 45.2 0.77 (0.59-1.02) 
Diabetes 7.3 5.7 1.27 (0.84-1.93) 
Angina 24.6 20.2 1.34 (1.04-1.72) 
Myocardial infarction 11.6 10.7 1.16 (0.82-1.62) 
Peripheral vascular disease 10.6 6.3 1.86 (1.31-2.65) 
Ischaernic heart disease 28.6 23.4 1.32 (1.05-1.67) 
Heart failure 16.1 12.1 1.42 (1.05-1.92) 
From Rodgers et al Stroke 2004 (Rodgers, 2004) 
For the purposes of analysis requiring binomial data, ex-smoker and never smoked status 
were subsequently collapsed into one category of 'not current smoker'. This was because 
many of the ex-smokers had stopped smoking more than 5 years prior to the study and a 
pragmatic decision to group these cases in the lower risk group seemed appropriate. 
Otherwise this group may have attained a disproportionate risk if classified the same as 
current smokers, since smoking risk declines significantly if several years have elapsed since 
discontinuation. Estimating pack years of smoking would have provided a more useful 
continuous marker of smoking risk 
There were high rates of smoking, both current and ex-smokers in the study group. Smoking 
can affect autonomic function. Decreased vagal indices, increased sympathetic activity during 
Valsalva manoeuvre and reduced Valsalva ratio and increased diastolic blood pressure 
response to isometric exercise have been reported as consequences of smoking (Kotamaki, 
1995; Niedermaier, 1993; Poulsen, 1998). Vagal dysfunction is common in alcohol-dependent 
adults (particularly those with liver disease) and 24 hour heart rate variability demonstrates 
autonomic damage in those with normal autonomic reflex tests (Duncan, 1980; Hendrickse, 
1992; Malpas, 1991). 
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The cohort had a low mean Modified Unified Parkinson's Disease Rating Scale. This 
modified version of motor section from the UPDRS contains 5 key items that are independent 
of cognitive impairment and is specific for neuropathological changes of idiopathic 
Parkinson's disease (Ballard, 1997). The observed low scores indicate absence of clinically 
significant extrapyramidal disease in this cohort. 
Scandinavian Neurological Stroke Scale scores were generally high, consistent with the 
selection of a post-stroke cohort alive and independent more than three months post-stroke. 
The index does not have any relevance for the autonomic investigations but does indicate the 
majority of the cases were free of disabling neurological deficit. 
There was a wide variation in interval between stroke and autonomic testing. The delays arose 
for two main reasons. Firstly most of the delay occurred early in the course of the study 
because patients had consented to COGFAST including MRI investigations but ethical 
approval for the cardiovascular investigations was outstanding. MRI investigations had to 
proceed in a timely manner and it was not Practical to defer until cardiovascular investigation 
was permissible. Secondly, duration of identification, screening and recruitment process 
simply meant that several months had elapsed before individuals could be investigated. 
The mean office systolic blood pressure was 150 mmHg. Ten cases had an office systolic 
blood pressure of > 180 mmHg and the highest value was 220 mmHg. Therefore accuracy of 
the Spacelabs 90207 monitor may have been below BHS limits in this small proportion of 
cases with very elevated blood pressure (Iqbal, 1996). However the office blood pressure 
value is from one measurement only and therefore may itself exaggerate actual blood 
pressure. The Spacelabs 90207 device was chosen because of familiarity with use with 
hospital staff. Overall this ambulatory blood pressure monitor was a satisfactory choice since 
few subjects had the very high pressures associated with diminishing accuracy of the device 
in the elderly. 
5.1.6 Conclusions 
Most of the patients in the cohort had a history of partial anterior, lacunar and posterior 
circulation stroke. Stroke risk factors were usually similar in prevalence to previous large 
scale epidemiological surveys. Two risk factors had high prevalence rates when compared to 
a recent incidence study in the UK. History of hypertension was particularly common 
affecting 66% of patients. Prevalence of atrial fibrillation was higher than might be expected 
at 22%. Generally the cohort is representative of an older post-stroke cohort. Comorbidity and 
medication use has implications for autonomic testing. 
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Cardiovascular autonomic reflex tests 
6.1 Introduction 
Tests of heart rate and blood pressure variation during cardiovascular provocation are 
established methods of measuring autonomic function. Autonomic function declines with age. 
Autonomic reflexes may be impaired in diabetes and other chronic diseases. The study cohort 
had high rates of co-morbidity. Co-existent chronic disease and medication may have 
impaired cardiovascular autonomic reflexes. This chapter investigates the impact of 
cardiovascular risk factors and medication on autonomic tests. 
6.2 Method 
A series of autonomic reflex tests were performed as described in Chapter 4. Only cases in 
sinus rhythm on the day of investigation were included. Mean, median and interquartile range 
values were calculated. Heart rate variation for the metronomic respiration was assessed for 
both mean ratio and difference in maximum and minimum heart rate for the purpose of 
comparison with previous studies. 
The relationship between co-morbid conditions and drug treatment was examined using 
correlation and then regression. Correlation was performed using Spearman's rank correlation 
coefficient between reflex test and co-morbid condition or drug. Multiple linear regression 
was performed using each cardiovascular autonomic reflex test as the dependent variable. The 
following were entered as independent co-morbid variables from clinical history: cardiac 
failure, ischaernic heart disease (history of myocardial infarction or angina), hypertension, 
peripheral vascular disease, respiratory disease (chronic obstructive pulmonary disease and/or 
asthma), diabetes mellitus, current smoker and current alcohol consumption. At the same 
time, use of the following drugs were also entered as independent variables: beta-blocker, 
thiazide diuretic, loop diuretic, ACE inhibitor or angiotensin 11 receptor antagonist, 
dihydropyridine calcium channel antagonist, nitrate, selective- serotonin receptor inhibitor, 
tricyclics and oxybuty-nin. Presence of co-morbid condition or drug use was assigned a value 
of one and absence a value of zero. Regression was performed by entering all candidate 
predictor variables, then excluding the least significant predictor variable in a stepwise 
manner. This was repeated until only predictor variables with a significance of p<0.05 
remained or there were no significant predictor variables. The regression model for each 
autonomic test was confirmed by forward regression. 
One sample Kolmogorov-Smirnov test revealed that RR ratio tests did not follow a normal 
distribution. To achieve a normal distribution for regression analysis, logarithmic 
transformation after subtraction of one was perfonned i. e. logio (x - 1). For the heart rate 
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difference during metronomic respiration, only logarithmic transformation was required to 
achieve a normal distribution (Ziegler, 1992b). 
6.3 Results 
Summary of the results is shown in Table 6.1. 
Table 6-1 Cardiovascular autonomic reflex test results 
Cardiovascular reflex test Number Mean ± SD Median (IQR) Range 
30: 15 ratio 71 1.14 ± 0.14 1.10 (1.04.1.18) 0.96,1.76 
Asystolic BP orthostasis (mmHg) 72 31.6 ± 31.3 26.0 (9.0,48.8) -18,116 
Adiastolic BP isometric exercise (mmHg) 74 18.4 ± 15.1 17.5 (7.8,30.3) -17,58 
Adiastolic BP cold pressor (mmHg) 72 10.7 ± 13.3 8.5 (4,14.8) -24,74 
Valsalva ratio 69 1.25 ± 0.17 1.23 (1.15,1.33) 1.03,117 
Asystolic BP Valsalva overshoot (mmHg) 68 16.4 ± 17.1 16.5 (4.8,30.0) -25,52 
E/I ratio metronomic respiration 73 1.11 ± 0.08 1.08 (1.06,1.13) 1.02,1.41 
AHR metronomic respiration (bpm) 73 6.3 ± 4.5 4.8 (3.3,7.9) 1.7,21.8 
Asystolic BP CSM (mmHg) 31 -28.3 ± 12.0 -30.0 (-38.0, -17.0) -51, -9 
ARR CSM (ms) 31 1191 ± 269 1122 (978,1418) 635,1662 
SD, standard deviation: IQR, interquartile range: BP, blood pressure: E/1, ratio of expiratory/inspiratory RR 
interval during metronomic respiration: HR, heart rate: CSM, carotid sinus massage 
Successful completion rates ranged from 89% for blood pressure overshoot during Valsalva 
manoeuvre to 97% for blood pressure change during isometric exercise. Fifty-one cases (67% 
of sinus rhythm cases) completed all heart rate response tests satisfactorily. This value 
excludes carotid sinus massage where number of completed tests was much lower due to 
exclusions from test contra-indication and test refusal. The number of cases completing all 
cardiovascular reflex tests was 47, representing 62% of sinus rhythm cases (i. e. all heart rate 
and blood pressure results available). 
For simple correlation tests, the only significant associations occurred between (1) cold 
pressor and ischaemic heart disease, (ii) Valsalva blood pressure overshoot and beta-blockers, 
loop diuretic or nitrate, and (iii) systolic blood pressure change from CSM and ACE 
inhibitors/AIIR antagonists or oxybutynin. There were trends towards correlation for other 
analyses. For the sake of completeness, all rank correlations with a significance value of less 
than 0- 10 are shown in Table 6.2. 
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Table 6-2 Correlation between autonomic reflex and co-morbid history or drugs: correlation co- 
efficient <0.10 
Cardiovascular reflex test Co-morbidity/drug No. Spearman's rho Significance 
Loglo (30: 15 ratio - 1) Cardiac failure 67 -0.24 0.0-52 
Respiratory disease 67 -0.22 0.069 
Asystolic BP orthostasis Tricyclic 67 -0.21 0.080 
Adiastolic BP isometric exercise ACEi/AHRA 74 -0.20 0.082 
Adiastolic BP cold pressor IIHD 70 +0.38 0.001 
Loglo (VR ratio - 1) Loop diuretic 69 -0.22 0.069 
Asystolic BP Valsalva overshoot Beta-blocker 68 -0.28 0.019 
Loop diuretic 68 -0.25 0.038 
Nitrate 68 -0.27 0.025 
Loglo (E/I ratio - 1) None 
Loge AHR metronomic respiration Hypertension 73 -0.23 0.051 
Asystolic BP CSM ACEi/AlIR. A 31 -0.41 0.021 
OxybutynM 31 -0.36 0.046 
ARR CSM None 
BP, blood pressure: ACEi/AIIRA, ACE inhibitor or angiotensin 11 receptor antagonist: IHD, ischaemic heart 
disease: VR, Valsalva ratio: E/1, ratio of expiratory/inspiratory RR interval during metronomic respiration: HR, 
heart rate: CSM, carotid sinus massage 
Results from multiple linear regression of co-morbid conditions and drugs on autonomic tests 
are shown in Table 6.3. History of ischaemic heart disease significantly increased the diastolic 
blood pressure response to cold cutaneous stress by 8.8 mmHg (95% Cl 4.2 to 13.4 mmHg). 
History of hypertension was a significant and negative predictor of the transformed value for 
the change in heart rate with metronomic respiration. Prescription of angiotensin system 
blocking drugs significantly decreased the systolic blood pressure reaction to carotid sinus 
massage by -13.5 mmHg (95% CI -24.6 to -2.4 mmHg). For the RR interval tests, 
transfon-ned values for the 30: 15 ratio, Valsalva ratio and E/I ratio were not significantly 
predicted by co-morbid conditions or drug therapy. 
Drop in blood pressure on standing produced contradictory predictor variables using entry 
method for regression. Drop in blood pressure on standing was reduced by history of diabetes 
and cardiac failure and worsened by the presence of loop diuretic and calcium channel 
blocker. However usingforward regression technique, there were no significant predictor 
variables for drop in blood pressure on standing. Blood pressure response to isometric 
exercise and Valsalva manoeuvre were not significantly predicted by any co-morbid 
conditions or drugs. 
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Table 6-3 Predictor variables for cardiovascular autonomic reflex tests 
Autonomic test Significant Predictor variable Regression coefficient 
Loglo (30: 15 ratio -1) 
Asystolic BP orthostasis 
Adiastolic BP isometric exercise 
Adiastolic cold pressor 
Loglo (VR - 1) 
Asystolic BP Valsalva overshoot 
Logio (E/I ratio - 1) 
Loge AHR metronomic respiration 
Asystolic BP CSM 
B 95% Cl 
None 
None* 
None 
Ischaemic heart disease +8.8 +4.2,13.4 
None 
None 
None 
Hypertension -0.31 -0.61, -0.02 
ACEVAHRA -13.5 -24.6, -2.4 
Asystolic RR CSM None 
BP, blood pressure: ACEi/AIIRA, ACE inhibitor or angiotensin II receptor antagonist: VR, Valsalva ratio: E/1, 
ratio of expiratory/inspiratory RR interval during metronomic respiration: HR, heart rate: CSNI. carotid sinus 
massage: *, see text. 
6.4 Discussion 
The majority of cases were able to complete cardiovascular autonomic reflex tests. This 
appears to be a reasonable yield of results considering the nature of the cohort. Many authors 
comment on difficulties in performing reflex tests in older subjects but rates of successful test 
completion are rarely quoted. In a review of 10 years performing clinical autonomic 
investigations, Ewing et al (Ewing, 1985) report 70% of 774 diabetic patients completed all 
five of his autonomic test battery. It would appear our completion rate compares favourably 
with this series, particularly as the Ewing patients were probably a younger group than our 
cohort. The overall completion rate of 62% includes two additional blood pressure tests 
compared with the Ewing protocol (systolic overshoot during Valsalva and cold pressor tests). 
In our study, the completion rate for the Ewing battery alone is 66%. 
Values from this cohort can be compared with published reports of normal values for 
autonomic reflex tests summarised in Table 6.4. There are few studies focussing on older 
adults comparable in age to our cohort. The closest match is probably Clark's study that 
included patients up to 92 years age (Clark and Mapstone, 1986). Most of the summarised 
studies in the table do not accurately state the proportion of older subjects; instead the older 
adults are included in the total number of subjects in each study. 
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Table 6-4 Normal values for cardiovascular autonomic reflex tests in older adults 
Autonomic Mathias. Wieling. Ziegler. O'Brien. Age Clark. Age Ewing. Age 
test Age >70. Age 75-80. Age 65. 75. Lower 80. Lower max. 69. - 
Mean ± Abnormal Lower 95%(90%) 90% Abnormal 
SEM (95% values 97.7 confidence confidence values 
CI) centile limit limit (est. ) 
value 
30: 15 ratio <1.00 1.06 1.01 (1.03) 1.01 <1.00 
AHR <11 3 (4) 
standing 
(beats/min) 
Valsalva. 1.33 < 1.00 1.16 1.09 (1.13) 1.02 <1.10 
ratio 0.06(l. 21 
to 1.45) 
E/I ratio 1.10 1.00 (1.02) 
respiration 
AHR 9±1 (8 to <7 2 (3) 8 <10 
respiration 10) 
(beats/min) 
ASBP -27 -30 <30 
standing/ 
mmHg 
ADBP 11 ±1 (9 +5 <10 
isometric/ to 13) 
mmHg 
ADBP cold 12 ±4 (5 < 10, > 15 
pressor/ to 19) 
mmHg 
ASBP 
Valsalva/ 
--9 
Mathias 1999 (Mathias and Bannister, 1999). Subjects aged >70, number not stated, estimate < 10 
subjects. Automated sphygmomanometer. Heart rate recording method not known. 
Wieling 1999 (Wieling and Karemaker, 1999). Subjects aged 75-80. Adapted from age group 70-74 
where no values given for 30: 15 and Valsalva ratios for 75-80 year olds. Number not known. Possible 
combination of Finapres and sphygmomanometer, and combination of pen recorder and computensed 
heart rate recording. 
Ziegler et al 1992 (Ziegler, 1992b). Subjects aged up to 67. Blood pressure changes during handgrýip 
and posture change independent of age. Quoted 2.3 centile values for RR interval ratios. Automated 
sphygmomanometer. Computerised heart rate recording. 
O'Brien 1986 (O'Brien, 1986). 36 subjects aged 70-85 years. Computerised heart rate recording 
Clark 1986 (Clark and Mapstone, 1986). 85 subjects aged 31-92, mean age 66 years. Values estimated 
from plots of mean, 90% and 95% confidence limits. Pen recorder for heart rate and manual 
sphygmomanometer for blood pressure recordings. 
Ewing 1985 (Ewing, 1985). Subjects aged 16-69, variable number for each autonomic test from 71 to 
139. Values for VR, postural blood pressure response and isometric exercise not age dependent. 
Standard sphygmomanometer, probable combination of pen recorder and computerised heart rate 
recording. 
182 
None of the studies provide a robust comparison for this cohort's results. The average age of 
subjects is usually younger than our cohort. Each report only includes a selection of the tests 
performed in this study. Finally the techniques used in the studies in Table 6.4 differ 
substantially from this cohort - only a few use computerised methods of measuring RR 
interval and most use intermittent blood pressure recording using manual/automated 
sphygmomanometers. Our computerised method is clearly different from intermittent 
sphygmomanometric methods of blood pressure measurement, in particular beat-to-beat 
blood pressure monitoring using Finapres and averaging short sections of blood pressure 
values. 
Consensus of opinion indicates heart rate variation diminution with age reduces the test range 
of RR ratio tests. This impairs ability to define abnormal from normal. Using change In heart 
rate during cardiovascular provocation may be more useful in older subjects, particularly for 
heart rate variation during metronomic respiration as suggested by Piha et al (Piha, 1993). 
Piha reported the tests of choice in the elderly were (i) from the Valsalva manoeuvre, heart 
rate difference and tachycardia difference and (ii) from the orthostatic test, max-rest 
difference, immediate and later change in systolic blood pressure. Usefulness of metronomic 
respiration heart rate change was limited, and Valsalva ratio and 30: 15 ratios were reported as 
not useful in the elderly. His test group included 26 adults aged over 70 years. The 
conclusions regarding test limitations were based on regression equation data that indicated 
4critical ages', where the tolerance limit (outer confidence limit of normal) reach a value 
where no response occurs. Our cohort does appear to display a reasonable range of results for 
the RR intervals, but as discussed no valid reference range is currently available to 
confidently define normal from abnormal autonomic function in this elderly stroke group. 
An inherent disadvantage of the study design was inclusion of subjects with conditions and 
drugs that may affect cardiovascular autonomic function. Correlation results indicated there 
were some associations with drugs or co-morbidity with reflex tests of heart rate and blood 
pressure. However multiple linear regression only found significant effects for ischaernic 
heart disease on cold pressor response, angiotensin-blocking drugs on blood pressure drop 
during carotid sinus massage and hypertension on heart rate difference during metrononuc 
respiration. These results are somewhat surprising; one would anticipate more marked effects 
on autonomic indices from the multitude of confounding factors. Absence of such effects 
could be related to reduced test range of autonomic response in the elderly and the number of 
subjects in the dependent variable group (approximately 70) in relation to the number of 
independent variables entered in to the regression model (17). Multiple regression results 
provide some reassurance for lack of interference from confounding factors but cannot be 
taken as evidence of absence of effect for these reasons. 
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Unfortunately one participant suffered a cerebrovascular event during carotid sinus massa2e 
requiring hospital admission. There was rapid onset of dysphasia and mild right limb 
weakness within minutes of left carotid sinus massage. Symptoms persisted beyond 24 hours 
but the patient did recover and was discharged home. There was minimal blood pressure fall 
and heart rate slowing during the carotid sinus massage, therefore it is assumed the event was 
embolic from carotid vessel atheroma. This is despite absence of significant carotid artery 
disease on prior carotid Duplex scanning. Carotid sinus massage was performed on a total of 
41 participants (42 %). This one case within such a small cohort suggests it may be necessary 
to re-evaluate the risk involved in carotid sinus massage following stroke. All participants 
gave informed and written consent to the procedure, with a risk of stroke estimated at one in 
one thousand people undergoing carotid sinus massage (Davies and Kenny, 1998). In view of 
the event in this small sample, the risk may now appear to be larger for stroke patients. 
6.5 Conclusions 
Successful acquisition of individual autonomic reflex data was achieved in 89-97% of cases. 
Sixty-two percent of cases completed all the intended reflex tests, similar to a previously 
reported large study. In spite of the large number of confounding factors, few autonomic 
reflexes were significantly predicted by co-morbidity or cardiovascular drug prescription. 
There are limited resources available for defining a normal reference range to define 
abnormal autonomic function in this cohort. 
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7A comparison of cardiovascular autonomic 
function between stroke patients and control 
cases 
7.1 Introduction 
Cardiovascular autonomic function controls blood pressure and heart rate homeostasis. Large 
studies indicate autonomic dysfunction is an independent risk factor for cardiovascular and all 
cause mortality - Framingham data, the Atherosclerosis Risk in Communities (ARIC) study 
(which used ECG RR variation) and the Autonomic Tone and Reflexes After Myocardial 
Infarction (ATRAMI) study (which analysed time domain heart rate variability during 24 
ECG recordings) (Dekker, 2000; La Rovere, 1998; Tsuji, 1994). Stroke prevalence in the UK 
is approximately 17.5/1000 population and the age standardised prevalence rate of stroke in 
people aged 55 years and over has been estimated at 47 per 1000 population (Geddes, 1996; 
O'Mahony, 1999). Autonomic dysfunction is potentially a common sequelae of stroke 
through damage to central autonomic regulatory structures. 
Studies of middle-aged stroke cases indicate that autonomic function is impaired in the early 
stages of stroke but may improve in the first six months post-stroke (Korpelainen, 1996a; 
Korpelainen, 1996b; Korpelainen, 1994). However, half of all strokes occur in older patients 
over the age of 75 years; to our knowledge this age category has not been studied in terms of 
autonomic reflexes and heart rate variability. Autonomic damage could have adverse 
consequences in stroke survivors. Firstly impaired baroreflex sensitivity could leave 
individuals vulnerable to fluctuations in systemic blood pressure, which may lead to 
progression of white matter lesions through transient hypotension (Skoog, 1998a). This may 
have particular relevance in older patients where baroreflex sensitivity is already diminished 
as a natural phenomenon of the ageing process (Collins, 1980; Gerritsen, 2000; Kardos, 2001; 
Piccirillo, 2001; Shimada, 1986; Veerman, 1994). It has also been clearly established that 
impaired heart rate variability is a marker for sudden cardiac death following myocardial 
infarction (Kleiger, 1987; La Rovere, 1998; Piccirillo, 2001; Shimada, 1986; Veerman, 1994; 
Zuanetti, 1996). The risk of sudden death may be mediated by sympathovagal imbalance, in 
particular reduced vagal activity which creates susceptibility to malignant arrhythmias. This 
risk is likely to extend to patients with cerebrovascular disease who clearly share similar risk 
factor profiles and vascular pathology with coronary artery disease populations. Summary 
data from three trials collecting data over nearly 20,000 patient years suggested incidence of 
sudden death following TIA/minor stroke was approximately 1.0 % per annum (95 % CI 0.8 
to I- 1) (Algra, 2003). However there are surprisingly few reports in the literature concerning 
any association between arrhythmic mortality and stroke: one study of 62 ischaernic stroke 
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patients indicated a link between insular cortex stroke, impaired heart rate variability and 
arrhythmic death and more recently it has been shown that impaired baroreflex sensitivity is 
associated with significantly increased mortality 4 years post-stroke (Robinson, 2003: 
Tokgozoglu, 1999). 
one single test in isolation is considered inadequate for assessment of cardiovascular 
autonomic function. A series of autonomic tests is required to describe the site and severity of 
autonomic dysfunction. The Ewing battery is an established and simple bedside series of tests 
measuring the heart rate and blood pressure response to autonomic stimuli (Ewing and 
Clarke, 1982). Sympathetic and parasympathetic damage produce a typical pattern of 
abnormal response, providing a qualitative picture of function. 
Heart rate variability is an alternative method of assessing autonomic behaviour based on 
computerized measures of RR variability from prolonged ECG recordings. The variability can 
be expressed in a number of methods, one of the more common techniques being power 
spectral analysis of RR frequencies. For short term power spectral analysis of heart rate 
variability, a five minute recording is recognised as being suitable for assessment of 
autonomic function (Task Force of the European Society of Cardiology and the North 
American Society of Pacing and Electrophysiology, 1996). Combined with blood pressure 
measurement, this technique can also measure baroreflex sensitivity. 
These two approaches to autonomic assessment have contrasting benefits. The Ewing battery 
has the advantages of being relatively simple and straightforward at the cost of requiring good 
subject compliance. Power spectral analysis of heart rate variability has the advantage of 
being independent of subject compliance at the cost of procedural complexity. The Ewing 
battery is in widespread clinical use whereas HRV is predominantly a research technique. 
We set out to investigate if autonomic function is impaired in a group of elderly stroke 
survivors, a group not previously reported in the literature, in comparison with community- 
living, age-matched controls with no history of cerebrovascular disease. 
7.2 Method 
Methodology is described in detail in Chapter 4. Controls were recruited from a community 
study of autonomic function in older people and from the relatives of persons taking part In 
another related study in Newcastle upon Tyne. Controls were matched for age and were 
community living subjects without any history of stroke. All subjects gave informed written 
and signed consent to the study. 
The investigation sequence was the same for cases and controls. All subjects were asked to 
refrain from smoking and caffeine ingestion on the day of the investigations and to eat a light 
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breakfast only. All investigations were performed between the hours of 09: 00 and 13: 00, and 
took place in a warm and quiet room. A ten minute rest phase was allowed before 
investigations commenced with the subject supine and not engaged in conversation. All 
sections of the investigation protocol were interspersed with a2 minute rest phase 
Cardiovascular autonomic reflex tests and power spectral analysis of heart rate variability 
were compared between stroke patients and controls. The following cardiovascular reflex 
tests were measured: 30: 15 ratio and postural change in blood pressure during standing, 
diastolic blood pressure change during isometric exercise, Valsalva ratio and systolic blood 
pressure overshoot during Valsalva manoeuvre and heart rate variation during metronomic 
respiration. Five minutes of resting RR interval and systolic blood pressure variation were 
analysed by power spectral analysis to obtain total, low and high frequency heart rate 
variability power and baroreflex sensitivity in low and high frequency bands. 
Carotid sinus massage was performed in the supine position for 5 seconds on the right then 
left carotid sinus (Brignole, 2001). Two values were obtained following carotid sinus 
massage. The cardio-inhibitory response was the value of the peak RR in the 30 seconds 
immediately after commencing carotid sinus massage. The vasodepressor response was the 
difference between the mean systolic blood pressure for 20 beats prior to carotid sinus 
massage and the nadir blood pressure in the 30 seconds post-carotid sinus massage. 
Autonomic data may vary with laboratory techniques, and it is recommended that centres use 
their own reference data. Since our group of cases were investigated using a locally developed 
software, we used the results from the control group to provide reference values. RR interval 
and power spectral analysis data were not normally distributed and group comparisons were 
calculated using Mann Whitney Signed Ranks Test. Interquartile ranges are provided to 
compare the distribution of data. Skewed data were transformed using the natural logarithm, 
and then group means were compared using the t test to provide a confidence interval for the 
observed differences. Blood pressure may influence autonomic function (Harrington, 2000a). 
Since there was a difference in systolic ambulatory blood pressure, linear regression using 
systolic ambulatory blood pressure was performed on transformed data. Blood pressure data 
from the Ewing and cold pressor tests were normally distributed; group comparisons were 
made using the students t test. A result was considered statistically significant if the p value 
was less than 0.05. 
7.3 Results 
Seventy-six cases and seventy controls consented to the study. There was no difference in age 
between the controls and cases (80.5 ± 4.3 vs. 80.1 ± 4.0, t-test p=0.592). There was a 
preponderance of males in controls and females in the cases that was not statistically 
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significant (54% male controls vs. 42% cases, Pearson Chi-Square p=0.14 1). Cases had a 
significantly higher mean systolic ambulatory blood pressure than controls (130 ± 13 vs. 138 
± 15 mmHg, p =- 0.001) but there was no significant difference between diastolic levels (70 
8 vs. 72 ±8 mmHg, p=0.143). Three cases did not tolerate the ambulatory blood pressure 
measurement. 
Table 7-1 Clinical characteristics of stroke patients and control cases 
Controls (n=70) ± SD Cases (n=76) ± SD 
Mean age 80.5 ± 4.3 80.1 ± 4.0 
Male: female (% male) 38: 32 (54%) 32: 44 (42%) 
Mean systolic ambulatory blood pressure (mnfflg) 130 ± 13 138± 15 
Mean diastolic ambulatory blood pressure (mmHg) 70 ±8 72 ±8 
Bodv mass index (kjz/mý) 25.08 ± 3.93 25.24 ± 3.90 
*t test: p=0.001: n= 73 for ambulatory blood pressure 
Table 7-2 Co-morbidity in stroke patients and control cases 
Self reported history Control Stroke RR 95% confidence P value 
Number (%) Number (%) intervals 
Cardiac failure 6(9) 9(12) 1.38 0.52-3.69 0.592 
Myocardial infarction 9(13) 13(17) 1.33 0.61-2.92 0.498 
Angina 17(24) 13(17) 0.70 0.37- 1.34 0.311 
MI or angina 22(31) 19(25) 1.17 0.64-2.11 0.696 
Hypertension 21 (30) 51 (67) 2.24 1.51 -3.31 <0.00 I 
PVD 6(9) 9(12) 1.38 0.52-3.69 0.592 
Asthma 2(3) 13(17) 5.98 1.40-25.64 0.005 
COPD 5(7) 15(20) 2.76 1.06-7.19 0.031 
Asthma or COPD 7(10) 20(26) 2.63 1.19-5.85 0.018 
Diabetes mellitus 6(9) 4(5) 0.61 0.18-2.09 0.521 
Hypercholesterolaemia 15(21) 19(25) 1.17 0.64-2.11 0.696 
Current smoker 33(47) 43(57) 1.20 0.87-1.65 0.320 
Current alcohol 47(67) 36(47) 0.71 0.53-0.94 0.019 
P value, Pearson Chi Square exact significance (2 sided): RR, Relative Risk: PVD, peripheral vascuiar cisease: 
COPD, chronic obstructive pulmonary disease 
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The mean interval between stroke and autonomic assessment was 0.75 ± 0.34 years. The 
stroke group had a mean Scandinavian Neurological Stroke Scale score of 55.6 s. d. -3.3. 
(median score 57, range 45 - 58). Thirty two cases had a partial anterior stroke. 26 lacunar 
stroke, 13 posterior, 2 total anterior circulation stroke and three were not classifiable. On 
brain imaging 53 cases had a visible cerebrovascular lesion (relevant or old) whilst 23 had no 
visible lesion on CT. In the cases where there was a visible cerebrovascular lesioll. 30 cases 
had a relevant lesion alone, of which 28 were ischaernic infarctions and 2 were haemorrhagic 
infarctions. Another thirteen cases had a combination of relevant plus old lesions which Nvere 
all ischaemic infarcts, and finally nine had only old lesions which were all ischaemic infarcts. 
Co-morbid conditions are shown in Table 7.2. There was a significantly higher number of 
cases in the stroke group with a history of hypertension (relative risk (RR) 2.24, p<0.00 1) 
and asthma or COPD ( RR 2.63, p=0.0 18 ). There was a significantly smaller number of 
cases in the stroke group who did not currently consume alcohol ( RR 0.7 1, p=0.0 19 ). 
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Table 7-3 Current drug use in stroke patients and control cases 
Drug class Control Stroke RR 95% CI P value 
Number (%) Number 
Beta-blocker 13(19) 20(26) 1.42 0.76 -2.63 0.323 
Thiazide 8(11) 32(42) 3.69 1.82- 7.46 <0.00 1 
Loop diuretic 9(13) 8(11) 0.82 0.33 -2.00 0.797 
ACE inhibitor or MIR blocker 14(20) 16(21) 1.05 0.56- 2.00 1.00 
Dihydropyridine CCB 7(10) 19(25) 2.50 1.12- 5.59 0.029 
Nitrate 7(10) 10(13) 1.32 0.53- 3.27 0.613 
SSRI 3(4) 7(9) 2.15 0.58- 8.00 0.331 
Tricyclic antidepressant 2(3) 4(5) 1.84 0.35- 9.71 0.683 
Oxvbutynin 0(0) 5(7) - 0.059 
P value, Pearson Chi-Square exact 2-sided test: RR, Relative risk: ACE, angiotensin-converting enzyme Inhibitor: 
AIIR blocker, angiotensin-11 receptor antagonist: SSRI, selective serotonin re-uptake inhibitor 
There was significantly higher prevalence of drug use in the stroke group for thiazide 
diuretics (RR =3.69, p<0.001) and dihydropyridine calcium channel antagonists (R-R 2.50, p 
= 0.029). There were no significant differences in the use of other cardiovascular-acting drugs 
between cases and controls (Table 7.3) 
Table 7-4 Cardiovascular reflex tests: RR interval changes 
Test Group Number Median Interquartile P value 
range 
30: 15 ratio Control 65 1.11 1.05,1.19 0.549 
Stroke 71 1.10 1.04,1.18 
Valsalva ratio Control 66 1.36 1.23,1.56 <0.001 
Stroke 69 1.23 1.15,1.33 
E/I ratio Control 68 1.11 1.08,1.17 0.005 
stroke 73 1.08 1.06,1.13 
AHR/ bpm Control 68 -6.87 -10.76, -5.05 0.002 
(respiration) 
Stroke 73 -4.85 -7.87, -3.31 
P value, Mann Whitney test, exact significance (2-tailed): Interquartile range, Weighted average: E/L 
expiratory/inspiratory ratio during metronomic respiration: AHR, difference in heart rate during metronomic 
respiration 
Regarding outliers, 30: 15 ratio results revealed I case and 2 controls with values > 1.60 and 
the Valsalva ratio revealed I case with a value greater than 2.0 but removal of these \, alues 
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did not have a significant bearing upon results. There were no outlying values for metronomic 
respiration. 
7.3.1 Heart rate changes 
There were significant differences in the RR interval measures (Table 7.4). Stroke cases had 
smaller Valsalva ratio (medians: control 1.36, stroke 1.23, p<0.001) and less heart rate 
variation during metronomic respiration (medians: control -6.87 beats per minute, stroke - 
4.85 beats per minute, p=0.002). There was no difference between groups for the 30: 15 ratio 
(median: controls 1.11, stroke 1.10, p=0.549). 
Table 7-5 Cardiovascular reflex tests: Transformed data and linear regression for systolic blood 
pressure 
Test Group Log, mean Log, mean P value SBP regression P value (2) 
s. d. difference (1) mean diff 
(95% Cl) 
30: 15 ratio Control 0.12 ± 0.10 0.00 0.956 0.01 0.710 
Stroke 0.11 ± 0.10 (-0.04,0.04) (-0.05,0.03) 
Valsalva Control 0.32 ± 0.15 0.11 0.000 0.11 0.000 
ratio Stroke 0.22 ± 0.13 (0.06,0.15) (0-06,0.16) 
E/I ratio Control 0.12 : L- 0.07 0.02 0.042 0.02 0.060 
stroke 0.10 ± 0.07 (0.00,0.05) (0-00,0.05) 
AHR/bpm Control 1.95 ± 0.57 0.30 0.003 0.30 0.005 
trPenircif; nim) 
Stroke 1.65 ± 0.61 ý0.11,0.50) (0.09,0.51) 
Log, mean ± s. d., Log, transformed values ± standard deviation: 
P value (1), Mest for the log, transformed mean difference: SBP regression mean diff, mean log, transformed 
differences after linear regression for ambulatory systolic blood pressure 
P value (2), west for the log, transformed differences after linear regression for ambulatory systolic blood pressure 
E/I ratio, mean of maximum/minimum RR intervals during metronomic respiration: AER/bpm, mean of variation 
in heart rate (maximum - minimum) during metronomic respiration 
Natural log transformation of the RR variables produced more normally distributed data. T- 
tests of the transformed mean differences yielded a similar pattern of results in that the stroke 
group had statistically significant smaller Valsalva. ratios and less heart rate variation during 
metronomic respiration than controls, with the change in heart rate during metronomic 
respiration more significant than the E/I ratio. Following linear regression for ambulatory 
systolic blood pressure, the pattern of differences did not change but the strength of the 
significance values did alter and the difference in E/I ratio lost significance (Table 7.5). 
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Table 7-6 Cardiovascular reflex tests: blood pressure changes and linear regression for s% stolic blood pressure 
Test Group Mean ± s. d. Mean P value Post- regression P value (2) (number) mmHg difference/ (1) difference 
mmHg (95% (95%Cl) 
Cl)_ 
ASBP 
standing 
ADBP 
Isometric 
exercise 
ADBP cold 
pressor 
ASBP phase 
TV Vnl-, qlvq 
Control (65) 
Stroke (72) 
Control (64) 
Stroke (74) 
Control (64) 
Stroke (72) 
Control (66) 
24.5 ± 14.7 -7.1 
31.6 ± 31.3 (-15.5,1.2) 
12.0 ± 11.4 -6.4 
18.4 ± 15.1 
8.6 ± 10.0 
10.7 ± 13.3 
24.3 ± 23.2 
(-10.9, -1.8) 
-2.2 
(-6.2,1.9) 
7.9 
0.096 
0.007 
0.289 
0.027 
-6.7 
(-15.5,2.1) 
-5.1 
(-9.7, -0.4) 
0.133 
0.033 
-1.57 0.471 
(-5.86,2.73) 
9.6 0.011 
.1 Stroke (68) 16.4 ±17.1 ý0.9,14.8) 
__ 
(2.3,16.9) 
P value (1), t test: P value (2), t test for mean differences following linear regression for ambulatory systolic blood 
pressure: ASBP, change in systolic blood pressure: ADBP, change in diastolic blood pressure 
Table 7.6 displays the results of reflex blood pressure responses. In the stroke group, there 
was a significantly smaller rise in systolic pressure from baseline to peak phase IV of the 
Valsalva manoeuvre (control 24.3 ± 23.2 mmHg, stroke 16.4 ± 17.1, p=0.027). 
The stroke group did display different responses to the control group for the baroreflex 
challenges of the isometric exercise and cold pressor tests. There were exaggerated increases 
in blood pressure following these autonomic stimuli. The increase in diastolic pressure during 
isometric exercise was significantly higher in stroke cases (control 12.0 ± 11.4 mmHg vs. 
stroke 18.4 ± 15.1 mmHg, p=0.007). The moderately larger increase in diastolic blood 
pressure in the stroke group during the cold pressor test did not reach significance (control 8.6 
± 10.0 mmHg, stroke 10.7 13.3 mmHg, p=0.289). Although there was a tendency for a 
larger fall in systolic blood pressure during change to standing posture in the stroke group, 
this was not statistically significant (control 24.46 mnfflg, stroke 31.60 mmHg, p=0.096). 
Afier linear regression for ambulatory systolic blood pressure, the differences in diastolic 
change during isometric exercise and systolic change to phase IV Valsalva remained 
significant (Table 7.6). The differences in systolic blood pressure change on standing and 
diastolic change during cold pressor were reduced after the regression for systolic ambulatory 
blood pressure. 
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Table 7-7 Power spectral analysis of heart rate variability 
Test Group Number Median Interquartile P value 
range 
SD RR Control 64 29.82 19.53,42.99 0.049 
interval, ms Stroke 68 24.26 18.82,34.54 
Total power, Control 64 649 243,1151 0.037 
ms 
2 
Stroke 68 327 212,739 
LF power, MS2 Control 64 191 75,438 0.008 
Stroke 68 94 62,225 
FIF power, MS2 Control 64 93 39,252 0.102 
Stroke 68 72 33,161 
LF/HF Control 64 1.71 0.79,3.40 0.316 
Stroke 68 1.39 0.69,3.00 
Alpha LF Control 41 6.02 3.99,9.70 0.004 
BRS, ms/ Stroke 39 3.72 2.92,6.05 
mndig 
Alpha HF Control 50 6.53 3.95,12.74 0.107 
BRS, ms/ Stroke 59 5.13 2.97,8.80 
9 
P value, Mann Whitney test, exact significance (2-tailed): Interquartile range, Weighted average: SD RR, standard 
deviation RR intervals: LF, low frequency: HF, high frequency: BRS, baroreflex sensitivity 
Table 7.7 displays results of power spectral analysis of heart rate variability and baroreflex 
sensitivity. Five minute heart rate variability was significantly worse in the stroke group for 
total power (p = 0.037) and low frequency power spectral densities (p = 0.008). There was a 
trend towards impaired high frequency heart rate variability for stroke cases in the high 
frequency range but this did not attain statistical significance (p = 0.102). Baroreflex 
sensitivity was reduced in the stroke group. The alpha co-efficient of baroreflex sensitivity 
was significantly worse in the low frequency range in stroke cases (p=0.004) and non- 
significantly worse in the high frequency range (p = 0.107). 
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Table 7-8 Power spectral analysis of heart rate variability: transformed data and linear 
regression for systolic blood pressure 
Test Group Log, mean Logmean P value SBP P value 
s. d. difference regression (2) 
(95% Cl) mean diff 
SD RR, ms Control 3.38 ± 0.54 0.17 0.044 0.16 0.0 85 
Stroke 3.21 ± 0.44 (0-00,0.34) (-. 02,0.33) 
Total Control 6.31 ± 1.17 0.40 0.032 0.34 0.084 
power, Stroke 5.90± 0.96 (0.04,0.77) (-0.05,0.72) 
ms 
2 
power, LF Control 5.16: L 1.28 0.51 0.014 0.42 0.052 
2 
ms Stroke 4.65 ± 1.05 (0.10,0.91) (-0.00,0.84) 
HF power, Control 4.70 ± 1.44 0.37 0.111 0.39 0.113 
Ins 
2 Stroke 4.33 ± 1.23 (-0.09,0.83) (409,0.88) 
LF/HF ratio Control 0.46 ± 0.98 0.13 0.422 0.03 0.882 
Stroke 0.33 ± 0.91 (419,0.46) (431,0.36) 
Alpha LF, Control 1.80 ± 0.67 0.40 0.006 0.38 0.012 
ms/ mmHg Stroke 1.40 ± 0.57 (0.12,0.68) (0.09,0.68) 
Alpha RF, Control 1.89 ± 0.85 0.20 0.189 0.18 0.270 
rns/ mmHg Stroke 1.68 ± 0.10 (-0.10,0.51) (-0.14,0.50) 
Log, mean ± s. d., Log, transformed values ± standard deviation: P value (1), t-test for the log, transformed mean 
difference: SBP regression mean diff., mean log, transformed differences after linear regression for ambulatory 
systolic blood pressure: P value (2), Mest for the loge transformed differences after linear regression for 
ambulatory systolic blood pressure: SID RR, standard deviation RR intervals: LF, low frequency: HF, high 
frequency: BRS, baroreflex sensitivity 
Linear regression for ambulatory systolic blood pressure did affect the significance of 
observations regarding 5 minute heart rate variability and baroreflex sensitivity (Table 7.8). 
7.4 Discussion 
This study has demonstrated abnormal cardiovascular autonomic function in elderly stroke 
survivors. Heart rate changes during metronomic respiration and the Valsalva ratio were 
significantly decreased in stroke cases. There was no difference in the mean 30: 15 ratio 
between stroke cases and controls. For the blood pressure measures, systolic response at 
phase IV of the Valsalva manoeuvre was significantly lower in stroke cases. Change in 
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diastolic pressure was significantly increased for isometric exercise in stroke cases compared 
with controls. There was a non-significant difference for the cold pressor change in diastolic 
pressure, with a trend towards a greater increase in stroke cases. There was also a trend 
towards an exaggerated fall in systolic pressure during orthostasis which did not reach 
statistical significance. Heart rate variability studies confirmed a picture of autonomic 
dysfunction in post-stroke cases with significantly reduced total and low power heart rate 
variability, but these differences may be related to systolic blood pressure. There was a trend 
towards reduced high frequency heart rate variability in the stroke group. Baroreflex 
sensitivity was significantly reduced in the low frequency range, and non-significantly lower 
in the high frequency range in the stroke group. 
The lower variation in heart rate with metronomic respiration and Valsalva ratio in stroke 
cases is consistent with impaired cardiovagal function. The lower peak systolic pressure at 
phase IV of the Valsalva manoeuvre indicates impaired sympathetic function. There were 
significantly different diastolic responses to the isometric exercise and cold pressor stimuli, 
but with higher diastolic pressure rises in the stroke group compared to the control group. The 
exaggerated rise in blood pressure during isometric exercise and cold pressor tests is 
somewhat surprising in that one may expect impaired responses to these tests in the context of 
reduced sympathetic function. However, it is consistent with the theory of impaired 
baroreflex function. This conclusion is supported by the finding of reduced baroreflex 
sensitivity from the power spectral analysis of heart rate and blood pressure variability. The 
tendency towards a greater drop in systolic pressure during orthostasis suggest how abnormal 
baroreflex function may have a clinical impact on patients. 
Lower peak systolic blood pressure during overshoot in phase IV of the Valsalva manoeuvre 
indicates impaired sympathetic response to a sudden hypotensive challenge. This is a result of 
reduced peripheral efferent sympathetic traffic and probably a reduced cardiac sympathetic 
response as well (Sandroni, 1991; Smith, 1996). The normal increase in blood pressure during 
isometric exercise is attributed to sympathetic efferent activity (Mark, 1985; Seals, 1988; 
Sundlof and Wallin, 1978) but in this study the stroke group had 'supranormal' increases 
during isometric exercise and cold pressor tests. Thus Valsalva and isometric/cold pressor 
results appear contradictory. There are a number of potential explanations. One hypothesis to 
explain the discrepancy is that sympathetic damage means that immediate blood pressure 
increase is impaired in the face of rapid hypotension due to neural damage but there is 
residual sympathetic efferent activity to drive a blood pressure over a more prolonged stress 
such as the three minute isometric exercise test. Even though this activity is subnormal, its 
effect will be compounded by absence of the damping effect from impaired baroreflex 
activity. 
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Furthermore the stimulus and afferent limb may differ between phase IV Valsalva blood 
pressure overshoot and isometric diastolic blood pressure responses. There are three proposed 
stimuli for the isometric exercise blood pressure response: central command, neural afferent 
reflex from the contracting muscle and ischaernic metabolite (Coote, 197 1; Goodwin, 1972. 
McCloskey and Mitchell, 1972). In contrast the stimulus for the Valsalva phase IV response 
is principally dependent on reduced peripheral resistance (Greenfield, 1967). Therefore there 
are a range of stimuli for the isometric response which may have an additive and 
compensatory action, whereas valsalva blood pressure overshoot is reliant on other immediate 
neural mechanisms. Isometric blood pressure response mechanisms are additive over the 
exercise time period (Seals, 1993; Seals, 1988; Smith, 1976). 
Vasopressin release can contribute to isometric blood pressure increase in hypotensive 
individuals under autonomic blockade but occurs later than the normal sympathetic mediated 
response (Jordan, 2000b). McAllister demonstrated augmented pressor response in isometric 
exercise pressure response in hypertensive patients on long-term propranolol therapy 
(McAllister, 1979). Jordan et al describe a family with monogenic hypertension related to 
central vascular anomaly where sympathetic stimuli produced excessive increases in blood 
pressure during autonomic testing, and the mechanism appeared to be failure of baroreflex 
buffering (Jordan, 2000c). Pressor response to simple water ingestion is augmented in healthy 
elderly compared with controls and this seems to be due to increased sympathetic activity that 
is not adequately buffered by baroreflex mechanisms (Jordan, 2000a). 
7.4.1 Previous studies of post-stroke autonomic function 
In general, studies of stroke cohorts younger than that described in our results have shown 
evidence of impaired autonomic dysfunction based on either Ewing battery or heart rate 
variability measures (Barron, 1994; Korpelainen, 1996a; Korpelainen, 1996b; Korpelainen, 
1994; Tokgozoglu, 1999). There appears to be a time dependent effect with improvement of 
autonomic function 6 months post stroke (Korpelainen, 1996b; Korpelainen, 1994). Stroke 
locality can influence autonomic function and insular cortex stroke in particular has been 
implicated in affecting autonomic control (Korpelainen, 1996a; Sander and Klingelhofer, 
1996; Tokgozoglu, 1999). Small post-stroke studies have indicated basal sympathetic nerve 
activity may be upregulated but with an attenuated response during cold pressor stimulation 
and impaired orthostatic blood pressure control (Mizushima, 1998; Robinson and Potter, 
1995). 
7.4.2 Dysautonomia and white matter lesions 
We have shown that in older stroke patients blood pressure may not respond appropriately to 
changes in systemic pressure. Others have shown disorders of baroreflex function post-stroke 
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in younger post-stroke cohorts (Robinson and Potter, 1997; Robinson and Potter, 1995). Our 
findings in this age group carry particular importance. Cognitive impairment is common in 
stroke survivors with a prevalence rates quoted at 17 - 29 % with the highest rates in the older 
age categories, such as the patients investigated in this study (Barba, 2000; Henon, 2001; 
Inzitari, 1998; Lowery, 2002). One of the key mechanisms in cognitive decline appears to be 
small vessel cerebrovascular disease in the white matter (Aharon-Peretz, 1988; Barber. 1999; 
Charletta, 1995; Liu, 1992; Pohjasvaara, 2000). These white matter lesions are associated 
with the typical neuropsychological. profile of impaired executive function and attentional 
deficits in post-stroke dementia (Desmond, 1999; Looi and Sachdev, 1999). The sequence of 
events driving the progression of white matter lesions is not clear. Key neuropathological 
features in white matter disease include sclerotic hypertrophied arterioles feeding the deep 
white matter (Fisher, 1969). It would seem plausible that transient drops in perfusion pressure 
cause white matter ischaemia in these 'at risk' areas (De Reuck, 1971). It could also be 
envisaged that an abnormally high surge in perfusion pressure could exacerbate hypertensive 
damage to the arteriolar tree or precipitate microscopic luminal wall damage that results in 
micro-haemorrhage. This cycle of damage could accumulate over a period, resulting in 
extensive white matter damage and clinically leading to cognitive decline. The elderly post- 
stoke patient who has apparently made a good recovery from stroke has a 'brain at risk'. 
impaired autonomic function is potentially an important part in the pathophysiology leading 
to subcortical dementia. 
The clinical significance of this hypothesis relates to the current interest in blood pressure 
control and stroke. Treatment of hypertension is clearly of benefit in primary prevention of 
stroke (Staessen, 2001). More recently secondary prevention of stroke and other 
cardiovascular events by blood pressure lowering has gained prominence (Collaborative 
Group of the Primary Prevention Project (PPP), 200 1). The optimal method of blood pressure 
management in the immediate aftermath of stroke is currently the subject of a large 
multicentre randomised prospective trial (Anonymous, 2004). In daily clinical practice, the 
decision to institute blood pressure lowering treatment is made in the context of the 
individual, some of whom clearly do not tolerate aggressive blood pressure reduction. There 
are reports that relative hypotension is more prevalent in vascular dementia in cross-sectional 
Post-stroke and community groups (Gorelick, 1993; Guo, 1996; Pohjasvaara, 1998). The 
Gothenberg community study group described how individuals who develop dementia have a 
higher, pathological blood pressure before the onset of dementia but that blood pressure 
declined more rapidly in those who developed dementia (Skoog, 1996). This raises two 
questions. Firstly, on the timing and degree to which blood pressure should be lowered, 
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particularly in the elderly. Secondly, does unforeseen autonomic impairment negate the 
benefits of anti -hypertensives? 
7.4.3 Dysautonornia and sudden death 
The second clinically relevant point regarding our results relates to the reduction in heart rate 
variability. Abnormal autonomic tone is an independent predictor of increased cardiovascular 
mortality following myocardial infarction (Kleiger, 1987; La Rovere, 1998; Zuanetti, 1996). 
The risk is most evident in those with other cardiac risk factors such as reduced left 
ventricular function (Bailey, 2001; Hartikairien, 1996). The postulated mechanism is a 
reduction in vagal activity, increasing vulnerability to malignant cardiac arrhythmias that lead 
to sudden death. Fei et al reported a decrease in the high frequency preceding ventricular 
tachycardia in ambulatory recordings (Fei, 1994), Chiladakis et al reported an increase in low 
frequency and decrease in high frequency spectral component of heart rate variability 
preceding accelerated idioventricular rhythm following thrombolysis for acute myocardial 
infarction (Chiladakis, 2001) and Huikiri found reduced long term RR variability with 
abnormal beat-to-beat heart rate dynamics preceding onset of ventricular tachycardia in 
ambulatory ECGs of 15 post-myocardial infarction patients (Huikuri, 1996). We have shown 
sinUlar abnormalities in heart rate variability in elderly stroke survivors. 
From this investigation, the so-called sympathovagal balance reflected by the LF/HF ratio 
was no different between stroke cases and controls and this might be seen as a mitigating 
factor against the hypothetical increased nsk of malignant arrhythrnia. However the clinical 
usefulness of this measure is not consistent in published reports (Lampert, 2003; Lanza, 1998) 
and caution is required when making assumptions on actual autonomic nerve activity from 
heart rate variability measures (Karemaker, 1997; Malik and Camm, 1993). In general, results 
from our investigations do indicate that elderly stroke survivors have a disordered 
cardiovascular autonomic system with reduced vagal activity and impaired baroreflexes. 
Another issue in our hypothesis is that we have investigated frequency domain heart rate 
variability in 5 minute recordings, whereas many of the important post-myocardial infarctIon 
findings are derived from time domain measures of 24 hour heart rate variability recordings 
(Kleiger, 1987; La Rovere, 1998; Zuanetti, 1996). From the CAPS study group, it has been 
shown that 24 hour spectral analysis of heart rate variability is a significant and independent 
risk for mortality when measured early post-myocardial infarction (Bigger, 1992b). 
Furthermore the same group has demonstrated frequency domain measures from randomly 
selected 2 to 15 minute recordings late post-myocardial infarction do have significant 
predictive value for mortality (Bigger, 1993). The Zutphen community study has reported that 
time domain variables from short ten-n 2 minute ECG recordings are significantly associated 
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with increased mortality (Dekker, 2000). Additionally there does appear to be a close 
association between 5 minute and 24 hour heart rate variability: low frequency and SDN-N' are 
very closely linked, and high frequency and pNN50 and rMSSD are also tightly correlated 
(Bigger, 1992a). One group has shown that a stepwise approach to identifying high risk 
patients using first short term 5 minute heart rate variability to screen for abnormal heart rate 
variability index before refining the risk stratification with 24 hour heart rate variability 
studies is an effective technique (Faber, 1996). Thus there is some validity in postulating the 
short term heart rate recording abnorrnalities from our study carry an adverse prognosis. 
Furthermore, we have shown that one time domain measure is reduced in the stroke group i. e. 
the standard deviation of all normal RR intervals (SDNN). This is significantly correlated (r 
0.51, p <. 001) with another time domain measure, the Heart Rate Variability index (HRVI). 
used by Camm's group and both SDNN and HRVi have predictive power for cardiovascular 
events post-myocardial infraction (Fei, 1996). 
Although reduced heart rate variability does indicate increased risk of mortality, it may be 
viewed as a treatment target. There are reports of propranolol, amiodarone and thrombolysis 
being associated with improvement in autonomic tone and a reduction in mortality (Lampert, 
2003; Lind, 2001; Malik, 2000). 
We are drawing comparisons between coronary artery disease and cerebrovascular disease in 
terms of a hypothetical shared risk for sudden death. Whilst recognising some of the 
differences between these patient groups, there are many similarities and it seems fair to 
hypothesise that stroke patients bear similar risks of sudden death related to autonomic 
dysftinction to that seen in post-myocardial infarction patients. However there is a surprising 
dearth of literature on the risk of sudden cardiac or arrhythmic death post-stroke. Recently 
Robinson et al demonstrated significantly increased all-cause mortality 'in a group of stroke 
survivors with impaired baroreflex sensitivity (Robinson, 2003). To our knowledge, only one 
study has quantified the risk of sudden death in stroke survivors (Pop, 1994). Prolonged QTc 
independently predicts cardiac death ( RR 2.8 ) and all cause mortality (RR 2.9 ) in stroke 
survivors (Wong, 2003) and there are reports linking QTc prolongation with cardiovascular 
autonomic neuropathy in diabetic patients (Jermendy, 1991). 
Stroke victims have high rates of cardiac arrhythmia in the acute post-stroke phase (Mikolich, 
198 1). Sudden cardiac death accounted for 43% of cardiac deaths in 3021 patients with minor 
stroke or TIA followed for more than 2 years post-stroke and older age was an independent 
predictor of sudden death (Pop, 1994). The high prevalence of deranged autonomic function 
in older stroke patients may explain this observation. 
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7.4.4 Study limitations 
Some of the weaknesses of this study are addressed in the previous discussion of heart rate 
variability investigation techniques. We have investigated a representative section of stroke 
survivors who were able to participate in the study protocol. These patients are involved 'in 
the longitudinal observational study on the natural history of cognitive function in elderly 
stroke survivors. Therefore we felt it was appropriate not to exclude patients '%vith co-morb id 
conditions or requiring treatment with cardiovascular medication. This resulted in a 
heterogeneous group of stroke patients with a number of factors which may influence 
autonomic function tests. Higher systolic blood pressure level in the stroke group was the 
most important difference, and hypertension is known to affect autonomic function 
(Harrington, 2000a). Indeed linear regression for 24 hour ambulatory systolic blood pressure 
did alter the strength of the significance for some differences, but did not completely eradicate 
the observed differences. Linear regression for a history of asthma or COPD did not negate 
the significance of the differences (see section 7.6). It should be noted that some of the 
subjects with a history of asthma or COPD were taking inhaled beta-agonists or 
antimuscarinic agents which may have influenced autonomic function. This was not 
examined in the data analysis. 
Regarding drug therapy, the only significant difference between stroke case and controls for 
cardiovascular medication use was for thiazide diuretics and dihydropyridine calcium channel 
blockers. Linear regression for each of these factors did not negate the significance our 
findings (see section 7.6). The literature suggests that some cardiovascular drugs have a 
neutral or even beneficial effect on autonomic function. Beta-adrenergic blocking drugs can 
improve autonomic function, in particular high frequency of heart rate variability (Goldsmith, 
1997; Lampert, 2003; Salo, 1999). ACE inhibitor drug studies indicate variable effect on 
autonomic function but mostly a neutral effect (Guasti, 200 1; Licker, 2000; Okabayashi, 
1997; Salo, 1999). Dihydropyridine calcium channel blocking drugs tend to improve 
baroreflex sensitivity but can increase low Erequency heart rate variability (James, 1999; 
Lefrandt, 2001; Lucini, 1997). 
Therefore we may argue the (non- significant) higher use of beta blockers and ACE inhibitors 
may potentially have masked further impairment in autonomic indices. In general, it would 
appear the deterioration in autonomic function in this cohort of stroke survivors was not the 
outcome of cardiovascular drug use. 
7.5 Conclusions 
In summary we have compared autonomic function in a group of elderly ambulant stroke 
survivors with a group of community living controls. Stroke cases demonstrated evidence of 
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impaired cardiovagal function. There were contrasting results with respect to sympathetic 
function tests. Blood pressure response in phase IV of the Valsalva manoeuvre was impaired 
but there was a 'supernormal' increase in diastolic blood pressure during isometric exercise. 
These findings may be related to reduced baroreceptor function observed from short term 
spectral analysis of heart rate and blood pressure variability. Some of the abnon-nalities in 
autonomic function, especially short term heart rate variability, may be related to the higher 
blood pressure autonomic reflexes seen in stroke survivors. Potentially important clinical 
implications of disordered autonomic function are the progression of white matter disease and 
risk of sudden death. 
7.6 Appendix 
Data from this chapter was accepted for publication in article form to the journal 'Stroke' 
(McLaren, 2005). Referees' comments included the suggestion that data should be 
amalgamated in one table and multiple regression performed for all potential confounding 
factors. Multiple linear regression was performed on logarithmic transformed RR indices and 
spectral powers of heart rate variability, and on raw blood pressure reflex data. Each 
autonomic variable was entered as a dependent variable and the following as independent 
variables: hypertension, asthma/COPD, myocardial infarction, peripheral vascular disease, 
diabetes mellitus, cardiac failure, alcohol habit, thiazide, calcium channel blocker, beta- 
blocker, age and systolic blood pressure from ambulatory blood pressure. Stepwise multiple 
linear regression was performed until only significant terms remained. Then case or control 
status was entered as an independent variable. The confidence interval and significance value 
of the regression coefficient for case/control status for each autonomic test are shown in Table 
7-9. It can be seen that significant differences persist after multiple linear regression. 
201 
Table 7-9 Summary data for difference between control and stroke cases: blood pressure 
variability and logarithmic transformed RR data with regression analyses 
Variable Mean ± standard Difference in means Difference in means Difference in means 
(control deviation Students t test adjusted for adjusted for all 
number, ambulatory SBP confounding factors 
stroke 
number) 
Control Stroke 95% Cl p 95% Cl p 95% CI p 
Log 0.12 ± 0.12 :E -0.04, 0.956 -0.05, 0.710 -0.04, 0.7 32 30: 15(65, 0.10 0.12 0.04 0.03 0.03 
71) 
Log VR 0.32 ± 0.22 :k 0.06, <0.00 1 0.06, <0.00 1 0.06, <0.00 1 
(66,69) 0.15 0.13 0.15 0.16 0.15 
Log E-1 1.95 ± 1.65 ± 0.11, 0.003 0.09, 0.005 0.00, 0.049 
(68,73) 0.57 0.61 0.50 0.51 0.42 
Log SD 3.3 8 :E 3.21 :L 0.00, 0.044 -0.02, 0.085 0.03, 0.025 
RR (64, 0.54 0.44 0.34 0.33 0.36 
68) 
Log Tot. 6.31 ± 5.90 ± 0.04, 0.032 -0.05, 0.084 0.04, 0.032 
power 1.17 0.96 0.77 0.72 0.77 
(64,68) 
Log LF 5.16 4.65 0.10, 0.014 -0.00, 0.052 0.10, 0.014 
(64,68) 1.28 1.05 0.91 0.84 0.91 
Log HF 4.70 ± 4.33 ± -0.09, 0.111 -0.09, 0.113 -0.14, 0.174 
(64,68) 1.44 1.23 0.83 0.88 0.77 
Log 1.80 A: 1.40 ± 0.12, 0.006 0.09, 0.012 0.23, <0.00 I 
aBRS LF 0.67 0.57 0.68 0.68 0.39 
(41,39) 
Log a 1.89 1.68 -0.10, 0.189 -0.14, 0.270 -0.06, 0.124 
BRSHF 0.85 0.10 0.51 0.50 0.51 
(50,59) 
A SBP 24.5 3 1.6 -15.5, 0.096 -15.5, 0.133 -14.5, 
0.153 
stand 14.7 31.3 1.2 2.1 2.3 
(65,72) 
A DBP 12.0 18.4 -10.9, - 0.007 -9.7, - 0.033 -17.0, - 
0.027 
isometric 11.4 15.1 1.8 0.4 1.1 
(64,74) 
A DBP 8.6 10.7± -6.2, 0.289 -5.86, 0.471 -5.6, 
0.398 
coldpress 10.0 13.3 1.9 2.73 2.2 
(64,72) 
A SBP 24.3 16.4 0.9, 0.027 2.3, 0.011 -0.1, 0.052 
Valsalva 23.2 17.1 14.8 16.9 13.3 
_(66,68) 
Log, logarithmic transformed value: 30: 15,30: 15 ratio: VR, Valsalva ratio: E-1, heart rate difference during 
metronomic respiration: sd RR, standard deviation of RR intervals over 5 minutes: Tot. power, total spectral power 
of 5 minutes heart rate variability: LF, low frequency spectral power: HIF, high frequency spectral power: aBRS. 
Alpha baroreflex sensitivity in high and low frequency ranges: ASBP stand, systolic blood pressure drop during 
Orthostasis: ADBP isometric, diastolic blood pressure change during isometric exercise: ADBP coldpress, change 
in diastolic blood pressure dur-ing cold pressor: ASBP Valsalva, change in systolic blood pressure during 
Valsalva 
manoeuvre 
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8 The association between autonomic function 
and white matter lesions 
8.1 Introduction 
White matter lesions (WML) are common abnormalities on brain imaging in older people. 
WML are independently associated with cognitive impairment in otherwise normal subjects 
(Breteler, 1994b; Schmidt, 1993). White matter lesions are also closely associated "N-Ith 
vascular dementia and Alzheimer's disease (Liu, 1992; Starkstein, 1997). Subcortical vascular 
dementia includes extensive white matter lesions as one of its diagnostic criteria (Erkinjuntti, 
2000b; Roman, 1993). 
Neuropathological features of white matter lesions are demyelination, neuronal loss and 
gliosis (Erkinjuntti, 1996). In older age, the deep penetrating vessels feeding white matter are 
altered by hyalinisation and sclerosis (Fisher, 1969). Cerebral perfusion is maintained by a 
combination of systemic arterial pressure buffered by cerebral autoregulation in order to 
maintain a constant smooth flow to cerebral tissue. Mechanisms for white matter lesion 
formation are likely to include hypoperfusion of the small vessels supplying the deep white 
matter (De Reuck, 1971). Arteriolar damage within the white matter renders tissue vulnerable 
to changes in blood flow. 
There is evidence pointing to a role for fluctuation in systemic perfasion pressure increasing 
white matter lesion burden (Pantoni and Garcia, 1997). Cardiovascular autonomic function is 
crucial in the control of systemic arterial pressure, in particular smoothing short term 
fluctuations in perfasion pressure. Therefore, impaired cardiovascular autonomic function 
could potentially exacerbate white matter lesions by failing to control arterial pressure. The 
role of autonomic dysfunction in white matter lesion progression has not been extensively 
reported in the literature. We hypothesised that cardiovascular autonomic dysfunction is 
associated with white matter lesions in older stroke survivors. 
There are a number of bedside cardiovascular autonomic reflex tests to assess sympathetic 
and parasympathetic function. The results of several tests can be summarised as a score 
(Ewing and Clarke, 1982; Low, 1993b). Such scores are preferred to individual tests since 
they provide a more complete picture of autonomic function (Ewing, 1985; Mathias and 
Bannister, 1999). We hypothesised there is an association between aggregate scores of 
autonomic function and MRI white matter lesions. 
8.2 Method 
Methodology is described in detall in Chapter 4. Stroke patients of 75 years of age or older 
were recruited from consecutive patients on representative hospital based stroke registers in 
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Tyneside and Wearside. These patients, who had been discharged from hospital, A-ere free of 
dementia and free of any disabilities which would preclude comprehension of and compliance 
with autonomic function tests. The patient cohort was comprehensively assessed at 3 months 
post stroke using a standardized neuropsychological battery to exclude dementia, allowing 
time for the resolution of post-stroke delirium and stabilization of physical impairment. The 
investigation sequence was the same for all Patients. 
The following cardiovascular reflex tests were measured: 30: 15 ratio and postural change in 
blood pressure during standing, diastolic blood pressure change during isometric exercise, 
Valsalva ratio and systolic blood pressure overshoot during Valsalva manoeuvre and heart 
rate variation during metronomic respiration. Five minutes of resting RR interval and systolic 
blood pressure variation were analysed by power spectral analysis to obtain total, low and 
high frequency heart rate variability spectral powers, and baroreflex sensitivity in low and 
high frequency bands. Carotid sinus massage was performed in the supine position for 5 
seconds on the right then left carotid sinus. Cardio-inhibitory and vasodeprcssor responses 
were recorded. Standard deviation of RR interval over five minute's supine rest was also 
included in the assessment. Only patients in sinus rhythm were included in the analysis. 
Technically poor quality data that made RR interval and blood pressure measurement 
unreliable were excluded from analysis. 
8.2.1 MRI scanning protocol 
A 1.5 GE Signa scanner (General Electric, Milwaukee, WI, USA) was used to acquire MR 
images. T2 images were acquired to perform visual ratings of white matter hyperintensities. 
Structural TI weighted 3D FSPGR (Fast Spoiled Gradient Echo) images were acquired for 
visual rating of medial temporal atrophy. Fluid Attenuated In version Recovery (FLAIR) 
images acquired axially were used to determine the volume of white matter hyperintensities 
using an automated measuring process. 
Hard copies of FLAIR and T2 images were used to visually rate the severity of white matter 
lesions, known as hyperintensities for the purpose of the scale. For this analysis, Scheltens 
regional sub-score for deep white matter hyperintensities and the total Schelten's score (see 
section 7.3.2) were correlated with autonomic function. All scans were rated blindly and 
consensus achieved between three trained raters. 
8.2.2 Statistical analysis 
White matter lesions were correlated with individual autonomic indices (Tables 8.2 and 8-3). 
Spearman's rank correlation was used since the majority of the autonomic indices appearcd to 
have a skewed distribution. Scheltens visual rating scale provides ordinal data, and the 
automated estimate of cortical white matter lesion percentage volume had a trend towards a 
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skewed distribution (one-sample Kolmogorov-Smirnov Z score 1.337, p=0.056). A result 
was considered statistically significant if the p value was less than 0.05. 
Chapter 7 discussed the issues behind forming normal values from which to create an 
autonomic scoring system. Three different scoring systems were explored. 
8.2.2.1 Ewing score 
The five autonomic tests described by Ewing (Ewing and Clarke, 1982) were selected for this 
score - 30: 15 ratio, Valsalva ratio, change in heart rate with metronomic respiration, drop in 
blood pressure on standing and change in diastolic blood pressure during isometric exercise. 
The 30: 15 ratio is the ratio of the longest RR interval at around the 30'h beat to the shortest 
RR interval at around the 15t" beat after standing. The Valsalva ratio is the ratio of the longest 
RR interval after the manoeuvre to the shortest RR interval during the Valsalva manoeuvre. 
Change in heart rate during metronomic respiration is the mean difference in maxima and 
minima heart rates during six cycles of timed, deep respiration. The drop in blood pressure 
during standing is the difference in systolic blood pressure from the supine baseline reading to 
the nadir occuring after standing. The change in diastolic blood pressure during isometric 
sitting exercise is the difference between the final peak value after 3 minutes exercise and 
resting pre-exercise value. 
Ewing's normal values were substituted by values derived from age-matched controls from 
the study in Chapter 7. Each autonomic test was considered abnormal if below the fifth 
percentile and allocated a score of 2, borderline if between the fifth and tenth percentile with a 
score of one and normal tests above the tenth percentile scored zero. Hence a normal subject 
scored zero and increasing autonomic impairment led to higher scores up to a maximum 
abnormal score of ten. Only cases completing all 5 Ewing tests were included in the 
correlation with cortical white matter lesion percentage volume, which was assessed using 
Spearman's rank correlation. 
8.2-2.2 Composite score A 
Since the Ewing test battery contained autonomic indices that did not differentiate between 
normal and abnormal autonomic function in stroke patients, a composite battery was selected 
that only contained autonomic indices that were significantly different between stroke patients 
and control cases (see Chapter 7). Therefore diastolic blood pressure change during isometric 
exercise, Valsalva ratio, Valsalva systolic blood pressure overshoot, heart rate variation 
during metronomic respiration and spectral power of total heart rate variability were included. 
Each autonomic test was considered abnormal if below the fifth percentile and allocated a 
score of one. Normal tests above the fifth percentile scored zero. Normal subjects scored zero 
and increasing autonomic impain-nent led to increasing scores with a maximum score of 5. 
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The total score was correlated with cortical white matter lesion percentage volume onl-, - for 
cases completing all 5 tests (Spearman's rank correlation). 
8.2.2.3 Composite score B 
This score was devised to see if (i) a score using all available reflex tests correlated with 
white matter lesion volume and (ii) how it performed in comparison with the Ewing score and 
Composite Score A. Table 8.1 lists indices included in composite score B and records the cut- 
off value for definition of abnormal score. The aim in choosing the thresholds was to identify 
at least some cases with abnormal scores for each test so that all autonomic indices could be 
utilised and contribute to the total score. Thus thresholds were chosen, not because they 
particularly represent the true abnormal value for the cohort but for their ability to 
discriminate 'good' versus 'poor' scores. 
One-way analysis of covariance was performed to investigate if there was a difference in 
white matter lesion volume between total scores within each scoring system. 
Table 8-1 Threshold for abnormal scores for composite score B 
Autonomic index Abnormal Reference 
result 
30: 15 ratio <1.01 Clark 1986 (Clark and Mapstone, 1986) 
Valsalva ratio <1.09 O'Brien 1986 (O'Brien, 1986) 
AHR metronomic <4 bpm. O'Brien 1986 (O'Brien, 1986) 
respiration 
SD RR interval <20 ms Dekker JM 1997 (Dekker, 1997) 
Asystolic BP orthostasis >30 mmHg Clark 1986 (Clark and Mapstone, 1986) 
Adiastolic BP isometric <5 or >15 Ziegler 1992, Wieling 1999 (Wieling and Karemaker, 
exercise mmHg 1999; Ziegler, 1992b) 
Adiastolic BP cold <5 or >15 Mathias, Wieling (Mathias and Bannister, 1999; Wleling 
pressor mmHg and Karemaker, 1999) 
Systolic BP overshoot <0 mmHg Low PA 1993 (Low, 1993a) 
Valsalva 
8.3 Results 
There were no significant correlations between Scheltens scale score and individual indices of 
autonomic function (Table 8.2). 
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Table 8-2 Correlation between cardiovascular autonomic function and Scheltens rating scale 
Autonomic test Number White matter hy perintensities Total hy penntensities 
rs P rs 
_ 
P 
30: 15 ratio 62 -0.057 0.661 -0-050 0.699 
Valsalva ratio 61 +0.001 0.996 -0-066 0.614 
E/I ratio 65 -0.081 0.522 -0-095 0.451 
AHR respiration 65 +0.017 0.891 -0.018 0.888 
ASBP standing 63 -0.142 0.266 -0.133 0.298 
ADBP Isometric exercise 66 +0.042 0.737 +0.091 0.468 
ADBP cold pressor 65 -0.083 0.510 -0.046 0.714 
ASBP Valsalva 60 -0.181 0.167 -0.179 0.170 
ARR CSM 26 +0.071 0.729 +0.132 0.521 
ASBP CSM 26 -0.180 0.380 -0.317 0.115 
Total HRV 61 -0.107 0.413 -0.133 0.307 
LF HRV 61 +0.007 0.958 -0.089 0.496 
BF HRV 61 -0.055 0.675 -0.050 0.703 
BRS low frequency 38 +0.056 0.738 +0.085 0.613 
BRS Md. freciuencv 55 -0.040 0.773 -0.027 0.847 
E/l, expiratory/inspiratory ratio during metronomic respiration: AHR respiration, mean change in heart rate during 
metronomic respiration: ASBP, change in systolic blood pressure: ADBP, change in diastolic blood pressure: ARR, 
change in RR interval: CSM, carotid sinus massage: Total HRV, spectral power of heart rate variability: LF, low 
frequency spectral power: HF, high frequency spectral power: BRS, baroreflex sensitivity 
Automated cortical WML percentage volume measurement demonstrated some trends 
towards correlation with two measures of blood pressure changes (Table 8.3). Increasing 
diastolic blood pressure increase during isometric exercise had a trend towards association 
with increasing white matter lesion damage. Larger blood pressure drop during carotid sinus 
massage indicated a trend towards association with increasing white matter lesion burden 
(blood pressure drop during carotid sinus massage measured as negative value). 
The automated measure of white matter lesion volume produced results for lesions within 
frontal, parietal, temporal and occipital lobes. The only significant correlation between white 
matter volume and autonomic function was for frontal white matter volume and high 
frequency range baroreflex sensitivity with a correlation co-efficient -0.276 (95% Cl -0.009 to 
-0.506, p == 0.044). 
Between 50 and 55 cases completed all parts of the autonomic scores for the correlation with 
white matter lesion volume. White matter lesion volume increased with higher composite A 
scores but this was not significant (Figure 8.2, Spean-nan's rank correlation coefficient rs = 
+0-127, p=0.358). There was no association between higher scores of autonom-ic impain-nent 
and white matter lesion using the Ewing score (Figure 8.1, rs = -0.004, p=0.975) or 
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composite score B (Figure 8.3, r, = 0.012, p=0.935). Few cases scored highly on any of the 
three scoring systems. 
Table 8-3 Correlation between cardiovascular autonomic function and cortical white matter 
lesion percentage volume 
Autonomic test Number 
-Cortical 
white matter lesion % volume 
rs P 
30: 15 ratio 61 -0-051 0.695 
Valsalva ratio 60 +0.031 0.814 
E/I ratio 64 -0.036 0.776 
E-1 difference 64 0.033 0.798 
SBP standing 62 -0-081 0.530 
DBP Isometric exercise 65 +0.208 0.097 
DBP cold pressor 64 +0.030 0.816 
SBP Valsalva 59 -0.201 0.126 
RR CSM 26 +0.043 0.833 
SBP CSM 26 -0.336 0.094 
Total HRV 60 -0.214 0.101 
LF HRV 60 -0.071 0.591 
RF HRV 60 -0.120 0.361 
BRS low frequency 38 -0.017 0.918 
BRS hiah freauencv 54 -0.159 0.249 
E/l, expiratory/inspiratory ratio during metronomic respiration: AHR respiration, mean change in heart rate during 
metronomic respiration: ASBP, change in systolic blood pressure: ADBP, change in diastolic blood pressure: ARR, 
change in RR interval: CSM, carotid sinus massage: Total HRV, spectral power of heart rate variability: LF, low 
frequency spectral power: HF, high frequency spectral power: BRS, baroreflex sensitivity 
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Figure 8-1 Cortical white matter lesion percentage volume according to Ewing score 
Numbers in bars = number of cases for each Ewing score: r, Spearman's rank correlation. 
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Figure 8-2 Cortical white matter lesion percentage volume according to Composite score A 
Numbers in bars = number of cases for each autonomic score: r, Spean-nan's rank correlation. 
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Figure 8-3 Cortical white matter lesion percentage volume according to Composite score B 
Numbers in bars = number of cases for each autonomic score: r, Spearman's rank correlation. 
There were no differences between scores within each of the scoring systems on one-way 
analysis of variance (Table 8.4). 
Table 8-4 One-way analysis of variance for cortical white matter lesion percentage volume 
according to autonomic score (Kruskal-Wallis test) 
Autonomic score Number (degrees of freedom) Chi square Significance 
Ewing 55 (5) 2.661 0.752 
Composite score A 54(3) 1.308 0.727 
Composite score B 50(4) 5.402 0.248 
8.4 Discussion 
From this analysis of autonomic function in stroke survivors, there is no significant 
association between single tests of cardiovascular autonomic function and white matter 
disease in the selected population studied. A composite score based on abnormal 
cardiovascular autonornic function indicated increasing cortical white matter damage in the 
presence of higher scores but this was not significant. Overall there is no evidence to support 
the hypothesis that autonomic damage will predispose to white matter ischaernia. Potential 
reasons for the lack of association with individual autonomic tests will be discussed first. 
Firstly this may be a false negative result. The study design may reduce the chance of 
detecting a pathophysiological link between autonomic damage and cerebral hypoperfusion. 
The cross-sectional nature of the analysis does not provide scope to detect a longitudinal 
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impact of autonomic dysfunction. It may be such a mechanism has already expressed itself at 
an earlier stage, and that the normal decline in autonomic function with age will lead to 
uniformly reduced autonomic indices that do not allow for differentiation between those 
individuals who had impaired autonomic function at a young age (Piha, 1993). Furthermore 
we know that autonomic tests lack good reproducibility (Braune, 1996; Gerritsen, 2003; 
Lawrence, 1992b). A single test as performed in this study may not accurately reflect 
autonomic function within individuals, even though we know that as a group, autononuic 
function is deranged in older stroke survivors compared with age matched controls (see 
Chapter 7). Even the summary scores of autonomic function did not show any linkage ývith 
white matter lesion volume. The longitudinal effect of impaired autonomic function on white 
matter lesions following stroke is examined in a subsequent chapter. 
The study may lack power to demonstrate a significant association between autonomic tests 
and white matter damage. The intended study size of 100 subjects was not attained and 
further loss of subjects occurred for a number of reasons. Principal reason for exclusion was 
atrial fibrillation. Nearly a quarter of the study group was in atrial fibrillation. Lack of sinus 
rhythm means that beat to beat RR variation is not under the same autonomic control as 
occurs during sinus rhythm, invalidating the cardiovascular reflex tests and power spectral 
analysis. The more prolonged blood pressure autonomic reflex tests (cold pressor and 
isometric exercise) are theoretically not so dependent on beat-to-beat control mechanisms. 
Therefore patients in atrial fibrillation could potentially be included in the analysis of cold 
pressor and isometric exercise tests to improve the power. However it is arguable whether this 
is valid since there is loss of normal beat-to-beat sympathovagal influence on RR interval. 
8.4.1.1 Cerebral autoregulation 
The absence of significant association between autonomic function and white matter damage 
suggests there is not a pathophysiological link between the two processes. Cerebral perfusion 
is dependent on systemic perfusion pressure but as discussed in section 2.6, cerebral 
autoregulation offers a protective mechanism. There is evidence that cerebral autoregulation 
can protect cerebral blood flow despite sharp drops in systemic perfusion pressure 
(Leftheriotis, 2000). Therefore we could support the hypothesis that despite transient systemic 
hypoperfusion from autonomic failure, normal cerebral perfusion will continue in those with 
normal cerebral autoregulation and protect the white matter from ischaernic insult (Novak, 
1998). The study did not include measures of cerebral autoregulation. Clearly this would be 
an interesting issue for future studies. One potential study design would be a between group 
comparison: a healthy control group, groups with isolated autonomic failure or isolated 
cerebral dysautoregulation, and a fourth group with combined autonomic and cerebral 
autoregulation failure. The hypothesis is that the combined failure group would have the most 
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extensive white matter disease, with intermediate levels of white matter disease in the other 
two abnormal groups. 
8.4.1.2 Stroke subtype 
inclusion of all different stroke subtype may have diluted the study's ability to find a 
significant association between autonomic dysfunction and white matter disease. The lacunar 
hypothesis suggests that individuals with small vessel disease strokes are the ones most at risk 
of subsequent white matter disease progression (Bamford and Warlow, 1988; Esin, 1997; 
Yao, 1992). In this study of 76 cases in sinus rhythm, 26 (34 %) cases had a history of lacunar 
stroke, a fraction of the total number. Thirteen cases (17 %) had a history of posterior 
circulation stroke, amongst whom there will have been a proportion of lacunar strokes as well 
as embolic and atherothrombotic events (Warlow, 2001). Therefore less than half the group 
could be considered as high risk cases for the study hypothesis. However the overlap of 
cerebrovascular pathology in stroke patients suggest that many of the anterior circulation 
stroke cases will have concomitant small vessel disease, and thus are at some sort of 
intermediate risk compared with those presenting with lacunar infarction (Brun, 1994). 
8.4.2 Composite scores 
It is interesting that a combination of autonomic results rated normal or abnormal using the 
composite score indicated increasing white matter lesion volume is associated with 
deterioration in overall autonomic function. Collating autonomic function results into a score 
theoretically provides a more balanced estimation of overall autonomic function (Bellavere, 
1983; Ewing and Clarke, 1982). Ewing's description of his autonomic test battery and other 
authorities have emphasised the importance of performing a variety of autonomic tests, rather 
than making assumptions based on one single autonon-iic test (Ewing and Clarke, 1982; 
Ewing, 1985; Low, 1993c; Mathias and Bannister, 1999). However a score requiring 
completion of a series of autonomic tests will introduce some bias, since it will select patients 
of an ability to satisfactorily perform all parts of the scoring system. More disabled 
individuals may have the worst autonomic function, therefore loss of cases may affect ability 
to detect an association with white matter lesion. 
Three scores were examined in this investigation. The Ewing based score was chosen since it 
corresponds to an established series of tests. It has the advantage of many years clinical 
experience and is useful in assisting prognostication of diabetic patients (Ewing, 1976a: 
Ewing, 1980a). It is recognised that there are differences between Ewings' original 
description and our methodology. The main differences are sitting instead of handgrip for 
isometric exercise, and the use of RR maxima and minima with wider *beat number' windo"'s 
rather than close adherence to the 30: 15 ratio. The drawbacks with the Ewing based score are 
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that the original non-nal values are clearly less appropriate for the age group under study in 
this investigation and it uses autonomic indices that do not appear to be any different in the 
stroke group compared with values in a control population (Chapter 7). Two of the tests did 
not indicate any difference between control and stroke groups - 30: 15 ratio, blood pressure 
response to standing. Therefore, normal and abnormal function in the stroke group could not 
be defined from 'control' data. 
8.4.2.1 Composite score A 
Therefore composite score A was devised on the basis of tests that were significantly 
abnormal in the stroke group when compared with the community living controls (see 
Chapter 7). In other words it concentrated on tests that were known to assist in differentiation 
of impaired from normal autonomic function. It is acknowledged this part of the analysis was 
not significant, and furthermore there was only one case in the highest scoring group (total 
composite score 3). The composite score A only included one measure from power spectral 
analysis of heart rate variability, the total power spectrum. Low frequency power spectra are 
closely correlated with the total value and would not offer any extra dimension to composite 
score A. Low frequency range baroreflex sensitivity was significantly lower in the stroke 
group compared with control cases but this item was not included since the lower number of 
individuals with baroreflex sensitivity data could have ftirther limited number available for 
study in the composite score. There are no grounds for supporting the use of composite score 
A beyond this investigation but it provides an illustration of a possible link between impaired 
autonomic function and white matter lesions. 
The composite score was derived using autonomic function data from community living 
controls, as described in Chapter 7. This group comprised community living elderly adults 
and did include patients with conditions that could affect cardiovascular autonomic function. 
Therefore it does not form a group suitable for defining normality data for cardiovascular 
autonomic function in this age group. However it does form a control group who were similar 
in most respects to the stroke group, bar the presence of cerebrovascular disease. Therefore 
the group provides appropriate normality data to examine the affects of impaired autonomic 
function in the presence of stroke disease. Relatively small numbers in the control group may 
have limited ability to accurately define the outer limits of normality using the standard 
deviation. In other words the smaller the number of cases means the study is less likely to 
represent the true population mean and distribution. Secondly normal autonomic test results 
generally diminish with age thus reduced test range may have further compromised ability to 
reliably identify abnormal autonomic function from the control group in Chapter 7 (O'Brien, 
1986; Piha, 1993). 
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8.4.2.2 Composite score B 
Composite score B was devised to utilise all recorded cardiovascular autonomic reflex tests. 
Standard deviation of RR interval (from five minutes of resting heart rate data) was added 
since this is a relatively straightforward measure of heart rate variation that is knoNN-n to be 
associated with adverse outcomes (Dekker, 2000). There were potential benefits to sensitivity 
of a scoring system by increasing the number of items, compared with the five items from 
Ewing score and composite score A. The method of defining normal and abnormal scores for 
B was far from robust, but the selection of thresholds from seven sources was a pragmatic 
solution and was achieved in some instances by a consensus method where there was no clear 
answer to the ideal normal value. In effect, composite score B did not show any association 
with white matter lesion volume. 
In addition to cerebral autoregulation, there may be other important influences on white 
matter disease progression; these other factors could have a more powerful effect than 
autonomic impairment. This is examined in the following chapter. 
8.5 Conclusion 
Individual and composite measures of cardiovascular autonomic function do not show an 
association with white matter lesion volume in selected older stroke survivors. 
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9 Blood pressure variability and white matter 
lesion volume 
9.1 Introduction 
Older stroke survivors are at high risk of cognitive decline and dementia. At three months 
post-stroke, dementia will affect up to one-quarter of patients (Desmond, 2000; Pohjasvaara, 
1997). In those who are not diagnosed with dementia at three months, the risks of incident 
dementia in the following 12 months remains greatly elevated compared with stroke-free 
controls, with estimated odds ratio between 6 and 9 (Kokmen, 1996; Tatemichi, 1994b). 
Trigger factors for conversion to cognitive impairment and dementia are not clear. White 
matter lesions may be an important mediator. White matter lesions are a substrate of cognitive 
deficit in older people both with and without dementia (Breteler, 1994c; CFAS, 200 1). 
Determinants of white matter lesions are not completely understood. Age is the strongest risk 
factor for white matter lesions but hypertension is the most important treatable risk factor yet 
identified (Breteler, 1994c; van Swieten, 1991 a). Historically, interest has centred on average 
clinic blood pressure to predict target organ damage. With the advent of ambulatory blood 
pressure monitoring, blood pressure variability is now recognised as an independent predictor 
of target organ damage (Sander, 2000a). This is particularly important for white matter 
lesions since brief but recurrent hypoperfusion may drive white matter lesion progression 
(Pantoni and Garcia, 1997). Abnormal blood pressure variability could potentiate white 
matter lesions by increasing ischaernic damage in the cerebral circulation from episodic low 
flow (Skoog, 1998a). Severity of white matter hyperintensities was significantly associated 
with transient drops in blood pressure in patients with neurodegenerative dementia (Ballard, 
2000). Ambulatory blood pressure studies indicate that increased blood pressure variability 
and loss of diurnal variation are associated with small vessel disease (Goldstein, 1998; Kario, 
2001; Kukla, 1998). Office blood pressure measurement has also shown that higher pulse 
pressure is related to small vessel disease (Liao, 1997). These studies utilised sermi- 
quantitative visual rating scales of white matter lesion burden and the majority of patients 
were less than 75 years old. Automated MIU analysis can now provide more reliable white 
matter lesion quantification than visual rating scales (Firbank, 2003). 
We hypothesised that blood pressure variability is a risk factor for white matter lesions in 
older stroke survivors without dementia, using a novel automated measure of white matter 
lesion volume. 
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9.2 Methods 
Stroke patients aged 75 years and over were recruited from consecutive patients on 
representative hospital based stroke registers in Tyneside, UK. Selection and initial 
assessment has been previously described in detail in Chapter 4. A nested sample of patients 
who were in sinus rhythm and able to comply with ambulatory blood pressure monitoring and 
head MRI scan were included in this substudy. Exclusion criteria were dementia (American 
Psychiatric Association, 1994) and contra-indication to MRI scan 
History of ischaemic heart disease (angina or myocardial infarction), hypertension, peripheral 
vascular disease, hypercholesterolaemia and diabetes were recorded. Patients were classified 
as smokers if a current smoker. Presence of risk factors was allocated a score of one, absence 
a score of zero. 
9.2.1 Ambulatory blood pressure monitoring 
Sinus rhythm was confirmed from twelve-lead ECG. Spacelabs Ambulatory Blood Pressure 
Monitor 90207 was used for ambulatory blood pressure recording (Spacelabs Medical, Inc, 
Redmond, Washington, USA). This oscillometric device has been validated by the British 
Hypertension Society (O'Brien, 199 1 a) and is also validated for clinical use in the elderly 
Qqbal, 1996). The automatic measurement interval was set at 30 minutes firom 07: 00 to 22: 00 
and 60 minutes from 22: 00 to 07: 00. Cuff size was chosen according to arm circumference 
and attached to the non-dominant arm, with the cuff bladder positioned over the brachial 
artery. Subjects were instructed to follow a normal daily routine but to keep the arm alongside 
the trunk during daytime measurement (Staessen, 1995). Recording commenced between 
10: 30 and 13: 30. The device was inactivated by the subject after a period of 24 hours. 
Data was downloaded from the monitor to a computer and a Spacelabs program automatically 
edited measurements (Ambulatory Blood Pressure Report Management System 9012 1, 
Spacelabs Medical inc 1996). Artifact that resulted in non-physiological blood pressure 
measurement was rejected. Values outside the following pre-set automatic edit limits were 
excluded from analysis: systolic range 70 - 240 mmHg, diastolic 40 - 150 mmHg, pulse 
pressure 20 - 150 mmHg. Manual editing was not performed. 
A minimum of 16 measurements over 24 hours were required for inclusion in analysis. For 
the purpose of analysis, the day period was fixed at 10: 00 to 20: 00 and night period 00: 00 to 
06: 00 (Staessen, 1997a; van Ittersurn, 1995). Variability of ambulatory blood pressure was 
defined as the standard deviation of the average systolic or diastolic level (systolic or diastolic 
SD) (Mancia, 1983b). Pulse pressure (PP) was the difference between mean systolic and 
diastolic blood pressure. Diurnal variation was the percentage change in blood pressure from 
day to night-time, calculated as ((day BP- night BP) /day BP) x 100%. For inclusion in 
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circadian variation analyses, a minimum of 10 measurements in the day and 5 in the rught 
period were required (Staessen, 1997a). 
9.2.2 MRI 
Subjects were scanned with a 1.5T GE Signa system (General Electric, Nfilwaukee, W1, 
USA). Axial FLAIR (Fluid Attenuated Inversion Recovery) images were acquired to 
visualise and determine the volume of white matter hyperintensities, as described in Chapter 
4. Data were transferred to a computer for analysis. The percentage of white matter 
hyperintensities in the brain was calculated by dividing the volume of segmented white matter 
hyperintensities by the volume of the brain as determMed from the SPM99 segmentation 
(Ashburner and Friston, 2000). 
9.2.3 Statistical analysis 
The association between ambulatory blood pressure data and white matter lesion volume was 
analysed in the three periods - 24 hours, day and night. Average blood pressure, variability, 
diumal variation and pulse pressure were examined for each period. For the former three 
variables, both systolic and diastolic blood pressure data were included in analysis. 
For each period, the level of confounding among the exploratory blood pressure variables was 
explored using the Pearson correlation coefficients. The association between white matter 
lesions and the explanatory variables (blood pressure variables and cardiovascular risk 
factors) was assessed using linear regression. Initially the explanatory variables were 
considered individually in a simple regression model. Multiple regression was then used to 
investigate the relative importance of the explanatory variables taking into account 
confounding and collinearity. Cardiovascular risk factors and one of the three time period 
ambulatory blood pressure variables were jointly entered into regression models. Initially 
explanatory variables were selected using a forward selection procedure; robustness of the 
results was checked by using backward elimination. Results are presented in the form of 
regression coefficients with 95% confidence intervals. The proportion of variance explained 
by the model (adjusted R2) is given. Statistical tests were performed using SPSS release II 
(Statistical Package for the Social Sciences Inc, Chicago, Illinois) and tests with p value <0.05 
were considered statistically significant. 
9.3 Results 
Ninety seven patients were assessed in the substudy. Twenty-one patients were excluded from 
ambulatory blood pressure analysis due to atrial fibrillation, 10 patients lacked MRI data 
(MRI contra-indication or movement artifact on images) and four cases had incomplete 
ambulatory data (intolerance of monitor in 3, <16 readings in 1). Clinical characteristics of 
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the 62 patients are shown in Table 9.1. The mean number of ambulatory blood pressure 
measurements was 34.5 ± 5.6. 
Table 9-1 Clinical characteristics (n = 62) 
Demographic/clinical feature Mean ± s. d. or number (%) 
Mean age, years 80 ±4 
Female 37(60%) 
Mean weight, kg 66 ± 13 
Mean body mass index, kg/rnI 25+4 
IRD 15(24%) 
Hypertension 45(73%) 
LVHonECG 3(5%) 
PVD 7(11%) 
Diabetes 4(7%) 
Hypercholesterolaernia 17(27%) 
Current smoker 36(58%) 
IRD, ischaemic heart disease: LVH, left ventricular hypertrophy: PVD, peripheral vascular disease. 
9.3.1 Correlations 
Correlations for 24 hour, day and night ambulatory blood pressure variables are shown in 
Table 9.4. As expected, there were strong correlations between systolic and diastolic 
measurements of the same variables (average pressure, variability, diurnal variation), and 
between the same systolic or diastolic variables of different time periods. There were only 
weak correlations between systolic average pressure and variability and no significant 
correlation between diastolic average pressure and variability. The correlation between 
systolic and diastolic variability was at least as strong as the association between average 
systolic and diastolic pressure. Pulse pressure strongly correlated with systolic but not 
diastolic pressure. 
9.3.2 Regression 
Regression coefficients for cardiovascular risk factors and ambulatory blood pressure 
variables on white matter lesion volume are shown in Table 9.2. 
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., I Table 9-2 Univariate regression of ambulatory blood pressure on white matter lesion ,o ume 
independent variable Regression coefficient BP 
B 95% Cl 
Age, years +0.158 +0.015, +0.302 0.031 
Gender' -0.714 -1.927, +0.499 0.244 
Smoking2 -0.755 -1.959, +0.449 0.215 
JIM3 
-0.947 -2.331, +0.437 0.176 
DiabeteS3 +1.813 -0.592, +4.218 0.137 
CholesteroJ3 -0.600 -1.940, +0.740 0.374 
LVH 3 -0.952 -3.747, +1.842 0.498 
24 hour (n=62) SBP +0.037 -0.002, +0.077 0.062 
DBP +0.096 +0.030, +0.163 0.005 
SSD +0.208 +0.066, +0.350 0.005 
DSD +0.282 +0.074, +0.490 0.009 
pp +0.009 -0.041, +0.058 0.724 
Day (n=60) SBP +0.039 +0.000, +0.079 0.052 
DBP +0.086 +0.024, +0.148 0.007 
SSD +0.201 +0.086, +0.316 0.001 
DSD +0.272 +0.101, +0.443 0.002 
pp +0.008 -0.040, +0.057 0.729 
Night (n=59) SBP +0.027 -0.008, +0.063 0.131 
DBP +0.083 +0.019, +0.148 0.012 
SSD +0.046 -0.074, +0.165 0.445 
DSD +0.004 -0.172, +0.179 0.967 
pp +0.006 -0.041, +0.053 0.801 
Day-night (n=57) SDV -0.012 -0.093, +0.070 
0.778 
DDV -0.008 -0.078, +0.062 
0.824 
'male =1, female=O 
2 current smoker-- 1, never or ex-smoker--O 
'positive history--I, negative=O 
24 hour, day and night values in mmHg. Day-night values are percentage change from day to night. 
IHD, ischaernic heart disease: LVH, left ventricular hypertrophy: PVD, peripheral vascular disease: SBP, DBP, 
average systolic and diastolic blood pressure: SSD, DSD, systolic or diastolic variability: PP, pulse pressure: 
SD%', 
DDV, systolic and diastolic diurnal variation 
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9.3.2.1 Cardiovascular risk factors 
When white matter lesion volume was regressed on all cardiovascular risk factors, age was 
the only risk factor with a significant regression coefficient with white matter lesion volume 
(p=0.03 1) and explained approximately 6% of the variance. 
9.3.2.2 24 hour ABP and cardiovascular risk factors 
Systolic variability and average diastolic pressure remained significant in the final model and 
diabetes was the only cardiovascular risk factor with a significant contribution (Table 9.3). 
This model explained approximately 22% of the variance (p==0.001). The same variables 
were produced in the final model using either forward or backward regression on white matter 
lesion volume. 
9.3.2.3 Daytime ABP and cardiovascular risk factors 
Mean number of daytime measurements was 18.1 ± 3.3. The final regression model of 
cardiovascular risk factors and daytime ambulatory blood pressure variables on white matter 
lesion volume was similar to the 24 hour model (Table 9.3). Systolic variability, average 
diastolic pressure and diabetes were the significant terms in the final regression model and 
explained approximately 24% of white matter lesion volume variance (p<0.00 1). Forward 
and backward regression produced the same results. 
9.3.2.4 Nighttime ambulatory blood pressure and cardiovascular risk 
factors 
Mean number of nighttime measurements was 5.9 s. d. 0.4. In the regression of cardiovascular 
risk factors and nighttime ambulatory blood pressure variables on white matter lesion volume, 
gender, diabetes and average diastolic pressure were the final significant terms but only 
explained approximately 20% of the white matter lesion volume variance (p=0.00 1, Table 
9.3). 
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Table 9-3 Ambulatory blood pressure regression models on white matter lesion volume: 24 hour 
day and night periods 
Phase Significant terms 
_ 
Regression coefficient Stand. coefficient P value 
B 95% Cl 
24 hr Constant -6.333 -11-104, -1.562 0.010 
(n=62) DBP +0.086 +0.022, +0.151 0.318 0.009 
SSD +0.174 +0.039, +0.308 0.300 0.012 
Diabetes +2.699 +0.554, +4.844 0.293 0.015 
Day Constant -5.214 -9.582, -0.846 0.020 
(n=60) SSD +0.160 +0.049, +0.271 0.339 0.005 
DBP +0.072 +0.013, +0.130 0.291 0.017 
Diabetes +2.419 +0.282, +4.556 0.263 0.027 
Night Constant -3.693 -7.768, +0.383 0.075 
(n=59) DBP +0.100 +0.039, +0.162 0.390 0.002 
Diabetes +2.900 +0.753, +5.047 0.328 0.009 
Gender -1.204 -2.304, -0.104 -0.264 0.033 
'male =1, female=O 
2 current smoker--I, never or ex-smokef--O 
3 positive history--I, negative=0 
24 hour, day and night values in mmHg. Day-night values are percentage change from day to night. 
SBP, DBP, average systolic and diastolic blood pressure: SSD, DSD, systolic or diastolic variability: PP, pulse 
pressure: SDV, DDV, systolic and diastolic diurnal variation 
See Table 2 for abbreviations. 
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9.4 Discussion 
We have shown that white matter lesion volume in older non-demented stroke survivors is 
associated with systolic blood pressure variability over 24 hour ambulatory monitoring. The 
other significant associations with white matter lesion volume were for increase in average 
diastolic blood pressure and diabetes. Systolic blood pressure variability was of similar 
importance to these other classic risk factors. The clinical relevance of our findings is further 
support for the hypothesis of episodic cerebral hypoperfusion causing white matter lesions 
(Pantoni and Garcia, 1997). While we cannot prove causation from this cross-sectional study, 
results are in keeping with our hypothesis that these changes will lead to cognitive decline. The 
importance of our work lies firstly in the use of an accurate white matter lesion volume 
measurement tool and secondly in focusing on elderly stroke survivors who are at particularly 
high risk of developing dementia late after stroke (Desmond, 2002; Kokmen, 1996). 
9.4.1 Systolic variability 
There is growing interest in the value of blood pressure variability markers from ambulatory 
recording. Average ambulatory blood pressure over 24 hours is a superior marker of end-organ 
damage and cardiovascular events than office blood pressure in both untreated and treated 
hypertensive patients (Clement, 2003; Staessen, 1999b). There is further evidence that 
ambulatory blood pressure variability is a predictor of end-organ damage and cardiovascular 
events, independent of average blood pressure (Kikuya, 2000; Sander, 2000a). Previous studies 
observe that daytime variability is more predictive of target organ damage than nighttime 
variability (Goldstein, 1998; Kikuya, 2000; Palatini, 1992) and systolic variability is more 
predictive than diastolic variability (Palatini, 1992; Sander, 2000a; Sander, 2000b). Our results 
miffor these findings because daytime systolic variability was more closely associated with white 
matter lesion volume than either nighttime or diastolic values. The greater number of 
measurements imparts greater statistical power to daytime values but there may be important 
pathophysiological reasons for the stronger association between daytime variability and end- 
organ damage. The erratic component of blood pressure variability for example orthostatic 
hypotension, post-prandial hypotension, stress-related hypertension is most likely to occur during 
daytime periods and these events may be a principal cause of end-organ hypoperfusion and 
endothelial stress (Sega, 2002). It has previously been shown that orthostatic hypotension is 
associated with white matter lesions (Ballard, 2000, Longstreth, 1996; Raiha, 1993). 
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It is postulated that blood pressure variability exerts adverse effects directly through physical 
means i. e. intermittent low cerebral perfusion (Skoog, 1998a). Other cellular or 
neurodegenerative mechanisms could also play a role. There is evidence that increased 
oscillatory shear stress enhances surface endothelial levels of cell adhesion molecules and alters 
cell oxidative mechanisms, changes that are likely to play a part in the atherosclerotic process 
(Chappell, 1998). In animal models, small decreases in cerebral blood flow over days or more 
prolonged hypoxic states enhance amyloid precursor protein generation which in turn may 
increase the burden of toxic amyloid beta-peptide (Green, 2002; Shi, 2000). Therefore frequent 
falls in cerebral blood flow in the already compromised ischaerruc penumbra or deep white matter 
of stroke patients could trigger neurodegenerative processes (Kobari, 1990). 
9.4.2 Average diastolic blood pressure 
Average diastolic blood pressure demonstrated a positive relationship with white matter lesion 
volume. Hypertension is an established risk factor for white matter lesions (Lewington, 2002: 
Skoog, 1998a). It is interesting that the correlation between diastolic blood pressure and white 
matter lesion volume was stronger than the correlation between systolic blood pressure and Ný'hite 
matter lesion volume since systolic pressure is usually the stronger predictor for end-organ 
damage (Lewington, 2002). There is a debate on the relative merits of systolic, diastolic and pulse 
pressure as risk markers of vascular events: a prominent opinion is that systolic blood pressure 
and diastolic blood pressure remain the most valuable markers and pulse pressure is less 
informative (Lewington, 2002). The positive linear relationship between blood pressure and 
stroke risk persists in older adults; the proportional change in stroke risk per unit change in blood 
pressure is less powerful compared to middle age but annual absolute differences M risk are 
greater in old age (Lewington, 2002). We should be wary regarding the role of our findings 
within the debate in view of our relatively small and selected cohort, and therefore we judge that 
the stronger correlation between diastolic blood pressure and white matter lesion volume than 
systolic blood pressure and white matter lesion volume is of -uncertain significance. In general, 
our findings do match the expected increase M white matter lesions with high blood pressure. The 
other component in considering the role of blood pressure in white matter lesions and cognitive 
function is the time course of events. There is some evidence regarding individuals with a history 
of hypertension who experience a decline in blood pressure with age later suffer progression of 
white matter lesions and cognitive impairment (Skoog, 1996). This question needs to be 
addressed in longitudinal studies. 
224 
9.4.3 Diabetes 
Our final regression model contained diabetes as a term that was significantly associated with 
white matter lesion volume. Diabetes has previously been linked with white matter lesions 
(Schmidt, 1992). Our findings are in keeping with the proposed vascular mechanisms behind 
white matter lesions, since diabetes is known to be a powerful predictor of microvascular 
pathology. 
9.4.4 Age 
increasing age is a well established risk factor for white matter lesions (Breteler, 1994c; 
Longstreth, 1996). Our study found a significant positive association between age and WML 
volume based on the univariate, regression between the two variables. When using backward 
elimination, age was the final non-significant term to be eliminated from each regression model. 
Age was closely associated with blood pressure variability; when this term was included in the 
model the improvement in fit obtained by adding age was not statistically significant. The small 
number in this cohort and the use of an older population with restricted age range may have 
limited the power to conf inn the importance of age in the final regression model. 
9.4.5 Ambulatory blood pressure time period 
The results for 24 hour and daytime ambulatory blood pressure regression models were very 
similar, with marginally greater variance of white matter lesion volume explained by the daytime 
model. One would expect daytime ambulatory variables to display stronger associations than 24 
hour variables since the latter included nighttime values. 
The contrast between day and night-time results in our study will have been influenced by the 
small number of ambulatory blood pressure measurements made over the night-time Period, 
therefore affecting accuracy. We have utilised narrow fixed time windows for the diurnal 
variation in ambulatory blood pressure, since the narrow six hour sleeping period is valid for 
accurate estimates of diary-based blood pressure during sleep without resorting to more complex 
analysis (van Ittersum, 1995). Furthermore the chosen time periods were recommended by the 
Working Group of the International Database, to facilitate comparison between studies (Staessen, 
1997a). Within our cohort, diurnal blood pressure variation did not show any correlation with 
white matter lesion volume. 
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9.4.6 Study limitations 
We have shown significant associations for white matter lesions with blood pressure markers and 
diabetes but the relatively small number of patients studied may have compromised power to 
detect weaker associations. Frequency of ambulatory blood pressure sampling was low, 
especially for nighttime period, and may have affected the accuracy of blood pressure variability 
but any greater frequency of ambulatory blood pressure sampling would reduce tolerability in this 
older and moderately frail cohort. The ambulatory monitor used in the study has been validated 
for use in the elderly but is less accurate in measuring systolic blood pressure, underestimating 
systolic blood pressure at higher pressures (Iqbal, 1996). This cross-sectional study is not able to 
determine whether increased systolic variability is a cause of white matter lesion volume. Indeed 
subcortical ischaemia may lead to central autonomic control damage and itself cause increases in 
blood pressure variability. However there is strong circumstantial evidence that increasing 
systolic variability will drive progression of small vessel cerebrovascular disease. 
9.5 Conclusion 
White matter lesion volume was significantly associated with systolic and diastolic blood 
pressure variability (p<0.0 1), average diastolic blood pressure (P<0.05) and age (P=0.03 1) on 
simple regression. Following multiple regression on white matter lesion volume, systolic blood 
pressure variability, average diastolic pressure and diabetes were the final terms in a model that 
explained 24% of white matter lesion variance (p<0.00 1). The low variance of the model 
indicates poor predictive value. In conclusion, we have shown that systolic blood pressure 
variability, average diastolic blood pressure and diabetes are significantly associated with white 
matter lesion volume in older stroke survivors. We hypothesise that individuals with greater 
blood pressure variability at risk of cognitive decline due to intermittent hypoperfusion of white 
matter regions. In addition to established vascular risk factors, increased ambulatory blood 
pressure variability may place older stroke survivors at increased risk of dementia. 
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10 Correlation of white matter lesion volume and 
pulmonary function 
10.1 Introduction 
MRI is an important step in the investigation of dementia. Dementia groups have characteristic 
structural changes on brain imaging studies (Scheltens, 2002). Cerebral atrophy is a predictor of 
Alzheimer's disease in healthy individuals from large scale community studies and in high risk 
individuals with a family history (Fox, 2001; Kuller, 2003). Longitudinal studies report the rate of 
brain atrophy is significantly increased in dementia (Cardenas, 2003, Chan, 200 1). Subcortical 
ischaemic vascular dementia is characterised by extensive deep white matter hyperintensities, 
best seen on MRI (Roman, 2002). 
Hypoxic or hypotensive disorders have been suggested as a mechanism for neurodegeneration 
leading to dementia, particularly in stroke survivors (Kokmen, 1996; Moroney, 1996; Tatemichl, 
1994b). Such events may result in vascular dementia but it is now clear that Alzheimer's disease 
shares risk factors and imaging abnormalities with vascular dementia (Barber, 1999; Skoog, 
1999). Vascular factors that potentiate hypoxic and ischaemic damage to the ageing brain may be 
important not only in prevention and treatment of the vascular dementia, but for Alzheimer' s 
disease as well. 
Respiratory disease will produce hypoxic episodes and could prove to be an important substrate 
in the pathogenesis of dementia. Hypoxic states are certainly a risk factor for neurodegenerative 
damage at a cellular level (Green, 2002). Some reports link respiratory disease with dementia but 
they are based on heterogeneous diseases or do not include imaging studies (Kokmen, 1996; 
Moroney, 1996; Schaub, 2000; Tatemichi, 1994b). To our knowledge, there are no reports 
examining the impact of pulmonary function on brain imaging indices. We set out to determine if 
there is an association between pulmonary function tests and MRI risk factors for dementia. 
10.2 Method 
The test procedure was explained and demonstrated to the subject. The subject was seated in an 
upright position after a prolonged rest period. Forced expiration for six seconds was performed up 
to a maximum of three attempts until a consistent trace was obtained. Forced expiratory volume 
in the first second (FEVI) and forced vital capacity (FVC) were recorded from the paper trace to 
the nearest 0.05 litre. Forced vital capacity was the maximum expired volume at six seconds. The 
largest of the three volume recordings was used for analysis. 
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10.2.1 Magnetic Resonance imaging 
Whole brain volume and cortical white matter lesion volume were measured as described in 
section 4.3. All cases with pulmonary function and whole brain volume data available were 
included. Cases were excluded if pulmonary function data was unreliable due to inadequate 
expiratory effort or technical errors with spirometry. 
10.2.2 Statistics 
10.2.2.1 Whole brain volume 
The association between pulmonary function and MRI whole brain volume was first examined by 
bivariate correlation. Next, in a multiple linear regression analysis, whole brain volume was 
entered as the dependent variable. Gender, age, history of cardiac failure, ischaemic heart disease, 
hypertension, respiratory disease or hypercholesterolaemia, current smoker or alcohol consumer 
status, forced expiratory volume, forced vital capacity, FEVI/FVC, height, weight and body mass 
index were entered as independent variables. Risk factors in binary data were assigned a value of 
I if present e. g. cardiac failure present = 1, cardiac failure absent = 0. 
10.2.2.2 Cortical white matter lesion volume 
To consider all potential predictor variables that may influence cortical white matter damage, 
multiple linear regression was performed using baseline cortical white matter lesion percentage 
volume as the dependent variable and all clinical features that achieved a significance level of 
less than 0.10 from single linear regression on cortical white matter lesion volume. The following 
explanatory variables were considered. Clinical features: gender, age, ECG rhythm, cardiac 
failure, ischaemic heart disease, hypertension, peripheral vascular disease, asthma/COPD, 
diabetes, hypercholesterolaemia, current smoker, current alcohol drinker, number of strokes, body 
mass index. Drugs: prescription of beta-blocker, thiazide, loop diuretic, ACE inhibitor or 
angiotensin 11 receptor blocker, calcium channel blocker, nitrate, anticoagulant, antiplatelet, 
neuroleptic, statin and oxybutynin were entered as an independent variable. Blood parameters: 
haematocrit, erythrocyte sedimentation rate, fibrinogen, homocysteine, C-reactive protein, fasting 
glucose, haemoglobin Alc, total cholesterol, high density cholesterol, low density cholesterol, 
triglyceride, vitamin B 12 and folate level were entered as independent variables. 
Other variables considered for entry to the multiple regression model were cardiovascular 
autonomic reflex tests, heart rate variability, baroreflex sensitivity and ambulatory blood pressure. 
From results seen in Chapters 8, no reflex tests achieved the <0. I significance level. From 
ambulatory blood pressure results in Chapter 9, only daytime and night-time variables wcre 
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considered for inclusion. Daytime mean systolic and diastolic levels, daytime systolic and 
diastolic variability and night-time mean diastolic blood pressure level met the inclusion 
significance level. From results in this chapter, FEVI and FVC met the criteria. Since cardiac 
failure status was strongly correlated with loop diuretic, the latter was excluded from the multiple 
regression analysis. HDL cholesterol was also excluded from multiple regression since the total 
number of cases with HDL data fell substantially below the number of cases with results for other 
independent variables in the multiple regression analysis. 
10.3 Results 
10.3.1 Whole brain volume 
Seventy five cases were analysed in the correlation between whole brain volume and pulmonary 
function, with results shown in Table 10.1. 
Table 10-1 Correlation between pulmonary function and whole brain volume (n = 75) 
Pulmonary ftinction Correlation coefficient P value 
FEV, +0.438 
FVC +0.454 
<0.001 
<0.00 I 
FEVI/FVC +0.183 0.115 
P values of Pearson correlation coefficient: FEVI, forced expiratory volume in one second: forced vital capacity 
There was a significant correlation between whole brain volume and FEV or FVC. However on 
multiple regression analysis, the only significant terms predicting whole brain volume were 
height and current smoker status. 
Whole brain volume = (535798 x height) - (41154 x current smoker) + 158040 
Height (metres): current smoker = 1, neverlex-smoker = 0. 
Increasing height had a significant linear association with whole brain volume. Smokers had a 
significant reduction in whole brain volume. 
10.3.2 White matter lesion volume 
Coefficients for simple regression of pulmonary function on cortical white matter lesion 
percentage volume at baseline are shown in Table 10.2. Following simple regression of potential 
risk factors on white matter lesion volume, only those factors with significance values less than 
10 are summarised in Table 10.3. 
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Table 10-2 Regression of pulmonary function on cortical white matter lesion volume 
White matter lesion Pulmonary Regression 95% confidence 
variable function 
_coefficient 
P value interval 
Baseline (n=81) FEV, -0.701 -1.419, +0.080 0.056 
FVC -0.681 -1.254, -0.108 0.020 
FEVI/FVC +0.183 -5-027, +5.393 0.944 
FEVI, forced expiratory volume in one second: FVC, forced vital capacity 
Table 10-3 Significant independent variables from simple linear regression on cortical white matter 
lesion volume 
Variable Total degrees freedom Regression coefficient 
95% confidence interval 
Age 82 +0.135 +0.024, +0.246 0.017 
Cardiac failure 82 +1.442 +0.258, +2.625 0.018 
Diabetes 82 +1.679 -0.151, +3.509 0.072 
Loop diuretic 82 +1.360 +0.064, +2.656 0.040 
Haernoglobin AIc 73 +0.793 -0.007, +1.594 0.052 
HDL cholesterol 54 +1.263 -0.093, +2.620 0.067 
All variables from Table 10.3, daytime systolic and diastolic levels and daytime systolic and 
diastolic variability (Table 9.3) and FEVI and FVC (Table 10.2) were entered into a multiple 
linear regression model. The least significant term was removed in a stepwise manner, until only 
terms with a significance level of less than 0.05 remained. The following model was obtained. 
White matter lesion % volume at baseline = (1.65 x CCF) + (2.04 x DM - (0.64 x FVQ 
+ (0.13x daytime diastolic variability)+ (0.07x night mean diastolic) -3-11 
Total degrees of freedom = 66, adjusted R2= 0.318, p<0.001 
The significant predictor variables from this equation are summarized in Table 10-4. 
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Table 10-4 Significant independent variables from multiple linear regression on white matter lesion 
volume at baseline MRI 
independent variable Regression co-efficient Significance 
B 95% confidence interval 
CCF +1.66 +0.50, +2.81 0.006 
Diabetes +2.04 +0.32, +3.76 0.021 
FVC -0.64 -1.17, -0.11 0.020 
ABP Systolic SD (day) +0.13 +0.04, +0.22 0.005 
ABP Diastolic mean (night) +0.07 +0.02, +0.13 0.022 
CCF, Congestive cardiac failure: FVC, Forced vital capacity: ABP systolic SD (day), Ambulatory systolic blood 
pressure variability 10: 00-20: 00: ABP diastolic mean (night), Ambulatory diastolic blood pressure mean 00: 00-06: 00. 
10.4 Discussion 
This chapter reports firstly the association between pulmonary function and MRI variables at 
baseline, and secondly reports the significant independent variables that predict cortical white 
matter lesion volume when including all independent variables from clinical records, 
cardiovascular autonomic reflex tests, heart rate variability, baroreflex sensitivity, pulmonary 
function, haernatological and biochemical indices. 
10.4.1 Whole brain volume and pulmonary function 
There was a close correlation between lung volumes and whole brain volume. Results show 
decreasing FEVi and FVC are associated with smaller whole brain volumes. The correlation is 
highly significant. However on multiple linear regression the only significant independent 
variables predicting whole brain volume were height and smoking status. The significance of 
height in the regression equation suggests the correlation between lung volumes and whole brain 
volume could be interpreted as a normal finding, reflecting the proportional variation in organ 
size. Pulmonary function variables were not significant independent predictors of whole brain 
volume but smoking did negatively predict whole brain volume. This association could be 
mediated by direct toxic effects of smoking, associated vascular disease or by smokings' harmful 
effects on respiratory function. Smoking is associated with a doubling of risk of dementia, and 
this link is traditionally thought to be a result of smoking-related vascular disease (Ott, 1998). 
Smoking is a potential causative link between reduced lung volume and structural brain changes, 
but these data only indicate an association. No firm conclusions can be drawn regarding a 
pathogenetic link between smoking and reduced whole brain volume. 
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There is large amount of evidence indicating whole brain atrophy cannot be regarded as a benign 
phenomenon. Whole brain atrophy on CT is associated with Alzheimer's disease and a controlled 
study found atrophy rates of 0.5 % in controls and greater than 2% per year in Alzheimer's 
disease (Fox, 1996; Freeborough and Fox, 1997; Smith and Jobst, 1996). Cardenas et al found 
increased rate of brain atrophy in patients with Alzheimer's disease or mixed vascular and 
Alzheimer's disease and there is a correlation between atrophy and cognitive decline on MMSE 
(Cardenas, 2003; Fox, 1999). 
From this basic cross-sectional study, bivariate correlation analysis indicates an association 
between reduced lung volume and whole brain volume. This does not provide evidence for 
reduced pulmonary function providing a cause for reduction in whole brain volume. After 
multiple regression on whole brain volume, smoking was a significant predictor variable whereas 
lung volumes were not. Thus smoking provides a potential pathological link between reduced 
respiratory function and decreasing brain volume. Longitudinal studies are required to further test 
the hypothesis, in particular to examine if there are increased rates of cerebral atrophy in smokers. 
If so, is smokings' effect dependent on decline in respiratory function and therefore related to 
hypoxia or is it independent of respiratory function and therefore more likely to be related to 
vascular factors and neurodegeneration? Mechanisms related to deteriorating respiratory ftinction 
could offer a novel therapeutic target in patients suffering cognitive decline. 
10.4.2 White matter lesion volume and pulmonary function 
Forced vital capacity was significantly associated with cortical white matter lesion volume at 
baseline MRI. There was a trend towards forced expiratory volume being associated with white 
matter lesion volume. These results support the hypothesis of hypoxic-hypotensive disorders 
potentiating cognitive decline. Reduced pulmonary function will enhance the risk of hypoxia, 
especially during systemic illness in those with respiratory reserve. Moroney et al (Moroney, 
1996) found that out of 185 stroke survivors (with a mean age of 70 years), those suffering a 
broad collection of so-called 'hypoxic-ischaemic' disorders were significantly more likely to 
develop dementia. The damage to white matter could be mediated by simple ischaernic damage 
from reduced oxygen tension. Other mechanisms may play a role, and we could hypothesise for a 
role in reduced respiratory function leading to alterations in metabolic conditions that may lead to 
a more insidious effect on brain structure and function, compared to transient short term hypoxia. 
Hypoxic states affect regulation of gene expression. Ischaernia generates amyloid precursor 
Protein as a protective action (Kogure and Kato, 1993; Koistinaho, 1996). Amyloid beta peptide 
is then produced as a derivative of amyloid precursor protein. Amyloid beta peptide is toxic to 
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neuronal cells and is an important neuropatho logical manifestation of Alzheimer's disease. There 
are reports confmning increased amyloid beta peptide formation after exposure to ischaemic 
conditions (Jendroska, 1997; Yokota, 1996). In particular, chronic hypoxia models suffer high 
levels of amyloid beta peptide, which in conjunction with reactive oxygen species leads to 
pathological remodeling of cell function (Green, 2002). Calcium handling by cortical astrocytes, 
crucial to neuronal activity, is severely disturbed in conditions of prolonged hypoxia and amylold 
beta peptide can play a role in generation of pathological calcium channels (Smith, 2003; Taylor, 
1999). These findings provide important biochemical evidence of a link between hypoxic 
conditions and neurodegenerative changes associated with dementia 
Aforementioned studies are largely experimental models. Clinical data from humans provides 
limited support of respiratory disease exacerbating cognitive decline. A small controlled study 
indicated that cerebral metabolism will change to anaerobic pathways in patients Nxith relatively 
moderate COPD. Ten patients (aged 65 years) with stable COPD revealed evidence of 
significantly altered cerebral metabolism. There were marked differences in phosphorus 
containing metabolites in the presence of respiratory disease, indicating much greater anaerobic 
metabolism within cerebral neurones in those with COPD (Mathur, 1999). 
There are reports linking COPD and cognitive impairment. Schaub et al performed a cross- 
sectional study of ventilatory capacity and dementia prevalence in 437 participants older than 69 
years. FEVI was one of four lung volume variables with significantly increased odds ratio of 
dementia in the group with the worst compared with best respiratory function (Schaub, 2000). An 
uncontrolled study of 18 patients with COPD reported neuropsychometric deficits in individuals 
with poorer respiratory function. Memory, attention and speed of information processing were 
closely associated with both arterial carbon dioxide partial pressure, and less strongly correlated 
with oxygen partial pressure (Stuss, 1997). 
The Rotterdam study, an epidemiological survey of 1077 community-living elderly, reported 
periventricular white matter lesions were significantly and independently associated with lower 
Oxygen saturation on pulse oximetry, and non- significantly associated with history of COPD (van 
Dijk, 2004). 
Our data shows that FEVI and FVC were associated with white matter lesion volume but the 
FEVI/FVC ratio was not associated with white matter lesion. This is not in keeping with the 
hypothesis that reduced respiratory function is associated with white matter lesions, since reduced 
FEVI/FVC is essential for the diagnosis of obstructive airways disease. However, a much 
larger 
2 3' 3 
study also failed to find a correlation between COPD (or oxygen saturation) and subcortical white 
matter lesions or lacunar infarcts (van Dijk, 2004). 
10.4.3 Multiple linear regression of all variables on white matter 
lesion volume 
Simple linear regression was performed to select a group of independent variables that 
demonstrate a strong association with white matter lesion volume. Thus more than 70 variables 
were narrowed down to a candidate list of 12 predictor variables (blood pressure, pulmonary 
function and blood indices). Multiple linear regression of the 12 clinical indices produced a 
model with five independent variables that were significantly associated with white matter lesion 
volume. The presence of cardiac failure or diabetes mellitus was associated with a 1.54 or 2.07 
percent increase in percentage white matter lesion volume compared with individuals without 
these conditions. For every 100 ml fall in FVC, percentage white matter lesion volume increased 
by 0.06%. From ambulatory blood pressure monitoring, each one mmHg increase in daytime 
systolic BP variability or night-time mean diastolic blood pressure was associated with 0.20 and 
0.08 percent increase in cortical white matter lesion percentage volume respectively. 
Methodology for obtaining this regression model bears some similarities with that previously 
described in Chapter 9, and may appear to be repetitious. The Chapter 9 analysis is based on a 
limited number of established vascular risk factors and includes cases in sinus rhythm only. The 
regression analysis performed in this chapter is more wide ranging and carries with it a larger 
element of speculation. It also includes cases in sinus rhythm and atrial fibrillation. In view of 
these different conditions, it appears pertinent to pose the same question. The final regression 
model in this chapter may be less robust than Chapter 9 regression model for two reasons. Firstly 
a very large number of potential independent variables are considered and secondly some cases 
lack data for some of the variables. In spite of these drawbacks, the regression model indicates a 
number of interesting associations with baseline cortical white matter lesions. 
There is little information in the literature relating to an association between cardiac failure and 
white matter lesions. Raiha et al (Raiha, 1993) divided 204 hospitalised patients with CT scan 
data into those with and without cardiac failure. White matter low attenuation was more cornmon 
in those with heart failure compared with those free of heart failure (34% vs. 14%, p=0.00 12), 
and the authors felt this supported the hypothesis of hypoperfusion driving white matter disease. 
More recently Zuccala et al (Zuccala, 2001) identified impaired cognitive function in heart failure 
patients in conjunction with hypotension. Cardioembolic disease or hypotension are both 
Potential mechanisms for white matter damage in the presence of left ventricular impairment 
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(Pullicino and Hart, 2001). Cardiac failure presents difficulties with respect to defining disease 
presence, particularly in large community studies. Definition could be based on clinical criteria 
which is time consuming and probably prone to inter-observer error. Alternatively definition 
could be based on echocardiographic assessment of left ventricular function. Definition in this 
study was not ideal: the participant was asked about history of heart failure or use of diuretic drug 
therapy. The response was almost invariably qualified by use of loop diuretic, which does not 
always equate to left ventricular failure in community living individuals. Therefore the 
association of cardiac failure in this regression model may relate more to an association between 
loop diuretic (and not left ventricular failure) with white matter lesions. 
Diabetes was a significant independent predictor variable for white matter lesions. This replicates 
the findings of Schmidt et al who found age and diabetes to be the only independent predictors of 
white matter lesions in a study of stroke patients and healthy volunteers. In Schmidt's study, 
mean age of both stroke and control groups was 54 years, and there was a surprisingly similar 
burden of white matter disease in the two groups (Schmidt, 1992). Another unusual finding in this 
report is history of cerebrovascular events did not appear to be an independent predictor of white 
matter lesion. Presence of diabetes as a significant explanatory variable of white matter lesions 
supports a role for microvascular disease in the aetiology of white matter lesions. 
These findings may provide a therapeutic target for prevention of white matter disease 
progression: there was a trend towards significance for an positive association between baseline 
white matter lesions and haemoglobin Al c(R= +0.793,95% CI -0.0 1 to + 1.5 9, p=0.052) that 
indicates the association is not just the presence of diabetes but linearly related to the degree of 
glycaemic control. One could hypothesise that good diabetic control may reduce small vessel 
disease progression, and also emphasizes the importance of identifýirig vascular risk factors in 
patients at risk of cognitive decline. The hypothesis would require a randomized controlled trial 
to investigate the value and safety of tight diabetic control, particularly since this approach can 
run the risk of hypoglycaemic episodes in older, frail patients with all its attendant risks. 
Forced vital capacity was independently associated with white matter lesion volume in the 
regression model. This provides further support for the hypoxic-ischaemic model of white matter 
disease. However the link remains purely speculative. It is quite possible that both white matter 
lesions and reduced lung volume are due to some unrelated process, but a number of candidate 
factors were considered in the regression model and did not significantly assist prediction of 
white matter disease. The association could be a reflection of proportional variation in organ size 
but (i) white matter lesions cannot be considered a normal process (ii) cortical white matter 
lesion 
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volume was measured in percentage terms and (iii) addition of height to the regression model did 
not alter the final and significant terms. The hypothesis could be tested by examining the risk to 
white matter from arterial oxygen saturation and partial pressure. Prolonged oxygen saturation 
monitoring is an even more attractive risk factor for investigation, as a means of investigating 
dynamic oxygen levels in the aetiology of white matter disease. A large community study has 
recently revealed an association between pulse oximetry and white matter lesions (van Dijk, 
2004). 
in Chapter 9, the focus was on ambulatory blood pressure variables and association with white 
matter lesion volume. Mean diastolic blood pressure was significantly associated with white 
matter lesion volume. Systolic blood pressure variability was also an independent predictor of 
white matter lesion volume in the cross-sectional study. These two predictor variables have 
retained their significance in the regression model in this more extensive examination of white 
matter disease. These risk factors were discussed in Chapter 9. The fact they remain significant in 
this second analysis confirms their importance. However the regression slope for these 
ambulatory blood pressure variables is shallower than slopes for cardiac failure, diabetes and 
forced vital capacity. 
10.5 Conclusions 
Smoking is associated with a significant reduction in whole brain volume. No other 
cardiovascular or pulmonary risk factors independently predicted baseline whole brain volume. In 
a repeat of the regression model for cortical white matter lesion volume, the following significant 
predictors for white matter damage were identified: cardiac failure, diabetes, forced vital 
capacity, daytime systolic blood pressure variability and diastolic blood pressure level at night. 
This supports the 'hypoxic-ischaeniic' theory of white matter lesions. 
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Correlation of autonomic function and ambulatory 
blood pressure with baseline neuropsychological 
function 
11.1 Introduction 
As discussed in Chapter 2, our hypothesis is that abnormal autonomic function will lead to 
cognitive impairment due to recurrent white matter ischaemia in older stroke survivors. Therefore 
cardiovascular autonomic reflexes may demonstrate an association with cognitive function tests. 
In this chapter the relationships between cognitive tests and cardiovascular indices are examined. 
11.2 Method 
Cardiovascular autonomic reflex tests, power spectral analysis of heart rate variability and 
baroreflex sensitivity and 24 hour ambulatory blood pressure were performed as described in 
Chapter 4. Subjects in atrial fibrillation were excluded from analysis. Neuropsycho logical tests 
were applied as described in Chapter 4. From the CAMCOG test, total score was used as a 
marker of global cognitive function and the executive and attentional subscores were used as a 
marker of subcortical function (Roth, 1986). A key mechanism in the hypothesis is that recurrent 
white matter ischaernia can lead to attentional and executive deficits. Numerical vigilance, choice 
reaction time and memory scanning were selected from the CDR battery as additional markers of 
subcortical circuit damage. Mean reaction time for number vigilance, choice reaction time and 
memory scanning tasks were recorded as well as the standard deviation from choice reaction 
time. These CDR indices assess alertness, attention, concentration and the standard deviation of 
choice reaction time reflects fluctuation in attention (Simpson, 1991). 
Correlation co-efficients were determined between each autonomic or blood pressure variable and 
neuropsychological test. Spearman's rank correlation was calculated in view of the skewed 
distribution of most RR interval tests, attentional and memory scores from CAMCOG and all 
CDR tests. 
11.3 Results 
11-3.1 CAMCOG Total and sub-scores 
There were inverse correlations between Adiastolic blood pressure during isometric exercise and 
both attention and executive subscores on the CAMCOG total score (p = 0.0 11 and 0.0 17 
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respectively). Attention subscore significantly and inversely correlated with total and high 
frequency power spectra of heart rate variability (p = 0.037 and 0.004 respectively, Table 11.1). 
Table 11-1 Correlation between CAMCOG subscores, CAMCOG total score with cardiovascular 
reflex tests and power spectral analysis 
Autonomic variable Number Attention Executive Memory Total 
subscore subscore subscore CANICOG 
RPRPRPRP 
Reflex tests 
30: 15 ratio 71 +0.179 0.135 -0.068 0.571 +0.068 0.572 -0.006 0.959 
Valsalva ratio 69 +0.164 0.178 +0.011 0.929 +0.100 0.415 +0-058 0.637 
dHR respiration 73 -0.094 0.431 -0.071 0.553 +0.127 0.283 +0.000 0.999 
ASBP orthostasis 72 +0.044 0.711 +0.139 0.245 +0.069 0.564 +0.090 0.45 4 
ADBP isometric 74 -0.293 0.011 -0.276 0.017 -0.178 0.130 -0.174 0.139 
ADBP cold press 72 -0.180 0.131 +0.018 0.883 -0.124 0.298 -0.77 0.519 
ASBP Valsalva. 68 +0.140 0.254 +0.117 0.340 +0.031 0.801 +0.133 0.279 
RR post-CSM 31 -0.022 0.906 +0.070 0.710 -0.129 0.488 -0.025 0.893 
ASBP post-CSM 31 -0.151 0.419 -0.068 0.715 +0.141 0.450 -0.008 0.964 
PSA 
sdRR 68 -0.278 0.022 -0.001 0.993 +0.002 0.987 -0.066 0.291 
Total HRV 68 -0.253 0.037 +0.061 0.622 +0.048 0.699 -0.012 0.920 
Low freq. HRV 68 -0.215 0.078 +0.122 0.320 +0.136 0.268 +0.069 0.578 
High freq. HRV 68 -0.344 0.004 +0.033 0.787 +0.064 0.605 -0.081 0.509 
Low freq. BRS 39 -0.278 0.087 +0.158 0.337 +0.057 0.732 +0.087 0.598 
HiRh frea. BRS 59 -0.162 0.220 +0.158 0.231 +0.023 0.860 +0-091 0.492 
dHR respiration, change in heart rate during metronomic respiration: ASBP, change in systolic blood pressure during: 
orthostasis, active standing: Valsalva, blood pressure overshoot during Valsalva: post-CSM, during carotid sinus 
massage: ADBP, change in diastolic blood pressure during isometric, isometric exercise: cold press., cold cutaneous 
stress: PSA, power spectral analysis: sdRR, standard deviation of mean RR interval: HRV, heart rate variability. BRS, 
baroreflex sensitivity. 
Executive subscore inversely correlated with mean diastolic and mean arterial daytime blood 
pressure level (p = 0.004 and 0.034, Table 11.2). Results indicated an inverse association between 
diumal blood pressure variation and cognitive function according to CAMCOG. Significant 
correlations were observed between larger night-time diastolic blood pressure dip and lower 
executive, memory and total CAMCOG scores (p = 0.0 115 0.004 and 0.0 12 respectively, Table 
11-2). There was a similar but slightly weaker pattern of correlation using systolic nocturnal dip. 
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Top and bottom quartiles of diastolic percentage nocturnal dippers were compared. The bottom 
quartile of dipping status had a daytime mean diastolic blood pressure of 69 ±9 mmHg and night- 
time mean of 69 ±8 mmHg (0 % nocturnal dip, 95 % CI for diastolic blood pressure dip -2.5 to + 
2.5 mmHg, p=1.00). The top quartile of dipping status had a daytime diastolic mean of 77 = 10 
mmHg and night-time mean of 60 ±9 mmHg, an average 22 % nocturnal dip in diastolic blood 
pressure (95 % Cl for diastolic blood pressure dip +14.6 to +19.0 mmHg, p<0.001). There was a 
significant difference between total CAMCOG scores for top and bottom quartiles of dippers of 
8.7 points (95 % CI 1.5 to 15.8, p=0.020) 
Table 11-2 Correlation between CAMCOG subscores, total CAMCOG score and ambulaton, blood 
pressure 
ABP variable Number Attention Executive Memory Total 
subscore subscore subscore CAMCOG 
RpRpRpRp 
Day 
Mean systolic 69 -0.088 0.474 -0.141 0.248 -0.066 0.592 -0.087 0.479 
Mean diastolic 69 -0.176 0.149 -0.345 0.004 -0.150 0.218 -0.228 0.059 
Mean arterial 69 -0.145 0.236 -0.256 0.034 -0.076 0.536 -0.151 0.215 
Systolic SD 69 -0.079 0.517 -0.050 0.682 +0.009 0.938 -0.029 0.813 
Diastolic SD 69 -0.193 0.112 -0.171 0.159 -0.123 0.314 -0.108 0.376 
Mean arterial SD 69 -0.086 0.482 -0.187 0.124 -0.079 0.518 -0.166 0.173 
Pulse pressure 69 +0.060 0.622 +0.067 0.585 +0.085 0.489 +0.086 0.482 
Night 
Mean systolic 67 +0.077 0.537 -0.020 0.874 +0.078 0.531 +0.043 0.727 
Mean diastolic 67 -0.028 0.820 -0.095 0.445 +0.052 
0.675 -0.029 0.818 
Mean arterial 67 +0.067 0.591 -0.077 0.536 +0.101 0.416 +0.026 
0.835 
Systolic SD 67 +0.033 0.793 -0.027 0.829 -0.131 0.292 -0.083 
0.502 
Diastolic SD 67 +0.017 0.894 -0.035 0.780 +0.008 0.949 -0.056 
0.650 
Mean arterial SD 67 +0.019 0.881 -0.133 0.284 -0.147 
0.235 -0.193 0.119 
Pulse pressure 67 +0.060 0.632 +0.014 0.907 +0.076 0.544 +0.045 0.719 
Diurnal variation 
Systolic 65 -0.220 0.078 -0.168 0.182 -0.275 
0.026 -0.264 0.034 
Diastolic 65 -0.165 0.190 -0.313 0.011 -0.349 
0.004 -0.310 0.012 
ABP, ambulatory blood pressure: SD, standard deviation of blood pressure 
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11.3.2 CDR results 
Table 11-3 Correlation between CDR scores with cardiovascular reflex tests and power spectral 
analysis 
Autonomic N Number vigilance 
Choice reaction Choice reaction Memory scanning variable time time s. d. 
RpRpRpRp 
Reflex tests 
30: 15 ratio 68 +0.09 0.486 -0.07 0.585 -0.05 0.705 -0.10 0.431 
Valsalva ratio 67 -0.17 0.183 -0.20 0.102 -0.11 0.394 -0.25 0.044 
dHR resp. 70 +0.03 0.778 -0.16 0.190 -0.03 0.793 +0.03 0.784 
ASBP stand 69 -0.10 0.400 -0.02 0.905 -0.19 0.121 -0.08 0.495 
ADBP isom. 71 +0.26 0.027 +0.18 0.145 +0.19 0.107 +0.20 0.102 
ADBP cold p. 69 +0.12 0.337 -0.06 0.600 +0.01 0.925 +0.01 0.909 
ASBP Valsal. 66 -0.13 0.296 -0.09 0.464 +0.03 0.828 -0.11 0.397 
RR post-CSM 29 -0.20 0.293 -0.14 0.471 -0.10 0.595 -0.30 0.126 
ASBP CSM 29 -0.04 0.848 +0.03 0.887 +0.13 0.505 +0.26 0.186 
PSA 
sdRR 65 +0.03 0.835 -0.08 0.517 -0.16 0.210 -0.05 0.684 
Total HRV 65 -0.02 0.857 -0.11 0.388 -0.18 0.157 -0.02 0.893 
LF HRV 65 +0.02 0.899 -0.25 0.048 -0.24 0.050 -0.11 0.678 
HF HRV 65 -0.00 0.983 -0.14 0.261 -0.16 0.192 -0.08 0.542 
LF BRS 37 +0.15 0.362 -0.06 0.727 -0.17 0.315 -0.11 0.512 
HF BRS 56 -0.05 0.735 -0.30 0.027 -0.40 0.002 -0.11 0.446 
dHR resp., change in heart rate during metronomic respiration: ASBP, change in systolic blood pressure during: stand, 
active standing: Valsal., blood pressure overshoot during Valsalva: post-CSM, during carotid sinus massage: ADBP, 
change in diastolic blood pressure during: isom., isometric exercise: cold p., cold cutaneous stress: PSA, power spectral 
analysis: sdRR, standard deviation of mean RR interval: HRV, heart rate variability: LF, low frequency: HF, high 
frequency: BRS. Baroreflex sensitivity. 
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Table 114 Correlation between CDR scores and ambulatory blood pressure 
ABP variable N Number Choice reaction Choice reaction Memory 
vigilance 
, 
time tune s. d. scanning 
rPRPRPR 
Day 
Mean systolic 66 +0.043 0.732 +0-062 0.621 +0.110 0.381 +0-118 0-351 
Mean diastolic 66 +0-109 0.385 +0-177 0.154 +0.266 0.031 -+--0.19 5 0.119 
Mean arterial 66 +0.040 0.752 +0.118 0.344 +0.195 0.117 -0.152 0.226 
Systolic SD 66 +0.132 0.290 +0.042 0.738 -0.021 0.867 -0.148 0.238 
Diastolic SD 66 +0.145 0.245 +0.021 0.865 +0.040 0.750 +0.218 0.082 
Mean arterial SD 66 +0.184 0.140 +0.139 0.266 +0.109 0.384 +0.238 0.056 
Pulse pressure 66 +0.006 0.962 -0.005 0.967 -0-052 0.680 +0.009 0.944 
Night 
Mean systolic 64 -0.075 0.554 +0.072 0.573 +0-060 0.635 +0.097 0.447 
Mean diastolic 64 -0.118 0.353 +0.003 0.982 +0.080 0.531 +0.024 0.851 
Mean arterial 64 -0.103 0.418 +0.040 0.753 +0.063 0.622 +0.084 0.510 
Systolic SD 64 -0.118 0.354 -0.008 0.953 -0.074 0.559 -0.170 0.179 
Diastolic SD 64 +0.023 0.855 +0.051 0.691 +0.157 0.216 +0.055 0.669 
Mean arterial SD 64 +0.001 0.993 +0.038 0.766 +0.083 0.513 +0.010 0.937 
Pulse pressure 64 -0.017 0.893 +0.101 0.426 +0.051 0.692 +0.145 0.254 
Diurnal variation 
Systolic 62 +0.043 0.738 -0.034 0.791 +0.081 0.532 +0.009 0.946 
Diastolic 62 +0.184 0.152 +0.176 0.170 +0.220 0.086 +0.102 0.430 
ABP, ambulatory blood pressure: SID, standard deviation of blood pressure 
11.4 Discussion 
11.4.1 Autonomic function and CAMCOG 
Table 11.1 indicates a negative association between diastolic blood pressure increase during 
isometric exercise and attention and executive subscores. In view of most of the other correlations 
being non-significant on a background of multiple significance testing, this may be a Type I error. 
The difference in isometric exercise diastolic blood pressure response between stroke cases and 
controls was an exaggerated increase in blood pressure following stroke (Chapter 7). A potential 
mechanism is impaired baroreflex control of sympathetic driven vasoconstriction during 
isometric stress (section 7.4.1). If we extrapolate results on exaggerated blood pressure during 
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isometric stress and impaired baroreflex sensitivity in stroke patients (section 7.3) to findings in 
this section regarding the association between isometric exercise and CAMCOG subscores. we 
could hypothesis that defective blood pressure control could lead to surges in cerebral perfusion 
pressure and microvascular damage of subcortical neuronal circuits. AltemativeIN, some other 
unknown neurodegenerative process could simultaneously damage baroreflex centres as well as 
centres controlling cognitive processes. 
The heart rate variability correlations record a negative significant association bemeen total and 
high frequency heart rate variability and attention CAMCOG subscore only. Again one suspects 
there is a substantial chance this is a Type I error, since there was multiple significance testing 
and none of the other hypothesised associations were significant. 
11.4.2 Ambulatory blood pressure and CAMCOG 
We have shown an inverse relationship between increasing circadian diastolic blood pressure 
variation and CAMCOG score. Larger drop in blood pressure overnight was associated with more 
impaired cognitive function in this cohort of older stroke survivors. 
Low blood pressure overnight will increase the risk of hypotensive episodes, possibly leading to 
cerebral hypoperfusion. This has special relevance in older stroke patients where cerebral 
autoregulation can shift rightwards following midlife hypertension, leaving the brain vulnerable 
to low perfusion pressure (Choi, 1998; Mehagnoul-Schipper, 2000; Wollner, 1979). Ensuing 
ischaemic damage, especially in the white matter, may result in cognitive decline, providing a 
likely mechanism for the observed association. 
These findings also raise the question of optimal blood pres sure- lowering strategy in older stroke 
patients. The benefits of blood pressure lowering in primary and secondary prevention of stroke 
are beyond doubt (MacMahon, 1990; Progress Collaborative Group, 2001). Recently randonýiised 
controlled trials have shown anti-hypertensive treatment reduces risk of cognitive decline in 
patients of any age with cerebrovascular disease but no benefit in cognitive outcome for >70 year 
old hypertensive patients (Lithell, 2003; Tzourio, 2003). We hypothesise that excessive blood 
pressure reduction, particularly for night-time blood pressure, may have a detrimental impact on 
cognitive function in older stroke survivors. Twenty four hour ambulatory blood pressure 
inonitoring could assist such decision making. 
11-4.3 Autonomic indices and CDR 
Table 11.3 reveals a small number of associations between CDR indices and cardiovascular 
autonomic reflex tests or heart rate variability. Larger Valsalva ratio was associated with 
faster 
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memory scanning time. Larger exercise-induced rises in blood pressure were associated ýý-ith 
prolongation in number vigilance reaction time. Higher levels of low frequency heart rate 
variability were weakly associated with faster choice reaction time and reduced fluctuation in 
choice reaction time. Better high frequency baroreflex sensitivity was strongly associated with 
faster choice reaction time and reduced fluctuation in choice reaction time. These results provide 
some indication of an association between impaired autonomic function and impairments in 
alertness, attention and concentration. The cardiovascular reflex test and power spectral analysis 
results indicate changes in cardiovagal activity, sympathetic function and baroreflex sensitivity. 
Damage to vagal mechanisms will result in loss of rapid heart rate adjustment during alterations 
in systemic pressure, and the isometric test indicates that during exercise, systemic blood pressure 
rises excessively perhaps through loss of baroreflex damping. The negative association between 
high frequency baroreflex sensitivity and mean choice reaction time and standard deviation is the 
most important finding. It suggests baroreflex damage could lead to deranged subcortical 
function. This could be mediated by fluctuation in systemic pressure resulting in ischaemic 
damage to central white matter. However in Chapter 10, the trend towards a negative association 
between baroreflex sensitivity and cortical white matter lesion volume was in the correct 
direction but not statistically significant (r = -0.159, p=0.249). In other words we have not 
demonstrated the hypothesised link between autonomic function and brain substrate of cognitive 
impairment. 
11.4.4 Ambulatory blood pressure and CDR 
There was only one significant correlation between ambulatory blood pressure indices and CDR 
results, namely an association between higher daytime diastolic blood pressure and increased 
fluctuation in choices reaction time. 
11.5 Conclusions 
To our knowledge, this is the first study to extensively study autonomic function and cognitIve 
function in older stroke patients. Results do confirm a small number of associations between 
dysautonomia and cognitive deficit. It provides limited support for the hypothesis of autonomic 
dysfunction leading to ischaernic-hypoxic cerebral damage and hence post-stroke cognitive 
decline. These results do not provide evidence of cause, and this will be explored in the 
following 
chapters. 
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12 Correlation between cardiovascular function and 
white matter disease progression on serial MR 
imaging 
12.1 Introduction 
The principal hypothesis, that increased RR interval and blood pressure variability increases 
white matter ischaemia, is examined in this chapter by performing sequential brain imaging. 
White matter lesion progression will lead to decline in cognitive function. Older stroke patients 
are at high risk of dementia, and decrements in cognition because of white matter disease could 
lead to dementia. This will have serious implications on the health and independence of patients. 
Most data describing risk factors for white matter lesions are derived from cross-sectional studies 
(section 2.5.2). Only a few studies have performed serial brain imaging on older patients to 
examine rate of change in white matter lesions and risk factors for lesion progression. Some 
studies were disadvantaged by use of insensitive CT or relatively small numbers of subjects 
(Veldink, 1998; Wahlund, 1996; Wohl, 1994). MRI scanning is the optimal method for 
quantifying white matter disease with its greater sensitivity for white matter lesion compared %vith 
CT scanning (van Swieten, 1990). Visual rating scales have reasonable inter-observer agreement 
but semi-automated methods offer the prospect of better accuracy and repeatability (Scheltens, 
1998). It also remains to be seen if progression in white matter lesions actually correlates with 
cognitive change, with some studies failing to establish such a connection (Schmidt, 1999; 
Wahlund, 1996). 
The aim was to examine risk factors for progression of white matter lesion volume. Candidate 
risk factors considered in correlation analysis were autonomic function indices, ambulatory blood 
pressure level and variability, clinical risk factors and haernoffheological factors. Brain MRI 
scanning was repeated after an interval of two years and cortical white matter lesion volume 
measured by a semi-automated method. 
12.2 Method 
Autonomic function and blood pressure variability were assessed as described in Chapter I 
These tests were performed once at baseline following study recruitment. Standard cardiovascular 
autonomic reflex tests were perfonned: postural blood pressure change and 30: 15 ratio during 
orthostasis, diastolic blood pressure change during three minute isometric exercise and one 
minute cold pressor tests, heart rate variation and systolic blood pressure change at oN-ershoot of 
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the Valsalva manoeuvre, and heart rate variation during metronomic respiration over one minute. 
Baseline MR1 scans was performed at approximately the same time as cardiovascular assessment. 
Study participants were invited to attend for repeat MRI scanning. Some candidates had deceased 
in the two year interim. Other exclusions included refusal to attend, poor physical health, 
pacemaker implantation and refusal. 
White matter lesion volume was measured by pixel volume and converted to a percentage of the 
total brain pixel volume. Only cortical white matter lesion volume was included. Cortical white 
matter volume is the most important of white matter lesion volume and is the key location for 
lesion that will lead to cognitive deficit. It is accepted that ischaemic white matter lesions do not 
improve and tend to increase over time in older subjects (Schmidt, 1999; Wahlund, 1996; 
Yamauchi, 2002). Therefore any individuals with a decrease in white matter lesion volume were 
excluded on the assumption this was due to technical factors or movement artifact from baseline 
scan. 
12.2.1 Statistical analysis 
Risk factors for white matter lesion progression were investigated using regression analysis. 
Regression of cardiovascular variables on white matter lesion volume was evaluated using the 
rate of cortical white matter lesion increase as the dependent variable. Second year cortical vhite 
matter lesion volume was subtracted from the baseline volume. The difference in volume was 
divided by time interval to obtain the rate of white matter change ((2 nd year WML - baseline 
WML)/2). 
Autonomic and blood pressure indices were correlated with rate of white matter lesion volume 
increase using Spearman's rank correlation. Only cases in sinus rhythm were selected for the 
correlation with autonomic indices. As a next step, all potential contributory factors were 
examined by simple linear regression. Rate of white matter lesion volume was entered as 
explanatory variable. The following were entered as predictor variables: gender, age, cardiac 
failure, ischaemic heart disease, hypertension, peripheral vascular disease, COPD/asthma, 
diabetes, hypercholesterolaemia, smoking history, alcohol consumption, FEVI, FVC, FEVI/FVC, 
prescription of beta-blocker, ACE inhibitor, calcium channel blocker or nitrate, haernorrhologic 
factors, all cardiovascular reflex tests and power spectral analysis variables and all ambulatory 
blood pressure variables from day and night phases. 
Explanatory variables with ap value less than 0.10 were entered into a multiple linear regression 
model. Backward elimination was performed to eliminate the least significant explanatory 
245 
variable in a stepwise method until a model containing only significant explanatory variables was 
obtained. 
As a supplementary study, basic cortical white matter lesion volume on second year MRI was 
entered as the dependent variable. The same process of simple linear regression to identify 
important candidate predictors followed by multiple linear regression was perforined but using 
the second year cortical white matter lesion volume as the explanatory variable. 
12.3 Results 
There were a total of 83 cases with valid white matter lesion volume data from baseline scan and 
45 attended for repeat MRI scanning. Of these 45 cases, four were excluded because the 
automated measurement effectively produced outliers i. e. large increases in white matter lesion 
volume out of keeping with most cases and probably due to movement artifact. Only one patient 
was excluded on the basis of spurious decrease in white matter lesion increase from baseline to 
second year. 
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Figure 12-1 Boxplot for cortical white matter lesion volume for all cases (sinus rhythm and AF) 
The mean cortical white matter lesion percentage volume was 2.0 ± 1.4 % at baseline and 2.6 ± 
1.9 % on second year scan, a significant mean difference of 0.6 % (95% Cl 0.3 to 0.8 %, p< 
0.001). A maximum of 30 patients were available for correlation between autonomic indices and 
rate of white matter lesion volume increase (mean age 79.1 ± 2.9 years, 17 male), and 27 
for the 
ambulatory blood pressure analysis (sinus rhythm only, mean age 79.1 ± 3.1 years, 15 male). 
246 
baseline 
Correlation coefficients between autonomic indices and rate of white matter lesion increase are 
shown in Table 12.1. 
Table 12-1 Cardiovascular autonomic function and rate of cortical white matter lesion increase 
Variable Number 
_Correlation coefficient 
p 
Reflex tests 
30: 15 ratio 27 +0321 0.102 
Valsalva ratio 29 +0.160 0.408 
E-1 difference 29 +0.033 0.863 
Active stand ASBP 29 -0.029 0.833 
ADBP Isometric exercise 30 -0.047 0.803 
ADBP cold pressor 30 +0.079 0.678 
ASBP Valsalva manoeuvre 29 -0.120 0.535 
ARR CSM 9 +0300 0.433 
ASBP CSM 9 -0.200 0.606 
Power spectral analysis 
SD RR 27 +0.025 0.901 
Total HRV 27 +0.017 0.933 
LF 27 +0.079 0.696 
BF 27 -0.076 0.707 
Alpha BRS LF 19 -0.082 0.737 
Alpha BRS FIF 22 -0.027 0.907 
E-1 difference, change in heart rate during metronomic respiration: ASBP, systolic blood pressure: ADBP, change in 
diastolic blood pressure: CSM, carotid sinus massage: SD RR, standard deviation of 5 minutes R-R intervals: HRV, 
heart rate variability power spectrum: LF, low frequency: HF, high frequency: BRS, baroreflex sensitivity. 
Correlation coefficients between ambulatory blood pressure indices and rate of white matter 
lesion increase are shown in Table 12.2. 
The correlation between ambulatory blood pressure indices and rate of white matter lesion 
increase was repeated using patients in both sinus rhythm and atrial fibrillation cases. These 
results are shown in Table 12.3. 
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Table 12-2 Ambulatory blood pressure and rate of cortical white matter lesion volume increase: 
sinus rhythm only 
BP variable Correlation coefficient P 
Day (n=27) 
SBP mean -0.263 0.185 
DBP mean -0.201 0.185 
MAP mean -0.271 0.171 
SBP variability +0.147 0.464 
DBP variability +0.046 0.821 
MAP variability +0.000 0.999 
Pulse pressure -0.210 0.294 
Night (n--26) 
SBP mean -0.301 0.136 
DBP mean -0.254 0.210 
MAP mean -0.332 0.098 
SBP variability +0.000 0.999 
DBP variability -0.080 0.699 
MAP variability -0.177 0.388 
Pulse pressure -0.190 0.353 
Diurnal variation 
SBP mean +0.137 0.504 
DBP mean -0.001 0.996 
SBP, systolic blood pressure: DBP, diastolic blood pressure: MAP, mean arterial pressure 
The strength of correlation between mean ambulatory pressure at night appeared to increase with 
the addition of cases in atrial fibrillation. 
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Table 12-3 Ambulatory blood pressure and rate of cortical white matter lesion volume increase: 
sinus rhythm and atrial fibrillation 
BP variable Correlation coefficient p 
Day (n=34) 
SBP mean -0.114 0.523 
DBP mean -0.302 0.083 
MAP mean -0.173 0.327 
SBP variability +0.301 0.084 
DBP variability +0.000 0.999 
MAP variability +0.120 0.498 
Pulse pressure +0-018 0.921 
Night (n--33) 
SBP mean -0.255 0.151 
DBP mean -0.408 0.018 
MAP mean -0.367 0.036 
SBP variability +0.025 0.891 
DBP variability +0.043 0.813 
MAP variability -0.075 0.677 
Pulse pressure -0.021 0.906 
Diurnal variation (n--32) 
SBP mean +0.117 0.523 
DBP mean +0.045 0.805 
SBP, systolic blood pressure : DBP, diastolic blood pressure: MAP, mean arterial pressure 
12.3.1.1 Multiple linear regression on rate of cortical white matter lesion 
volume increase 
Only those predictor variables with a significance value less than 0.10 are shown in Table 12.4. 
All variables shown in Table 12.4 were considered for inclusion in multiple linear regression on 
rate of white matter lesion increase. All cases with valid repeat MR1 scans were included. 
Inclusion of all the variables in Table 12.4 in led to the following equation for predicting rate of 
increase of white matter lesion volume 
Rate of cortical white matter lesion increase= (0.393xIHD) + (0.00]xfolate) -0.320 
(IHD, ischaemic heart disease) 
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Table 12-4 Independent predictor variables for rate of white matter lesion increase: all -, -ariables 
with p<0.10 
Explanatory variable Degrees of freedom Reg ression coefficient P 
B 95% confidence interval 
Cardiac failure 39 +0.417 +0-097, +0.737 0.012 
Ischaernic heart disease 39 +0.314 +0.069, +0.558 0.013 
Diabetes 39 +0.379 -0-076, +0.834 0.100 
Thiazide 39 -0.321 -0.547, -0.096 0.006 
ACEi or AIIRA 39 +0.300 +0-006, +0.595 0.046 
Nitrate 39 +0.338 -0.021, +0.697 0.064 
MAP mean (day) 33 -0.012 -0.025, +0.002 0.100 
SBP mean (night) 32 -0.008 -0.016, +0.000 0.050 
MAP mean (night) 32 -0.0136 -0.026, -0.001 0.038 
DBP mean (night) 32 -0.017 -0.033,0.000 0.050 
Haemoglobin AIc 34 +0.246 +0.062, +0.430 0.010 
Glucose 35 +0.132 +0.004, +0.261 0.044 
Red cell folate, 33 +0.001 +0.000, +0.003 0.021 
Vitamin B 12 34 +0.001 -0.000, +0.002 0.073 
ACEi or AURA, ACE inhibitor or angiotensin-11 receptor antagonist: MAP, mean arterial pressure: SBP, systolic blood 
pressure: DBP, diastolic blood pressure. 
Table 12-5 Regression coefficients for pulmonary function regression on rate of cortical white matter 
lesion volume increase and total second year white matter lesion percentage volume 
White matter lesion Pulmonary Regression 95% confidence P value 
variable function coefficient interval 
Rate of change (n=42) FEV, -0.022 -0.267, +0.223 0.854 
FVC -0.026 -0.227, +0.174 
0.792 
FEVI/FVC +0.558 -1.347, +2.464 0.557 
Year 2 (n==42) FEV, -0.681 -1.801, +0.439 
0.227 
FVC -0.698 -1.605, +0.209 
0.128 
FEVI/IFVC +0.186 -8.723, +9.095 0.967 
FEVI, forced expiratory volume in one second: FVC, forced vital capacity. 
Therefore cases with a history of ischaemic heart disease had a higher rate of white matter 
lesion 
increase than those without ischaemic heart disease in the order of 0.4% per year. The equation 
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also predicts a 0.01% annual increase in white matter lesion volume for each 10 microgram per 
litre increase in red cell folate level. The final model predicts 32% of the variance of white matter 
lesion increase and the ANOVA model has 33 total degrees of freedom and a significance value 
of 0.003. 
The regression analysis was repeated on two occasions for the purpose of assessing impact of 
different inclusion criteria. The principle was to assess impact of tightening restrictions on 
predictor variables entered in the multiple regression analysis. Numbers available for analysis 
were relatively small and there was a proportionately higher number of predictor variables. 
The first repeat regression analysis was in two steps. The first step was to only include cases 
where the scatter plots were consistent with a potential association with white matter lesion 
increase. For example, cardiac failure was excluded since there were only a small number of 
positive cases with relatively high levels of white matter lesion increase, with the impression of a 
skewed effect. ACE inhibitor and nitrate use, and mean night-time systolic blood pressure level 
were excluded for similar reasons. Additional selection criteria of cases meeting the 24 hour 
ambulatory inclusion criteria were applied i. e. number of day and night blood pressure readings 
more than 9 and 4 respectively. The ensuing low numbers of cases with haemoglobin AIc, 
glucose, red cell folate and vitamin B 12 data led to the second step of excluding these variables, 
since numbers were deemed inadequate for inclusion in the regression equation. The remaining 
variables were then regressed on white matter lesion increase: ischaernic heart disease, thiazide 
prescription, daytime mean MAP, night-time mean MAP and diastolic blood pressure, with the 
result. 
Rate of white matter lesion increase = (+0-285 x IHD) - (0.294 x thia-zide) + 0.33 7 
This equation predicts 29% of white matter lesion increase variance, with 31 degrees of freedom 
and significance level of 0.003 in the ANOVA model. 
The second repeat in regression analysis was to only include predictor variables where results 
were available for all cases selected. Thus cardiac failure, ischaernic heart disease, diabetes, 
thiazide, ACE inhibitor and nitrate use were included in the regression equation. This produced 
the following equation (see Table 12.6): 
Rate of white matter lesion increase = (0.321 x CCF) + (0.307 x IHD) - (0-256 x 
thiazide) + 0.264 
CCF, congestive cardiacfailure: IHD, ischaemic heart disease 
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This model predicts 36% of white matter lesion increase variance, and the ANOVA model has '19 
degrees of freedom with a significance level of < 0.001. It indicates that presence of cardiac 
failure or ischaernic heart disease is associated with 0.32 and 0.31 percent higher annual increase 
in white matter lesion burden compared with individuals without these risk factors. In contrast 
prescription of thiazide is associated with a reduction in white matter lesion progression, around 
0.26 percent annual reduction compared with those not taking thiazide drugs. 
Table 12-6 Regression co-efficients for predictor variables of cortical white matter lesion N-olume 
progression 
Predictor variable Regression coefficient 95 % Cl for coefficient Significance 
Congestive cardiac failure +0.312 +0-036, +0.606 0.029 
Ischaemic heart disease +0.307 +0.097, +0.517 0.005 
Thiazide -0.256 -0.460, -0.052 0.015 
12.3.1.2 Total volume of cortical white matter lesions on year 2 MRI scan 
Regression coefficients for those predictor variables with significance value < 0.10 for regression 
on total white matter lesion percentage are shown in Table 12.7. 
The variables shown in Table 12.7 were considered for inclusion in multiple linear regression on 
second year white matter lesion volume. Scatter plots indicated the association between white 
matter lesion volume and C-reactive protein and glucose was not robust due to outliers. The 
association with loop diuretic appeared less robust due to small number in the positive group. 
Two other variables - HDL cholesterol and homocysteine - were excluded on the basis of low 
numbers of cases with results. Therefore the following variables were entered into multiple linear 
regression on second year white matter lesion volume: cardiac failure, thiazide, ACE inhibitor, 
nitrate, haemoglobin Al c and folate. This produced the following model: 
Secondyear white matter lesion percentage volume == (1.099 x haemoglobin A 1c) + 
(0.008 xfolate) - 6.243 
This model predicted 48% of white matter lesion variance, and the ANOVA model had a total of 
29 degrees of freedom and a significance value of < 0.00 1. The model predicts that every one 
percent increase in haernoglobin AIc was associated with approximately 1.1 % increase in white 
matter lesion. 
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Table 12-7 Significant predictor variables on regression on white matter lesion volume at -ear 2 (p < 0.10) 
Explanatory variable Degrees of freedom Regression coefficient P 
B 95% confidence interval 
Cardiac failure 39 +2.484 +0-918, +4-050 0.003 
Diabetes 39 +2.316 +0.046, -4.586 0.046 
Thiazide 39 -1.034 -2.250, +0.183 0.093 
ACEi/AHRA 39 +1.417 -0.089, +2.924 0.064 
Nitrate 39 +1.976 +0.184, +3.769 0.032 
Loop diuretic 39 +2.198 -0.085, +4.481 0.059 
C-reactive protein 38 +0.023 -0.001, +0.047 0.061 
Glucose 35 +0.654 -0.018, +1.326 0.056 
Haemoglobin AIc 34 +1.264 +0.232, +2.297 0.018 
HDL cholesterol 28 -1.719 -3.287, -0.152 0.033 
Red cell folate 33 +0.010 +0.001, +0.015 0,001 
Homocysteine 21 -0.136 -0.295, +0-022 0.088 
ACEi/AIERA, ACE inhibitor or angiotensin-11 receptor antagonist: HDL, high density lipoprotein 
A second regression analysis was performed to examine the effect of loosening inclusion criteria 
for entry in the regression model. This second regression analysis included all variables in Table 
12.7 in regression on second year white matter lesion volume. This produced the following model 
Secondyear white matter lesion percentage volume = (1.851 x haemoglobin AI c) - 
(1.875 x HDL cholesterol) - 5.862 
This model predicted 44% of white matter lesion volume variance, and the ANOVA model had a 
total 26 degrees of freedom and a significance value of < 0.001. The model predicts that every 
one percent increase in haemoglobin AIc is associated with an increase in 1.8% increase in white 
matter lesion volume but each I mmol/I increase in HDL cholesterol is associated with a 1.9% 
decrease in second year white matter lesion volume. 
12.4 Discussion 
Multiple linear regression of individual independent variables on rate of white matter lesion 
increase identified ischaemic heart disease and cardiac failure as significant risk factors for 
Progression of white matter disease, with thiazide prescription being associated with a protective 
action against white matter lesion volume progression. When regressing multiple independent 
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variables on MRI white matter lesion on the scan performed two years after cardiovascular 
assessment, haemoglobin A Ic had a positive and HDL cholesterol an inverse relationship with 
total cortical white matter lesion volume. 
12.4.1 Rate of white matter lesion increase from baseline to year 2: correlation 
Taking the correlation results first, there is an interesting association between higher nocturnal 
diastolic blood pressure and reduced rate of white matter lesion progression. This correlation was 
only significant when including both sinus rhythm and atrial fibrillation in the correlation. Thus 
strength of correlation between mean ambulatory pressure at night appeared to increase with the 
addition of cases in atrial fibrillation but regression analysis indicated this association was 
independent of atrial fibrillation. 
Therefore baseline nighttime blood pressure was inversely associated with rate of white matter 
lesion volume increase. Higher nocturnal blood pressure at baseline led to slower progression in 
white matter lesion damage. It suggests that older stroke patients with higher diastolic blood 
pressure in the first year after stroke suffer less white matter ischaemia in the subsequent two 
years. Conversely those with lower systemic perfusion pressure overnight will suffer higher rates 
of central neuronal damage. 
This needs to be put in context of section 11.4.2 results where nocturnal blood pressure dip was 
inversely associated with total CAMCOG score. One could hypothesise that a combination of 
large nocturnal diastolic blood pressure dip in the first year after stroke and low overnight mean 
diastolic blood pressure could have an synergistic and detrimental effect. Large nocturnal 
pressure dips will be associated with poorer cognitive function at the outset and if the same 
individuals are subjected to low mean diastolic pressure overnight in the years following stroke, 
they will suffer the highest rates of white matter lesion progression, further worsening cognitive 
performance. 
These findings make for interesting comparison with the results from the Gothenberg and 
Kungsholmen cohorts. Guo et al (Guo, 1996) report blood pressure was lower in patients with 
vascular dementia in the Kungsholmen community cross-sectional study. Both low and high 
levels of baseline systolic blood pressures were associated with follow-up MMSE score (Guo, 
1997). Further longitudinal studies revealed that low diastolic and high systolic pressure were 
significantly associated with incidence of all-cause dementia (Qiu, 2003). For low diastolic blood 
pressure (, 
_S65 mnfflg vs. 
66-90 mmHg), the adjusted relative risk of Alzheimer disease was 1.7 
(95% Cl I-I to 2.4) and 1.5 (95% CI 1 .0 to 2.1) for all-cause 
dementia. Results from our study 
254 
provide further evidence that low baseline diastolic blood pressure could lead to white matter 
hypoperfusion and potentiate cognitive decline in post-stroke patients. 
Although diastolic blood pressure significantly correlated with rate of white matter lesion 
increase, it did not remain a significant predictor variable in the regression models. Multiple 
regression is discussed below. 
None of the autonomic indices predicted rate of white matter lesion increase. Lack of association 
with white matter lesion volume at baseline was reported in Chapter 9. Therefore it is not 
surprising that autonomic function did not significantly predict deterioration in ischaen-ýc white 
matter damage. Reasons for the lack of association as discussed in Chapter 9 may also apply for 
this longitudinal study. Despite the inclusion of 76 sinus rhythm cases in the baseline study, 
reduced number available for study at 2 years will have impaired power to detect significant 
associations. The largest number for correlation with rate of white matter lesion increase was 30 
for blood pressure increase during isometric exercise and the smallest number just 9 cases for 
carotid sinus massage results. 
Cerebral autoregulation may be a more important factor in maintaining white matter blood flow 
and avoiding ischaernic lesions. Repeatability of the reflex autonomic tests is suboptimal, thus 
results from our single assessment may have lacked accuracy. The reflex tests describe short term 
RR and blood pressure variability in response to cardiovascular stress over a period of seconds to 
minutes. The ischaernic conditions required to cause white matter lesions may be a more severe 
and prolonged alteration in cerebral perfusion over several minutes or even hours. Other 
mechanisms may be more important determinants of white matter lesion progression. 
12.4.2 Rate of white matter lesion increase from baseline to year 2: 
regression models 
Multiple linear regression of risk factors on rate of white matter lesion progression identified 
ischaemic heart disease and cardiac failure as predictors of white matter lesion volume. This is 
the first study to report these conditions as risk factors for white matter lesion progression. 
Findings provide further evidence for the ischaemic nature of white matter lesions in older adults 
(Ferro and Madureira, 2002; Jeerakathil, 2004; Roman, 2002). Ischaemic heart disease could act 
as a mediator by two mechanisms. The presence of classic vascular risk factors - hypertension, 
diabetes, smoking, hypercholesterolaemia - may be best summarised by presence of 
ischaemic 
heart disease, and indicate similar biological mechanisms driving both coronary artery disease 
and small vessel cerebrovascular disease. Alternatively those with ischaemic heart disease may 
be 
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individuals who suffer dysrhythmias, hypotensive episodes etc that are central to the 'hypoxic- 
ischaernic' hypothesis of white matter disease. 
Presence of cardiac failure in the regression model was dependent on data analysis technique. 
This highlights a weakness of the study: results were susceptible to modelling technique which 
raises questions on robustness. Inclusion of the different models allows one to judge their 
strengths and weaknesses. Larger numbers and obtaining data for all variables in all indiNiduals 
would allow confident selection of regression technique. These difficulties stem from the nature 
of the cohort; an older group of volunteers who were not able to tolerate all investigations and 
suffer high mortality rates, thus limiting the scope for successful completion of longitudinal 
studies - 
The Protective value against white matter lesion volume progression obtained from thiazide use 
seems very pertinent in the light of the PROGRESS group results. Not only did thiazide 
prescription (as part of a blood pressure lowering regimens) reduce risk of stroke and 
cerebrovascular events, there was also evidence of decreased risk of cognitive decline in stroke 
patients (Lithell, 2003; Progress Collaborative Group, 2001). Our firidings are in keeping Nvith the 
PROGRESS group. Thiazide use benefited patients by association with reduced progression of 
white matter lesion volume. Commentators on the PROGRESS study attribute thiazide benefits to 
blood pressure lowering and perhaps additional metabolic actions of thiazides especially with 
indapamide. 
12.4.3 Previous studies 
There are a few studies examining risk factors for white matter lesion progression. A very small 
study of 16 healthy elderly subjects assessed at an interval of three years found no difference in 
white matter lesions on MRI and no overt cognitive change (Wohl, 1994). Wahlund et al 
(Wahlund, 1996) performed MRI scans on three occasions over five years on 13 healthy adults 
aged over 70 years. Different MRI scanners were used over the three investigations, and the 
higher field strength on repeat MRI scanning may have increased lesion detection by virtue of 
greater sensitivity. The study was further weakened by small number of participants. Cerebral 
white matter hyperintensities significantly increased but periventricular hyperintensities did not 
significantly change. Neuropsychometric performance did not deteriorate over the five year 
assessment period. 
The largest serial imaging study was part of the Austrian Stroke Prevention Study (Schmidt, 
1999). Two hundred and seventy three community living adult volunteers, mean age 60 ±6 years 
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and free of cerebrovascular disease, were examined with serial 1.5 Tesla MR imaging three years 
apart. Using the visual rating scale of Fazekas, 65% of subjects had white matter hypenntensities, 
and 18 % percent suffered progression in white matter hyperintensty grade over three years. 
Individuals with lesion progression were older, had higher diastolic blood pressure, higber 
fibrinogen levels and had higher grades of white matter hyperintensity on baseline Lmaging. 
Following logistic regression, diastolic blood pressure and moderately severe white matter 
hyperintensity at baseline remained the only significant and independent predictors of lesion 
progression. This contrasts with our study where diastolic blood pressure did not predict 
progression. It is known that diastolic blood pressure increases in middle age, plateaus and can 
then fall after the seventh decade (Franklin, 1997a); hence diastolic blood pressure may have lost 
its predictive strength in our older cohort. Weaknesses of the Schmidt study (Schmidt, 1999) 
included poor interrater reliability for rating minor white matter disease and use of the 4-grade 
Fazekas scale. This white matter lesion rating scale probably lacked sensitivity for accurate 
quantification of white matter lesion progression. It is interesting to note this study did not find 
any association between lesion progression and cognitive decline. Short follow-up period, 
relatively young cohort and neuropsychometric test repeatability were probably factors 
contributing to these negative firidings. 
Similar to Schmidt et al (Schmidt, 1999), Veldink's study (Veldink, 1998) in a community study 
in Amsterdam also reported higher diastolic blood pressure was a significant predictor using 
multiple linear regression on progression of white matter hyperintensity rating. But again this 
study only assessed a small number of subjects (14) and used a visual rating scale (Scheltens, 
1993). In contrast our study benefited from larger number of participants and more accurate and 
sensitive semi-automated white matter lesion volume measurement. Mean age in Veldink et al's 
study (Veldink, 1998) at 76 ±5 years was more comparable to our study. 
Yamauchi et al (Yamauchi, 2002) performed serial MRI on 89 Japanese patients mean age 66 ±9 
years at an interval of 51 ± 19 months. The 79 patients without severe WML at baseline were 
analysed by multiple linear regression to determine independent risk factors for increase in white 
matter lesion score. The following significant predictor variables were identified: moderate 
hypertension (p = 0.0016), uncontrolled diabetes (p = 0.0038) and current smoking 
(p = 0.04). 
It is notable that age did not predict white matter lesion progression in our study. This 
is in 
keeping with results from the studies of Schmidt and Veldink (Schmidt, 1999; Veldink, 
1998). 
Although age is closely associated with accumulation of white matter lesions, it is not necessarily 
a risk factor for progression. 
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Baseline folate level was a significant and positive predictor of white matter lesion progression in 
the first regression model. However high folate levels have no hypothetical relationship to white 
matter lesions and this seems very likely to be a chance finding. Furthen-nore the regression slope 
for the relationship between folate and white matter lesion increase was shallow. 
To the best of our knowledge, this also appears to be one of a few studies reporting white matter 
lesion progression using semi-automated measurement of white matter lesions quantified as a 
continuous variable. The studies of Scbn-Lidt, Wahlund, Veldink and Yamauchi (Schmidt, 1999; 
Veldink, 1998; Wahlund, 1996; Yamauchi, 2002) all used visual rating scales, which are 
reasonably sensitive but lack the accuracy and absence of bias obtained with automated 
measurement. Taylor et al used a semi-automated white matter lesion volume measurement to 
obtain actual volumes. Following multiple logistic regression, age (p =0.01 17) and diabetes 
(0.0215) were significant predictors of increase in lesion volume in Taylor's study (Taylor, 2003). 
12.4.4 Total volume of cortical white matter lesions on year 2 MRI 
scan 
in contrast to the regression model for rate of white matter progression, only haemoglobin AIc 
had significant predictive value for the cortical white matter lesion volumes at two years after 
study recruitment. Haemoglobin Alc reflects long-term glycaernic control which is a strong risk 
factor for arteriosclerotic disease. Passare et al (Passare, 2004) found that loop diuretic use Nvas 
significantly and independently associated with elevated haemoglobin AIc in older community 
living subjects. They suggest diuretics may lead to hyperglycaemia. If this was correct, it could be 
hypothesised that since cardiac failure was as an independent predictor of white matter lesion 
progression, these patients were all treated with loop diuretics and may have led to higher 
haemoglobin Alc levels. An inverse association with HDL cholesterol level is again consistent 
with the ischaernic basis of white matter lesions in older age - elevated HDL indicates favourable 
cholesterol metabolism with lower risk of coronary artery disease. Glycaemic control and 
cholesterol metabolism offer plausible treatment targets for white matter lesion progression. 
One suspects total white matter lesion volume at second year MRI is an inferior outcome measure 
to the 'repeat-baseline MRI difference' method. The latter measures the real change in white 
matter lesion volume over two years and means that each patient acts as their own control. 
Simply using the total white matter lesion volume at two years does not provide a dynamic 
measure of white matter variation, and is more akin to a cross-sectional study. But it does allow 
an estimation of future white matter lesion burden from baseline risk factors. This analysis 
did 
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identify some interesting risk factors which are even more consistent with the ischaemic 
hypothesis of white matter lesions than predictor variables for rate of white matter lesion change. 
12.4.5 Blood pressure variability in atrial fibrillation 
There are few studies examining the impact of atrial fibrillation on ambulatory blood pressure. 
Some question the validity of using ambulatory blood pressure monitoring in atrial fibrillation 
because of technical factors that make measurement problematic and introduce larger margins of 
error compared with sinus rhythm (Stewart, 1995). But office sphygmomanometry-based blood 
pressure readings can also be inconsistent in atrial fibrillation due to the erratic nature of 
Korotkov sounds in atrial fibrillation (Sykes, 1990). Ambulatory monitoring should provide an 
advantage by producing an average of multiple measurements. A study by Lip et al (Lip, 1996) 
proved the feasibility of ambulatory recording in atrial fibrillation. There were a high percentage 
of successful recordings at 80%, a figure not too different to sinus rhythm. Furthen-nore the first 
measurement on the ambulatory recorders matched the mean of two manual blood pressure 
measurements for systolic (but not diastolic) pressure. Another report suggests that validated 
monitors have a satisfactory frequency response to provide an adequate measurement (OBrien, 
1990). 
There is evidence that accurate information can be obtained by ambulatory blood pressure 
monitoring in atrial fibrillation. From 42 patients undergoing cardioversion for AF, 22 completed 
before and after 24 hour ambulatory blood pressure recordings (Olsen, 2002). In the group of 22, 
12 reverted to sinus rhythm whilst 10 remained in atrial fibrillation. There were no significant 
differences in mean systolic and diastolic levels for both sinus rhythm and atrial fibrillation 
groups before and after cardioversion. Blood pressure variability and repeatability attained similar 
levels in both groups (SD/mean). 
12.4.6 Study limitations 
Interval between imaging was chosen to balance the need to allow time for significant 
progression of lesions against the risk of high rates of participant attrition. One study found no 
change over one year but significant white matter lesion progression after two years on MRI 
scanning (Veldink, 1998). Our study did suffer from a high attrition rate of participants over two 
years, due to further clinical events rendering subjects unfit for imaging, refusal for repeat 
scanning and deaths. Larger interval would certainly provided greater change in white matter 
lesion burden and improve ability to define risk factors but at the cost of higher attrition rates. 
The substantial loss of individuals at second scan may have hindered the study's power. 
Severe 
259 
white matter lesion at baseline is reported as an independent predictor of stroke risk, and 
individuals with mild white matter lesions that progress also have high stroke rates (Yamauchi, 
2002). Therefore selection bias may have affected our study, since those not attending for repeat 
scan are more likely to suffer the highest rates of cerebrovascular disease (Ferro and Madureira, 
2002). Performance bias is less likely to have influenced outcome since most patients secondary 
prevention treatment was optimized following presentation with stroke at secondary care sen-ices. 
Five individuals with repeat MRI data were excluded from data analysis. Four recorded large 
increases in white matter lesion volume that suggested movement artifact leading to falsely 
elevated increases. This assumption is difficult to disprove and may have led to loss of 
individuals with true and severe white matter lesion progression. This could weaken ability to 
detect predictor variables. 
Identifying individuals with progression in white matter lesion volume could benefit targeting 
treatment at those with high rates of lesion progression. Such patients are theoretically at greatest 
risk of cognitive decline. A similar approach has been suggested for hippocampal and whole 
brain atrophy in Alzheimer's disease (Fox and Schott, 2004; Scheltens, 2002). Reduction in rate 
of progression could provide evidence that a treatment is effective in preventing ischaernic white 
matter damage and provide a useful diagnostic tool. However it remains to be seen whether 
progression in white matter lesions correlates with deterioration in cognitive function. Clinical 
relevance extends beyond cognitive function. A recent report has found an association between 
white matter lesion progression and both gait disorder and bladder dysfunction in older adults 
(Whitman, 2 00 1). 
12.5 Conclusions 
Autonomic and ambulatory blood pressure indices do not predict rate of white matter lesion 
progression. Ischaernic heart disease and cardiac failure are associated with higher rates of white 
matter lesion progression, whereas thiazide diuretic prescription is associated with reduced rate of 
white matter lesion progression. Mechanisms for these associations deserve further study. This 
study does not provide supportive evidence that autonomic dysfunction mcreases damage to 
subcortical circuits in the white matter. 
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13 Correlation between cardiovascular autonomic tests and blood pressure variability with longitudinal CAMCOG and CDR 
13.1 Introduction 
Loss of cardiovascular autonomic function can produce large fluctuations in systemic perfusion 
pressure. White matter damage may follow where cerebral autoregulation is unable to maintain 
cerebral perfusion pressure. Therefore hypoxic and ischaernic injury can lead to decline in 
cognitive function. In this chapter, the relationship between baseline cardiovascular autonomic 
function and cognitive function after one and two years is explored. 
13.2 Method 
Cardiovascular investigations were performed at baseline as described in Chapter 4. Autonomic 
reflex tests, heart rate variability and ambulatory blood pressure were performed. The following 
variables were obtained for analysis. From reflex tests, 30: 15 ratio and change in systolic blood 
pressure on standing, change in diastolic blood pressure during isometric exercise and cold 
cutaneous stress, Valsalva ratio and change in systolic blood pressure from baseline to overshoot 
during Valsalva manoeuvre and change in heart rate during metronomic respiration for one 
minute. From heart rate variability, total, low and high frequency spectral powers and baroreflex 
sensitivity for low and high frequencies. From 24 hour ambulatory blood pressure recording, 
mean systolic and diastolic levels, variability of systolic and diastolic blood pressure (standard 
deviation of the mean), pulse pressure and difference between day and night levels of systolic and 
diastolic blood pressure. Only cases with more than 15 readings over 24 hours were included. 
Cases in non-sinus rhythm were excluded from analysis. 
Serial cognitive function was performed at baseline, then one and two years later. The full 
neuropsychometric schedule is described in section 4.4. CAMCOG variables were total score and 
attention and executive subscores. CDR battery variables were choice reaction time, memory 
scanning and number vigilance. Total CAMCOG is an indicator of global cognitive function. The 
other cognitive variables reflect executive and attentional performance which are impaired 
fOllOwing white matter damage. 
13-2.1 Statistical analysis 
The difference in CAMCOG score and CDR mean times were compared within subjects using the 
Friedman Test for the change between three points, baseline to year I to year 2. Differences 
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between each separate interval were compared within subjects using W11coxon Signed Ranks 
Test: baseline to year 1, year I to year 2 and baseline to year 2. 
Association was explored using linear regression. To obtain a sense of how much baseline 
cognitive function predicts performance at years one and two, linear regression xvas used to 
describe the variance of follow-up cognitive score determined by baseline fiinction. Thus for each 
cognitive variable, the score at year 1 and year 2 were treated as explanatory variables and the 
score at baseline was entered as the predictor variable. The variance of year I or 2 according to 
baseline values and the significance of the ANOVA model are reported. 
Cardiovascular predictor variables were then added to the regression model containing baseline 
neuropsychometric as the other independent variable and neuropsychometric variable at N'ear I or 
2 as the dependent variable. The candidate Independent variables were obtained from 
cardiovascular reflex tests, spectral analysis of heart rate variability and 24 hour ambulatory 
blood pressure variability. Each one of the six terms from the neuropsychometric tests was 
entered as explanatory variable. The regression coefficient and its significance value are reported 
in Tables 13.3 to 13.8. 
13.3 Results 
The mean interval between neuropsychometric testing from baseline to year one was 397 ± 61 
An 
. ys, and from year one to year two was 356 ± 57 days. 
13.3.1 CAMCOG 
There was no significant change in total CAMCOG score and attention subscore frorn year to 
year. There was a significant improvement in CAMCOG executive subscore in the period of 
cognitive follow-up (Friedman Test < 0.00 1, Table 13.1). Assessing the year-on-year change, 
executive subscore change improved from baseline to year I and from baseline to year 2 (p < 
0.00 1) but not from year I to year 2 (p = 0.080, Table 13.2). 
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Table 13-1 CAMCOG total score and attention and executive subscores at baseline and vear I 
Total (0-107) Attention (0-7) Executive (0-28) 
Baseline (n=76) 87(81-92) 6(5-7) 13(10-17) 
Year I (n=62) 89(84-93) 6(5-7) 16(14-19) 
Year 2 (n=52) 90(84-94) 6(5-7) 16(14-20) 
Chi-square (n=49) 1.319 0.124 24.29 
p 0.517 0,940 <0.001 
Scores are median (in terquartile range) : Friedman Test, degrees of freedom = 2. 
Table 13-2 CAMCOG total score and attention and executive subscores year-on-year change 
CAMCOG Year on year change N Z score Significance 
Total Baseline to year 1 62 -1.006 0.314 
Year I to 2 49 -1.550 0.121 
Baseline to year 2 52 -1.351 0.177 
Attention subscore Baseline to year 1 62 -1.423 0.155 
Year I to 2 49 -0.854 0.393 
Baseline to year 2 52 -0.544 0.587 
Executive subscore Baseline to year 1 62 -4.135 <0.00 I 
Year I to 2 49 -1.752 0.080 
Baseline to vear 2 52 -4.907 <0.001 
Wilcoxon Signed Ranks Test 
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Figure 13-1 Total CAMCOG score for patients in sinus rhythm 
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13.3.1.1 Total CAMCOG 
Scatterplots indicate a trend towards improvement in total CAMCOG score over one and two 
years but this was not significant (Figure 13.1 and Table 13-2). Baseline CAMCOG score 
explained 49 % and 43 % of the variance of year I and year 2 CAMCOG scores respectively. 
Valsalva ratio significantly predicted total CAMCOG score after two years (B = +11.4.95 % Cl 
for B +1.5 to 21.2, p=0.025) but there were no other significant predictors of total CAMCOG 
from the cardiovascular assessment (Table 13.3). 
CAMCOG year I= (CAMCOG baseline x 0.720) + 24.9 
Adjusted r' =0.491 P<0.00 1 
CAMCOG year 2= (CAMCOG baseline x 0.698) +27.6 
Adjusted e =0.431 P<0.001 
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Table 13-3 Correlation between autonomic tests and total CAMCOG score after I and 2 vears 
Autonomic vanable CAMCOG total year I CAMCOG total vear 2 
n Regression coefficient p n Regression coefficient p 
Reflex tests 
30: 15 ratio 59 -3.308 0.516 47 -3.123 0.688 
Valsalva ratio 56 +0.306 0.941 47 +11.352 0.025 
E-1 ratio 60 +0.141 0.369 47 -0.169 0.431 
ASBP orthostasis 60 +0.036 0.130 48 +0.023 0.472 
ADBP isometric exercise 61 +0.015 0.765 50 +0.029 0.659 
ADBP cold pressor 59 +0.006 0.912 51 -0.023 0.737 
ASBP Valsalva 55 +0.033 0.473 45 +0.076 0.238 
RR post-CSM 24 -0.009 0.141 21 -0.007 0.206 
ASBP post-CSM 24 +0.125 0.334 21 -0.004 0.969 
Power spectral analysis 
Total HRV 58 +0.000 0.797 35 +0.001 0.577 
Low frequency HRV 58 +0.017 0.504 35 +0.003 0.488 
High frequency HRV 58 +0.001 0.663 35 +0.002 0.577 
Low frequency BRS, 36 +0.059 0.889 24 -0.413 0.362 
High frequency BRS 50 -0.101 0.523 29 -0.198 0.370 
24 hour blood pressure 
Systolic mean BP 59 +0.032 0.500 49 +0.014 0.836 
Diastolic mean BP 59 +0.005 0.956 49 +0.191 0.181 
Systolic variability 59 +0.128 0.457 49 +0.002 0.995 
Diastolic variability 59 -0.118 0.649 49 +0.199 0.641 
Pulse pressure 59 +0.046 0.426 49 -0.043 0.601 
Systolic diurnal change 57 -0.029 0.778 49 -0.120 0.463 
Diastolic diurnal chanae 57 +0.021 0.809 49 +0.028 0.841 
ASBP, change in systolic blood pressure: ADBP, change in diastolic blood pressure: CSM, carotid sinus massage: HRV, 
heart rate variability: BRS, baroreflex sensitivity: BP, blood pressure 
13-3.1.2 CAMCOG attention subscore 
There was a clear ceiling effect on CAMCOG attention subscore. There was no significant 
change in attention subscore at one and two years follow-up (Table 13.2 and Figure 13.2). 
Regression analysis indicates baseline attention subscore explains 12 % and 44 % of the variance 
of attention subscore, at one and two years respectively. There was a trend towards higher mean 
'165 
24 hour systolic blood pressure reducing attention score at one year (p = 0.079) but no slgnlficant 
predictors from the cardiovascular assessment (Table 13.4). 
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Figure 13-3 Executive subscore for patients in sinus rhythm 
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Table 13-4 Correlation of autonomic function and ambulatory blood pressure with CANICOG 
attention subscore 
Autonomic variable CAMCOG attention year I CAMCOG attention vear 2 
n Regression coefficient p n Regression coefficient P 
Reflex tests 
30: 15 ratio 59 +1.184 0.359 47 -0.617 0,5 40 
Valsalva ratio 56 -0.968 0.358 47 -0.096 0.890 
E-1 ratio 60 +0.023 0.581 47 -0.015 0.61 
ASBP orthostasis n 60 -0.001 0.870 48 +0.002 0.616 
ADBP isometric exercise 61 +0.012 0.375 50 +0.006 0.565 
ADBP cold pressor 59 -0.008 0.593 51 -0.010 0.360 
ASBP Valsalva 55 +0.007 0.577 45 -0.004 0.13 5 
RR post-CSM 24 -0.005 0.136 21 -0.002 0.519 
ASBP post-CSM 24 +0.065 0.404 21 +0.059 0.338 
Power spectral analysis 
Total HRV 58 +0.000 0.184 35 +0.000 0.067 
Low frequency HRV 58 +0.001 0.170 35 +0.001 0.047 
High frequency HRV 58 +0.001 0.074 35 +0.001 0.025 
Low frequency BRS 36 +0.021 0.534 24 +0.067 0.282 
High frequency BRS 50 +0.014 0.876 29 +0.001 0.945 
24 hr blood pressure 
Systolic mean BP 59 -0.023 0.079 49 -0.026 0.805 
Diastolic mean BP 59 -0.036 0.125 49 +0.018 0.389 
Systolic variability 59 -0.030 0.518 49 +0.011 0.774 
Diastolic variability 59 -0.124 0.071 49 -0.033 0.598 
Pulse pressure 59 -0.018 0.259 49 -0.011 0.411 
Systolic diurnal change 57 -0.018 0.516 49 +0.001 0.981 
Diastolic diurnal chanae 57 -0.000 0.988 49 +0.008 0.695 
ASBP, change in systolic blood pressure: ADBP, change in diastolic blood pressure: CSM, carotid sinus massage: HRV, 
heart rate variability: BRS, baroreflex sensitivity: BP, blood pressure 
13.3-1.3 CAMCOG executive subscore 
There was a significant improvement in CAMCOG executive subscore from baseline to year I 
and baseline to year 2 (Table 13.2 and Figure 13.3). Baseline executive subscore explained 17 % 
and 35 % of the variance at year one and two respectively. Higher 24 hour systolic blood pressure 
Predicted higher executive subscore, at year one only (B = +0.066,95% Cl +0.006 to +0.126, p= 
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0.032, Table 13.5). Better systolic blood pressure response to Valsalva manoeuvre predicted 
higher executive score at year 2 (B = +0.079,95 % Cl +0.023 to +0.135, p=0.006). 
Executive subscore from CAMCOG 
CAMCOG executive I= (CAMCOG baseline x 0.40 7) + 10.5 
Adjusted RI = 0.17 1, p<0.00 1 
CAMCOG executive 2= (CAMCOG baseline x 0.514) + 9.9 
Adjusted RI = 0.346, p<0.001 
Table 13-5 Correlation of autonomic function and ambulatory blood pressure with CANICOG 
executive subscore 
Autonomic variable CAMCOG executive year I CAMCOG executive vear 2 
n Regression coefficient p n Regression coefficient P 
Reflex tests 
30: 15 ratio 59 -3.452 0.285 47 +1.884 0.594 
Valsalva ratio 56 -1.630 0.539 47 +4.004 0.096 
E-1 ratio 60 +0.081 0.423 47 -0.017 0.860 
ASBP orthostasis 60 +0.013 0.394 48 -0.010 0.460 
ADBP isometric exercise 61 +0.007 0.818 50 +0.035 0.235 
ADBP cold pressor 59 -0.047 0.177 51 -0.043 0.165 
ASBP Valsalva 55 +0.000 0.991 45 +0.079 0.006 
RR post-CSM 24 -0.005 0.136 21 -0.002 0.519 
ASBP post-CSM 24 +0.065 0.404 21 +0.059 0.338 
Power spectral analysis 
Total HRV 58 -0.000 0.522 35 -0.000 0.901 
Low frequency HRV 58 -0.000 0.911 35 +0.000 0.789 
High frequency HRV 58 -0.001 0.314 35 -0.000 0.971 
Low frequency BRS 36 +0.126 0.550 24 -0.092 0.694 
High frequency BRS 50 -0.052 0.592 29 -0.030 0.747 
24 hr blood pressure 
Systolic mean BP 59 +0.066 0.032 49 +0.000 0.993 
Diastolic mean BP 59 +0.080 0.168 49 -0.000 1.000 
Systolic variability 59 +0.110 0.328 49 -0.011 0.919 
Diastolic variability 59 +0.144 0.410 49 +0.098 0.611 
Pulse pressure 59 +0.063 0.092 49 +0.000 0.992 
Systolic diurnal change 57 -0.015 0.821 49 -0.016 0.822 
Diastolic diurnal change 57 +0.038 0.519 49 -0.001 0.989 
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ASBP, change in systolic blood pressure: ADBP, change in diastolic blood pressure: CSM, carotid sinus massage . HRV, heart rate variability: BRS, baroreflex sensitivity: BP, blood pressure 
13.3.2 CDR results 
There was no significant change in mean times for number vigilance, choice reaction and 
memory scanning tests (Table 13.6-7, Figures 13.4-13.6). 
Table 13-6 CDR mean times for baseline, year 1 and 2 
Number vigilance Choice reaction time Memory scanning 
Baseline (n=73) 511 (475-596) 610 (531-834) 1064 (967-1441) 
Year I (n=58) 519 (459-599) 593 (535-751) 1077 (856-1268) 
Year 2 (n=38) 
Chi-square 
509 (474-581) 
0.788 1.697 
1028 (866-1374) 
2.182 
p 0.674 0.428 0.336 
Scores are median (interquartile range): Friedman Test, degrees of freedom =2 
Table 13-7 CDR mean times: year-on-year change 
CDR Year on year N Z score Significance 
Number vigilance Baseline to year 1 56 -0-057 0.954 
Year I to year 2 34 -0.778 0.437 
Baseline to year 2 37 -0-173 0.862 
Choice reaction time Baseline to year 1 56 -0.131 0.896 
Year I to year 2 34 -0.966 0.334 
Baseline to year 2 37 -1-079 0.281 
Memory scanning Baseline to year 1 56 -1-785 0.074 
Year I to year 2 34 -1.051 0.293 
Baseline to year 2 37 -0.430 0.667 
Wilcoxon Signed Ranks Test 
13.3.2.1 CDR: number vigilance 
There was no change in number vigilance score at one and two years. Number vigilance at 
baseline predicted 45 % and 14 % of the variance of year I and year 2 times respectively. Higher 
Valsalva ratio predicted better number vigilance performance at year 2 (B = -193.6,95"0 
Cl - 
382.8 to -4.4, p=0.045). Higher total and high frequency spectral powers of 
heart rate N, ariability 
602 (528-704) 
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predicted longer number vigilance time at year 2 (p = 0.050 and 0.021 respectively). There were 
no other cardiovascular predictors of CDR number vigilance times (Table 13.8). 
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Adjusted RI = 0.452, p <0.001 
Number vigilance 2= (n umber vigilance baseline x 0.4 71) +277.9 
Adjusted R2=0.144, p=0.012 
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Figure 13-4 Mean number vigilance time for patients in sinus rhythm 
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Table 13-8 Correlation of autonomic function and ambulato 
on CDR test 
ry blood pressure with number vigilance 
Autonomic variable Number viEilance year I Number vigilance year 2_ 
n Regression coefficient p n Regression coefficient P 
Reflex tests 
30: 15 ratio 53 +65.5 0.251 34 +23.34 0.790 
Valsalva ratio 51 -63.9 0.184 35 -193.56 0.045' 
E-1 ratio 54 -1.58 0.376 36 +1.46 0.677 
ASBP orthostasis 54 -0.16 0.571 35 -0.52 0.246 
ADBP isometric exercise 55 +0.29 0.603 35 +0.45 0.648 
ADBP cold pressor 54 -0.01 0.988 38 +0.45 0.667 
ASBP Valsalva 50 -0.85 0.123 35 -0.99 0.308 
RR post-CSM 21 +0.01 0.060 19 -0.11 0.2 1? 
ASBP post-CSM 21 +0.26 0.828 19 -0.04 0.982 
Power spectral analysis 
Total HRV 54 +0.02 0.121 35 +0.03 0.050 
Low frequency HRV 54 +0.02 0.423 35 +0.06 0.102 
High frequency IIRV 54 +0.05 0.118 35 +0.10 0.021 
Low frequency BRS 34 +1.84 0.690 24 -1.47 0.804 
High frequency BRS 46 +1.95 0.238 24 +3.04 0.241 
24 hr blood pressure 
Systolic mean BP 55 -0.31 0.573 35 +1.03 0.281 
Diastolic mean BP 55 -0.44 0.644 35 +1.11 0.532 
Systolic variability 55 -0.36 0.852 35 +0.99 0.817 
Diastolic variability 55 +3.47 0.229 35 +7.10 0.292 
Pulse pressure 55 -0.26 0.706 35 +0.99 0.383 
Systolic diurnal change 53 +0.40 0.719 35 +0.55 0.801 
Diastolic diurnal chanLye 53 +0.89 0.344 35 +0.53 0.762 
ASBP, change in systolic blood pressure: ADBP, change in diastolic blood pressure: CSM, carotid sinus massage: HRV, 
heart rate variability: BRS, baroreflex sensitivity: BP, blood pressure 
13.3.2.2 CDR: choice reaction time 
Scatterplots indicate wide variance in choice reaction time with outlying values. Baseline choice 
reaction time predicted 13 % and 14 % of the variance at year I and year 2 respectively. Larger 
increases in diastolic blood pressure during isometric exercise predicted worse choice reaction 
time at year I (B = +2.9,95% Cl +0.1 to +5.6, p=0.04 1). Better blood pressure response during, 
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Valsalva manoeuvre predicted quicker choice reaction time at year I (B = -3.1,95% Cl -5.7 to - 
0.5, p=0.019). There were no other cardiovascular predictors of choice reaction time at \-Car 
and 2 (Table 13.9). 
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Figure 13-5 Mean choice reaction time for patients in sinus rhythm 
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Table 13-9 Correlation of autonomic function and ambulatory blood pressure with Choice reaction time on CDR test 
Autonomic variable CRT year I CRT % ear 2 
n Regression coefficient p n Regression coefficient p 
Reflex tests 
30: 15 ratio 55 -40.85 0.785 34 -145.62 0,260 
Valsalva ratio 52 -112.70 0.380 35 -129.6 0.3233 
E-I ratio 56 -2.70 0.570 36 +2.29 0.622 
ASBP orthostasis 56 +0.14 0.851 35 -0.051 0.468 
ADBP isometric exercise 57 +2.88 0.041 38 +0.33 0.794 
ADBP cold pressor 56 +0.01 0.994 38 +0.36 0.788 
ASBP Valsalva 51 -3.12 0.019 35 -1.76 0.152 
RR post-CSM 23 +0.04 0.796 19 -0.08 0.566 
ASBP post-CSM 23 +0.064 0.837 19 +4.06 0.107 
Power spectral analysis 
Total HRV 54 +0.01 0.756 35 +0.04 0.053 
Low frequency HRV 54 -0.00 0.968 35 +0.02 0.588 
High frequency HRV 54 -0.01 0.951 35 +0.10 0.034 
Low frequency BRS 34 -2.40 0.843 24 -4.16 0.5 -14 
High frequency BRS 46 -0.88 0.853 29 +1.83 0.557 
24 hr blood pressure 
Systolic mean BP 55 +0.14 0.922 35 -1.07 0.373 
Diastolic BP 55 +1.20 0.635 35 +1.03 0.647 
Systolic variability 55 +6.51 0.195 35 +3.69 0.497 
Diastolic variability 55 +11.09 0.183 35 +7.68 0.385 
Pulse pressure 55 -0.39 0.829 35 -1.98 0.166 
Systolic diurnal change 53 +4.48 0.104 35 -1.36 0.628 
Diastolic diurnal chanve 53 +3.59 0.133 35 -1.73 0.462_ 
ASBP, change in systolic blood pressure: ADBP, change in diastolic blood pressure: CSM, carotid sinus massage: HRV, 
heart rate variability: BRS, baroreflex sensitivity: BP, blood pressure 
13.3.2.3 CDR: memory scanning 
There was no significant change in memory scanning time from baseline to year I or year 2. 
Baseline time predicted 26% and 24 % of memory scanning time at year 1 and 2 respectively. 
There were no significant cardiovascular predictors of memory scanning time during cognltl%, e 
fOllow-up (Table 13.10). 
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Memory scanning I= (memory scanning baseline x 0.412) - 608.5 
Adjusted R=0.256, p<0.001 
Memory scanning 2= (memory scanning baseline x 0.4 72) 
Adjusted R=0.242, p=0.002 
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Figure 13-6 Mean memory scanning time for patients in sinus rhythm 
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Table 13-10 Correlation of autonomic function and ambulatory blood pressure -Aith memorv scanning on CDR test 
Autonomic variable Memory scanning year Memory scanninia vear 21 
n Regression coefficient p n Regression coefficient p 
Reflex tests 
30: 15 ratio 55 +315.5 0.264 34 -254.1 0.458 
Valsalva ratio 52 +324.2 0.158 35 +179.9 0.582 
E-1 ratio 56 -8.84 0.325 36 -19.17 0.061 
ASBP orthostasis 55 +0.19 0.895 35 
ADBP isometric exercise 57 +1.64 0.548 38 -0.82 0.792 
ADBP cold pressor 56 +2.58 0.374 38 +3.27 0.290 
ASBP Valsalva 51 -2.60 0.320 35 4.45 0,136 
RR post-CSM 23 +0.37 0.179 19 +0.40 0.171 
ASBP post-CSM 23 +2.70 0.665 19 -7.50 0.169 
PSA 
Total HRV 54 +0.08 0.201 32 +0.03 0.575 
Low frequency HRV 54 +0.04 0.777 32 -0.01 0.911 
High frequency HRV 54 +0.17 0.302 32 +0.09 0.500 
Low frequency. BRS 34 +5.86 0.794 22 -20.05 0.203 
High frequency BRS 46 +12.72 0.142 26 -0.80 0.924 
24 hr blood pressure 
Systolic mean 55 -0.04 0.989 35 +0.90 0.741 
Diastolic mean 55 -4.96 0.280 35 +1.65 0.746 
Systolic variability 55 +15.02 0.094 35 -3.21 0.795 
Diastolic variability 55 +17.13 0.253 35 -27.36 0.165 
Pulse pressure 55 +239 0.460 35 +0.62 0.850 
Systolic diurnal change 53 -5.32 0.336 35 -2.04 0.748 
Diastolic diurnal chanize 53 -2.66 0.573 35 -0.36 
0.945 
ASBP, change in systolic blood pressure: ADBP, change in diastolic blood pressure: CSM, carotid sinus massage: HRV, 
heart rate variability: BRS, baroreflex sensitivity: BP, blood pressure 
13.4 Discussion 
In this group of older stroke survivors, results do not indicate consistent, significant associations 
between post-stroke autonomic function and subsequent CAMCOG score or measures of 
attention, vigilance and executive function from the CDR battery. The majority of the regression 
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analyses do not reach statistical significance. A minority are significant but caution should be 
adopted for several reasons. Firstly none are highly significant. In view of the large number of 
statistical tests performed, there is a high chance of a false positive result. This raises the issue of 
setting a more stringent threshold for statistical significance than the frequently used but arbitrary 
value of 0.05. None of the significance tests attain significance less than 0.0 1. Secondly if there 
were a true effect one would anticipate consistently significant effects on both year I and year 2 
scores, which did not occur. This underlines the possibility of the few significant results being a Z7 
chance effect. 
13.4.1 Study limitations 
The p value is the probability of having observed experimental data when the null hypothesis is 
true. The null hypothesis is the concept that when an experiment is performed comparing 
populations, there will be no difference between the two groups. Thus when the p value becomcs 
smaller, the null hypothesis becomes less likely until we reach an arbitrary cutoff point i. c. 0.05 
indicating the null hypothesis is rejected and we conclude there is a difference between the 
groups in the study population. In the results shown above the general lack of significance 
indicates that there is no effect of cardiovascular autonomic function on subsequent cognitive 
function, as measured by CAMCOG and CDR tests. However it is important to consider the 
possibility of errors made in using the significance level. A Type I error is already mentioned 
above, in that the few significant results seen in this regression study may be chance findings due 
to multiple significance testing. A Type II error may also have occurred from insufficient sample 
size. This is an important consideration, with approximately 60-70 subjects tested at year I and 
only 30 or so at year 2. 
Other reasons contributing to the possibly false negative findings need consideration. As 
discussed in Chapter 3, the cardiovascular autonornic tests have weaknesses. Repeatability of 
reflex tests, power spectral analysis and ambulatory blood pressure is not good and questions the 
accuracy of each test. Within the cardiovascular reflex tests, heart rate change during metronomic 
respiration offers the best repeatability. Repeatability of cognitive function is also poor, 
Particularly for the CDR scores (section 4.4.3). Thus the variation in time for CAMCOG and 
CDR scores may be partly due to natural fluctuation in score over time and not necessarily due to 
true change in cognition. From the linear regression analysis the variance of CDR scores at year 
and 2 is surprisingly low, suggesting poor repeatability, even allowing for the time interval 
between annual tests. One would expect more of the year 1 and 2 scores to be influenced by 
baseline score. Interobserver differences may influence performance on CAMCOG and CDR 
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testing. Interobserver differences could also lead to variation in autonomic reflex tests and po%ý-er 
spectral analysis (in the latter's editing), and to a lesser degree ambulatory blood pressure 
although the potential for observer error is probably smaller with the automated nature of power 
spectral analysis data collection. Inter-rater difference is less relevant for the single assessment of 
cardiovascular function at baseline but could affect repeated measures of neuropsychometric 
performance. No data is available on interrater reliability with respect to neuropsychometfic 
testing. 
The cohort was not homogenous. For example, stroke type, comorbidity and medication varied 
quite widely between individuals. These clinical factors may exert far greater influence on 
cognitive function than the autonomic function. The relatively small number studied at follow-up 
in conjunction with 'noise' from potent established risk factors probably reduced the power of the 
study to identify any significant impact of dysautonomia on neuropsychological measures. ltý 
13.4.2 Post-stroke dementia rates 
Improvement in cognitive function was not expected since the effect of age and high risk of 
ffirther cerebrovascular events would make cognitive decline much higher than the background 
community rates. Kokmen et al (Kokmen, 1996) report a nine-fold risk in dementia risk in the 
first year after stroke and remains twice the expected rate in the following years. Loeb report 
dementia rates 4-12 times the expected rate in the four years following lacunar stroke (Loeb, 
1992). Tatemichi et al (Tatemichi, 1994b) have also shown greatly elevated relative risk of 
incident dementia for 4 years following stroke. Most of the incident cases of dementia in Henon 
et al's three year post-stroke study occured within 6 months of stroke (Henon, 200 1). Zhu et al 
(Zhu, 2000) reported significantly elevated 2.4 relative risk of dementia for the three years 
following stroke, but after three years the relative risk was no longer significant. However there 
are data indicating how a large proportion of stroke patients do experience improvement in 
cognitive function in the months and years following stroke. Wade et al (Wade, 1988) noted 
improvements in certain cognitive domains more than three months after stroke. Desmond et al 
estimated cognitive improvement in approximately a third of patients and this occurred after the 
three month post-stroke interval, indicating this change was not likely to be resolvmg delirium of 
the acute post-stroke phase (Desmond, 1996). Components increasing the chance of recovery 
include visual neglect and left hemisphere stroke, suggesting that cortical anterior circulation 
strokes fare better (Desmond, 1996; Wade, 1988). It's likely that small vessel disease may nullify 
chance of improvement as a result of progressive white matter ischaernia and associated 
neurodegeneration (Ballard, 2003a; Desmond, 1996). Data from our own cohort identified 50 % 
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of older stroke survivors achieving improvement in global cognition whilst 9% developed 
incident dementia from assessment 3 and 15 months post-stroke (Ballard, 2003a). 
13.4.3 Absence of post-stroke cognitive decline 
The absence of cognitive decline, and in some instances improvement in function, in the sinus 
rhythm cohort may therefore be part of a natural phenomenon in the long-term recovery of older 
stroke patients. A potentially more important factor is selection bias for follow-up 
neuropsychmetric testing. Indications for frequent testing to capture incident cognitive decline 
was discussed in Chapter 2. It is possible those not attending for cognitive assessment at year I 
and year 2 (14 and 24 respectively) were the individuals suffering significant cognitive 
impairment and dementia. Post-stroke cognitive impairment is associated with higher mortality 
and adverse outcomes (Desmond, 1998b; Tatemichi, 1994a). Reduced detection of cognitive 
decline will impair ability to identify the significant predictors of cognitive impairment. 
Neuropsychornetric tools used in this study are probably reliable in detection of cognitive deficit. 
CAMCOG has been validated in the detection of dementia in stroke patients (de Koning, 1998). 
The CDR battery has not been validated for detection of post-stroke dementia but was chosen for 
its ability to detect abnormal 'central processing speed', particularly relevant in the aetiology of 
vascular dementia (Erkinjuntti, 2000a; O'Brien, 2003). The body of knowledge is far greater for 
the CAMCOG than CDR. CDR is a useful and sensitive tool that is able to detect abnon-nal 
cognitive function in patients with Alzheimer's disease and dementia with Lewy bodies compared 
with control values and additionally was strongly related to MMSE score (Ballard, 2001). CDR 
has also shown responsiveness to cognitive drug enhancer treatment (Wesnes, 2002). Data from 
the COGFAST cohort indicates CDR is able to define impaired cognitive processing speed, 
working memory and executive function in post-stroke patients compared with elderly controls 
(Ballard, 2003b). CDR indices are also related to white matter lesion volume, especially frontal 
lobe damage, from COGFAST data (Burton, 2004). 
13.4.4 Previous studies 
There is a dearth of reports investigating the impact of cardiovascular autonomic function on 
cognitive function in normal individuals. Compared with normal controls, Aharon-Peretz et al 
(Aharon-Peretz, 1992) identified changes in power spectra of heart rate variability in Alzheimer's 
disease indicating relatively higher ratio of low: high frequency power ratio. This study used 
unconventional definitions for power spectra bands and the low: high frequency ratio measure 
has 
proved unreliable as a means of quantifying sympathetic/parasympathetic balance in other work. 
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Elmstahl et al (Elmstahl, 1992) did not detect any difference in the expiration: inspiration RR 
interval ratio between elderly patients with Alzheimer's disease and controls but impaired heart 
rate deceleration with 8 minute tilting suggesting impaired dynamic vagal response in 
Alzheimer's disease. Franceschi et al (Franceschi, 1986) were unable to reliably perform 
cardiovascular reflex tests in a cohort of 18 patients with Alzheimer's disease, therefore used a 
sleep-dependent measure of autonomic activity. Results suggested defective cardiac autonomic 
control, predominantly from sympathetic dysfunction. Heart rate and blood pressure response to 
standing were satisfactory in a handful of studied patients. Passant et al (Passant, 1996) recorded 
asymptornatic orthostatic hypotension in patients with dementia (Alzheimer's disease and 
vascular) during head-up tilt in association with decrease in frontal lobe cerebral blood flow. 
Prevalence of carotid sinus hypersensitivity is elevated in dementia with Lewy bodies (Ballard, 
1998). Patients with neurodegenerative dementia have greatly increased odds ratio for deep white 
matter lesions in the presence of vasodepressor carotid sinus hypersensitivity or orthostatic 
hypotension with drop in blood pressure greater than 30 mmHg (Ballard, 2000). All these studies 
are cross -sectional. 
A handful of studies have investigated the association of blood pressure variability with cognitive 
parameters. Cicconetti et al's (Cicconetti, 2003) study of 40 hypertensives divided into dippers 
and non-dippers did not find any difference in MMSE score or other cognitive damage between 
the two groups. Van Boxtel's analysis (van Boxtel, 1998) of 115 community living adults 
ambulatory blood pressure data concluded that reduced circadian variation was associated with 
poorer cognitive measures. The deficits were characterised by impaired memory and reduced 
processing speed. Belleli et al (Bellelli, 2002) reported an association between 24 hour 
ambulatory blood pressure variability and MMSE score. Deterioration in visual processing skills 
was associated with increased daytime short-term blood pressure variability and higher nocturnal 
blood pressure in a Japanese study of 88 older adults (Kanemaru, 2001). 
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14 Discussion 
This chapter will discuss issues surrounding data acquisition and analysis and address study 
limitations as a whole. The focus is on the cardiovascular investigations. Cardiovascular 
autonomic function testing has formed the focus of this thesis, and this discussion Nvill mainly 
examine issues around cardiovascular autonomic reflex tests, heart rate and blood pressure 
variability. Limitations of the MRI data and neuropsychometric data are treated as beyond the 
scope of this discussion for reasons of brevity. 
14.1 Recruitment 
Recruitment required a longer period than anticipated and just failed to reach the target. 
Recruitment rates were partially governed by the number recruited to the COGFAST study. Just 
over half those within COGFAST gave additional consent for the cardiovascular and MRI 
investigations. The majority of non-responders were simply participants declining to take part in 
the clinical investigations. A minority were excluded because of potential history of intraocular 
foreign body. Since there was no permission from the Ethical Committee for orbital radiographs 
to be performed (from risk of exposure to ionising radiation) all candidates recalling previous 
ocular injury from metallic objects were automatically excluded from the cardiovascular and %I RI 
investigations. All these injuries occurred in the workplace many years prior to the study and it is 
almost certain the injuries were superficial corneal abrasions but since orbital radiograph xas a 
prerequisite for MRI scanning they could not be recruited to the study. Inclusion of pennission to 
radiograph orbits in these circumstances could have enhanced recruitment rates. 
Case selection should lend caution to the application of results to the larger post-stroke population 
in the community. Only cases presenting to hospital were screened and recruited to the study. It is 
likely that patients with milder strokes do not present to secondary care. Thus conclusions on 
autonomic function in stroke survivors may not hold true in these less severe stroke cases. 
One prominent limitation of the data within this thesis is lack of information on the total number 
of stroke patients screened within each hospital database. This information was not routinely 
collected within the study and it is impossible to accurately state the total number of patients 
admitted with stroke, those surviving to three months, those suitable for inclusion and the number 
who refused to be considered for the study. It is clear the 97 participants in the cardiovascular 
substudy are a highly selected group of stroke survivors. The information on exclusions would 
assist interpretation of applicability of results to the wider population. One could assume the 
candidates who declined and were not suitable for inclusion are probably no fitter than those 
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willing to commit to hospital-based research investigations and may have higher levels of 
comorbidity. Section 5.1.5 discusses the similarities in clinical composition of this cohort and 
much larger post-stroke cohorts in epidemiological surveys. 
14.2 Clinical data acquisition 
The clinical characteristics were collapsed into binomial groups for the purposes of simplifying 
analysis. This resulted in some loss of definition of some risk factors. For the most part this was 
not of consequence, for example the very small numbers of 'not known' entries "rere collapsed 
into 'not present' categories for clinical characteristics such as hypertension or myocardial 
infarction. However identification of risk from alcohol and smoking habit could have been 
affected by collapsing details into binomial groups. Alcohol status was collapsed into non-drinker 
or drinker. 
Participants' past medical history was obtained by direct interview at the time of cardiovascular 
testing. Advantages conferred included ensuring completeness of data and avoiding retrospectiVe 
data collection. Disadvantages were possibility of recall bias and lack of clinical data to 
corroborate data in the case of uncertainty. However it has been shown that face-to-face mterview 
is a reasonably reliable method of collating clinical data in similar clinical studies (Davis T 
communication to Northern BGS Meeting 2002 regarding data collection for Rodgers et al 
(Rodgers, 2004)). For participants from the Queen EliZabeth Hospital, hospital casenotes were 
viewed as part of the COGFAST screening programme. Past medical history in those people who 
subsequently agreed to the study was noted and used to clarify any areas of uncertainty regarding 
clinical history from face-to-face interview. Casenotes were scrutinised for all study participants 
to ascertain clinical risk factors prior to stroke, to provide data in the same manner for all 
COGFAST participants. This provided a ftirther source of information if there was uncertainty 
from interview. However original information recorded in hospital notes was obtained by 
numerous medical staff, with the absence of a structured questionnaire for all cases: therefore 
data could be incomplete and interviewee response could lack consistency. Furthermore there is a 
similar risk of recall bias (perhaps higher risk for elderly patients with an acute illness) and events 
could have occurred in the intervening period between hospital admission and study participation. 
The ideal source of past clinical data is probably Primary Care casenotes but the study did not 
have Ethical Committee approval for such access. 
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14.3 Clinical study design 
Several important issues concern the general approach to our study design. Issues that may have 
limited the ability of the study to accurately record autonomic function are discussed below. Such 
limitations may have undermined the ability to detect association between dysautonorma and 
cognitive decline. As discussed above, study recruitment was slower than anticipated and had to 
stop just short of the intended target of 100 since the time limit for clinical data acquisition came 
to a close. Prevalence of atrial fibrillation further reduced the total number whose autonomic 
function could be fully assessed. It could be argued that sinus rhythm should have been a criterion 
for study inclusion. This would not have made any difference to the total number of participants 
in sinus rhythm since strenuous efforts were made to screen all candidates. The overall effect of 
excluding participants in atrial fibrillation would be to reduce numbers available for MRI 
scanning. Furthermore, it would have led to further selection of cases for MRI studies, whereas 
the main COGFAST study required a representative cohort of older stroke survivors. 
There are no similar studies on which one could perform a power calculation to inforin the study 
of number of stroke patients required to detect effects on cognitive data and white matter lesion 
from variation in autunornic function 
14.4 Finapres operation 
Cardiovascular autonomic investigation is reliant on beat-to-beat blood pressure monitoring. The 
FinapreSTm and PortapreSTMsystems used in this study are widely used and benefit from a v--ealth 
of research experience. Difficulties often appear in practice and this was our experience. In some 
STý I instances, setting up the finger cuff took 5-10 minutes because the Finapre 'ý or PortapreST" was 
unable to measure the finger arterial pressure. Joint disease, cold hands and good cuff fit were 
important limiting factors. The Finapres may not accurately reflect true blood pressure due to 
transmission of the pressure pulse along the arm arteries that distorts waveform and lo%,,, crs mean 
blood pressure. This is Particularly relevant in our cohort with high rates of systolic hypertension 
that is associated with arterial wall stiffening. Imholz's review underlines how FM'apresT'*' is 
adequate in recording average pressure across a group but lacks accuracy in individuals (Imholz, 
1998), which may have undermined power to match white matter lesion and cognitive change to 
autonomic function within individuals. 
Data quality was easily degraded by movement artifact. This was particularly true for the 
orthostatic reflex and isometric exercise tests. The frailer patients usually required some 
assistance during standing. In the course of maintaining balance on standing, upper limb 
-)8-) 
movement was common. Muscle movement interfered with RR interval and blood pressure data 
during selection of single data points for the 30: 15 ratio and systolic pressure nadir. It 'xas 
possible to overcome this pitfall for the isometric exercise by editing and appropriate selection of 
4clean' data points to obtain a representative mean blood pressure over 20 beats. 
14.5 Cardiovascular autonomic reflex tests 
Orthostasis was often difficult to perform in a timely manner for some participants. The baseline 
RR interval and blood pressure trace suggested an alerting response in some participants as well. 
it is likely such factors may have altered RR and blood response to orthostasis. This could 
potentially have altered blood pressure drop during standing which is dependent on precedirio rest 
tiine (Ten Harkel, 1990). Emotional stress or alerting response could upregulate sympathetic 
activity prior to standing. Most achieved standing balance within a reasonable time frame. 
Appliance of the RRmax. /RRmin principle (as opposed to stricter 15 th and 30'hR-R interval ratios) 
was essential to allow correct identification of heart rate maxima and minima. The initial 
intention was to adhere to Ziegler's recommended window of beats 5-25 for the minimum RR 
and 20-40 for maximum RR interval (Ziegler, 1992b). In fact some cases had RR maxima 
substantially beyond the 40 beat mark: 3 were between beat numbers 40 and 50, one at beat 53 
and one at beat number 64. It seemed valid to still include these examples since there were 
recognisable RR peaks and troughs and there is little reason to doubt they do not have the same 
underlying physiological basis as other participants. Secondly there was variance in supine-to- 
stand time which could not have been fairly represented on the 'start' marker during offline 
analysis of autonomic data. 
Valsalva manoeuvre presented its own set of difficulties. Many subjects did not understand the 
procedure during initial explanation. Attaining the 40 mmHg expiratory pressure was universally 
difficult but most subjects did achieve this target. It is difficult to quantify the overall 
performance of actual expiratory pressure and duration because there was no recording system for 
these values. In practice the following criteria needed to be met in order to include a subjects' 
Valsalva manoeuvre data; evidence that satisfactory expiratory pressure was attained, surpassing 
the 10 second expiration time, absence of excessive artifact at critical data points and most 
importantly, the presence of the expected pattern of heart rate and blood pressure fluctuation 
during Valsalva manoeuvre (Denq, 1998). Variation in expiratory pressure and duration can 
significantly affect Valsalva reflex results. It seems likely that difficulty in adhering to the 
protocol could have influenced accuracy of Valsalva ratio and systolic blood pressure overshoot 
data. 
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Isometric exercise was performed using a three minute sitting exercise. This was chosen over the 
more usual handgrip exercise which in our experience is not adequately performed by older 
subjects. The sitting position produced the required isometric stress in a manner that older 
subjects could understand and usually achieve. It certainly required isometric exercise that led to 
fatigue, which is the crucial issue in stimulating the autonomic system (Donald, 1967; Hultman 
and Sjohohn, 1982; Seals, 1988) 
Cold pressor test was surprisingly well tolerated with nearly all participants completing one 
minute of hand immersion in the iced-water bath. Most required some encouragement and 
guidance regarding remaining time for the test. This seemed only fair to improve completion 
rates, and is unlikely to substantially affect the pressor response from any emotional stress 
resulting from verbal intervention. All subjects were reassured they could discontinue the test at 
any point. The immersion time of one minute was influenced by a desire to maximise 
compliance. Two minutes of immersion is theoretically advantageous; two minutes allows 
maximal blood pressure response as a result of MSNA activity (Stancak, 1996; Victor, 1987). 
Diastolic response may have been submaximal in one minute but conditions were the same for all 
participants. Fresh ice was used in all cases but ideally temperature should be recorded to ensure 
standardisation of stimulus, which can vary according to temperature and hence alter intensity of 
cardiovascular response (Kregel, 1992; Ng, 1994). 
Metronomic respiration was successful in nearly all cases. All participants were able to follow 
instructions. The exclusions applied to individuals where non-sinus activity during metronomic 
respiration made it impossible to accurately identify peak and trough RR data points. Optimal 
position for metronomic respiration (supine or sitting) is debatable, supine is deemed satisfactorý' 
and sitting position does not offer any known performance advantage for RR interval variation 
(Ewing, 198 1; Ten Harkel, 1990). However sitting position may have improved participants 
ability to follow instructions through visual cueing and may have assisted maximal inspiration in 
participants with respiratory muscle weakness: tidal volume is known to alter heart rate vanation 
during metronomic respiration (Brown, 1993). 
14.5.1 Carotid sinus massage 
Consent to carotid sinus massage was low and there were also a number of exclusions based on 
carotid Duplex results. Therefore the number available for data analysis was low, affecting power 
to detect association. The safety of carotid sinus massage for patients with cerebrovascular 
disease is brought into question following side-effects in one case resulting from carotid sinus 
massage. 
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14.6 Heart rate variability 
The three principal components of heart rate variability, total, high and low frequency spectral 
powers did not provide any predictive power with regard to white matter lesion and 
neuropsychological outcomes. This is somewhat surprising since the technique has distinct 
advantages over the reflex tests. Five minutes of heart rate variability data theoretically reflects 
cardiac autonomic modulation over a longer period than the shorter reflex tests. Heart rate 
variability studies eliminate the need for the subject to understand and comply with correct 
procedure for reflex tests, which appears a very attractive proposition in frail older patients. The 
literature contains extensive work on the origins of spectral powers of heart rate variability, and it 
was anticipated results could inform hypotheses regarding autonomic pathology. 
In practice the complexity of heart rate variability analysis in this cohort presented some 
difficulties. Recording environment was not ideal. Quiet, temperature controlled conditions free 
of external noise and distraction are the optimal conditions (Bemardi, 2000). Our recording 
environment was close to a busy clinical area which may have led to minor noise disturbance. 
The couch was not designed with providing perfect supine resting conditions in mind and some 
patients clearly indicated they felt a little restless during the recording. There is also the issue of 
physical comorbidity and drug therapy. It seems likely these confounding factors exerted some 
influence on results. Whether these effects were sufficient to mask the natural underlying heart 
rate variation is debatable. 
As discussed in Section 4.1 , the underlying purpose of 
COGFAST at large Is the study of the 
natural history of cognitive function and neuropathological correlates thereof in older stroke 
patients. To eliminate all subjects with any cardiovascular disease or prescribed drugs in the 
cardiovascular substudy would not accurately represent this group of patients. One could argue 
that a moderate tightening of exclusion criteria may have improved the situation but case 
recruitment was sufficiently challenging without further restriction on entrants. ORUssion of drug 
therapy for a prescribed period is an attractive concept to eliminate drug confounding effects. One 
could propose any cardiovascular drug could be stopped a period of days before cardiovascular 
assessment. However this approach can also present problems. Clear instructions and perhaps 
extra manpower would be required to ensure the appropriate drugs were omitted at the correct 
time. A more serious concern is the ethical ramifications of withdrawing cardiovascular 
drugs for 
a voluntary research study. For example adequate beta-blocker withdrawal raises the possibility 
of a rebound syndrome. Wholesale anti-hypertensive withdrawal could lead to rebound 
hypertension with a risk of further cerebrovascular event (a risk that is 
difficult to quantiýy and 
-)8ý 
probably very small but still present for a group of this size and age). Omission of diuretics could 
lead to decompensation in heart failure. Overall, inclusion of patients on cardiovascular drugs in 
the study may raise concerns on their confounding effects but in practice it minimised nsk and 
disruption for participants and improved recruitment. Section 7.3 contains data indicating there 
were actually few significant differences between the stroke cohort and commuruity control group 
with regard to prevalence of confounding factors. Secondly, results of multiple regression 
analysis shown in Table 7.9 indicate differences in autonomic function bemeen these groups still 
hold true after allowing for potential confounding factors. 
Editing heart rate variability data raised further issues on the techniques' usefulness. The concept 
of power spectral analysis is reliant on sinus rhythm. Ascertaining sinus rhythm from the 12 lead 
ECG was straightforward but confirming sinus rhythm over five minutes data was often 
challenging. Non-sinus activity was frequent, usually in the form of a limited number of ectopic 
beats that were easily removed using CRISP software. Other recordings had more frequent 
ectopic data that in some instances were time-consuming to eradicate using the software and more 
rarely led to doubts on the underlying rhythm. Textbook depictions of power spectra describe 
neat, defined peaks but in practice for this cohort the power spectrum seemed often rather chaotic 
with no discernable low and high frequency peaks and the majority of the power concentrated in 
the < 0.04 Hz band. Difficult cases were discussed with senior Medical Physicists to ensure 
correct application of the technology and exclusion of unsuitable data. Despite these steps, data 
for total, high and low frequency power spectra were widely dispersed. A threshold value for 
inclusion (total HRV less than 7000 ms') was chosen, partly arbitrarily and partly after further 
review of individual data, to exclude the more extreme outliers. There appears to be little data in 
the literature to allow direct comparison of results for a group of this age and clinical description. 
Comparison with normative value is also hindered by the different hardware and software 
employed by research groups. 
The discussion in section 3.2.4 focused on the value of heart rate variability analysis to infonn 
about sympathetic and parasympathetic mechanisms. Since the low and high frequency spectral 
power were relatively small compared with the spectral power less than 0.04 Hz ( i. e. very low 
frequency), one could hypothesise the total heart rate variability data is more informative on the 
non-neural components of heart rate variability (Task Force of the European Society of 
Cardiology and the North American Society of Pacing and Electrophysiology, 1996). 
It appears that any extrapolation on cardiovascular autonomic function from the 
five minute heart 
rate variability study may have been overwhelmed by 'noise' from environmental 
issues, 
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confounding effects of drugs and comorbidity and editing process. The technique has clearly 
proved useful in other 'cleaner' cohorts, mostly as a means of detecting autonomic neuropathy in 
diabetic patients and mortality risk in ischaernic heart disease (see Section 7.4.3). It should be 
remembered there were significant differences in total and low frequency spectral powers 
compared with community living, stroke-free control cases. The absence of predictive power for 
white matter disease and neuropsychometric outcomes tends to refute the hypothesis that 
cardiovascular autonomic dysfunction will increase risk of cognitive impairment. Baroreflex 
sensitivity indices from power spectral analysis offers an attractive risk marker for white matter 
disease but also lacked any significant association with the outcomes. The smaller number of 
stroke patients with follow-up data at two years must have affected power to identify predictive 
value. It would be interesting to examine heart rate variability and baroreflex sensitivity as a 
predictor of mortality, and sufficient data to inform such a study may become apparent with 
prolonged follow-up of the cohort. Robinson et al (Robinson, 2003) concluded baroreflex 
sensitivity was useful in identifying raised mortality risk in stroke patients. Their cohort was 
slightly younger but larger (124 patients, mean age 70 years) and mortality differences were 
apparent after 4 1/2years follow-up. 
Revisions to heart rate variability methodology could improve the data quality and confidence in 
relationship to underlying autonomic activity. Inclusion criteria could be made more stringent as 
discussed above. The recording environment could be optimised by isolation in quiet 
surroundings with complete absence of distraction (Bernardi, 2000). Prolongation of the 
recording period to approximately 15 or 20 minutes would allow three or four separate blocks of 
heart rate variability and baroreflex sensitivity data that could be averaged to provide more 
accurate data. This approach has been used elsewhere (time constraints did not allow this method 
for this study) (Harrington, 2000a). Editing criteria could be set to produce strict inclusion and 
exclusion criteria. Information about dynamic autonomic behaviour could be obtained by 
incorporating autonomic challenges (Karemaker, 1997). For example five minutes of data at rest 
and normal respiratory rate could act as a baseline, metronomic respiration for five minutes can 
provide a vagal stimulus and passive tilt for five minutes could provide stimulus for sympathetic 
activity. Some may argue that respiration should be controlled in any situation of heart rate 
variability analysis (Bernardi, 2000). The logistics of adequate respiratory rate control in this type 
of older cohort remains to be seen. Finally this study has concentrated solely on the 
frequency 
domain of heart rate variability for five minutes of data. Time domain analysis of 
heart rate 
variability over longer periods (typically 24 hours) offers benefits in terms of robustness and 
proven clinical value, and also confers the ability to make direct comparison with other 
data in 
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the literature (Task Force of the European Society of Cardiology and the North Amencan Society 
of Pacing and Electrophysiology, 1996). 
14.7 Review of autonomic function after stroke 
Frank et al (Frank, 1992) anecdotally noticed reduced heart rate variability was diminished in 
patients in neurology intensive care and subsequently in an uncontrolled study demonstrated 
reduced heart rate variability during deep breathing in 27 patients with a variety of focal 
intracranial lesions. Barron et al (Barron, 1994), in a controlled study, found total heart rate 
variability significantly diminished in stroke survivors, mean age 69 years, within II days of an 
anterior circulation infarct with CT evidence of infarction. Korpelainen et al (Korpelamen, 1994) 
investigated parasympathetic mediated responses in 40 stroke patients mean age 51 years and 
found significantly impaired heart rate responses to normal and deep breathing, Valsalva 
manoeuvre and tilting in the acute phase post-stroke (2- 10 days). However at 6 months 
parasympathetic function appeared to have recovered since the only significant difference 
remained in the parasympathetic response to tilt. The same group investigated heart rate 
variability from prolonged 24 hour ECG recordings in the acute phase, and I and 6 months post- 
stroke and repeated the finding of impaired heart rate variability immediately post-stroke (31 
cases with hemispheric infarctions, mean age 52 years, compared with controls) (Korpelainen, 
1996b). Results indicate a moderate improvement in heart rate variability and sympathovagal 
balance at 6 months, but do not indicate if this was a significant change form the acute phase. 
Heart rate variability was also reduced immediately post-stroke in patients with medullary 
infarction with subsequent improvement but pontine infarction did not affect heart rate variability 
at any stage (Korpelainen, 1996a). 
Tokgozoglu et al (Tokgozoglu, 1999) performed power spectral analysis of heart rate variability 
in a controlled study of 62 patients with ischaernic stroke and concluded that stroke patients had 
significantly reduced low and high frequency HRV. In a small number of patients who died 
suddenly there was a preponderance of patients with right insula stroke involvement who also 
had 
the worst heart rate variability. It was suggested this area may be an important anatomic 
location 
in the control of autonomic tone. The autonomic response to insular stroke appears to 
be 
influenced by blood pressure: normotensive cases demonstrate more abnormal 
diurnal blood 
pressure variation, higher serum norepinephrine levels and higher rates of QTc prolongation and 
arrhythmias than hypertensive cases (Sander and Klingelhofer, 1996). 
A case-controlled study of heart rate variability during deep breathing 
in 23 stroke patients, mean 
age 59 years, found a significant reduction in RR variability limited to right sided stroke 
lesions 
"I, I's 11ý 
(Naver, 1996). Cases with left sided lesions had similar RR variability to controls and there xvas a 
significant difference between left and right sided cases. Sympathetic function ýý, as assessed by 
examining blood pressure changes during isometric exercise which did not reveal any difference 
between cases and controls nor left and right sided strokes 
Symptoms suggestive of unilateral autonomic dysfunction are common following stroke. One 
study found 43% of cases complained of coldness in the limb contra-lesional to the stroke that 
was related to skin vasomotor reflex asymmetry (Naver, 1995). A controlled study of changes in 
muscle sympathetic nerve activity during cold pressor in 8 males, mean age 58 years, found 
increased MSNA in the basal state: MSNA increased in both groups but the increase was 
attenuated in the stroke group, suggesting that post-stroke autonomic dysfunction may be caused 
by central damage leading to tonic activation of MSNA (Mizushima, 1998). 
One study indicated development of autonomic dysfunction 5 years after onset of Type 2 diabetes 
mellitus was associated with increased stroke risk, an effect which persisted after allowing for the 
influence of known cardiovascular risk factors (Toyry, 1996). 
Robinson et al (Robinson and Potter, 1997) demonstrated impaired baroreflex function in a group 
of 13 stroke patients mean age 64 years. Stroke cases did not match the increase in forearrn 
vascular resistance that occured in controls during lower body negative pressure induced 
hypotension (but did manage to mount a similar systemic blood pressure response, probably by, 
an increase in cardiac output). They speculated this effect could be due to either abnormal 
cardiopulmonary/baroreceptor mediated reflexes or impairment of the efferent vasoconstrictor 
function. In a small group of 9 stroke cases, orthostatic blood pressure control was impaired but 
there was no evidence of post-prandial hypotension compared with controls (Robinson and 
Potter, 1995). Cardiac baroreceptor sensitivity measured using the power spectral analysis 
derived alpha index was found to be significantly lower in a group of 124 ischaemic stroke 
patients (mean age 70.4 years) than controls. Additionally stroke cases with the more impaired 
baroreflex sensitivity (less than median value) had significantly poorer long-term outcome, with a 
mortality rate of 28% compared with 8% over a median follow-up of over 4 years (Robinson, 
2003). 
14.8 Summary of results 
Chapter 7 reported on differences in autonomic function in the stroke patients compared with 
stroke free control adults. Stroke patients had deficits in RR variation during metronomic 
respiration and Valsalva manoeuvre, exaggerated diastolic blood response during isometric 
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exercise and a trend towards impaired blood pressure response to Valsalva manoeu%-re. Spectral 
powers of total and low frequency heart rate variability were reduced in stroke cases, who also 
had impaired baroreflex sensitivity in the low frequency range. This makes a significant addition 
to the literature. To the author's knowledge, this is one of the oldest post-stroke groups in whom 
autonomic function has been investigated and one of very few to be studied at a time distant from 
incident stroke. The studies detailed above show that autonomic function is impaired in the acute 
aftermath of stroke. Our results indicate autonomic function is impaired in older stroke patients 
and these deficits persist following stroke recovery. Mizushima et al's (Mizushima, 1998) 
identification of abnormal MSNA following stroke could explain the exaggerated blood pressure 
response we observed during isometric exercise. We have also recorded impaired vagal function 
similar to Korpelainen et al (Korpelainen, 1996a; Korpelainen, 1996b; Korpelainen, 1994) but in 
our cohort the deficit persists long after resolution of the stroke. 
14.8.1 Cardiovascular autonomic reflex tests 
There was little evidence to support the hypothesis that autonomic dysfunction is associated with 
white matter lesions and cognitive decline. There was no correlation between autonomic function 
and baseline cortical white matter lesion volume. It is noteworthy that the few weak associations 
between autonomic function and neuropsychometric tests occurred with the autonomic indices 
that were abnormal in the stroke group. From results in section 7.3, it is assumed the exaggerated 
diastolic blood pressure response to isometric exercise is abnormal, as suggested by others Le. the 
stroke group had the abnormally elevated diastolic response and it was not a case of the controls 
having an abnormally suppressed response (Mathias and Bannister, 1999). Higher diastolic 
response in isometric exercise was associated with poorer attention score and number vigilance 
time. It is suggested that hypertension is the cause of exaggerated isometric exercise response 
(Mathias and Bannister, 1999) and previous work has shown that hypertension is associated with 
deterioration in subcortical function (Harrington, 2000b). However the abnormal isometric 
exercise response in the stroke group appears to occur independently of elevated blood pressure 
(Table 7.9). Discussion in section 3.1.4.1 of isometric exercise neural substrate highlights the 
various components of blood pressure response over three minutes, with sympathetic muscle 
sympathetic nerve activity playing a dominant role. Baroreflex function will normally control the 
extent of blood pressure elevation. It is hypothesised that the defective baroreflex sensitivity 
allows undamped blood pressure rise in older stroke patients. This could lead to small vessel 
damage in the white matter, and account for the abnormal subcortical cognitive 
function. 
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Consistent with this hypothesis is the association of better high frequency baroreflex sensitivity 
with quicker choice reaction time and fluctuation time. 
Longitudinal data did not provide strong evidence of an association between autonomic 
dysfunction and subsequent white matter lesion increase and cognitive decline. The analyses in 
Chapters 12 and 13 involve multiple significance testing therefore the few significant associations 
need to be interpreted with caution. Furthermore there were no autonomic correlates of white 
matter disease progression, which conflicts with the above hypothesis where autonomic indices 
were associated with CAMCOG scores and CDR times. 
Higher Valsalva ratio was associated with better total CAMCOG score and numbervigilance 
time at year 2. Therefore better vagal responsiveness links with higher global cognitive score and 
measures of attention. Choice reaction time is one of the more consistent indices on the CDR 
battery, reflecting attention and concentration skills. Quicker choice reaction time at year I of 
neuropsychometric follow-up was associated with better systolic blood pressure response during 
Valsalva manoeuvre, which is a measure of intact sympathetic function (with a contribution form 
vagal activity). Participants with the higher blood pressure overshoot also performed better on the 
CAMCOG executive subscore at year 2 (but not year 1). RR and blood pressure response to 
Valsalva manoeuvre seems to be the autonomic test with most evidence of an association with 
cognitive function from these investigations. Reasons why this may have occurred include the 
larger test range for Valsalva ratio compared with RR variation during orthostasis and 
metronomic respiration. Thus the Valsalva ratio has more power to identify normal and abnormal 
autonomic function. Secondly the Valsalva manoeuvre was performed on three occasions with 
the largest value of three (for ratio and systolic overshoot) used for data purposes. Hence three 
tests improved the likelihood of a participant providing the optimal response to the autonomic 
stimulus, whereas other tests were performed once and therefore prone to interindividual 
variation. 
Returning to the theme of exaggerated isometric blood pressure response in the stroke group, the 
tests' potential role as a marker of adverse outcome is strengthened by the association with 
prolonged choice reaction time at year one of follow-up. 
14.8.2 Power spectral analysis 
There was no strong evidence of spectral powers of heart rate variability acting as marker of 
white matter lesion and cognitive outcomes. Low and high frequency spectral powers were 
significantly associated with CAMCOG attention subscore at year 2 only, 
but the regression 
291 
coefficient indicated this relationship was a shallow slope. There were no other significant 
associations as hypothesised for heart rate variability and baroreflex sensitiý, ity. But there was a 
significant association between increasing high frequency power and prolonged number vigilance 
and choice reaction at year 2. This result is contrary to expectations and one suspects this is a 
chance finding. 
14.8.3 Blood pressure variability 
One of the main findings from this investigation is the ability for systolic blood pressure 
variability to independently predict cortical white matter lesion volume. Twenty-four hour and 
daytime systolic blood pressure variability were both significant predictor variables in a 
regression model for cross-sectional white matter lesion volume. This is similar to results from 
previous studies (Mancia, 2001; Mancia, 1996; Sander, 2000a). Our results extend this 
association to an older post-stroke cohort. The mechanism underlying excessive blood pressure 
variation may include cardiovascular autonomic dysfunction (Kario, 1997; Kohara, 1995; 
Pickering, 1990; Vagaonescu, 2000). Increased blood pressure variability is closely linked to 
impaired baroreflex. sensitivity, which has also been demonstrated in our cohort (section 7.3) 
(Mancia, 1986; Watson, 1980). Another issue linking increased blood pressure variability and 
end-organ damage is that abnormal blood pressure variability persists even after treatment of 
hypertension, therefore increased variability may be a surrogate marker of significant midlife 
hypertension (Mancia, 1989). 
The strength of the cross-sectional association meant the lack of longitudinal association for 
white matter lesion progression and cognitive decline was surprising given the reasonably strong 
hypothesis. In terms of methodology, there were some limitations in ambulatory blood pressure 
data acquisition. Sampling frequency was 30 minutes in the daytime and hourly overnight, in 
order to maximise participant tolerance. However optimal ambulatory blood pressure sampling is 
thought to be a minimum of every 20 minutes. Slower frequencies diminish repeatability and 
weaken the association between ambulatory non-continuous recordings and intra-arterial 
blood 
Pressure variability (Bevan, 1969; di Rienzo, 1983; Palatini, 1994). Therefore our method may 
have weakened the ability to accurately measure blood pressure variability and reduce power to 
predict outcomes. The minimum data set required for ambulatory blood pressure recording was 
relatively low at 15 within 24 hours. This mirrored the minimum requirement 
for the International 
Database survey but did not meet more stringent standards from other sources which range 
from 
21 to 72 measurements within 24 hours (O'Brien, 2000; Sega, 2002). In a similar manner 
the 
number of measurements obtained in the night-time phase was set at the 
bare minimum and the 
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relatively low mean number of night-time blood pressure values may have impaired abilitv to 
accurately defme circadian variation in ambulatory blood pressure. Pulse pressure did not seem to 
hold any predictive value for white matter lesions or cognitive outcomes. This concurs with 
themes emerging from studies in the last 20 years which indicate that pulse pressure is not a 
consistent risk marker for cerebrovascular events (Amery, 1985; Benetos, 1997). 
Simple mean blood pressure levels carried some predictive power for adverse outcomes although 
not as many as one might anticipate. Mean diastolic blood pressure was an independent predictor 
of cortical white matter lesion volume on baseline MRI scan. Mean systolic and diastolic blood 
pressure were associated with reduced executive subscore on the baseline CAMCOG assessment. 
Harrington et al (Harrington, 2000b) is just one study that identified reduced central processing 
speed in older hypertensive patients using the same CDR battery featured in this study. 
Hypertension is a clear risk factor for cerebrovascular disease so these findings are not 
unexpected. 
Diurnal variation in blood pressure did not reveal many significant associations with outcomes 
apart from the link between increased nocturnal dip and lower CAMCOG score. Consideration is 
also given to other results - higher mean night-time diastolic pressure was associated with 
reduced rate of white matter lesion progression, and higher mean systolic pressure was associated 
with better CAMCOG executive subscores. Therefore in certain situations a higher blood 
pressure may be preferable to improve cerebral perfusion and avoid white matter ischaernia. This 
hypothesis is probably most relevant to higher night-time diastolic pressure which will reduce the 
percentage circadian variation of blood pressure. Large drop in blood pressure overnight is 
theoretically poorly tolerated by impaired baroreflex sensitivity. 
14.9 Further studies 
A small number of significant associations between RR interval and blood pressure variability 
with white matter lesions and cognitive impairment does provide some limited support for the 
hypotensive-ischaernic theory of subcortical ischaernic vascular dementia. The hypothesis has 
gathered much attention and further work is required to clarify the role of cardiovascular risk 
factors in the pathogenesis of white matter disease (Ferro and Madureira, 2002; O'Brien, 2003; 
Roman, 2002). The cardiovascular autonomic reflex tests and power spectral analysis of heart 
rate variability have not demonstrated strong and consistent links with the outcomes under 
investigation. Limitations of the reflex tests in the elderly appear to restrict usefulness 
but 
investigation of a younger age group may uncover a role in cerebral ischaernia. 
Strength of 
autonomic tests as reliable risk markers could also be enhance by repeated measures of the reflex 
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tests. Cerebral autoregulation is an attractive risk marker in the hypothesis and this has not been 
addressed in this study. Future studies combining cardiovascular autonomic reflexes and cerebral 
autoregulatory function could determine which plays the key role in pathogenesis of white matter 
disease. Ambulatory blood pressure is clearly an important risk marker that also has relevance for 
current clinical practice. Studies evaluating treatment of abnormal long term variability of 
ambulatory blood pressure will prove valuable as this parameter emerges as a potent predictor of 
adverse outcome. Finally a longer interval for brain imaging and cognitive assessment may 
uncover more pronounced structural and functional changes in older stroke patients that are 
related to perturbation of heart rate and blood pressure variability. 
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